<SEC-DOCUMENT>0001213900-26-003169.txt : 20260112
<SEC-HEADER>0001213900-26-003169.hdr.sgml : 20260112
<ACCEPTANCE-DATETIME>20260112084019
ACCESSION NUMBER:		0001213900-26-003169
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20260109
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260112
DATE AS OF CHANGE:		20260112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ondas Holdings Inc.
		CENTRAL INDEX KEY:			0001646188
		STANDARD INDUSTRIAL CLASSIFICATION:	RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39761
		FILM NUMBER:		26524847

	BUSINESS ADDRESS:	
		STREET 1:		222 LAKEVIEW AVENUE
		STREET 2:		SUITE 800
		CITY:			WEST PALM BEACH
		STATE:			FL
		ZIP:			33401
		BUSINESS PHONE:		6314187044

	MAIL ADDRESS:	
		STREET 1:		222 LAKEVIEW AVENUE
		STREET 2:		SUITE 800
		CITY:			WEST PALM BEACH
		STATE:			FL
		ZIP:			33401

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZEV VENTURES INC.
		DATE OF NAME CHANGE:	20150624
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0272419-8k_ondas.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ONDS="http://ondas.com/20260109">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_ONDS_ondas.com_20260109 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20260109_20260109 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0001646188 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000004" name="dei:EntityCentralIndexKey">0001646188</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="onds-20260109.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-01-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001646188</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-01-09</xbrli:startDate>
        <xbrli:endDate>2026-01-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90C_edei--DocumentType_c20260109__20260109_zkRc5Ptg2KC7"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)
<b><span id="xdx_903_edei--DocumentPeriodEndDate_c20260109__20260109_zWYNEgavou1e"><ix:nonNumeric contextRef="AsOf2026-01-09" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">January 9, 2026</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90B_edei--EntityRegistrantName_c20260109__20260109_zyJ8GdCNhJu3"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000011" name="dei:EntityRegistrantName">Ondas Holdings Inc.</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20260109__20260109_zCiVFxAsNNpa"><ix:nonNumeric contextRef="AsOf2026-01-09" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20260109__20260109_zww1Ek5FteW4"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000013" name="dei:EntityFileNumber">001-39761</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityTaxIdentificationNumber_c20260109__20260109_zkF7hbGTtBh2"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000014" name="dei:EntityTaxIdentificationNumber">47-2615102</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or other jurisdiction<br/>
of incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(IRS Employer<br/>
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_902_edei--EntityAddressAddressLine1_c20260109__20260109_zWvsmOXj3xsd"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000015" name="dei:EntityAddressAddressLine1">222 Lakeview Avenue</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressAddressLine2_c20260109__20260109_zOGS2e3HRm41"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 800</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressCityOrTown_c20260109__20260109_zxC5iopRNc4c"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000017" name="dei:EntityAddressCityOrTown">West Palm
Beach</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20260109__20260109_zW9M6bqFxLJ2"><ix:nonNumeric contextRef="AsOf2026-01-09" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Florida</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20260109__20260109_zjkjwjMeASO5"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000019" name="dei:EntityAddressPostalZipCode">33401</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code <b>(<span id="xdx_909_edei--CityAreaCode_c20260109__20260109_z1rsWiYfxs8j"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000020" name="dei:CityAreaCode">888</ix:nonNumeric></span>) <span id="xdx_90D_edei--LocalPhoneNumber_c20260109__20260109_zw4g8hnRLdn6"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000021" name="dei:LocalPhoneNumber">350-9994</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">N/A</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--WrittenCommunications_c20260109__20260109_zmvQUT9Bpc6j"><ix:nonNumeric contextRef="AsOf2026-01-09" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SolicitingMaterial_c20260109__20260109_zdseV1MYepPi"><ix:nonNumeric contextRef="AsOf2026-01-09" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20260109__20260109_z2p8am3wLp9b"><ix:nonNumeric contextRef="AsOf2026-01-09" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20260109__20260109_z8lNfGgT9UZg"><ix:nonNumeric contextRef="AsOf2026-01-09" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol</b></span></td>
    <td style="width: 2%; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20260109__20260109_zGUY4XrgmzB6"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000026" name="dei:Security12bTitle">Common Stock par value $0.0001</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20260109__20260109_zqopVZpB7UNf"><ix:nonNumeric contextRef="AsOf2026-01-09" id="Fact000027" name="dei:TradingSymbol">ONDS</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The <span id="xdx_909_edei--SecurityExchangeName_c20260109__20260109_zjwHSFz03lc9"><ix:nonNumeric contextRef="AsOf2026-01-09" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20260109__20260109_zyFy0fGwaXob"><ix:nonNumeric contextRef="AsOf2026-01-09" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by checkmark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
January 9, 2026, Ondas Holdings Inc. (the &#8220;Company&#8221; or &#8220;Ondas&#8221;) entered into a placement agent agreement (the
&#8220;Placement Agent Agreement&#8221;) with Oppenheimer &amp; Co. Inc., as representative of the placement agents named in Schedule
I thereto (the &#8220;Placement Agents&#8221;), relating to the Company&#8217;s offering (the &#8220;Offering&#8221;) of (i) 19,000,000
shares (the &#8220;Shares&#8221;) of Company common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;), or (ii) in lieu of
Common Stock, pre-funded warrants (the &#8220;Pre-Funded Warrants,&#8221; together with the Shares, the &#8220;Common Stock Equivalents&#8221;)
to purchase up to 41,790,274 shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;). The Common Stock Equivalents were accompanied
by warrants (the &#8220;Common Warrants,&#8221; together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;) to purchase a total
of 121,580,548 shares of Common Stock (the &#8220;Common Warrant Shares,&#8221; together with the Pre-Funded Warrant Shares, the &#8220;Warrant
Shares&#8221;). The Common Stock Equivalents with the accompanying Common Warrants are being sold pursuant to the terms of a Securities
Purchase Agreement, dated January 9, 2026 (the &#8220;Securities Purchase Agreement&#8221;), by and between the Company and each investor
listed on the Schedule of Buyers attached thereto (the &#8220;Investor&#8221;) in connection with this Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Shares and Warrants shall be offered, issued, and sold pursuant to a prospectus supplement and accompanying prospectus that form part
of an effective shelf registration statement on Form S-3ASR (File No. 333-290121), which was filed with the Securities and Exchange Commission
(the &#8220;SEC&#8221;) and automatically became effective upon filing on September 9, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Offering price for (i) each Share and accompanying Common Warrant to purchase two (2) shares of Common Stock was $16.45 and (ii) each
Pre-Funded Warrant and accompanying Common Warrant to purchase two (2) shares of Common Stock was $16.45 (with all but a nominal exercise
price of $0.0001 per share prepaid as of the issuance date). The Pre-Funded Warrants are immediately exercisable and will expire seven
years from the date of issuance. The Common Warrants have an exercise price of $28.00 per share, are immediately exercisable and will
expire seven years from the date of issuance. The net proceeds to the Company from the Offering are approximately $959.2 million, after
deducting placement agent fees and estimated offering expenses payable by the Company and excluding any proceeds that may be received
from the exercise of the Warrants. If the Common Warrants are fully exercised on a cash basis, the Company has the potential to raise
approximately $3.4 billion in additional gross proceeds. No assurance can be given that any of the Common Warrants will be exercised.
The Company intends to use the net proceeds of the Offering for corporate development and strategic growth, including acquisitions, joint
ventures and investments. The Offering is expected to close on or about January 12, 2026, subject to the satisfaction of customary closing
conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Placement Agent Agreement includes customary representations, warranties, and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company and the Placement Agents, including for liabilities under the Securities Act of 1933, as amended,
other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Placement
Agent Agreement were made only for purposes of such Placement Agent Agreement and as of specific dates, were solely for the benefit of
the parties to the Placement Agent Agreement and were subject to limitations agreed upon by the contracting parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Securities Purchase Agreement provides that the obligations of the Investor is subject to certain conditions precedent, including, among
other things, the absence of any material adverse change in the Company's business and the receipt of customary opinions and closing certificates.
The Company established the price following negotiations with prospective investors and with reference to the prevailing market price
of the Common Stock, recent trends in such price and other factors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
foregoing summaries of the Securities Purchase Agreement, Placement Agent Agreement, Common Warrant and Pre-Funded Warrant do not purport
to be complete and are subject to, and qualified in their entirety by, such documents attached as Exhibits 10.1, 10.2, 4.1 and 4.2, respectively,
to this Current Report on Form 8-K (the &#8220;Form 8-K&#8221;), which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A
copy of the opinion of Akerman LLP relating to the legality of the issuance and sale of the Warrants is attached as Exhibit 5.1 hereto.
A copy of the opinion of Snell &amp; Wilmer L.L.P. relating to the legality of the issuance and sale of the Shares and the Warrant Shares
is attached as Exhibit 5.2 hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
January 9, 2026, the Company issued a press release announcing the pricing of the Offering. The press release is attached as Exhibit 99.1
to this Form 8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; padding-left: 10pt; text-align: justify; text-indent: -10pt"><span style="font-size: 10pt">(d)</span></td>
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt">Exhibits</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 9%; text-align: justify"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%; text-align: justify"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">4.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027241901ex4-1_ondas.htm"><span style="font-size: 10pt">Form of Common Warrant.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">4.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027241901ex4-2_ondas.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">5.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027241901ex5-1_ondas.htm"><span style="font-size: 10pt">Opinion of Akerman LLP.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">5.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027241901ex5-2_ondas.htm"><span style="font-size: 10pt">Opinion of Snell &amp; Wilmer L.L.P.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027241901ex10-1_ondas.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement, dated January 9, 2026 by and between Ondas Holdings Inc. and each investor listed on the Schedule of Buyers attached thereto.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">10.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027241901ex10-2_ondas.htm"><span style="font-size: 10pt">Placement Agent Agreement, dated January 9, 2026, between Ondas Holdings Inc. and Oppenheimer &amp; Co. Inc., as representative of the placement agents named in Schedule I thereto.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">23.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027241901ex5-1_ondas.htm"><span style="font-size: 10pt">Consent of Akerman LLP (included in Exhibit 5.1).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">23.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027241901ex5-2_ondas.htm"><span style="font-size: 10pt">Consent of Snell &amp; Wilmer L.L.P. (included in Exhibit 5.2).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">99.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027241901ex99-1_ondas.htm"><span style="font-size: 10pt">Press Release, dated January 9, 2026.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">104</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Forward Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Statements made in this Current
Report on Form 8-K that are not statements of historical or current facts are &#8220;forward-looking statements&#8221; within the meaning
of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the intended use of net proceeds
of the offering and the exercise of the Common Warrants prior to their expiration. We caution readers that forward-looking statements
are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance
and are subject to risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties relate, among other
things, to fluctuations in our stock price and changes in market conditions. Our actual results, performance, or achievements could differ
materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including the risks discussed
under the heading &#8220;Risk Factors&#8221; discussed under the caption &#8220;Item 1A. Risk Factors&#8221; in Part I of our most recent
Annual Report on Form 10-K or any updates discussed under the caption &#8220;Item 1A. Risk Factors&#8221; in Part II of our Quarterly
Reports on Form 10-Q and in our other filings with the SEC. We undertake no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise that occur after that date, except as required by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: January 12, 2026</span></td>
    <td colspan="2"><span style="font-size: 10pt">ONDAS HOLDINGS INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%"><span style="font-size: 10pt">/s/ Eric A. Brock</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Eric A. Brock</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LLOboLJHh4o4RcYQX4vLpLg1I61TP8m/tNsQQyAk955cISZiSxtdI8NllWdQYNPWyiHkWCGjuaJ3pLt9An7meNPWsTJuWH9gSp5Bz8zDmfL3wdlpi2UCMppGchrPQS6TeAGngwh6PSVT6RKN06oGZUo4MbWs0Sl+jx8K9SJDzXtIOiNbTSaBKJSj/IFYRjEcqVNP4ruFLEtFMBkqEFumR+td65dD05OwrrHxcXak/x18AcvTSl0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea027241901ex4-1_ondas.htm
<DESCRIPTION>FORM OF COMMON WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 4.1</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Ondas Holdings Inc.</B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Form
of Warrant To Purchase Common Stock</B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant No.: [&nbsp;&nbsp;&nbsp;&nbsp;  ]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Number of Shares of Common Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date of Issuance: January 12, 2026 (&ldquo;<B>Issuance Date</B>&rdquo;)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Ondas Holdings Inc., a
company organized under the laws of State of Nevada (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged<FONT STYLE="text-transform: uppercase">,</FONT> [
&nbsp;&nbsp; ], the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the
terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times
on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below),
[&nbsp;&nbsp;&nbsp; ] fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein
(the &ldquo;<B>Warrant Shares</B>&rdquo;). Except as otherwise defined herein, capitalized terms in this Warrant to purchase Common
Stock (including any Warrants to purchase Common Stock issued in exchange, transfer or replacement hereof, this
&ldquo;<B>Warrant</B>&rdquo;), shall have the meanings set forth in Section 11. This Warrant is one of the Warrants to purchase
Common Stock (the &ldquo;<B>Warrants</B>&rdquo;) issued pursuant to (i) Section 1 of that certain Securities Purchase Agreement,
dated as of January 9, 2026 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among the Company and the investors (the
&ldquo;<B>Buyers</B>&rdquo;) referred to therein, as amended from time to time (the &ldquo;<B>Securities Purchase
Agreement</B>&rdquo;), (ii) the Company&rsquo;s Registration Statement on Form S-3ASR (File No. 333-290121) (the
&ldquo;<B>Registration Statement</B>&rdquo;) and (iii) the Company&rsquo;s prospectus supplement dated as of January [&nbsp;&nbsp;&nbsp; ], 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.   <U>EXERCISE
OF WARRANT.</U></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>Mechanics
of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(e)),
this Warrant may be exercised by the Holder at any time or times on or after the Issuance Date (an &ldquo;<B>Exercise Date</B>&rdquo;),
in whole or in part, by delivery (whether via electronic mail or otherwise) of a written notice, in the form attached hereto as <U>Exhibit
A</U> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. Within one (1) Trading Day
following the delivery of the Exercise Notice, the Holder shall make payment to the Company of an amount equal to the Exercise Price in
effect on the date of such exercise multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the &ldquo;<B>Aggregate
Exercise Price</B>&rdquo;) in cash by wire transfer of immediately available funds or, if the provisions of Section 1(d) are applicable,
by notifying the Company pursuant to the Exercise Notice that this Warrant is being exercised pursuant to a Cashless Exercise (as defined
in Section 1(d)). Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have the same
effect as cancellation of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of
Warrant Shares and the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within five (5) Trading Days of the date on which the final Exercise Notice has been delivered
to the Company. On or before the first (1<SUP>st</SUP>) Trading Day following the date on which the Holder has delivered the applicable
Exercise Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation of receipt of the Exercise Notice, in
the form attached to the Exercise Notice, to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;).
So long as the Holder delivers the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) on or prior to the first
(1<SUP>st</SUP>) Trading Day following the date on which the Exercise Notice has been delivered to the Company, then on or prior to the
number of Trading Days comprising the Standard Settlement Period following the date on which the Exercise Notice has been delivered to
the Company, or, if the Holder does not deliver the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) on or prior
to the first (1<SUP>st</SUP>) Trading Day following the date on which the Exercise Notice has been delivered to the Company, then on or
prior to the date on which the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) is delivered (such earlier date,
or if later, the earliest day on which the Company is required to deliver Warrant Shares pursuant to this Section 1(a), the &ldquo;<B>Share
Delivery Date</B>&rdquo;), the Company shall (X) provided that the Transfer Agent is participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;)
Fast Automated Securities Transfer Program (&ldquo;<B>FAST</B>&rdquo;), credit such aggregate number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal
At Custodian system, or (Y) if the Transfer Agent is not participating in the FAST, issue and dispatch by overnight courier to the address
as specified in the Exercise Notice, a certificate or evidence of a credit book entry of shares, registered in the name of the Holder
or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise. The Company shall be responsible
for all fees and expenses of the Transfer Agent and all fees and expenses with respect to the issuance of Warrant Shares via DTC, if any,
including without limitation for same day processing. On the Share Delivery Date, the Holder shall be deemed for all corporate purposes
to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date
such Warrant Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the certificates evidencing such Warrant
Shares, as the case may be; provided, that the Holder shall be deemed to have waived any voting rights of any such Warrant Shares that
may arise with respect to the period commencing on such Exercise Date, through, and including, such applicable Share Delivery Date, as
necessary, such that the aggregate voting rights of any shares of Common Stock (including such Warrant Shares) beneficially owned by the
Holder and/or any Attribution Parties, collectively, on any such date of determination shall not exceed the Maximum Percentage (as defined
below) as a result of any such exercise of this Warrant. If this Warrant is physically delivered to the Company in connection with any
exercise pursuant to this Section 1(a) and the number of Warrant Shares represented by this Warrant submitted for exercise is greater
than the number of Warrant Shares being acquired upon an exercise, then the Company shall as soon as practicable and in no event later
than three (3) Trading Days after any exercise and at its own expense, issue and deliver to the Holder (or its designee) a new Warrant
(in accordance with Section 7(b)) representing the right to purchase the number of Warrant Shares issuable immediately prior to such exercise
under this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised. No fractional Warrant Shares are
to be issued upon the exercise of this Warrant, but rather the number of Warrant Shares to be issued shall be rounded down to the nearest
whole number. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or any incidental expense
in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares
shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that, in the event
that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be
accompanied by the Assignment Form attached hereto as <U>Exhibit B</U> duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. Subject to the foregoing, the Holder
shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant
Shares upon exercise hereof, including any United States withholding taxes imposed on any dividends or deemed dividends, and the Company
shall be entitled to withhold such tax liability from shares of Common Stock, sales proceeds subsequently paid or credited, or other amounts
payable or distributable to the relevant Holder as required by applicable law. The Company will not close its shareholder books or records
in any matter that prevents the timely exercise of this Warrant, pursuant to the terms hereof. The Company&rsquo;s obligations to issue
and deliver Warrant Shares in accordance with the terms and subject to the conditions hereof are absolute and unconditional, irrespective
of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery
of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination;
<U>provided</U>, <U>however</U>, that the Company shall not be required to deliver Warrant Shares with respect to an exercise prior to
the Holder&rsquo;s delivery of the Aggregate Exercise Price (or notice of a Cashless Exercise) with respect to such exercise. <B>The Holder
and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>Exercise
Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $28.00 per share, subject to adjustment as provided
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)   <U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. If either (I) the Company shall fail for any reason or for no reason to issue or credit, as
the case may be, to the Holder on or prior to the applicable Share Delivery Date, if (x) the Transfer Agent is not participating in the
FAST, a certificate or evidence of a book-entry credit for the number of shares of Common Stock to which the Holder is entitled and register
such Common Stock on the Company&rsquo;s share register or (y) the Transfer Agent is participating in the FAST, to credit the Holder&rsquo;s
balance account with DTC, for such number of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise of
this Warrant or (II) a registration statement (which may be the Registration Statement) covering the issuance or resale of the Warrant
Shares that are the subject of the Exercise Notice (the &ldquo;<B>Exercise Notice Warrant Shares</B>&rdquo;) is not available for the
issuance or resale, as applicable, of such Exercise Notice Warrant Shares and (x) the Company fails to promptly, but in no event later
than one (1) Business Day after such registration statement becomes unavailable, to so notify the Holder and (y) the Company is unable
to deliver the Exercise Notice Warrant Shares electronically without any restrictive legend by crediting such aggregate number of Exercise
Notice Warrant Shares to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian
system (the event described in the immediately foregoing clause (II) is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo;
and together with the event described in clause (I) above, an &ldquo;<B>Exercise Failure</B>&rdquo;), then, in addition to all other remedies
available to the Holder, if on or prior to the applicable Share Delivery Date either (I) if the Transfer Agent is not participating in
the FAST, the Company shall fail to issue and deliver a certificate or evidence of a book-entry credit to the Holder and register such
shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating in the FAST, credit the Holder&rsquo;s
balance account with DTC for the number of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder
or pursuant to the Company&rsquo;s obligation pursuant to clause (ii) below or (II) if a Notice Failure occurs, and, in each case, if
after such date the Holder is required by its broker to acquire (in an open market transaction, stock loan or otherwise) or the Holder&rsquo;s
brokerage firm otherwise acquires, shares of Common Stock corresponding to all or any portion of the number of shares of Common Stock
issuable upon such exercise which the Holder anticipated receiving upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company
shall, within five (5) Trading Days after the Holder&rsquo;s request, (A) pay in cash to the Holder the amount, if any, by which (x) the
Holder&rsquo;s total purchase price (including customary brokerage commissions, stock loan costs and other out-of-pocket expenses, if
any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that
the Company was required to deliver to the Holder in connection with the exercise at issue times and (2) the price at which the sell order
giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant
and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded)
or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise
and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover
a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms
hereof. The Company&rsquo;s current transfer agent participates in the FAST. In the event that the Company changes transfer agents while
this Warrant is outstanding, the Company shall select a transfer agent that participates in FAST. While this Warrant is outstanding, the
Company shall cause its transfer agent to participate in FAST with respect to this Warrant. In addition to the foregoing rights, (i) if
the Company fails to deliver the applicable number of Warrant Shares upon an exercise pursuant to Section 1 by the applicable Share Delivery
Date, then the Holder shall have the right to rescind such exercise in whole or in part and retain and/or have the Company return, as
the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the rescission
of an exercise shall not affect the Company&rsquo;s obligation to make any payments that have accrued prior to the date of such notice
pursuant to this Section 1(c) or otherwise, and (ii) if a registration statement (which may be the Registration Statement) covering the
issuance or resale of the Warrant Shares that are subject to an Exercise Notice is not available for the issuance or resale, as applicable,
of such Exercise Notice Warrant Shares and the Holder has submitted an Exercise Notice prior to receiving notice of the non-availability
of such registration statement and the Company has not already delivered the Warrant Shares underlying such Exercise Notice electronically
without any restrictive legend by crediting such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise
to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian system, the Holder
shall have the option, by delivery of notice to the Company, to (x) rescind such Exercise Notice in whole or in part and retain or have
returned, as the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that
the rescission of an Exercise Notice shall not affect the Company&rsquo;s obligation to make any payments that have accrued prior to the
date of such notice pursuant to this Section 1(c) or otherwise, and/or (y) switch some or all of such Exercise Notice from a cash exercise
to a Cashless Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)   <U>Cashless
Exercise</U>. If at the time of exercise hereof, there is no effective registration statement, or the prospectus contained therein is
not available for the issuance or resale of the Warrant Shares to or by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; (a &ldquo;<B>Cashless Exercise</B>&rdquo;) in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing (A-B) * (X) by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD>
    <TD STYLE="width: 0.25in; text-align: left">A</TD>
    <TD STYLE="width: 0.25in">=</TD><TD STYLE="text-align: justify">as applicable, (i) the VWAP (as defined herein) on the Trading
Day immediately preceding the date of the applicable Exercise Notice if such Exercise Notice is (1) both executed and delivered pursuant
to Section 1(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 1(a) hereof on a Trading
Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(88) of Regulation NMS promulgated under the
federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding
the date of the applicable Exercise Notice or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg
as of the time of the Holder&rsquo;s execution of the applicable Exercise Notice if such Exercise Notice is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 1(a) hereof or (iii) the VWAP on the date of the applicable
Exercise Notice if the date of such Exercise Notice is a Trading Day and such Exercise Notice is both executed and delivered pursuant
to Section 1(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD>
    <TD STYLE="width: 0.25in">B</TD><TD STYLE="width: 0.25in; text-align: left">=</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD>
    <TD STYLE="width: 0.25in">X</TD><TD STYLE="width: 0.25in; text-align: left">=</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If Warrant Shares are issued
in such a cashless exercise, the Company acknowledges and agrees that in accordance with Section 3(a)(9) of the Securities Act of 1933,
as amended, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to
take any position contrary to this Section 1(d).<FONT STYLE="background-color: white">&nbsp;</FONT>Without limiting the rights of a Holder
to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to receive the cash payments contemplated pursuant to Sections 1(c)
and 3(b), in no event will the Company be required to net cash settle a Warrant exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e) <U>Beneficial
Ownership</U>. Notwithstanding anything to the contrary contained herein, the Company shall not effect the exercise of any portion
of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the terms and
conditions of this Warrant and any such exercise shall be null and void and treated as if never made, to the extent that after
giving effect to such exercise, the Holder together with the other Attribution Parties collectively would beneficially own in excess
of the Maximum Percentage (as defined below). For purposes of the foregoing sentence, the aggregate number of shares of Common Stock
beneficially owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock held by the
Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which the determination of such sentence is being made, but shall exclude the number of shares of Common Stock which
would be issuable upon (A) exercise of the remaining, unexercised portion of this Warrant beneficially owned by the Holder or any of
the other Attribution Parties and (B) exercise or conversion of the unexercised or unconverted portion of any other securities of
the Company (including, without limitation, any convertible notes or convertible preferred stock or warrants, including the other
Warrants) beneficially owned by the Holder or any other Attribution Party subject to a limitation on conversion or exercise
analogous to the limitation contained in this Section 1(e). For purposes of this Section 1(e), beneficial ownership shall be
calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;). In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Warrant, in determining
the number of outstanding shares of Common Stock the Holder may acquire upon the exercise of this Warrant without exceeding the
Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company&rsquo;s
most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q or other public filing with the Securities and Exchange
Commission (the &ldquo;<B>SEC</B>&rdquo;), as the case may be, (y) a more recent public announcement by the Company or (z) any other
written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding (the
&ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If the Company receives an Exercise Notice from the Holder at a time when
the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall (i)
notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Exercise Notice
would otherwise cause the Holder&rsquo;s beneficial ownership, as determined pursuant to this Section 1(e), to exceed the Maximum
Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be acquired pursuant to such Exercise Notice
(the number of shares by which such purchase is reduced, the &ldquo;<B>Reduction Shares</B>&rdquo;) and (ii) as soon as reasonably
practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction Shares. For any reason
at any time, upon the written or oral request of the Holder, the Company shall within one (1) Business Day confirm orally and in
writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
Company, including this Warrant, by the Holder and any other Attribution Party since the date as of which the Reported Outstanding
Share Number was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results in the
Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the
number of outstanding shares of Common Stock (as determined under Section 13(d) of the Exchange Act), the number of shares so issued
by which the Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds the Maximum Percentage
(the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not
have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares
has been deemed null and void, the Company shall return to the Holder the Exercise Price paid by the Holder for the Excess Shares.
The Maximum Percentage shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the
issuance of shares of Common Stock issuable upon exercise of this Warrant (the &ldquo;<B>Maximum Percentage</B>&rdquo;). Upon
delivery of a written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any
other percentage not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage
will not be effective until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company and (ii) any such
increase or decrease will apply only to the Holder and the other Attribution Parties and not to any other holder of Warrants that is
not an Attribution Party of the Holder. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this
Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for
purposes of Section 13(d) or Rule 16a-1(a)(1) of the Exchange Act. No prior inability to exercise this Warrant pursuant to this
paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent
determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 1(e) to the extent necessary to correct this paragraph or any portion of this
paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 1(e) or
to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this
paragraph may not be waived, modified or amended and shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)   <U>Disputes</U>.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares to
be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed
and resolve such dispute in accordance with Section 10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.   <U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and the number of Warrant Shares shall be adjusted from time to
time as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>Adjustment
Upon Stock Dividends and Splits</U>. If the Company at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for the avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of
this Warrant), (ii) subdivides outstanding shares of Common Stock into a greater number of shares, (iii) combines (including by way of
reverse stock split) outstanding shares of Common Stock into smaller number of shares, or (iv) issues by reclassification of shares of
the Common Stock any shares of capital stock of the Company, then, in each case, the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the Exercise Price of this Warrant
shall remain unchanged. Any adjustment under this Section&nbsp;2(b) shall become effective immediately after the record date for the determination
of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the
case of a subdivision, combination or reclassification. If any event requiring an adjustment under this paragraph occurs during the period
that an Exericse Price is calculated hereunder, then the calculation of such Exericse Price shall be adjusted appropriately to reflect
such event. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 2(b), the number of Warrant Shares that
may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate
Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price in effect
immediately prior to such adjustment (without regard to any limitations on exercise contained herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.   <U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. In addition to any adjustments pursuant to Section 2 above or Section 4(a) below, during such time as
this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution
of cash, stock or other securities, property, options, evidence of indebtedness or any other assets by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) other than dividends or distributions subject to Section
2(b) above (a &ldquo;<B>Distribution</B>&rdquo;), or other than a reclassification to which Section 4(b) applies, then at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without limitation, the Maximum
Percentage) immediately before the date on which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however,
that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder and the other Attribution
Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution in excess of the Maximum
Percentage (and shall not be entitled to beneficial ownership of any applicable securities issued as a result of such Distribution to
the extent of any such excess) and the portion of such Distribution constituting such excess shall be treated as an Extraordinary Distribution
Dividend as set forth below) (any such event being referred to herein as an &ldquo;<B>Extraordinary Distribution Dividend</B>&rdquo;),
then the Exercise Price shall be decreased, effective immediately after the record date for the determination of the holders of the Common
Stock entitled to receive such Extraordinary Distribution Dividend, by (x) with respect to the cash portion of any Distribution, the amount
of cash and/or (y) with respet to the non-cash portion of any Distribution, the fair market value (as determined by a nationally recognized
investment bank or appraisal firm selected by the Holder and approved by the Company, such approval not to be unreasonably or untimely
withheld or delayed) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Distribution
Dividend, provided that, with respect to the non-cash portion of any Distribution, if the economic value of a Warrant immediately following
such adjustment (the &ldquo;<B>Adjusted Economic Value</B>&rdquo;) is less than the economic value of a Warrant immediately prior to such
adjustment (the &ldquo;<B>Pre-Adjustment Economic Value</B>&rdquo;) (in each case, as determined by the Holder in good faith) using the
Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg) due solely to such adjustment, the Exercise
Price shall be further reduced to the extent necessary to ensure that the Adjusted Economic Value is not less than the Pre-Adjustment
Economic Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4. <U>PURCHASE RIGHTS;
FUNDAMENTAL TRANSACTIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>Purchase
Rights</U>. In addition to any adjustments pursuant to Section 2 or 3 above, if during such time as this Warrant is outstanding, the Company
grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata
to the record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions
on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken
for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common
Stock are to be determined for the grant, issuance or sale of such Purchase Rights (provided, however, that to the extent that the Holder&rsquo;s
right to participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,
then the Holder shall not be entitled to participate in such Purchase Right in excess of the Maximum Percentage (and shall not be entitled
to beneficial ownership of any applicable securities issued as a result of such Purchase Right (and beneficial ownership) to the extent
of any such excess) and the portion of such Purchase Right constituting such excess shall be treated as an Extraordinary Dividend as set
forth below) (any such event being referred to herein as an &ldquo;<B>Extraordinary Purchase Right Dividend</B>&rdquo;), then the Exercise
Price shall be decreased, effective immediately after the record date for the determination of the holders of the Common Stock entitled
to receive such Extraordinary Purchase Right Dividend, by the fair market value (as determined by a nationally recognized investment bank
or appraisal firm selected by the Holder and approved by the Company, such approval not to be unreasonably or untimely withheld or delayed)
of such Purchase Right in respect of such Extraordinary Purchase Right Dividend, provided that, if the applicable Adjusted Economic Value
is less than the applicable Pre-Adjustment Economic Value due solely to such adjustment, the Exercise Price shall be further reduced to
the extent necessary to ensure that the Adjusted Economic Value is not less than the Pre-Adjustment Economic Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>Fundamental
Transactions</U>. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity assumes
in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section&nbsp;4(b) pursuant to written agreements in form and substance satisfactory to the Holder and approved by the Holder (without
unreasonable delay) prior to such Fundamental Transaction, including agreements to deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including,
without limitation, which is exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock
acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such
Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking
into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of
capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose of protecting the
economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction) and (ii)&nbsp;the Successor Entity
(including its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market.
Upon the consummation of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and
after the date of the applicable Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor
Entity had been named as the Company herein. Upon consummation of each Fundamental Transaction, the Successor Entity shall deliver to
the Holder confirmation that there shall be issued upon exercise of this Warrant at any time after the consummation of the applicable
Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except such items
still issuable under Sections&nbsp;3 and 4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise of
this Warrant prior to the applicable Fundamental Transaction, such shares of publicly traded common stock (or its equivalent) of the Successor
Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental
Transaction had this Warrant been exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations
on the exercise of this Warrant), as adjusted in accordance with the provisions of this Warrant. Notwithstanding the foregoing, and without
limiting Section 1(e) hereof, the Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section&nbsp;4(b)
to permit the Fundamental Transaction without the assumption of this Warrant. In addition to and not in substitution for any other rights
hereunder, prior to the consummation of each Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled
to receive securities or other assets with respect to or in exchange for shares of Common Stock (a &ldquo;<B>Corporate Event</B>&rdquo;),
the Company shall make appropriate provision to insure that the Holder will thereafter have the right to receive upon an exercise of this
Warrant at any time after the consummation of the applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the
shares of the Common Stock (or other securities, cash, assets or other property (except such items still issuable under Sections&nbsp;3
and 4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise of the Warrant prior to such Fundamental
Transaction, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or
subscription rights) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction
had this Warrant been exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations on the
exercise of this Warrant). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory
to the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)   <U>Black
Scholes Value</U>. Notwithstanding the foregoing and the provisions of Section 4(b) above, at the request of the Holder delivered at any
time commencing on the earliest to occur of (x) the public disclosure of a Change of Control, (y) the consummation of a Change of Control
and (z) the Holder first becoming aware of a Change of Control through the date that is ninety (90) days after the public disclosure of
the consummation of such Change of Control by the Company pursuant to a Current Report on Form 8-K filed with the SEC, the Company or
the Successor Entity (as the case may be) shall purchase this Warrant from the Holder on the date of such request by paying to the Holder
cash in an amount equal to the Black Scholes Value. Payment of such amounts shall be made by the Company (or at the Company&rsquo;s direction)
to the Holder on or prior to the later of (x) the second (2<SUP>nd</SUP>) Trading Day after the date of such request and (y) the date
of consummation of such Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)   <U>Application</U>.
The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and Corporate Events and shall
be applied as if this Warrant (and any such subsequent warrants) were fully exercisable and without regard to any limitations on the exercise
of this Warrant (provided that the Holder shall continue to be entitled to the benefit of the Maximum Percentage, applied however with
respect to shares of capital stock registered under the 1934 Act and thereafter receivable upon exercise of this Warrant (or any such
other warrant)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)   <U>Calculations</U>.
All calculations under Sections 2, 3 and 4 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of Sections 2, 3 and 4, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be
the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.   <U>NONCIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its articles of incorporation or bylaws, or through
any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all
times in good faith carry out all of the provisions of this Warrant and take all action as may be required to protect the rights of the
Holder. Without limiting the generality of the foregoing, the Company (i)&nbsp;shall not increase the par value of any shares of Common
Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii)&nbsp;shall take all such actions as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock
upon the exercise of this Warrant, and (iii) shall, so long as any of the Warrants are outstanding, take all action necessary to reserve
and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise of the
Warrants, the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of the Warrants then outstanding
(without regard to any limitations on exercise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.   <U>WARRANT
HOLDER NOT DEEMED A STOCKHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,
any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section&nbsp;6, the Company shall provide
the Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously
with the giving thereof to the stockholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7. <U>REISSUANCE OF
WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>Transfer
of Warrant</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder are transferable, in
whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three Trading Days of the date on which the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 7(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)   <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<B>Warrant
Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.   <U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, including, without limitation, an Exercise Notice, unless otherwise provided
herein, such notice shall be given in writing, (i) if delivered (a) from within the domestic United States, by first-class registered
or certified airmail, or nationally recognized overnight express courier, postage prepaid or electronic mail or (b) from outside the United
States, by International Federal Express or electronic mail, and (ii) will be deemed given (A) if delivered by first-class registered
or certified mail domestic, three (3) Business Days after so mailed, (B) if delivered by nationally recognized overnight carrier, one
(1) Business Day after so mailed, (C) if delivered by International Federal Express, two (2) Business Days after so mailed and (D) at
the time of transmission, if delivered by electronic mail to each of the email addresses specified in this Section 8 prior to 5:00 p.m.
(New York time) on a Trading Day, and (E) the next Trading Day after the date of transmission, if delivered by electronic mail to each
of the email addresses specified in this Section 8 on a day that is not a Trading Day or later than 5:00 p.m. (New York time) on any Trading
Day:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(i)   if to the Company,
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Ondas Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">222 Lakeview Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Suite 800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">West Palm Beach, FL 33401</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Eric Brock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: eric.brock@ondas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Akerman LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Three Brickell City Centre</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">98 Southeast Seventh Street, Suite 1100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Miami, FL 33131</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Christina Russo</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: christina.russo@akerman.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">(ii) if to the Holder,
at such address or other contact information delivered by the Holder to the Company or as is on the books and records of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company will give written
notice to the Holder (i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, and certifying, the
calculation of such adjustment and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a
record (A) with respect to any dividend or distribution upon the shares of Common Stock or (B) for determining rights to vote with respect
to any Fundamental Transaction, dissolution or liquidation; <U>provided</U> in each case that such information shall be made known to
the public prior to or in conjunction with such notice being provided to the Holder. It is expressly understood and agreed that the time
of exercise specified by the Holder in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.   <U>MISCELLANEOUS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 1(a), except as expressly set forth
in Sections 2, 3 and 4. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 1(d), or to receive cash payments contemplated by Sections 1(a) and 1(c) herein, in no event will the Company be required to
net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)   <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(1)   The
Company covenants that at any time this Warrant remains outstanding, it will reserve from its authorized and unissued Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of this Warrant (the &ldquo;<B>Required Reserve Amount</B>&rdquo;).
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the
duty of issuing the necessary Warrant Shares upon the exercise of this Warrant. The Company will take all such reasonable action as may
be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of this Warrant will, upon exercise hereunder and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company
in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(2)   Except
and to the extent waived or consented to by the Holder in writing, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(3)   Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(4)   If,
notwithstanding the foregoing, and not in limitation thereof, at any time while any of the Warrants remain outstanding, the Company does
not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve the Required Reserve
Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall immediately take all action necessary to increase the
Company&rsquo;s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount
for all the Warrants then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable after the date
of the occurrence of an Authorized Share Failure, but in no event later than sixty (60) days after the occurrence of such Authorized Share
Failure, the Company shall hold a meeting of its stockholders for the approval of an increase in the number of authorized shares of Common
Stock. In connection with such meeting, the Company shall provide each stockholder with a proxy statement and shall use its best efforts
to solicit its stockholders&rsquo; approval of such increase in authorized shares of Common Stock and to cause its board of directors
to recommend to the stockholders that they approve such proposal. Notwithstanding the foregoing, if at any such time of an Authorized
Share Failure, the Company is able to obtain the written consent of a majority of the shares of its issued and outstanding shares of Common
Stock to approve the increase in the number of authorized shares of Common Stock, the Company may satisfy this obligation by obtaining
such consent and submitting for filing with the SEC an Information Statement on Schedule 14C. In the event that the Company is prohibited
from issuing shares of Common Stock upon an exercise of this Warrant (without regard to any limitations on exercise of this Warrant) due
to the failure by the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common
Stock (such unavailable number of shares of Common Stock, the &ldquo;<B>Authorization Failure Shares</B>&rdquo;), solely to the extent
such Authorization Share Failure exists at such time of determination, the Holder shall have the right, at such Holder&rsquo;s option,
by delivery written notice to the Company (each, an &ldquo;<B>Authorization Failure Redemption Notice</B>&rdquo;, and the date thereof,
each an &ldquo;<B>Authorization Failure Redemption Date</B>&rdquo;), to require the Company to redeem (each, an &ldquo;<B>Authorization
Failure Redemption</B>&rdquo;) up to such portion of this Warrant exercisable (without regard to any limitations on exercise of this Warrant)
into such Authorization Failure Shares (such applicable portion of this Warrant, each an &ldquo;<B>Authorization Failure Redemption Warrant</B>&rdquo;)
in cash at a price equal to such applicable Black-Scholes Authorization Failure Price of such applicable Authorization Failure Redemption
Warrant. Payment of such amounts shall be made by the Company (or at the Company&rsquo;s direction) to the Holder on or prior to the second
(2nd) Trading Day after the date of such request. Nothing contained in this Section 9(c) shall limit any obligations of the Company under
any other provision of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)   <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed
and enforced in accordance with the internal laws of the State of New York, without giving effect to any provision or rule (whether of
the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State
of New York. The Company and, by accepting this Warrant, the Holder each agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Warrant (whether brought against the Company or the Holder or their respective
affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and
federal courts sitting in the City of New York. The Company and, by accepting this Warrant, the Holder each hereby irrevocably submits
to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The Company and, by
accepting this Warrant, the Holder each hereby irrevocably waives personal service of process and consents to process being served in
any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to it at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If the Company or the Holder shall commence an action, suit or proceeding to enforce any provisions of
this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. <B>EACH OF
THE COMPANY AND EACH HOLDER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)   <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)   <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Securities Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)   <U>Warrant
Agent</U>. The Company shall initially serve as warrant agent under this Warrant. Upon ten (10) days&rsquo; notice to the Holder, the
Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation
resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company
or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant
agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant
agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&rsquo;s last address as shown on the Warrant Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)   <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)   <U>Remedies,
Characterization, Other Obligations, Breaches and Injunctive Relief</U>. The remedies provided in this Warrant shall be cumulative and
in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual and consequential
damages for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that there shall
be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with
respect to payments, exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall
not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the holder
of this Warrant shall be entitled, in addition to all other available remedies, to specific performance and/or temporary, preliminary
and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity of
proving actual damages and without posting a bond or other security. The Company shall provide all information and documentation to the
Holder that is reasonably requested by the Holder to enable the Holder to confirm the Company&rsquo;s compliance with the terms and conditions
of this Warrant. The issuance of shares and certificates for shares as contemplated hereby upon the exercise of this Warrant shall be
made without charge to the Holder or such shares for any issuance tax or other costs in respect thereof, provided that the Company shall
not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate
in a name other than the Holder or its agent on its behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)   <U>Payment
of Collection, Enforcement and Other Costs</U>. If (a) this Warrant is placed in the hands of an attorney for collection or enforcement
or is collected or enforced through any legal proceeding or the holder otherwise takes action to collect amounts due under this Warrant
or to enforce the provisions of this Warrant or (b) there occurs any bankruptcy, reorganization, receivership of the company or other
proceedings affecting company creditors&rsquo; rights and involving a claim under this Warrant, then the Company shall pay the costs incurred
by the Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other
proceeding, including, without limitation, attorneys&rsquo; fees and disbursements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)   <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)   <U>Amendment</U>.
Except for Section 1(e) and this Section 9(k) which may not be amended, modified or waived, this Warrant may be modified or amended or
the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)   <U>Severability</U>.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(n)   <U>Headings</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(o)   <U>Disclosure</U>.
Upon delivery by the Company to the Holder (or receipt by the Company from the Holder) of any notice in accordance with the terms of this
Warrant, unless the Company has in good faith determined that the matters relating to such notice do not constitute material, non-public
information relating to the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York city time on the Business
Day immediately following such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form
8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information relating to the Company
or any of its Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt
of notice from the Holder, as applicable), and in the absence of any such written indication in such notice (or notification from the
Company immediately upon receipt of notice from the Holder), the Holder shall be entitled to presume that information contained in the
notice does not constitute material, non-public information relating to the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(p)   <U>Absence
of Trading and Disclosure Restrictions</U>. The Company acknowledges and agrees that the Holder is not a fiduciary or agent of the Company
and that the Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain
from trading any securities while in possession of such information in the absence of a written non-disclosure agreement signed by an
officer of the Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed,
written non-disclosure agreement, the Company acknowledges that the Holder may freely trade in any securities issued by the Company, may
possess and use any information provided by the Company in connection with such trading activity, and may disclose any such information
to any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.   <U>DISPUTE
RESOLUTION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(a)   <U>Submission
to Dispute Resolution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(1)   In
the case of a dispute relating to the Exercise Price, the Closing Sale Price, the Bid Price, Black Scholes Authorization Failure Price,
Black Scholes Value or fair market value or the arithmetic calculation of the number of Warrant Shares (as the case may be) (including,
without limitation, a dispute relating to the determination of any of the foregoing), the Company or the Holder (as the case may be) shall
submit the dispute to the other party via electronic mail (A) if by the Company, within two (2) Business Days after the occurrence of
the circumstances giving rise to such dispute or (B) if by the Holder, at any time after the Holder learned of the circumstances giving
rise to such dispute. If the Holder and the Company are unable to promptly resolve such dispute relating to such Exercise Price, such
Closing Sale Price, such Bid Price, such Black Scholes Authorization Failure Price, Black Scholes Value or such fair market value or such
arithmetic calculation of the number of Warrant Shares (as the case may be), at any time after the second (2<SUP>nd</SUP>) Business Day
following such initial notice by the Company or the Holder (as the case may be) of such dispute to the Company or the Holder (as the case
may be), then the Holder may, at its sole option, select an independent, reputable investment bank to resolve such dispute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(2)   The
Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance
with the first sentence of this Section&nbsp;10 and (B) written documentation supporting its position with respect to such dispute, in
each case, no later than 5:00 p.m. (New York time) by the fifth (5<SUP>th</SUP>) Business Day immediately following the date on which
the Holder selected such investment bank (the &ldquo;<B>Dispute Submission Deadline</B>&rdquo;) (the documents referred to in the immediately
preceding clauses (A) and (B) are collectively referred to herein as the &ldquo;<B>Required Dispute Documentation</B>&rdquo;) (it being
understood and agreed that if either the Holder or the Company fails to so deliver all of the Required Dispute Documentation by the Dispute
Submission Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be entitled to (and
hereby waives its right to) deliver or submit any written documentation or other support to such investment bank with respect to such
dispute and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was delivered to such
investment bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company and the Holder or
otherwise requested by such investment bank, neither the Company nor the Holder shall be entitled to deliver or submit any written documentation
or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(3)   The
Company and the Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and the Holder
of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The reasonable fees and
expenses of such investment bank shall be borne solely by the Company, and such investment bank&rsquo;s resolution of such dispute shall
be final and binding upon all parties absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>Miscellaneous</U>.
The Company expressly acknowledges and agrees that (i) this Section&nbsp;10 constitutes an agreement to arbitrate between the Company
and the Holder (and constitutes an arbitration agreement) under the rules then in effect under &sect; 7501, et seq. of the New York Civil
Practice Law and Rules (&ldquo;<B>CPLR</B>&rdquo;) and that the Holder is authorized to apply for an order to compel arbitration pursuant
to CPLR &sect; 7503(a) in order to compel compliance with this Section&nbsp;10, (ii) the terms of this Warrant and each other applicable
Transaction Document shall serve as the basis for the selected investment bank&rsquo;s resolution of the applicable dispute, such investment
bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like that such investment bank
determines are required to be made by such investment bank in connection with its resolution of such dispute and in resolving such dispute
such investment bank shall apply such findings, determinations and the like to the terms of this Warrant and any other applicable Transaction
Documents, (iii) the Holder (and only the Holder), in its sole discretion, shall have the right to submit any dispute described in this
Section&nbsp;10 to any state or federal court sitting in The City of New York, Borough of Manhattan in lieu of utilizing the procedures
set forth in this Section&nbsp;10 and (iv) nothing in this Section&nbsp;10 shall limit the Holder from obtaining any injunctive relief
or other equitable remedies (including, without limitation, with respect to any matters described in this Section&nbsp;10).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">11.   <U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   &ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control
with, such Person, as such terms are used in and construed under Rule 405 under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   &ldquo;<B>Attribution
Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder funds
or managed accounts, currently, or from time to time after the Subscription Date, directly or indirectly managed or advised by the Holder&rsquo;s
investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder or any of the foregoing,
(iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing and (iv) any other
Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated with the Holder&rsquo;s and the other
Attribution Parties for purposes of Section 13(d) of the Exchange Act. For clarity, the purpose of the foregoing is to subject collectively
the Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)
&ldquo;<B>Bid Price</B>&rdquo; means, for any security as of the particular time of determination, the bid price for such security on
the Principal Market as reported by Bloomberg as of such time of determination, or, if the Principal Market is not the principal securities
exchange or trading market for such security, the bid price of such security on the principal securities exchange or trading market where
such security is listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing does not apply, the bid
price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg as of
such time of determination, or, if no bid price is reported for such security by Bloomberg as of such time of determination, the average
of the bid prices of any market makers for such security as reported on the Pink Open Market as of such time of determination. If the
Bid Price cannot be calculated for a security as of the particular time of determination on any of the foregoing bases, the Bid Price
of such security as of such time of determination shall be the fair market value of such securities as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company. All such determinations shall be appropriately adjusted for any stock dividend,
stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)   &ldquo;<B>Black
Scholes Authorization Failure Price</B>&rdquo; means, with respect to any given Authorization Failure Redemption, the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the applicable
Authorization Failure Redemption Date for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury
rate for a period equal to the time between such Authorization Failure Redemption Date and the Expiration Date, (B) an expected volatility
equal to the 30-day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of
the Trading Day immediately prior to such Authorization Failure Redemption Date, (C) the underlying price per share used in such calculation
shall be the highest VWAP during the sixty (60) Trading Day period ending on, and including, the Trading Day immediately prior to such
Authorization Failure Redemption Date and (D) a remaining option time equal to the time between such Authorization Failure Redemption
Date and the Expiration Date and (E) a zero cost of borrow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)   &ldquo;<B>Black
Scholes Value</B>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg determined as of the day of consummation of the applicable Change of Control for pricing purposes and reflecting
(A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
of the applicable Change of Control and the Expiration Date, (B) an expected volatility equal to the 30-day volatility obtained from the
HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following the public
announcement of the applicable Change of Control, (C) the underlying price per share used in such calculation shall be the greater of
(i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Change of Control and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement
of the applicable Change of Control (or the consummation of the applicable Change of Control, if earlier) and ending on the Trading Day
of the Holder&rsquo;s request pursuant to Section 4(b) and (D) a remaining option time equal to the time between the date of the public
announcement of the applicable Change of Control and the Expiration Date and (E) a zero cost of borrow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)   &ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg Financial Markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)   &ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)   &ldquo;<B>Change
of Control</B>&rdquo; means any Fundamental Transaction other than (i) any reorganization, recapitalization or reclassification of the
Common Stock in which holders of the Company&rsquo;s voting power immediately prior to such reorganization, recapitalization or reclassification
continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly,
are, in all material respects, the holders of the voting power of the surviving entity (or entities with the authority or voting power
to elect the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such
reorganization, recapitalization or reclassification, (ii) pursuant to a migratory merger effected solely for the purpose of changing
the jurisdiction of incorporation of the Company or (iii) an acquisition or a merger in connection with a bona fide acquisition by the
Company of any Person in which (x) the gross consideration paid, directly or indirectly, by the Company in such acquisition or merger
is not greater than 50% of the Company&rsquo;s market capitalization as calculated on the date of the consummation of such acquisition
or merger and (y) such acquisition or merger does not contemplate a change to the identity of a majority of the board of directors of
the Company and the holders of the Company&rsquo;s voting power eligible to elect a majority of the board of directors of the Company
immediately prior to such transaction, directly or indirectly, are, in all material respects, the holders of the voting power of the surviving
entity with voting power to elect a majority of the members of the board of directors (or entities with the authority or voting power
to elect the majority of the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities)
after such transaction, as applciable. Notwithstanding anything herein to the contrary, any transaction or series of transactions that,
directly or indirectly, results in the Company or the Successor Entity not having Common Stock or common stock, as applicable, registered
under the Exchange Act and listed on an Eligible Market shall be deemed a Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)   &ldquo;<B>Common
Stock</B>&rdquo; means (i)&nbsp;the Company&rsquo;s Common Stock, par value $0.0001 per share, and (ii)&nbsp;any capital stock into which
such Common Stock shall have been changed or any capital stock resulting from a reclassification of such Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)   &ldquo;<B>Convertible
Securities</B>&rdquo; means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)   &ldquo;<B>Eligible
Market</B>&rdquo; means The NASDAQ Capital Market, the NYSE American LLC, The NASDAQ Global Select Market, The NASDAQ Global Market or
The New York Stock Exchange, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)   &ldquo;<B>Expiration
Date</B>&rdquo; means the date that is the seventh anniversary after the date hereof or, if such date falls on a day other than a Business
Day or on which trading does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;), the next day that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)
&ldquo;<B>Fundamental Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the
surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all
of the properties or assets of the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of Regulation
S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject
to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is
accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock, (y) 50% of the outstanding shares of Common
Stock calculated as if any shares of Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities
making or party to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of Common Stock such that
all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer,
become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common
Stock, or (iv) consummate a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually
or in the aggregate, acquire, either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares
of Common Stock calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any
Subject Entity making or party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number
of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the
1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common Stock, (B)
that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions,
allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the &ldquo;beneficial owner&rdquo; (as
defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender,
tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation, business combination, reorganization,
recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever,
of either (x) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock, (y) at least 50%
of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by all such Subject Entities as of
the date of this Warrant calculated as if any shares of Common Stock held by all such Subject Entities were not outstanding, or (z) a
percentage of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock or other equity securities
of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring other
shareholders of the Company to surrender their shares of Common Stock without approval of the shareholders of the Company or (C) directly
or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering
into any other instrument or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which
case this definition shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition
to the extent necessary to correct this definition or any portion of this definition which may be defective or inconsistent with the intended
treatment of such instrument or transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(n)   &ldquo;<B>Group</B>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the Exchange Act and as defined in Rule 13d-5 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(o)   &ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(p)   &ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person, including such entity whose
common stock or equivalent equity security is quoted or listed on an Eligible Market (or, if so elected by the Holder, any other market,
exchange or quotation system), or, if there is more than one such Person or such entity, the Person or such entity designated by the Holder
or in the absence of such designation, such Person or entity with the largest public market capitalization as of the date of consummation
of the Fundamental Transaction or Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(q)   &ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(r)   &ldquo;<B>Principal
Market</B>&rdquo; means The NASDAQ Capital Market (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(s)   &ldquo;<B>Required
Holders</B>&rdquo; means the holders of the Warrants representing at least a majority of the shares of Common Stock underlying the Warrants
then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(t)   <B>&ldquo;Standard
Settlement Period&rdquo;</B> means the standard settlement period, expressed in a number of Trading Days, for the Company&rsquo;s primary
trading market or quotation system with respect to the Common Stock that is in effect on the date of receipt of an applicable Exercise
Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(u)   &ldquo;<B>Subject
Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)   &ldquo;<B>Successor
Entity</B>&rdquo; means one or more Person or Persons (or, if so elected by the Holder, the Company or Parent Entity) formed by, resulting
from or surviving any Fundamental Transaction or Change of Control or one or more Person or Persons (or, if so elected by the Holder,
the Company or the Parent Entity) with which such Fundamental Transaction or Change of Control shall have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(w)   &ldquo;<B>Trading
Day</B>&rdquo; means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal
trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then
traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x)   &ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(y)   &ldquo;<B>Transaction
Documents</B>&rdquo; shall have the meaning as set forth in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(z)   &ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
the Company has caused this Warrant to purchase Common Stock to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">Ondas Holdings Inc. </FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>By:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Name:&nbsp;</TD>
  <TD>Eric Brock</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Warrant</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE
THIS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WARRANT TO PURCHASE COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Ondas
Holdings Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned holder hereby
exercises the right to purchase _________________ shares of Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;) of <FONT STYLE="text-transform: uppercase">Ondas
Holdings Inc.</FONT>, a corporation organized under the laws of the State of Nevada (the &ldquo;<B>Company</B>&rdquo;), evidenced by the
attached Warrant to Purchase Common Stock (the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined
shall have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Form of Exercise Price</U>.
The Holder intends that payment of the Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">____________ a
&ldquo;<U>Cash Exercise&rdquo;</U> with respect to _________________ Warrant Shares; and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">____________ a
<U>&ldquo;Cashless Exercise&rdquo;</U> with respect to _______________ Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Section 1(d) the Holder [is][is not]
exercising its option to have the VWAP determined by reference to [the VWAP on the Trading Day immediately preceding the date of the applicable
Exercise Notice] or [the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the
Holder&rsquo;s execution of the applicable Exercise Notice if such Exercise Notice is executed during &ldquo;regular trading hours&rdquo;
on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 1(d) of the Warrant].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Payment of Exercise
Price</U>. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant
hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance with the terms
of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Beneficial Ownership
Representation</U>. Notwithstanding anything to the contrary contained herein, this Exercise Notice shall constitute a representation
by the Holder of the Warrant submitting this Exercise Notice that after giving effect to the exercise provided for in this Exercise Notice,
such Holder (together with its affiliates) will not have beneficial ownership (together with the beneficial ownership of such Person&rsquo;s
affiliates) of a number of shares of Common Stock which exceeds the Maximum Percentage (as defined in the Warrant) of the total outstanding
shares of Common Stock of the Company as determined pursuant to the provisions of Section 1(e) of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Delivery of Warrant
Shares</U>. The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: _______________ __, ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">&nbsp;</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Name of Registered Holder</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>By:</TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 5%">Name:&nbsp;</TD>
  <TD STYLE="width: 31%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby acknowledges
this Exercise Notice and hereby directs Broadridge Corporate Issuer Solutions to issue the above indicated number of shares of Common
Stock on or prior to the applicable Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">Ondas Holdings Inc. </FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>By:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Name:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 30%">Name:</TD>
  <TD STYLE="width: 70%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>(Please Print)</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Address:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>(Please Print)</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Phone Number:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Email Address:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">Dated: __________________________________ __, ______</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Holder&rsquo;s Signature:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Holder&rsquo;s Address:</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea027241901ex4-2_ondas.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Ondas Holdings Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Form
of Prefunded Warrant To Purchase Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant No.: [&nbsp;&nbsp;&nbsp;&nbsp;  ]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Number of Shares of Common Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date of Issuance: January 12, 2026 (&ldquo;<B>Issuance Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Ondas Holdings Inc., a
company organized under the laws of State of Nevada (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged<FONT STYLE="text-transform: uppercase">,</FONT> [
&nbsp;&nbsp; ], the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the
terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times
on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below),
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein
(the &ldquo;<B>Warrant Shares</B>&rdquo;). Except as otherwise defined herein, capitalized terms in this Warrant to purchase Common
Stock (including any Warrants to purchase Common Stock issued in exchange, transfer or replacement hereof, this
&ldquo;<B>Warrant</B>&rdquo;), shall have the meanings set forth in Section 11. This Warrant is one of the Warrants to purchase
Common Stock (the &ldquo;<B>Warrants</B>&rdquo;) issued pursuant to (i) Section 1 of that certain Securities Purchase Agreement,
dated as of January 9, 2026 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among the Company and the investors (the
&ldquo;<B>Buyers</B>&rdquo;) referred to therein, as amended from time to time (the &ldquo;<B>Securities Purchase
Agreement</B>&rdquo;), (ii) the Company&rsquo;s Registration Statement on Form S-3ASR (File No. 333-290121) (the
&ldquo;<B>Registration Statement</B>&rdquo;) and (iii) the Company&rsquo;s prospectus supplement dated as of January [ ], 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Notwithstanding anything herein
to the contrary, the Aggregate Exercise Price (as defined below) of this Warrant, except for a nominal exercise price of $0.0001 per Warrant
Share (the &ldquo;Nominal Exercise Price&rdquo;), was pre-funded to the Company on or prior to the initial Issuance Date and, consequently,
no additional consideration (other than the Nominal Exercise Price per Warrant Share) shall be required to be paid by the Holder to any
Person to effect any exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.   <U>EXERCISE
OF WARRANT.</U></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>Mechanics
of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(e)),
this Warrant may be exercised by the Holder at any time or times on or after the Issuance Date (an &ldquo;<B>Exercise Date</B>&rdquo;),
in whole or in part, by delivery (whether via electronic mail or otherwise) of a written notice, in the form attached hereto as <U>Exhibit
A</U> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. Within one (1) Trading Day
following the delivery of the Exercise Notice, the Holder shall make payment to the Company of an amount equal to the Exercise Price in
effect on the date of such exercise multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the &ldquo;<B>Aggregate
Exercise Price</B>&rdquo;) in cash by wire transfer of immediately available funds or, if the provisions of Section 1(d) are applicable,
by notifying the Company pursuant to the Exercise Notice that this Warrant is being exercised pursuant to a Cashless Exercise (as defined
in Section 1(d)). Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have the same
effect as cancellation of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of
Warrant Shares and the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within five (5) Trading Days of the date on which the final Exercise Notice has been delivered
to the Company. On or before the first (1<SUP>st</SUP>) Trading Day following the date on which the Holder has delivered the applicable
Exercise Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation of receipt of the Exercise Notice, in
the form attached to the Exercise Notice, to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;).
So long as the Holder delivers the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) on or prior to the first
(1<SUP>st</SUP>) Trading Day following the date on which the Exercise Notice has been delivered to the Company, then on or prior to the
number of Trading Days comprising the Standard Settlement Period following the date on which the Exercise Notice has been delivered to
the Company, or, if the Holder does not deliver the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) on or prior
to the first (1<SUP>st</SUP>) Trading Day following the date on which the Exercise Notice has been delivered to the Company, then on or
prior to the date on which the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) is delivered (such earlier date,
or if later, the earliest day on which the Company is required to deliver Warrant Shares pursuant to this Section 1(a), the &ldquo;<B>Share
Delivery Date</B>&rdquo;), the Company shall (X) provided that the Transfer Agent is participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;)
Fast Automated Securities Transfer Program (&ldquo;<B>FAST</B>&rdquo;), credit such aggregate number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal
At Custodian system, or (Y) if the Transfer Agent is not participating in the FAST, issue and dispatch by overnight courier to the address
as specified in the Exercise Notice, a certificate or evidence of a credit book entry of shares, registered in the name of the Holder
or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise. The Company shall be responsible
for all fees and expenses of the Transfer Agent and all fees and expenses with respect to the issuance of Warrant Shares via DTC, if any,
including without limitation for same day processing. On the Share Delivery Date, the Holder shall be deemed for all corporate purposes
to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date
such Warrant Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the certificates evidencing such Warrant
Shares, as the case may be; provided, that the Holder shall be deemed to have waived any voting rights of any such Warrant Shares that
may arise with respect to the period commencing on such Exercise Date, through, and including, such applicable Share Delivery Date, as
necessary, such that the aggregate voting rights of any shares of Common Stock (including such Warrant Shares) beneficially owned by the
Holder and/or any Attribution Parties, collectively, on any such date of determination shall not exceed the Maximum Percentage (as defined
below) as a result of any such exercise of this Warrant. If this Warrant is physically delivered to the Company in connection with any
exercise pursuant to this Section 1(a) and the number of Warrant Shares represented by this Warrant submitted for exercise is greater
than the number of Warrant Shares being acquired upon an exercise, then the Company shall as soon as practicable and in no event later
than three (3) Trading Days after any exercise and at its own expense, issue and deliver to the Holder (or its designee) a new Warrant
(in accordance with Section 7(b)) representing the right to purchase the number of Warrant Shares issuable immediately prior to such exercise
under this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised. No fractional Warrant Shares are
to be issued upon the exercise of this Warrant, but rather the number of Warrant Shares to be issued shall be rounded down to the nearest
whole number. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or any incidental expense
in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares
shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that, in the event
that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be
accompanied by the Assignment Form attached hereto as <U>Exhibit B</U> duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. Subject to the foregoing, the Holder
shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant
Shares upon exercise hereof, including any United States withholding taxes imposed on any dividends or deemed dividends, and the Company
shall be entitled to withhold such tax liability from shares of Common Stock, sales proceeds subsequently paid or credited, or other amounts
payable or distributable to the relevant Holder as required by applicable law. The Company will not close its shareholder books or records
in any matter that prevents the timely exercise of this Warrant, pursuant to the terms hereof. The Company&rsquo;s obligations to issue
and deliver Warrant Shares in accordance with the terms and subject to the conditions hereof are absolute and unconditional, irrespective
of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery
of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination;
<U>provided</U>, <U>however</U>, that the Company shall not be required to deliver Warrant Shares with respect to an exercise prior to
the Holder&rsquo;s delivery of the Aggregate Exercise Price (or notice of a Cashless Exercise) with respect to such exercise. <B>The Holder
and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) <U>Exercise Price</U>.
For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $16.45 (with all but the Nominal Exercise Price per share prepaid
as of the Issuance Date), subject to adjustment as provided herein.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)   <U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. If either (I) the Company shall fail for any reason or for no reason to issue or credit, as
the case may be, to the Holder on or prior to the applicable Share Delivery Date, if (x) the Transfer Agent is not participating in the
FAST, a certificate or evidence of a book-entry credit for the number of shares of Common Stock to which the Holder is entitled and register
such Common Stock on the Company&rsquo;s share register or (y) the Transfer Agent is participating in the FAST, to credit the Holder&rsquo;s
balance account with DTC, for such number of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise of
this Warrant or (II) a registration statement (which may be the Registration Statement) covering the issuance or resale of the Warrant
Shares that are the subject of the Exercise Notice (the &ldquo;<B>Exercise Notice Warrant Shares</B>&rdquo;) is not available for the
issuance or resale, as applicable, of such Exercise Notice Warrant Shares and (x) the Company fails to promptly, but in no event later
than one (1) Business Day after such registration statement becomes unavailable, to so notify the Holder and (y) the Company is unable
to deliver the Exercise Notice Warrant Shares electronically without any restrictive legend by crediting such aggregate number of Exercise
Notice Warrant Shares to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian
system (the event described in the immediately foregoing clause (II) is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo;
and together with the event described in clause (I) above, an &ldquo;<B>Exercise Failure</B>&rdquo;), then, in addition to all other remedies
available to the Holder, if on or prior to the applicable Share Delivery Date either (I) if the Transfer Agent is not participating in
the FAST, the Company shall fail to issue and deliver a certificate or evidence of a book-entry credit to the Holder and register such
shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating in the FAST, credit the Holder&rsquo;s
balance account with DTC for the number of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder
or pursuant to the Company&rsquo;s obligation pursuant to clause (ii) below or (II) if a Notice Failure occurs, and, in each case, if
after such date the Holder is required by its broker to acquire (in an open market transaction, stock loan or otherwise) or the Holder&rsquo;s
brokerage firm otherwise acquires, shares of Common Stock corresponding to all or any portion of the number of shares of Common Stock
issuable upon such exercise which the Holder anticipated receiving upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company
shall, within five (5) Trading Days after the Holder&rsquo;s request, (A) pay in cash to the Holder the amount, if any, by which (x) the
Holder&rsquo;s total purchase price (including customary brokerage commissions, stock loan costs and other out-of-pocket expenses, if
any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that
the Company was required to deliver to the Holder in connection with the exercise at issue times and (2) the price at which the sell order
giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant
and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded)
or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise
and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover
a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms
hereof. The Company&rsquo;s current transfer agent participates in the FAST. In the event that the Company changes transfer agents while
this Warrant is outstanding, the Company shall select a transfer agent that participates in FAST. While this Warrant is outstanding, the
Company shall cause its transfer agent to participate in FAST with respect to this Warrant. In addition to the foregoing rights, (i) if
the Company fails to deliver the applicable number of Warrant Shares upon an exercise pursuant to Section 1 by the applicable Share Delivery
Date, then the Holder shall have the right to rescind such exercise in whole or in part and retain and/or have the Company return, as
the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the rescission
of an exercise shall not affect the Company&rsquo;s obligation to make any payments that have accrued prior to the date of such notice
pursuant to this Section 1(c) or otherwise, and (ii) if a registration statement (which may be the Registration Statement) covering the
issuance or resale of the Warrant Shares that are subject to an Exercise Notice is not available for the issuance or resale, as applicable,
of such Exercise Notice Warrant Shares and the Holder has submitted an Exercise Notice prior to receiving notice of the non-availability
of such registration statement and the Company has not already delivered the Warrant Shares underlying such Exercise Notice electronically
without any restrictive legend by crediting such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise
to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian system, the Holder
shall have the option, by delivery of notice to the Company, to (x) rescind such Exercise Notice in whole or in part and retain or have
returned, as the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that
the rescission of an Exercise Notice shall not affect the Company&rsquo;s obligation to make any payments that have accrued prior to the
date of such notice pursuant to this Section 1(c) or otherwise, and/or (y) switch some or all of such Exercise Notice from a cash exercise
to a Cashless Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)   <U>Cashless
Exercise</U>. If at the time of exercise hereof, there is no effective registration statement, or the prospectus contained therein is
not available for the issuance or resale of the Warrant Shares to or by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; (a &ldquo;<B>Cashless Exercise</B>&rdquo;) in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing (A-B) * (X) by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD>
    <TD STYLE="width: 0.25in; text-align: left">A</TD>
    <TD STYLE="width: 0.25in">=</TD><TD STYLE="text-align: justify">as applicable, (i) the VWAP (as defined herein) on the Trading
Day immediately preceding the date of the applicable Exercise Notice if such Exercise Notice is (1) both executed and delivered pursuant
to Section 1(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 1(a) hereof on a Trading
Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(88) of Regulation NMS promulgated under the
federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding
the date of the applicable Exercise Notice or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg
as of the time of the Holder&rsquo;s execution of the applicable Exercise Notice if such Exercise Notice is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 1(a) hereof or (iii) the VWAP on the date of the applicable
Exercise Notice if the date of such Exercise Notice is a Trading Day and such Exercise Notice is both executed and delivered pursuant
to Section 1(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD>
    <TD STYLE="width: 0.25in">B</TD><TD STYLE="width: 0.25in; text-align: left">=</TD><TD STYLE="text-align: justify">the Nominal Exercise Price of this Warrant, as adjusted hereunder; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD>
    <TD STYLE="width: 0.25in">X</TD><TD STYLE="width: 0.25in; text-align: left">=</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If Warrant Shares are issued
in such a cashless exercise, the Company acknowledges and agrees that in accordance with Section 3(a)(9) of the Securities Act of 1933,
as amended, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to
take any position contrary to this Section 1(d).<FONT STYLE="background-color: white">&nbsp;</FONT>Without limiting the rights of a Holder
to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to receive the cash payments contemplated pursuant to Sections 1(c)
and 3(b), in no event will the Company be required to net cash settle a Warrant exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e) <U>Beneficial
Ownership</U>. Notwithstanding anything to the contrary contained herein, the Company shall not effect the exercise of any portion
of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the terms and
conditions of this Warrant and any such exercise shall be null and void and treated as if never made, to the extent that after
giving effect to such exercise, the Holder together with the other Attribution Parties collectively would beneficially own in excess
of the Maximum Percentage (as defined below). For purposes of the foregoing sentence, the aggregate number of shares of Common Stock
beneficially owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock held by the
Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which the determination of such sentence is being made, but shall exclude the number of shares of Common Stock which
would be issuable upon (A) exercise of the remaining, unexercised portion of this Warrant beneficially owned by the Holder or any of
the other Attribution Parties and (B) exercise or conversion of the unexercised or unconverted portion of any other securities of
the Company (including, without limitation, any convertible notes or convertible preferred stock or warrants, including the other
Warrants) beneficially owned by the Holder or any other Attribution Party subject to a limitation on conversion or exercise
analogous to the limitation contained in this Section 1(e). For purposes of this Section 1(e), beneficial ownership shall be
calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;). In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Warrant, in determining
the number of outstanding shares of Common Stock the Holder may acquire upon the exercise of this Warrant without exceeding the
Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company&rsquo;s
most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q or other public filing with the Securities and Exchange
Commission (the &ldquo;<B>SEC</B>&rdquo;), as the case may be, (y) a more recent public announcement by the Company or (z) any other
written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding (the
&ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If the Company receives an Exercise Notice from the Holder at a time when
the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall (i)
notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Exercise Notice
would otherwise cause the Holder&rsquo;s beneficial ownership, as determined pursuant to this Section 1(e), to exceed the Maximum
Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be acquired pursuant to such Exercise Notice
(the number of shares by which such purchase is reduced, the &ldquo;<B>Reduction Shares</B>&rdquo;) and (ii) as soon as reasonably
practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction Shares. For any reason
at any time, upon the written or oral request of the Holder, the Company shall within one (1) Business Day confirm orally and in
writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
Company, including this Warrant, by the Holder and any other Attribution Party since the date as of which the Reported Outstanding
Share Number was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results in the
Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the
number of outstanding shares of Common Stock (as determined under Section 13(d) of the Exchange Act), the number of shares so issued
by which the Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds the Maximum Percentage
(the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not
have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares
has been deemed null and void, the Company shall return to the Holder the Exercise Price paid by the Holder for the Excess Shares.
The Maximum Percentage shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the
issuance of shares of Common Stock issuable upon exercise of this Warrant (the &ldquo;<B>Maximum Percentage</B>&rdquo;). Upon
delivery of a written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any
other percentage not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage
will not be effective until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company and (ii) any such
increase or decrease will apply only to the Holder and the other Attribution Parties and not to any other holder of Warrants that is
not an Attribution Party of the Holder. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this
Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for
purposes of Section 13(d) or Rule 16a-1(a)(1) of the Exchange Act. No prior inability to exercise this Warrant pursuant to this
paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent
determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 1(e) to the extent necessary to correct this paragraph or any portion of this
paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 1(e) or
to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this
paragraph may not be waived, modified or amended and shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)   <U>Disputes</U>.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares to
be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed
and resolve such dispute in accordance with Section 10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.   <U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and the number of Warrant Shares shall be adjusted from time to
time as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>Adjustment
Upon Stock Dividends and Splits</U>. If the Company at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for the avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of
this Warrant), (ii) subdivides outstanding shares of Common Stock into a greater number of shares, (iii) combines (including by way of
reverse stock split) outstanding shares of Common Stock into smaller number of shares, or (iv) issues by reclassification of shares of
the Common Stock any shares of capital stock of the Company, then, in each case, the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the Exercise Price of this Warrant
shall remain unchanged. Any adjustment under this Section&nbsp;2(b) shall become effective immediately after the record date for the determination
of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the
case of a subdivision, combination or reclassification. If any event requiring an adjustment under this paragraph occurs during the period
that an Exericse Price is calculated hereunder, then the calculation of such Exericse Price shall be adjusted appropriately to reflect
such event. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 2(b), the number of Warrant Shares that
may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate
Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price in effect
immediately prior to such adjustment (without regard to any limitations on exercise contained herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.   <U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. In addition to any adjustments pursuant to Section 2 above or Section 4(a) below, during such time as
this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution
of cash, stock or other securities, property, options, evidence of indebtedness or any other assets by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) other than dividends or distributions subject to Section
2(b) above (a &ldquo;<B>Distribution</B>&rdquo;), or other than a reclassification to which Section 4(b) applies, then at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without limitation, the Maximum
Percentage) immediately before the date on which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however,
that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder and the other Attribution
Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution in excess of the Maximum
Percentage (and shall not be entitled to beneficial ownership of any applicable securities issued as a result of such Distribution to
the extent of any such excess) and the portion of such Distribution constituting such excess shall be treated as an Extraordinary Distribution
Dividend as set forth below) (any such event being referred to herein as an &ldquo;<B>Extraordinary Distribution Dividend</B>&rdquo;),
then the Exercise Price shall be decreased, effective immediately after the record date for the determination of the holders of the Common
Stock entitled to receive such Extraordinary Distribution Dividend, by (x) with respect to the cash portion of any Distribution, the amount
of cash and/or (y) with respet to the non-cash portion of any Distribution, the fair market value (as determined by a nationally recognized
investment bank or appraisal firm selected by the Holder and approved by the Company, such approval not to be unreasonably or untimely
withheld or delayed) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Distribution
Dividend, provided that, with respect to the non-cash portion of any Distribution, if the economic value of a Warrant immediately following
such adjustment (the &ldquo;<B>Adjusted Economic Value</B>&rdquo;) is less than the economic value of a Warrant immediately prior to such
adjustment (the &ldquo;<B>Pre-Adjustment Economic Value</B>&rdquo;) (in each case, as determined by the Holder in good faith) using the
Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg) due solely to such adjustment, the Exercise
Price shall be further reduced to the extent necessary to ensure that the Adjusted Economic Value is not less than the Pre-Adjustment
Economic Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4. <U>PURCHASE RIGHTS;
FUNDAMENTAL TRANSACTIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>Purchase
Rights</U>. In addition to any adjustments pursuant to Section 2 or 3 above, if during such time as this Warrant is outstanding, the Company
grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata
to the record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions
on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken
for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common
Stock are to be determined for the grant, issuance or sale of such Purchase Rights (provided, however, that to the extent that the Holder&rsquo;s
right to participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,
then the Holder shall not be entitled to participate in such Purchase Right in excess of the Maximum Percentage (and shall not be entitled
to beneficial ownership of any applicable securities issued as a result of such Purchase Right (and beneficial ownership) to the extent
of any such excess) and the portion of such Purchase Right constituting such excess shall be treated as an Extraordinary Dividend as set
forth below) (any such event being referred to herein as an &ldquo;<B>Extraordinary Purchase Right Dividend</B>&rdquo;), then the Exercise
Price shall be decreased, effective immediately after the record date for the determination of the holders of the Common Stock entitled
to receive such Extraordinary Purchase Right Dividend, by the fair market value (as determined by a nationally recognized investment bank
or appraisal firm selected by the Holder and approved by the Company, such approval not to be unreasonably or untimely withheld or delayed)
of such Purchase Right in respect of such Extraordinary Purchase Right Dividend, provided that, if the applicable Adjusted Economic Value
is less than the applicable Pre-Adjustment Economic Value due solely to such adjustment, the Exercise Price shall be further reduced to
the extent necessary to ensure that the Adjusted Economic Value is not less than the Pre-Adjustment Economic Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>Fundamental
Transactions</U>. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity assumes
in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section&nbsp;4(b) pursuant to written agreements in form and substance satisfactory to the Holder and approved by the Holder (without
unreasonable delay) prior to such Fundamental Transaction, including agreements to deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including,
without limitation, which is exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock
acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such
Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking
into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of
capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose of protecting the
economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction) and (ii)&nbsp;the Successor Entity
(including its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market.
Upon the consummation of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and
after the date of the applicable Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor
Entity had been named as the Company herein. Upon consummation of each Fundamental Transaction, the Successor Entity shall deliver to
the Holder confirmation that there shall be issued upon exercise of this Warrant at any time after the consummation of the applicable
Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except such items
still issuable under Sections&nbsp;3 and 4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise of
this Warrant prior to the applicable Fundamental Transaction, such shares of publicly traded common stock (or its equivalent) of the Successor
Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental
Transaction had this Warrant been exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations
on the exercise of this Warrant), as adjusted in accordance with the provisions of this Warrant. Notwithstanding the foregoing, and without
limiting Section 1(e) hereof, the Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section&nbsp;4(b)
to permit the Fundamental Transaction without the assumption of this Warrant. In addition to and not in substitution for any other rights
hereunder, prior to the consummation of each Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled
to receive securities or other assets with respect to or in exchange for shares of Common Stock (a &ldquo;<B>Corporate Event</B>&rdquo;),
the Company shall make appropriate provision to insure that the Holder will thereafter have the right to receive upon an exercise of this
Warrant at any time after the consummation of the applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the
shares of the Common Stock (or other securities, cash, assets or other property (except such items still issuable under Sections&nbsp;3
and 4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise of the Warrant prior to such Fundamental
Transaction, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or
subscription rights) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction
had this Warrant been exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations on the
exercise of this Warrant). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory
to the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;<U>[</U>I<U>ntentionally
Omitted]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)   <U>Application</U>.
The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and Corporate Events and shall
be applied as if this Warrant (and any such subsequent warrants) were fully exercisable and without regard to any limitations on the exercise
of this Warrant (provided that the Holder shall continue to be entitled to the benefit of the Maximum Percentage, applied however with
respect to shares of capital stock registered under the 1934 Act and thereafter receivable upon exercise of this Warrant (or any such
other warrant)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)   <U>Calculations</U>.
All calculations under Sections 2, 3 and 4 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of Sections 2, 3 and 4, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be
the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.   <U>NONCIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its articles of incorporation or bylaws, or through
any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all
times in good faith carry out all of the provisions of this Warrant and take all action as may be required to protect the rights of the
Holder. Without limiting the generality of the foregoing, the Company (i)&nbsp;shall not increase the par value of any shares of Common
Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii)&nbsp;shall take all such actions as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock
upon the exercise of this Warrant, and (iii) shall, so long as any of the Warrants are outstanding, take all action necessary to reserve
and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise of the
Warrants, the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of the Warrants then outstanding
(without regard to any limitations on exercise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.   <U>WARRANT
HOLDER NOT DEEMED A STOCKHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,
any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section&nbsp;6, the Company shall provide
the Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously
with the giving thereof to the stockholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7. <U>REISSUANCE OF
WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>Transfer
of Warrant</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder are transferable, in
whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three Trading Days of the date on which the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 7(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)   <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<B>Warrant
Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.   <U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, including, without limitation, an Exercise Notice, unless otherwise provided
herein, such notice shall be given in writing, (i) if delivered (a) from within the domestic United States, by first-class registered
or certified airmail, or nationally recognized overnight express courier, postage prepaid or electronic mail or (b) from outside the United
States, by International Federal Express or electronic mail, and (ii) will be deemed given (A) if delivered by first-class registered
or certified mail domestic, three (3) Business Days after so mailed, (B) if delivered by nationally recognized overnight carrier, one
(1) Business Day after so mailed, (C) if delivered by International Federal Express, two (2) Business Days after so mailed and (D) at
the time of transmission, if delivered by electronic mail to each of the email addresses specified in this Section 8 prior to 5:00 p.m.
(New York time) on a Trading Day, and (E) the next Trading Day after the date of transmission, if delivered by electronic mail to each
of the email addresses specified in this Section 8 on a day that is not a Trading Day or later than 5:00 p.m. (New York time) on any Trading
Day:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(i)   if to the Company,
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Ondas Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">222 Lakeview Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Suite 800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">West Palm Beach, FL 33401</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Eric Brock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: eric.brock@ondas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Akerman LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Three Brickell City Centre</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">98 Southeast Seventh Street, Suite 1100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Miami, FL 33131</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Christina Russo</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: christina.russo@akerman.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">(ii) if to the Holder,
at such address or other contact information delivered by the Holder to the Company or as is on the books and records of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company will give written
notice to the Holder (i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, and certifying, the
calculation of such adjustment and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a
record (A) with respect to any dividend or distribution upon the shares of Common Stock or (B) for determining rights to vote with respect
to any Fundamental Transaction, dissolution or liquidation; <U>provided</U> in each case that such information shall be made known to
the public prior to or in conjunction with such notice being provided to the Holder. It is expressly understood and agreed that the time
of exercise specified by the Holder in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.   <U>MISCELLANEOUS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   <U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 1(a), except as expressly set forth
in Sections 2, 3 and 4. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 1(d), or to receive cash payments contemplated by Sections 1(a) and 1(c) herein, in no event will the Company be required to
net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)   <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(1)   The
Company covenants that at any time this Warrant remains outstanding, it will reserve from its authorized and unissued Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of this Warrant (the &ldquo;<B>Required Reserve Amount</B>&rdquo;).
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the
duty of issuing the necessary Warrant Shares upon the exercise of this Warrant. The Company will take all such reasonable action as may
be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of this Warrant will, upon exercise hereunder and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company
in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(2)   Except
and to the extent waived or consented to by the Holder in writing, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(3)   Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(4)   If,
notwithstanding the foregoing, and not in limitation thereof, at any time while any of the Warrants remain outstanding, the Company does
not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve the Required Reserve
Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall immediately take all action necessary to increase the
Company&rsquo;s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount
for all the Warrants then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable after the date
of the occurrence of an Authorized Share Failure, but in no event later than sixty (60) days after the occurrence of such Authorized Share
Failure, the Company shall hold a meeting of its stockholders for the approval of an increase in the number of authorized shares of Common
Stock. In connection with such meeting, the Company shall provide each stockholder with a proxy statement and shall use its best efforts
to solicit its stockholders&rsquo; approval of such increase in authorized shares of Common Stock and to cause its board of directors
to recommend to the stockholders that they approve such proposal. Notwithstanding the foregoing, if at any such time of an Authorized
Share Failure, the Company is able to obtain the written consent of a majority of the shares of its issued and outstanding shares of Common
Stock to approve the increase in the number of authorized shares of Common Stock, the Company may satisfy this obligation by obtaining
such consent and submitting for filing with the SEC an Information Statement on Schedule 14C. In the event that the Company is prohibited
from issuing shares of Common Stock upon an exercise of this Warrant (without regard to any limitations on exercise of this Warrant) due
to the failure by the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common
Stock (such unavailable number of shares of Common Stock, the &ldquo;<B>Authorization Failure Shares</B>&rdquo;), solely to the extent
such Authorization Share Failure exists at such time of determination, the Holder shall have the right, at such Holder&rsquo;s option,
by delivery written notice to the Company (each, an &ldquo;<B>Authorization Failure Redemption Notice</B>&rdquo;, and the date thereof,
each an &ldquo;<B>Authorization Failure Redemption Date</B>&rdquo;), to require the Company to redeem (each, an &ldquo;<B>Authorization
Failure Redemption</B>&rdquo;) up to such portion of this Warrant exercisable (without regard to any limitations on exercise of this Warrant)
into such Authorization Failure Shares (such applicable portion of this Warrant, each an &ldquo;<B>Authorization Failure Redemption Warrant</B>&rdquo;)
in cash at a price equal to such applicable Black-Scholes Authorization Failure Price of such applicable Authorization Failure Redemption
Warrant. Payment of such amounts shall be made by the Company (or at the Company&rsquo;s direction) to the Holder on or prior to the second
(2nd) Trading Day after the date of such request. Nothing contained in this Section 9(c) shall limit any obligations of the Company under
any other provision of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)   <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed
and enforced in accordance with the internal laws of the State of New York, without giving effect to any provision or rule (whether of
the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State
of New York. The Company and, by accepting this Warrant, the Holder each agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Warrant (whether brought against the Company or the Holder or their respective
affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and
federal courts sitting in the City of New York. The Company and, by accepting this Warrant, the Holder each hereby irrevocably submits
to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The Company and, by
accepting this Warrant, the Holder each hereby irrevocably waives personal service of process and consents to process being served in
any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to it at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If the Company or the Holder shall commence an action, suit or proceeding to enforce any provisions of
this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. <B>EACH OF
THE COMPANY AND EACH HOLDER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)   <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)   <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Securities Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)   <U>Warrant
Agent</U>. The Company shall initially serve as warrant agent under this Warrant. Upon ten (10) days&rsquo; notice to the Holder, the
Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation
resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company
or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant
agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant
agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&rsquo;s last address as shown on the Warrant Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)   <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)   <U>Remedies,
Characterization, Other Obligations, Breaches and Injunctive Relief</U>. The remedies provided in this Warrant shall be cumulative and
in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual and consequential
damages for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that there shall
be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with
respect to payments, exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall
not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the holder
of this Warrant shall be entitled, in addition to all other available remedies, to specific performance and/or temporary, preliminary
and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity of
proving actual damages and without posting a bond or other security. The Company shall provide all information and documentation to the
Holder that is reasonably requested by the Holder to enable the Holder to confirm the Company&rsquo;s compliance with the terms and conditions
of this Warrant. The issuance of shares and certificates for shares as contemplated hereby upon the exercise of this Warrant shall be
made without charge to the Holder or such shares for any issuance tax or other costs in respect thereof, provided that the Company shall
not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate
in a name other than the Holder or its agent on its behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)   <U>Payment
of Collection, Enforcement and Other Costs</U>. If (a) this Warrant is placed in the hands of an attorney for collection or enforcement
or is collected or enforced through any legal proceeding or the holder otherwise takes action to collect amounts due under this Warrant
or to enforce the provisions of this Warrant or (b) there occurs any bankruptcy, reorganization, receivership of the company or other
proceedings affecting company creditors&rsquo; rights and involving a claim under this Warrant, then the Company shall pay the costs incurred
by the Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other
proceeding, including, without limitation, attorneys&rsquo; fees and disbursements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)   <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)   <U>Amendment</U>.
Except for Section 1(e) and this Section 9(k) which may not be amended, modified or waived, this Warrant may be modified or amended or
the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)   <U>Severability</U>.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(n)   <U>Headings</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(o)   <U>Disclosure</U>.
Upon delivery by the Company to the Holder (or receipt by the Company from the Holder) of any notice in accordance with the terms of this
Warrant, unless the Company has in good faith determined that the matters relating to such notice do not constitute material, non-public
information relating to the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York city time on the Business
Day immediately following such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form
8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information relating to the Company
or any of its Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt
of notice from the Holder, as applicable), and in the absence of any such written indication in such notice (or notification from the
Company immediately upon receipt of notice from the Holder), the Holder shall be entitled to presume that information contained in the
notice does not constitute material, non-public information relating to the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(p)   <U>Absence
of Trading and Disclosure Restrictions</U>. The Company acknowledges and agrees that the Holder is not a fiduciary or agent of the Company
and that the Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain
from trading any securities while in possession of such information in the absence of a written non-disclosure agreement signed by an
officer of the Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed,
written non-disclosure agreement, the Company acknowledges that the Holder may freely trade in any securities issued by the Company, may
possess and use any information provided by the Company in connection with such trading activity, and may disclose any such information
to any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.   <U>DISPUTE
RESOLUTION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(a)   <U>Submission
to Dispute Resolution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(1)&nbsp;In
the case of a dispute relating to the Exercise Price, the Closing Sale Price, the Bid Price, Black Scholes Authorization Failure Price,
or fair market value or the arithmetic calculation of the number of Warrant Shares (as the case may be) (including, without limitation,
a dispute relating to the determination of any of the foregoing), the Company or the Holder (as the case may be) shall submit the dispute
to the other party via electronic mail (A) if by the Company, within two (2) Business Days after the occurrence of the circumstances giving
rise to such dispute or (B) if by the Holder, at any time after the Holder learned of the circumstances giving rise to such dispute. If
the Holder and the Company are unable to promptly resolve such dispute relating to such Exercise Price, such Closing Sale Price, such
Bid Price, such Black Scholes Authorization Failure Price or such fair market value or such arithmetic calculation of the number of Warrant
Shares (as the case may be), at any time after the second (2<SUP>nd</SUP>) Business Day following such initial notice by the Company or
the Holder (as the case may be) of such dispute to the Company or the Holder (as the case may be), then the Holder may, at its sole option,
select an independent, reputable investment bank to resolve such dispute.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(2)   The
Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance
with the first sentence of this Section&nbsp;10 and (B) written documentation supporting its position with respect to such dispute, in
each case, no later than 5:00 p.m. (New York time) by the fifth (5<SUP>th</SUP>) Business Day immediately following the date on which
the Holder selected such investment bank (the &ldquo;<B>Dispute Submission Deadline</B>&rdquo;) (the documents referred to in the immediately
preceding clauses (A) and (B) are collectively referred to herein as the &ldquo;<B>Required Dispute Documentation</B>&rdquo;) (it being
understood and agreed that if either the Holder or the Company fails to so deliver all of the Required Dispute Documentation by the Dispute
Submission Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be entitled to (and
hereby waives its right to) deliver or submit any written documentation or other support to such investment bank with respect to such
dispute and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was delivered to such
investment bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company and the Holder or
otherwise requested by such investment bank, neither the Company nor the Holder shall be entitled to deliver or submit any written documentation
or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.5in">(3)   The
Company and the Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and the Holder
of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The reasonable fees and
expenses of such investment bank shall be borne solely by the Company, and such investment bank&rsquo;s resolution of such dispute shall
be final and binding upon all parties absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   <U>Miscellaneous</U>.
The Company expressly acknowledges and agrees that (i) this Section&nbsp;10 constitutes an agreement to arbitrate between the Company
and the Holder (and constitutes an arbitration agreement) under the rules then in effect under &sect; 7501, et seq. of the New York Civil
Practice Law and Rules (&ldquo;<B>CPLR</B>&rdquo;) and that the Holder is authorized to apply for an order to compel arbitration pursuant
to CPLR &sect; 7503(a) in order to compel compliance with this Section&nbsp;10, (ii) the terms of this Warrant and each other applicable
Transaction Document shall serve as the basis for the selected investment bank&rsquo;s resolution of the applicable dispute, such investment
bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like that such investment bank
determines are required to be made by such investment bank in connection with its resolution of such dispute and in resolving such dispute
such investment bank shall apply such findings, determinations and the like to the terms of this Warrant and any other applicable Transaction
Documents, (iii) the Holder (and only the Holder), in its sole discretion, shall have the right to submit any dispute described in this
Section&nbsp;10 to any state or federal court sitting in The City of New York, Borough of Manhattan in lieu of utilizing the procedures
set forth in this Section&nbsp;10 and (iv) nothing in this Section&nbsp;10 shall limit the Holder from obtaining any injunctive relief
or other equitable remedies (including, without limitation, with respect to any matters described in this Section&nbsp;10).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">11.   <U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)   &ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control
with, such Person, as such terms are used in and construed under Rule 405 under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)   &ldquo;<B>Attribution
Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder funds
or managed accounts, currently, or from time to time after the Subscription Date, directly or indirectly managed or advised by the Holder&rsquo;s
investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder or any of the foregoing,
(iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing and (iv) any other
Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated with the Holder&rsquo;s and the other
Attribution Parties for purposes of Section 13(d) of the Exchange Act. For clarity, the purpose of the foregoing is to subject collectively
the Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)
&ldquo;<B>Bid Price</B>&rdquo; means, for any security as of the particular time of determination, the bid price for such security on
the Principal Market as reported by Bloomberg as of such time of determination, or, if the Principal Market is not the principal securities
exchange or trading market for such security, the bid price of such security on the principal securities exchange or trading market where
such security is listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing does not apply, the bid
price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg as of
such time of determination, or, if no bid price is reported for such security by Bloomberg as of such time of determination, the average
of the bid prices of any market makers for such security as reported on the Pink Open Market as of such time of determination. If the
Bid Price cannot be calculated for a security as of the particular time of determination on any of the foregoing bases, the Bid Price
of such security as of such time of determination shall be the fair market value of such securities as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company. All such determinations shall be appropriately adjusted for any stock dividend,
stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)   &ldquo;<B>Black
Scholes Authorization Failure Price</B>&rdquo; means, with respect to any given Authorization Failure Redemption, the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the applicable
Authorization Failure Redemption Date for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury
rate for a period equal to the time between such Authorization Failure Redemption Date and the Expiration Date, (B) an expected volatility
equal to the 30-day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of
the Trading Day immediately prior to such Authorization Failure Redemption Date, (C) the underlying price per share used in such calculation
shall be the highest VWAP during the sixty (60) Trading Day period ending on, and including, the Trading Day immediately prior to such
Authorization Failure Redemption Date and (D) a remaining option time equal to the time between such Authorization Failure Redemption
Date and the Expiration Date and (E) a zero cost of borrow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&nbsp;[Intentionally Omitted]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)   &ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg Financial Markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)   &ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&nbsp;[Intentionally
Omitted]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)   &ldquo;<B>Common
Stock</B>&rdquo; means (i)&nbsp;the Company&rsquo;s Common Stock, par value $0.0001 per share, and (ii)&nbsp;any capital stock into which
such Common Stock shall have been changed or any capital stock resulting from a reclassification of such Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)   &ldquo;<B>Convertible
Securities</B>&rdquo; means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)   &ldquo;<B>Eligible
Market</B>&rdquo; means The NASDAQ Capital Market, the NYSE American LLC, The NASDAQ Global Select Market, The NASDAQ Global Market or
The New York Stock Exchange, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)   &ldquo;<B>Expiration
Date</B>&rdquo; means the date that is the seventh anniversary after the date hereof or, if such date falls on a day other than a Business
Day or on which trading does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;), the next day that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)
&ldquo;<B>Fundamental Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the
surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all
of the properties or assets of the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of Regulation
S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject
to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is
accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock, (y) 50% of the outstanding shares of Common
Stock calculated as if any shares of Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities
making or party to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of Common Stock such that
all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer,
become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common
Stock, or (iv) consummate a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually
or in the aggregate, acquire, either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares
of Common Stock calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any
Subject Entity making or party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number
of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the
1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common Stock, (B)
that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions,
allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the &ldquo;beneficial owner&rdquo; (as
defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender,
tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation, business combination, reorganization,
recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever,
of either (x) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock, (y) at least 50%
of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by all such Subject Entities as of
the date of this Warrant calculated as if any shares of Common Stock held by all such Subject Entities were not outstanding, or (z) a
percentage of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock or other equity securities
of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring other
shareholders of the Company to surrender their shares of Common Stock without approval of the shareholders of the Company or (C) directly
or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering
into any other instrument or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which
case this definition shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition
to the extent necessary to correct this definition or any portion of this definition which may be defective or inconsistent with the intended
treatment of such instrument or transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(n)   &ldquo;<B>Group</B>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the Exchange Act and as defined in Rule 13d-5 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(o)   &ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(p)   &ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person, including such entity whose
common stock or equivalent equity security is quoted or listed on an Eligible Market (or, if so elected by the Holder, any other market,
exchange or quotation system), or, if there is more than one such Person or such entity, the Person or such entity designated by the Holder
or in the absence of such designation, such Person or entity with the largest public market capitalization as of the date of consummation
of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(q)   &ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(r)   &ldquo;<B>Principal
Market</B>&rdquo; means The NASDAQ Capital Market (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(s)   &ldquo;<B>Required
Holders</B>&rdquo; means the holders of the Warrants representing at least a majority of the shares of Common Stock underlying the Warrants
then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(t)   <B>&ldquo;Standard
Settlement Period&rdquo;</B> means the standard settlement period, expressed in a number of Trading Days, for the Company&rsquo;s primary
trading market or quotation system with respect to the Common Stock that is in effect on the date of receipt of an applicable Exercise
Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(u)   &ldquo;<B>Subject
Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)&nbsp;&ldquo;<B>Successor
Entity</B>&rdquo; means one or more Person or Persons (or, if so elected by the Holder, the Company or Parent Entity) formed by, resulting
from or surviving any Fundamental Transaction or one or more Person or Persons (or, if so elected by the Holder, the Company or the Parent
Entity) with which such Fundamental Transaction or shall have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(w)   &ldquo;<B>Trading
Day</B>&rdquo; means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal
trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then
traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x)   &ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(y)   &ldquo;<B>Transaction
Documents</B>&rdquo; shall have the meaning as set forth in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(z)   &ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
the Company has caused this Warrant to purchase Common Stock to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">Ondas Holdings Inc. </FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>By:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Name:&nbsp;</TD>
  <TD>Eric Brock</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Warrant</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE
THIS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PREFUNDED WARRANT TO
PURCHASE COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Ondas
Holdings Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned holder hereby
exercises the right to purchase _________________ shares of Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;) of <FONT STYLE="text-transform: uppercase">Ondas
Holdings Inc.</FONT>, a corporation organized under the laws of the State of Nevada (the &ldquo;<B>Company</B>&rdquo;), evidenced by the
attached Warrant to Purchase Common Stock (the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined
shall have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Form of Exercise Price</U>.
The Holder intends that payment of the Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">____________ a
&ldquo;<U>Cash Exercise&rdquo;</U> with respect to _________________ Warrant Shares; and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">____________ a
<U>&ldquo;Cashless Exercise&rdquo;</U> with respect to _______________ Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Section 1(d) the Holder [is][is not]
exercising its option to have the VWAP determined by reference to [the VWAP on the Trading Day immediately preceding the date of the applicable
Exercise Notice] or [the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the
Holder&rsquo;s execution of the applicable Exercise Notice if such Exercise Notice is executed during &ldquo;regular trading hours&rdquo;
on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 1(d) of the Warrant].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Payment of Exercise
Price</U>. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant
hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance with the terms
of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Beneficial Ownership
Representation</U>. Notwithstanding anything to the contrary contained herein, this Exercise Notice shall constitute a representation
by the Holder of the Warrant submitting this Exercise Notice that after giving effect to the exercise provided for in this Exercise Notice,
such Holder (together with its affiliates) will not have beneficial ownership (together with the beneficial ownership of such Person&rsquo;s
affiliates) of a number of shares of Common Stock which exceeds the Maximum Percentage (as defined in the Warrant) of the total outstanding
shares of Common Stock of the Company as determined pursuant to the provisions of Section 1(e) of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Delivery of Warrant
Shares</U>. The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: _______________ __, ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">&nbsp;</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Name of Registered Holder</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>By:</TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 5%">Name:&nbsp;</TD>
  <TD STYLE="width: 31%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby acknowledges
this Exercise Notice and hereby directs Broadridge Corporate Issuer Solutions to issue the above indicated number of shares of Common
Stock on or prior to the applicable Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">Ondas Holdings Inc. </FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>By:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Name:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 30%">Name:</TD>
  <TD STYLE="width: 70%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>(Please Print)</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Address:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>(Please Print)</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Phone Number:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Email Address:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">Dated: __________________________________ __, ______</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Holder&rsquo;s Signature:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Holder&rsquo;s Address:</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ea027241901ex5-1_ondas.htm
<DESCRIPTION>OPINION OF AKERMAN LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 100%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Akerman LLP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Three Brickell City Centre</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">98 Southeast Seventh Street</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Suite 1100</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Miami, FL 33131</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">T: +1 305 374 5600</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">F: +1 305 374 5095</P>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 12, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ondas Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">222 Lakeview Avenue, Suite 800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">West Palm Beach, FL 33401</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Re: Prospectus Supplement
to Registration Statement on Form S-3ASR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel to
Ondas Holdings Inc., a Nevada corporation (the &ldquo;Company&rdquo;), in connection with the preparation and filing with the Securities
and Exchange Commission (the &ldquo;Commission&rdquo;) of a Prospectus Supplement dated January 9, 2026 (the &ldquo;Prospectus Supplement&rdquo;),
pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the &ldquo;Act&rdquo;). The Prospectus Supplement supplements the
Company&rsquo;s Registration Statement on Form S-3ASR (File No. 333-290121) which automatically became effective upon filing on September
9, 2025, as amended from time to time (such Registration Statement in the form in which it became effective is referred to herein as the
&ldquo;Registration Statement&rdquo;), including the base prospectus dated September 9, 2025 (together with the Prospectus Supplement,
the &ldquo;Prospectus&rdquo;), relating to the registration and offering by the Company of 19,000,000 shares (the &ldquo;Shares&rdquo;)
of the Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;Common Stock&rdquo;), pre-funded warrants (the &ldquo;Pre-Funded
Warrants&rdquo;) to purchase up to 41,790,274 shares of Common Stock (the &ldquo;Pre-Funded Warrant Shares&rdquo;), and common warrants
(the &ldquo;Common Warrants,&rdquo; together with the Pre-Funded Warrants, the &ldquo;Warrants&rdquo;) to purchase up to 121,580,548 shares
of Common Stock (the &ldquo;Common Warrant Shares,&rdquo; together with the Pre-Funded Warrant Shares, the &ldquo;Warrant Shares&rdquo;),
pursuant to the Securities Purchase Agreement (the &ldquo;Securities Purchase Agreement&rdquo;), dated January 9, 2026, by and between
the Company, on the one hand, and the investors, on the other hand, that certain Placement Agent Agreement (the &ldquo;Placement Agent
Agreement&rdquo;), dated January 9, 2026, by and between the Company, on the one hand, and Oppenheimer &amp; Co. Inc., as representative of the several placement agents named in Schedule I to the Placement Agent Agreement (collectively, the &ldquo;Placement Agents&rdquo;),
on the other hand. The Shares, Warrants and the Warrant Shares are collectively referred to as the &ldquo;Offered Securities.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with this opinion,
we have examined originals or copies, certified or otherwise identified to our satisfaction, of: (i) the Registration Statement and exhibits
thereto, including the Prospectus, (ii) the Amended and Restated Articles of Incorporation of the Company, as amended, as currently in
effect (the &ldquo;Articles of Incorporation&rdquo;); (iii) the Amended and Restated Bylaws of the Company, as amended, as currently in
effect (the &ldquo;Bylaws&rdquo;); (iv) the Securities Purchase Agreement; (v) the Placement Agent Agreement; (vi) the form of Pre-Funded
Warrant; (vii) the form of Common Warrant; and (viii) certain resolutions and unanimous written consents of the Board of Directors of
the Company and the Pricing Committee of the Board of Directors of the Company. We have also examined originals or copies, certified or
otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates of public officials, certificates
of officers or other representatives of the Company and others, and such other documents, certificates and records as we have deemed necessary
or appropriate as a basis for the opinion set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ondas Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">January 12, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our examination, we have
assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us
as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified, conformed or
photostatic copies, and the authenticity of the originals of such copies. In making our examination of executed documents, we have assumed
that the parties thereto, other than the Company, had the power, corporate or other, to enter into and perform all obligations thereunder
and have also assumed the due authorization by all requisite action, corporate or other, and the execution and delivery by such parties
of such documents and the validity and binding effect thereof on such parties. As to any facts material to the opinion expressed herein
which we have not independently established or verified, we have relied upon statements and representations of officers and other representatives
of the Company and others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With your consent, we have
assumed that none of (i) the execution, delivery and performance of any of the Securities Purchase Agreement, the Placement Agent Agreement,
the Warrants and the Prospectus, (ii) the terms of any of the Warrants, (iii) the issuance and delivery of such Warrants, including the
issuance of the Warrant Shares upon exercise of the Warrants in accordance with the terms of the Securities Purchase Agreement and Warrants
or (iv) the compliance by the Company with the terms of the Warrants will (a) violate any applicable law, rule or regulation to which
the Company is then subject or the Articles of Incorporation or Bylaws, each as then in effect, (b) result in a breach of or default under
any instrument or agreement then binding upon the Company or any of its properties, or (c) violate, or cause the Company not to comply
with, any consent, approval, license, authorization, restriction or requirement imposed by, or any filing, recording or registration with,
any court or governmental body having jurisdiction over the Company. With your consent, we have also assumed that a sufficient number
of shares of Common Stock will remain authorized and reserved for issuance in accordance with the terms of the Securities Purchase Agreement,
Placement Agent Agreement and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon the foregoing and
subject to the limitations set forth below, as of the date hereof, we are of the opinion that the Securities Purchase Agreement, Placement
Agent Agreement and the Warrants constitute valid and binding obligations of the Company, enforceable against the Company in accordance
with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors&rsquo; rights generally, concepts
of reasonableness and equitable principles of general applicability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this opinion,
we express no opinion as to matters governed by laws of any jurisdiction other than New York. We neither express nor imply any obligation
with respect to any other laws or the laws of any other jurisdiction or of the United States. For purposes of this opinion, we assume
that the Offered Securities will be issued in compliance with all applicable state securities or blue sky laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are opining only as to
matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is rendered as of the date
hereof and is based upon currently existing statutes, rules, regulations and judicial decisions. We disclaim any obligation to advise
you of any change in any of these sources of law or subsequent legal or factual developments that affect any matters or opinions set forth
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We understand that you wish
to file this opinion as an exhibit to the Current Report on Form 8-K dated the date hereof filed by the Company, and we hereby consent
thereto. We hereby further consent to the reference to us under the caption &ldquo;Legal Matters&rdquo; in the Prospectus Supplement.
In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the
Act or the rules and regulations of the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Akerman LLP</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>5
<FILENAME>ea027241901ex5-2_ondas.htm
<DESCRIPTION>OPINION OF SNELL & WILMER L.L.P
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Snell &amp;
Wilmer L.L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">1700 S.
PAVILION CENTER DRIVE, SUITE 700</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">LAS VEGAS,
NV 89135</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">TELEPHONE:
702.784.5200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">FACSIMILE:
702.784.5252</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 12, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ondas Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">222 Lakeview Avenue, Suite 800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">West Palm Beach, FL 33401</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Re: Prospectus Supplement to Registration Statement on Form S-3ASR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as Nevada counsel
to Ondas Holdings Inc., a Nevada corporation (the &ldquo;Company&rdquo;), in connection with the preparation and filing with the Securities
and Exchange Commission (the &ldquo;Commission&rdquo;) of a Prospectus Supplement dated January 9, 2026 filed with the Commission pursuant
to Rule 424(b) of the Securities Act Regulations (&ldquo;Prospectus Supplement&rdquo;) on January 9, 2026, which supplements the Company&rsquo;s
Registration Statement on Form S-3ASR (File No. 333-290121) which automatically became effective upon filing on September 9, 2025, as
amended from time to time (such Registration Statement in the form in which it became effective is referred to herein as the &ldquo;Registration
Statement&rdquo;), under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), including the base prospectus dated
September 9, 2025 (together with the Prospectus Supplement, the &ldquo;Prospectus&rdquo;), relating to the registration and offering by
the Company of 19,000,000 shares (the &ldquo;Shares&rdquo;) of the Company&rsquo;s Common Stock, par value $0.0001 per share (the &ldquo;Common
Stock&rdquo;), pre-funded warrants (the &ldquo;Pre-Funded Warrants&rdquo;) to purchase up to 41,790,274 shares of Common Stock (the &ldquo;Pre-Funded
Warrant Shares&rdquo;), and common warrants (the &ldquo;Common Warrants,&rdquo; together with the Pre-Funded Warrants, the &ldquo;Warrants&rdquo;)
to purchase up to 121,580,548 shares of Common Stock (the &ldquo;Common Warrant Shares,&rdquo; together with the Pre-Funded Warrant Shares,
the &ldquo;Warrant Shares&rdquo;), pursuant to that certain Securities Purchase Agreement, dated January 9, 2026, by and between the Company,
on the one hand, and the investors, on the other hand (the &ldquo;Securities Purchase Agreement&rdquo;) and that certain Placement Agent
Agreement (the &ldquo;Placement Agent Agreement&rdquo;), dated January 9, 2026, by and between the Company, on the one hand, and Oppenheimer
&amp; Co. Inc., as representative of the several placement agents named in Schedule I to the Placement Agent Agreement (collectively,
the &ldquo;Placement Agents&rdquo;), on the other hand. The Shares, Warrants and the Warrant Shares are collectively referred to as the
&ldquo;Offered Securities.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion is being furnished
in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act in connection with the filing of the
Registration Statement. All capitalized terms used herein and not otherwise defined shall have the respective meanings given to them in
the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with this opinion,
we have examined originals or copies, certified or otherwise identified to our satisfaction, of (i) the Registration Statement and exhibits
thereto, including the Prospectus; (ii) the Amended and Restated Articles of Incorporation of the Company, as amended, as currently in
effect (the &ldquo;Charter&rdquo;); (iii) the Amended and Restated Bylaws of the Company, as amended, as currently in effect; (iv) the
Securities Purchase Agreement; (v) the Placement Agent Agreement; (vi) the form of Pre-Funded Warrant; (vii) the form of Common Warrant;
and (viii) certain resolutions and unanimous written consents of the board of directors of the Company (the &ldquo;Board&rdquo;) and the
pricing committee of the Board relating to (A) the issuance and sale of the Offered Securities, (B) the specimen of Common Stock certificate,
and (C) other related matters. For the purpose of rendering this opinion, we have made such factual and legal examinations as we deemed
necessary under the circumstances, and in that connection therewith we have examined, among other things, originals or copies, certified
or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials, certificates of officers
or other representatives of the Company, and other instruments and have made such inquiries as we have deemed appropriate for the purpose
of rendering this opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our examination, we have
assumed without independent verification the legal capacity of all natural persons, the genuineness of all signatures, the authenticity
of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic,
certified, conformed or photostatic copies, and the authenticity of the originals of such copies. In making our examination of executed
documents, we have assumed that the parties thereto, other than the Company, had the power, corporate or other, to enter into and perform
all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and the execution
and delivery by such parties of such documents and the validity and binding effect thereof on such parties. For purposes of the opinions
expressed herein, we assumed that the Warrants will constitute valid and legally binding obligations of the Company, enforceable against
the Company in accordance with their terms. Our opinions are subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium and similar laws affecting creditors&rsquo; rights and remedies generally, and subject, as to enforceability, to general principles
of equity, including principles of commercial reasonableness, good faith and fair dealing (regardless of whether enforcement is sought
in a proceeding at law or in equity). As to any facts material to the opinions expressed herein which were not independently established
or verified, we have relied upon oral or written statements and representations of officers or other representatives of the Company and
others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ondas Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 12, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the basis of, and in reliance
on, the foregoing examination and subject to the assumptions, exceptions, qualifications and limitations contained herein, we are of the
opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the Shares and Warrants to be issued and sold by the Company under the Securities Purchase Agreement and
Placement Agreement have been duly authorized, and when the Shares are delivered to and paid for by the investors in accordance with the
terms of the Securities Purchase Agreement and Placement Agent Agreement, the Shares will be validly issued, fully paid and nonassessable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the Pre-Funded Warrant Shares will be duly authorized and, when the Pre-Funded Warrant Shares are issued
and delivered upon exercise of the Pre-Funded Warrants and payment of any consideration for the Pre-Funded Warrant Shares in accordance
with the terms of the Securities Purchase Agreement, the Placement Agent Agreement and the Pre-Funded Warrants, as applicable, will be
validly issued, fully paid and nonassessable; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the Common Warrant Shares will be duly authorized and, when the Common Warrant Shares are issued and delivered
upon exercise of the Common Warrants and payment of any consideration for the Common Warrant Shares in accordance with the terms of the
Securities Purchase Agreement, the Placement Agent Agreement and the Common Warrants, as applicable, will be validly issued, fully paid
and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We render this opinion only
with respect to the general corporate law of the State of Nevada as set forth in Chapter 78 of the Nevada Revised Statutes. We neither
express nor imply any obligation with respect to any other laws or the laws of any other jurisdiction or of the United States. For purposes
of this opinion, we assume that the Shares and Warrant Shares will be issued in compliance with all applicable state securities or blue
sky laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We assume no obligation to
update or supplement this opinion if any applicable laws change after date of this opinion or if we become aware after the date of this
opinion of any facts, whether existing before or arising after the date hereof, that might change the opinions expressly so stated. Without
limiting the generality of the foregoing, we neither express nor imply any opinion regarding the contents of the Registration Statement,
other than as expressly stated herein with respect to the Shares and Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are opining only as to
matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is rendered as of the date
hereof and is based upon currently existing statutes, rules, regulations and judicial decisions. We disclaim any obligation to advise
you of any change in any of these sources of law or subsequent legal or factual developments that affect any matters or opinions set forth
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the filing
of this opinion letter with the Commission as an exhibit to the Current Report on Form 8-K dated the date hereof filed by the Company.
We also consent to the reference to our firm under the heading &ldquo;Legal Matters&rdquo; in the Prospectus Supplement. In giving such
consent, we do not thereby concede that we are included in the category of persons whose consent is required under Section 7 of the Securities
Act or the rules and regulations of the Commission promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding: 0.25pt">&nbsp; &nbsp; &nbsp;</TD>
    <TD STYLE="width: 40%; padding: 0.25pt; font-size: 10pt; text-align: justify">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify">/s/ Snell &amp; Wilmer L.L.P.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>ea027241901ex10-1_ondas.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, DATED JANUARY 9, 2026 BY AND BETWEEN ONDAS HOLDINGS INC. AND EACH INVESTOR LISTED ON THE SCHEDULE OF BUYERS ATTACHED THERETO
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF SECURITIES PURCHASE AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>SECURITIES PURCHASE
AGREEMENT</B> (this &ldquo;<B>Agreement</B>&rdquo;), dated as of January [&nbsp; ], 2026, is by and among Ondas Holdings Inc., a Nevada corporation
with offices located at 222 Lakeview Avenue, Suite 800, West Palm Beach, Florida 33401 (the &ldquo;<B>Company</B>&rdquo;), and each of
the investors listed on the Schedule of Buyers attached hereto (individually, a &ldquo;<B>Buyer</B>&rdquo; and collectively, the &ldquo;<B>Buyers</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>RECITALS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;The
Company and each Buyer desire to enter into this transaction to purchase (i) the Common Shares (as defined below), and (ii) Warrants (as
defined below) pursuant to a currently effective shelf registration statement on Form S-3ASR (Registration Number 333-290121) (the &ldquo;<B>Registration
Statement</B>&rdquo;), which Registration Statement has been declared effective in accordance with the Securities Act of 1933, as amended
(the &ldquo;<B>1933 Act</B>&rdquo;), by the United States Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;Each
Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, (i) such aggregate number
of shares of Common Stock as set forth opposite such Buyer&rsquo;s name in column (3) on the Schedule of Buyers (which aggregate amount
for all Buyers shall be [ ] shares of Common Stock and shall collectively be referred to herein as the &ldquo;<B>Common Shares</B>&rdquo;),
(ii) a Pre-Funded Warrant to initially acquire up to such aggregate number of shares of Common Stock set forth opposite such Buyer&rsquo;s
name in column (4) on the Schedule of Buyers, as evidenced by a certificate in the form attached hereto as <B><U>Exhibit A-1</U></B> (the
&ldquo;<B>Pre-Funded Warrants</B>&rdquo;) (as exercised, collectively, the &ldquo;<B>Pre-Funded Warrant Shares</B>&rdquo;) and (iii) a
Warrant to initially acquire up to such aggregate number of shares of Common Stock set forth opposite such Buyer&rsquo;s name in column
(5) on the Schedule of Buyers, as evidenced by a certificate in the form attached hereto as <B><U>Exhibit A-2</U></B> (the &ldquo;<B>Common
Warrant</B>&rdquo;, and together with the Pre-Funded Warrant, the &ldquo;<B>Warrants</B>&rdquo;) (as exercised, collectively, the &ldquo;<B>Common
Warrant Shares</B>&rdquo;, and together with the Pre-Funded Warrant Shares, the &ldquo;<B>Warrant Shares</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.&nbsp;The
Common Shares, the Warrants and the Warrant Shares are collectively referred to herein as the &ldquo;<B>Securities</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Company and each Buyer hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><B>PURCHASE AND SALE OF COMMON SHARES AND WARRANTS.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Purchase
of Common Shares and Warrants</U>. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 6 and 7 below, the
Company shall issue and sell to each Buyer, and each Buyer severally, but not jointly, agrees to purchase from the Company on the Closing
Date (as defined below) (A) such aggregate number of Common Shares as is set forth opposite such Buyer&rsquo;s name in column (3) on the
Schedule of Buyers, (B) Pre-Funded Warrant to initially acquire up to that aggregate number of Pre-Funded Warrant Shares as is set forth
opposite such Buyer&rsquo;s name in column (4) on the Schedule of Buyers and (C) Common Warrant to initially acquire up to such aggregate
number of Common Warrant Shares as is set forth opposite such Buyer&rsquo;s name in column (5) on the Schedule of Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Closing</U>.
The closing (the &ldquo;<B>Closing</B>&rdquo;) of the purchase of the Common Shares and the Warrants by the Buyers shall occur at the
offices of Kelley Drye &amp; Warren LLP, 3 World Trade Center, 175 Greenwich Street, New York, NY 10007. The date and time of the Closing
(the &ldquo;<B>Closing Date</B>&rdquo;) shall be 10:00 a.m., New York time, on the first (1st) Business Day (as defined below) on which
the conditions to the Closing set forth in Sections 6 and 7 below are satisfied or waived (or such other date as is mutually agreed to
by the Company and each Buyer). As used herein &ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day
on which commercial banks in The City of New York are authorized or required by law to remain closed; <U>provided</U>, <U>however</U>,
for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;,
&ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for
wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Purchase
Price.</U> The aggregate purchase price for the Common Shares and the Warrants to be purchased by each Buyer (the &ldquo;<B>Purchase Price</B>&rdquo;)
shall be the amount set forth opposite such Buyer&rsquo;s name in column (6) on the Schedule of Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Form
of Payment; Deliveries</U>. On the Closing Date, (i) each Buyer shall pay its respective Purchase Price to the Company for the Common
Shares and the Warrants to be issued and sold to such Buyer at the Closing, by wire transfer of immediately available funds in accordance
with the Flow of Funds Letter (as defined below) (less, in the case of the lead Buyer, the amounts withheld pursuant to Section 4(j))
and (ii)&nbsp;the Company shall (A) cause Broadridge Financial Solutions, Inc. (together with any subsequent transfer agent, the &ldquo;<B>Transfer
Agent</B>&rdquo;) through the Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program, to credit
such aggregate number of Common Shares that each Buyer is purchasing as is set forth opposite such Buyer&rsquo;s name in column (3) of
the Schedule of Buyers to such Buyer&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal at Custodian
system, and (B) deliver to each Buyer (x) a Pre-Funded Warrant pursuant to which such Buyer shall have the right to initially acquire
up to that aggregate number of Pre-Funded Warrant Shares as is set forth opposite such Buyer&rsquo;s name in column (4) on the Schedule
of Buyers and (y) a Common Warrant pursuant to which such Buyer shall have the right to initially acquire up to such aggregate number
of Common Warrant Shares as is set forth opposite such Buyer&rsquo;s name in column (5) on the Schedule of Buyers, in each case, duly
executed on behalf of the Company and registered in the name of such Buyer or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Sales
During Pre-Settlement Period</U>. Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of
this Agreement by the Company and an applicable Buyer, through, and including the time immediately prior to the Closing (the &ldquo;<B>Pre-Settlement
Period</B>&rdquo;), such Buyer sells (excluding &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO) to any Person all,
or any portion, of any Common Shares to be issued hereunder to such Buyer at the Closing (collectively, the &ldquo;<B>Pre-Settlement Common
Shares</B>&rdquo;), such Buyer shall, automatically hereunder (without any additional required actions by such Buyer or the Company),
be deemed to be unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement
Common Shares to such Buyer at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Common Shares
to such Buyer prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement Common Shares hereunder; and provided
further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such Buyer
as to whether or not during the Pre-Settlement Period such Buyer shall sell any Common Shares to any Person and that any such decision
to sell any Common Shares by such Buyer shall be made, in the sole discretion of such Buyer, at the time such Buyer elects to effect any
such sale, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><B>BUYER&rsquo;S REPRESENTATIONS AND WARRANTIES.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Buyer, severally and
not jointly, represents and warrants to the Company with respect to only itself that, as of the date hereof and as of the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Organization;
Authority</U>. Such Buyer is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
(as defined below) to which it is a party and otherwise to carry out its obligations hereunder and thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Validity;
Enforcement</U>. This Agreement has been duly and validly authorized, executed and delivered on behalf of such Buyer and shall
constitute the legal, valid and binding obligations of such Buyer enforceable against such Buyer in accordance with its terms,
except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable
creditors&rsquo; rights and remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>No
Conflicts</U>. The execution, delivery and performance by such Buyer of this Agreement and the consummation by such Buyer of the transactions
contemplated hereby will not (i) result in a violation of the organizational documents of such Buyer, (ii) conflict with, or constitute
a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such Buyer is a party or (iii) result in a
violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to such Buyer,
except, in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which could not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of such Buyer to perform its obligations
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>No
Group</U>. Other than affiliates of such Buyer who are also Buyers under this Agreement, such Buyer is not under common control with or
acting in concert with any other Buyer and is not part of a &ldquo;group&rdquo; for purposes of the 1934 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>3.</B></FONT></TD><TD STYLE="text-align: justify"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company represents and
warrants to each of the Buyers that, as of the date hereof and as of the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Organization
and Qualification</U>. Each of the Company and each of its Subsidiaries are entities duly organized and validly existing and in good standing
under the laws of the jurisdiction in which they are formed, and have the requisite power and authority to own their properties and to
carry on their business as now being conducted and as presently proposed to be conducted. Each of the Company and each of its Subsidiaries
is duly qualified as a foreign entity to do business and is in good standing in every jurisdiction in which its ownership of property
or the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified
or be in good standing would not reasonably be expected to have a Material Adverse Effect (as defined below). As used in this Agreement,
&ldquo;<B>Material Adverse Effect</B>&rdquo; means any material adverse effect on (i) the business, properties, assets, liabilities, operations
(including results thereof), condition (financial or otherwise) or prospects of the Company or any Subsidiary, individually or taken as
a whole, (ii) the transactions contemplated hereby or in any of the other Transaction Documents or any other agreements or instruments
to be entered into in connection herewith or therewith or (iii) the authority or ability of the Company or any of its Subsidiaries to
perform any of their respective obligations under any of the Transaction Documents (as defined below). Except as disclosed in the SEC
Reports, the Company has no Subsidiaries. &ldquo;<B>Subsidiaries</B>&rdquo; means a significant subsidiary as defined in Rule 1-02(w)
of Regulation S-X, and each of the foregoing, is individually referred to herein as a &ldquo;<B>Subsidiary</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Authorization;
Enforcement; Validity</U>. The Company has the requisite power and authority to enter into and perform its obligations under this Agreement
and the other Transaction Documents and to issue the Securities in accordance with the terms hereof and thereof. The execution and delivery
of this Agreement and the other Transaction Documents by the Company and the consummation by the Company of the transactions contemplated
hereby and thereby (including, without limitation, the issuance of the Common Shares, the issuance of the Warrants and the reservation
for issuance and issuance of the Warrant Shares issuable upon exercise of the Warrants) have been duly authorized by the Company&rsquo;s
board of directors and (other than the filing with the SEC of the prospectus supplement required by the Registration Statement pursuant
to Rule 424(b) under the 1933 Act (the &ldquo;<B>Prospectus Supplement</B>&rdquo;) supplementing the base prospectus forming part of the
Registration Statement (the &ldquo;<B>Prospectus</B>&rdquo;), (C) the filing of an Additional Listing Application with the Principal Market
and (D) any other filings as may be required by any state securities agencies (collectively, the &ldquo;<B>Required Approvals</B>&rdquo;)
and no further filing, consent or authorization is required by the Company, its board of directors or its stockholders or other governing
body. This Agreement has been, and the other Transaction Documents will be prior to the Closing, duly executed and delivered by the Company,
and each constitutes the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with its respective
terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo; rights and
remedies and except as rights to indemnification and to contribution may be limited by federal or state securities law. &ldquo;<B>Transaction
Documents</B>&rdquo; means, collectively, this Agreement, the Common Shares, the Warrants, the Irrevocable Transfer Agent Instructions
(as defined below) and each of the other agreements and instruments entered into or delivered by any of the parties hereto in connection
with the transactions contemplated hereby and thereby, as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Issuance
of Securities; Registration Statement</U>. The issuance of the Common Shares and the Warrants are duly authorized and, upon issuance and
payment in accordance with the terms of the Transaction Documents shall be validly issued, fully paid and non-assessable and free from
all preemptive or similar rights, mortgages, defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security
interests and other encumbrances (collectively &ldquo;<B>Liens</B>&rdquo;) with respect to the issuance thereof. As of the Closing, the
Company shall have reserved from its duly authorized capital stock not less than 100% of the maximum number of shares of Common Stock
issuable upon exercise of the Warrants (without taking into account any limitations on the exercise of the Warrants set forth in the Warrants).
Upon exercise in accordance with the Warrants, the Warrant Shares, when issued, will be validly issued, fully paid and nonassessable and
free from all preemptive or similar rights or Liens with respect to the issue thereof, with the holders being entitled to all rights accorded
to a holder of Common Stock. The issuance by the Company of the Securities has been registered under the 1933 Act, the Securities are
being issued pursuant to the Registration Statement and all of the Securities are freely transferable and freely tradable by each of the
Buyers without restriction, whether by way of registration or some exemption therefrom. The Registration Statement is effective and available
for the issuance of the Securities thereunder and the Company has not received any notice that the SEC has issued or intends to issue
a stop-order with respect to the Registration Statement or that the SEC otherwise has suspended or withdrawn the effectiveness of the
Registration Statement, either temporarily or permanently, or intends or has threatened in writing to do so. The &ldquo;Plan of Distribution&rdquo;
section under the Registration Statement permits the issuance and sale of the Securities hereunder and as contemplated by the other Transaction
Documents. Upon receipt of the Securities, each of the Buyers will have good and marketable title to the Securities. The Registration
Statement and any prospectus included therein, including the Prospectus and the Prospectus Supplement, complied in all material respects
with the requirements of the 1933 Act and the Securities Exchange Act of 1934, as amended (the &ldquo;<B>1934 Act</B>&rdquo;) and the
rules and regulations of the SEC promulgated thereunder and all other applicable laws and regulations. At the time the Registration Statement
and any amendments thereto became effective, at the date of this Agreement and at each deemed effective date thereof pursuant to Rule
430B(f)(2) of the 1933 Act, the Registration Statement and any amendments thereto complied and will comply in all material respects with
the requirements of the 1933 Act and did not and will not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus and any amendments or supplements
thereto (including, without limitation the Prospectus Supplement), at the time the Prospectus or any amendment or supplement thereto was
issued and at the Closing Date<U>,</U> complied, and will comply, in all material respects with the requirements of the 1933 Act and did
not, and will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading. The Company meets all of the requirements for the use
of Form S-3 under the 1933 Act for the offering and sale of the Securities contemplated by this Agreement and the other Transaction Documents,
and the SEC has not notified the Company of any objection to the use of the form of the Registration Statement pursuant to Rule 401(g)(1)
under the 1933 Act. The Registration Statement meets the requirements set forth in Rule 415(a)(1)(x) under the 1933 Act. At the earliest
time after the filing of the Registration Statement that the Company or another offering participant made a bona fide offer (within the
meaning of Rule 164(h)(2) under the 1933 Act) relating to any of the Securities, the Company was not and is not an &ldquo;Ineligible Issuer&rdquo;
(as defined in Rule 405 under the 1933 Act). The Company (i) has not distributed any offering material in connection with the offer or
sale of any of the Securities and (ii) until no Buyer holds any of the Securities, shall not distribute any offering material in connection
with the offer or sale of any of the Securities to, or by, any of the Buyers (if required), in each case, other than the Registration
Statement, the Prospectus or the Prospectus Supplement. In accordance with Rule 5110(b)(7)(C)(i) of the Financial Industry Regulatory
Authority Manual, the offering of the Securities has been registered with the SEC on Form S-3 under the 1933 Act pursuant to the standards
for Form S-3 in effect prior to October 21, 1992, and the Securities are being offered pursuant to Rule 415 promulgated under the 1933
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>No
Conflicts</U>. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Common Shares, the Warrants and
the Warrant Shares and the reservation for issuance of the Warrant Shares) will not (i) result in a violation of the Articles of Incorporation
(as defined below) (including, without limitation, any certificate of designation contained therein), Bylaws (as defined below), certificate
of formation, memorandum of association, articles of association, bylaws or other organizational documents of the Company or any of its
Subsidiaries, or any capital stock or other securities of the Company or any of its Subsidiaries, (ii) conflict with, or constitute a
default (or an event which with notice or lapse of time or both would become a default) in any respect under, or give to others any rights
of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its
Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including, without limitation,
foreign, federal and state securities laws and regulations and the rules and regulations of the Nasdaq Capital Market (the &ldquo;<B>Principal
Market</B>&rdquo;) and including all applicable foreign, federal and state laws, rules and regulations) applicable to the Company or any
of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Consents</U>.
Neither the Company nor any Subsidiary is required to obtain any consent from, authorization or order of, or make any filing or registration
with (other than the Required Approvals), any Governmental Entity (as defined below) or any regulatory or self-regulatory agency or any
other Person in order for it to execute, deliver or perform any of its respective obligations under or contemplated by the Transaction
Documents, in each case, in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and registrations
which the Company or any Subsidiary is required to obtain pursuant to the preceding sentence have been or will be obtained or effected
on or prior to the Closing Date, and neither the Company nor any of its Subsidiaries are aware of any facts or circumstances which might
prevent the Company or any of its Subsidiaries from obtaining or effecting any of the registration, application or filings contemplated
by the Transaction Documents. The Company is not in violation of the requirements of the Principal Market and has no knowledge of any
facts or circumstances which could reasonably lead to delisting or suspension of the Common Stock in the foreseeable future. &ldquo;<B>Governmental
Entity</B>&rdquo; means any nation, state, county, city, town, village, district, or other political jurisdiction of any nature, federal,
state, local, municipal, foreign, or other government, governmental or quasi-governmental authority of any nature (including any governmental
agency, branch, department, official, or entity and any court or other tribunal), multi-national organization or body; or body exercising,
or entitled to exercise, any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any
nature or instrumentality of any of the foregoing, including any entity or enterprise owned or controlled by a government or a public
international organization or any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Acknowledgment
Regarding Buyer&rsquo;s Purchase of Securities</U>. The Company acknowledges and agrees that each Buyer is acting solely in the capacity
of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby and
that no Buyer is (i) an officer or director of the Company or any of its Subsidiaries, (ii) an &ldquo;affiliate&rdquo; (as defined in
Rule 144 promulgated under the 1933 Act (or a successor rule thereto) (collectively, &ldquo;<B>Rule 144</B>&rdquo;)) of the Company or
any of its Subsidiaries or (iii) to its knowledge, a &ldquo;beneficial owner&rdquo; of more than 10% of the shares of Common Stock (as
defined for purposes of Rule 13d-3 of the 1934 Act). The Company further acknowledges that no Buyer is acting as a financial advisor or
fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the transactions
contemplated hereby and thereby, and any advice given by a Buyer or any of its representatives or agents in connection with the Transaction
Documents and the transactions contemplated hereby and thereby is merely incidental to such Buyer&rsquo;s purchase of the Securities.
The Company further represents to each Buyer that the Company&rsquo;s decision to enter into the Transaction Documents has been based
solely on the independent evaluation by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Placement
Agents&rsquo; Fees</U>. The Company shall be responsible for the payment of any placement agent&rsquo;s fees, financial advisory fees,
or brokers&rsquo; commissions (other than for Persons engaged by any Buyer or its investment advisor) relating to or arising out of the
transactions contemplated hereby, including, without limitation, placement agent fees payable to Oppenheimer &amp; Co. Inc., as representative
(the &ldquo;Representative&rdquo;) of the placement agents (the &ldquo;<B>Placement Agents</B>&rdquo;) named in the Placement Agent Agreement,
by and between the Company and the Representative, dated as of the date hereof, in connection with the sale of the Securities. The fees
and expenses of the Placement Agent to be paid by the Company are set forth on Schedule 3(g) attached hereto. The Company shall pay, and
hold each Buyer harmless against, any liability, loss or expense (including, without limitation, attorney&rsquo;s fees and out-of-pocket
expenses) arising in connection with any such claim. The Company acknowledges that it has engaged the Placement Agents in connection with
the sale of the Securities. Other than the Placement Agents, neither the Company nor any of its Subsidiaries has engaged any placement
agent or other agent in connection with the offer or sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>No
Integrated Offering</U>. None of the Company, its Subsidiaries or any of their affiliates, nor any Person acting on their behalf has,
directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause this offering of the Securities to require approval of stockholders of the Company under any applicable stockholder approval
provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on which any
of the securities of the Company are listed or designated for quotation. None of the Company, its Subsidiaries, their affiliates nor any
Person acting on their behalf will take any action or steps that would cause the offering of any of the Securities to be integrated with
other offerings of securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Dilutive
Effect</U>. The Company understands and acknowledges that the number of Warrant Shares will increase in certain circumstances. The Company
further acknowledges that its obligation to issue the Warrant Shares upon exercise of the Warrants in accordance with this Agreement and
the Warrants is, absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of
other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Application
of Takeover Protections; Rights Agreement</U>. The Company and its board of directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, interested stockholder, business combination, poison pill (including, without limitation,
any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover provision under the Articles of Incorporation,
Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation or otherwise which is or could become applicable
to any Buyer as a result of the transactions contemplated by this Agreement, including, without limitation, the Company&rsquo;s issuance
of the Securities and any Buyer&rsquo;s ownership of the Securities. The Company and its board of directors have taken all necessary action,
if any, in order to render inapplicable any stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership
of shares of Common Stock or a change in control of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>SEC
Documents; Financial Statements</U>. During the two (2) years prior to the date hereof, the Company has timely filed all reports, schedules,
forms, proxy statements, statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements
of the 1934 Act (all of the foregoing filed prior to the date hereof and all exhibits and appendices included therein and financial statements,
notes and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the &ldquo;<B>SEC Documents</B>&rdquo;).
The Company has delivered or has made available to the Buyers or their respective representatives true, correct and complete copies of
each of the SEC Documents not available on the EDGAR system. As of their respective dates, the SEC Documents complied in all material
respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents,
and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. As of their respective dates, the financial statements of the Company included in the SEC
Documents complied in all material respects with applicable accounting requirements and the published rules and regulations of the SEC
with respect thereto as in effect as of the time of filing. Such financial statements have been prepared in accordance with generally
accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;), consistently applied, during the periods involved (except (i) as may be otherwise
indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may
exclude footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the
Company as of the dates thereof and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited
statements, to normal year-end audit adjustments which will not be material, either individually or in the aggregate). The reserves, if
any, established by the Company or the lack of reserves, if applicable, are reasonable based upon facts and circumstances known by the
Company on the date hereof and there are no loss contingencies that are required to be accrued by the Statement of Financial Accounting
Standard No. 5 of the Financial Accounting Standards Board which are not provided for by the Company in its financial statements or otherwise.
No other information provided by or on behalf of the Company to any of the Buyers which is not included in the SEC Documents (including,
without limitation, information in the disclosure schedules to this Agreement) contains any untrue statement of a material fact or omits
to state any material fact necessary in order to make the statements therein not misleading, in the light of the circumstance under which
they are or were made. The Company is not currently contemplating to amend or restate any of the financial statements (including, without
limitation, any notes or any letter of the independent accountants of the Company with respect thereto) included in the SEC Documents
(the &ldquo;<B>Financial Statements</B>&rdquo;), nor is the Company currently aware of facts or circumstances which would require the
Company to amend or restate any of the Financial Statements, in each case, in order for any of the Financial Statements to be in compliance
with GAAP and the rules and regulations of the SEC. The Company has not been informed by its independent accountants that they recommend
that the Company amend or restate any of the Financial Statements or that there is any need for the Company to amend or restate any of
the Financial Statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Absence
of Certain Changes</U>. Except as set forth in the SEC Documents, since the date of the Company&rsquo;s most recent audited financial
statements contained in a Form 10-K, there has been no material adverse change and no material adverse development in the business, assets,
liabilities, properties, operations (including results thereof), condition (financial or otherwise) or prospects of the Company or any
of its Subsidiaries. Except as set forth in the SEC Documents, since the date of the Company&rsquo;s most recent audited financial statements
contained in a Form 10-K, neither the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any assets,
individually or in the aggregate, outside of the ordinary course of business or (iii) made any capital expenditures, individually or in
the aggregate, outside of the ordinary course of business. Neither the Company nor any of its Subsidiaries has taken any steps to seek
protection pursuant to any law or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up,
nor does the Company or any Subsidiary have any knowledge or reason to believe that any of their respective creditors intend to initiate
involuntary bankruptcy proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so. The Company and
its Subsidiaries, individually and on a consolidated basis, are not as of the date hereof, and after giving effect to the transactions
contemplated hereby to occur at the Closing, will not be Insolvent (as defined below). For purposes of this Section 3(l), &ldquo;<B>Insolvent</B>&rdquo;
means, (i) with respect to the Company and its Subsidiaries, on a consolidated basis, (A) the present fair saleable value of the Company&rsquo;s
and its Subsidiaries&rsquo; assets is less than the amount required to pay the Company&rsquo;s and its Subsidiaries&rsquo; total Indebtedness
(as defined below), (B) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated, contingent or otherwise,
as such debts and liabilities become absolute and matured or (C) the Company and its Subsidiaries intend to incur or believe that they
will incur debts that would be beyond their ability to pay as such debts mature; and (ii) with respect to the Company and each Subsidiary,
individually, (A) the present fair saleable value of the Company&rsquo;s or such Subsidiary&rsquo;s (as the case may be) assets is less
than the amount required to pay its respective total Indebtedness, (B) the Company or such Subsidiary (as the case may be) is unable to
pay its respective debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured
or (C) the Company or such Subsidiary (as the case may be) intends to incur or believes that it will incur debts that would be beyond
its respective ability to pay as such debts mature. Neither the Company nor any of its Subsidiaries has engaged in any business or in
any transaction, and is not about to engage in any business or in any transaction, for which the Company&rsquo;s or such Subsidiary&rsquo;s
remaining assets constitute unreasonably small capital with which to conduct the business in which it is engaged as such business is now
conducted and is proposed to be conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>No
Undisclosed Events, Liabilities, Developments or Circumstances</U>. No event, liability, development or circumstance has occurred or exists,
or is reasonably expected to exist or occur with respect to the Company, any of its Subsidiaries or any of their respective businesses,
properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (i) would be required
to be disclosed by the Company under applicable securities laws on a registration statement on Form S-1 filed with the SEC relating to
an issuance and sale by the Company of its Common Stock and which has not been publicly announced, (ii) could have a material adverse
effect on any Buyer&rsquo;s investment hereunder or (iii) could have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Conduct
of Business; Regulatory Permits</U>. Neither the Company nor any of its Subsidiaries is in violation of any term of or in default under
its <U>Articles</U> of Incorporation, any certificate of designation, preferences or rights of any other outstanding series of preferred
stock of the Company or any of its Subsidiaries or Bylaws or their organizational charter, certificate of formation, memorandum of association,
articles of association, <U>Articles</U> of Incorporation or certificate of incorporation or bylaws, respectively. Neither the Company
nor any of its Subsidiaries is in violation of any judgment, decree or order or any statute, ordinance, rule or regulation applicable
to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct its business in violation
of any of the foregoing, except in all cases for possible violations which could not, individually or in the aggregate, have a Material
Adverse Effect. Without limiting the generality of the foregoing, the Company is not in violation of any of the rules, regulations or
requirements of the Principal Market and has no knowledge of any facts or circumstances that could reasonably lead to delisting or suspension
of the Common Stock by the Principal Market in the foreseeable future. Since the Common Stock were first listed or designated for quotation
on the Principal Market, (i) the Common Stock has been listed or designated for quotation on the Principal Market, (ii) trading in the
Common Stock has not been suspended by the SEC or the Principal Market and (iii) the Company has received no communication, written or
oral, from the SEC or the Principal Market regarding the suspension or delisting of the Common Stock from the Principal Market. The Company
and each of its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate regulatory authorities necessary
to conduct their respective businesses, except where the failure to possess such certificates, authorizations or permits would not have,
individually or in the aggregate, a Material Adverse Effect, and neither the Company nor any such Subsidiary has received any notice of
proceedings relating to the revocation or modification of any such certificate, authorization or permit. There is no agreement, commitment,
judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the Company or any of its Subsidiaries
is a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of
the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its Subsidiaries or the conduct of business
by the Company or any of its Subsidiaries as currently conducted other than such effects, individually or in the aggregate, which have
not had and would not reasonably be expected to have a Material Adverse Effect on the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Foreign
Corrupt Practices</U>. Neither the Company, the Company&rsquo;s subsidiary or any director, officer, agent, employee, nor any other person
acting for or on behalf of the foregoing (individually and collectively, a &ldquo;<B>Company Affiliate</B>&rdquo;) have violated the U.S.
Foreign Corrupt Practices Act (the &ldquo;<B>FCPA</B>&rdquo;) or any other applicable anti-bribery or anti-corruption laws, nor has any
Company Affiliate offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised to give, or authorized
the giving of anything of value, to any officer, employee or any other person acting in an official capacity for any Governmental Entity
to any political party or official thereof or to any candidate for political office (individually and collectively, a &ldquo;<B>Government
Official</B>&rdquo;) or to any person under circumstances where such Company Affiliate knew or was aware of a high probability that all
or a portion of such money or thing of value would be offered, given or promised, directly or indirectly, to any Government Official,
for the purpose of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;(A)
influencing any act or decision of such Government Official in his/her official capacity, (B) inducing such Government Official to do
or omit to do any act in violation of his/her lawful duty, (C) securing any improper advantage, or (D) inducing such Government Official
to influence or affect any act or decision of any Governmental Entity, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;assisting
the Company or its Subsidiaries in obtaining or retaining business for or with, or directing business to, the Company or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Sarbanes-Oxley
Act</U>. The Company and each Subsidiary is in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002,
as amended, and any and all applicable rules and regulations promulgated by the SEC thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Transactions
With Affiliates</U>. No current or former employee, partner, director, officer or stockholder (direct or indirect) of the Company or its
Subsidiaries, or any associate, or, to the knowledge of the Company, any affiliate of any thereof, or any relative with a relationship
no more remote than first cousin of any of the foregoing, is presently, or has ever been, (i) a party to any transaction with the Company
or its Subsidiaries (including any contract, agreement or other arrangement providing for the furnishing of services by, or rental of
real or personal property from, or otherwise requiring payments to, any such director, officer or stockholder or such associate or affiliate
or relative Subsidiaries (other than for ordinary course services as employees, officers or directors of the Company or any of its Subsidiaries))
or (ii) except as set forth in the SEC Documents, the direct or indirect owner of an interest in any corporation, firm, association or
business organization which is a competitor, supplier or customer of the Company or its Subsidiaries (except for a passive investment
(direct or indirect) in less than 5% of the common stock of a company whose securities are traded on or quoted through an Eligible Market
(as defined below)), nor does any such Person receive income from any source other than the Company or its Subsidiaries which relates
to the business of the Company or its Subsidiaries or should properly accrue to the Company or its Subsidiaries. No employee, officer,
stockholder or director of the Company or any of its Subsidiaries or member of his or her immediate family is indebted to the Company
or its Subsidiaries, as the case may be, nor is the Company or any of its Subsidiaries indebted (or committed to make loans or extend
or guarantee credit) to any of them, other than (i) for payment of salary for services rendered, (ii) reimbursement for reasonable expenses
incurred on behalf of the Company, and (iii) for other standard employee benefits made generally available to all employees or executives
(including stock option agreements outstanding under any stock option plan approved by the Board of Directors of the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;<U>Equity
Capitalization.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify"><U>Definitions</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(A)&nbsp;&ldquo;<B>Common
Stock</B>&rdquo; means (x)&nbsp;the Company&rsquo;s shares of common stock, $0.0001 par value per share, and (y) any capital stock into
which such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(B)&nbsp;&ldquo;<B>Preferred
Stock</B>&rdquo; means (x) the Company&rsquo;s blank check preferred stock, $0.0001 par value per share, the terms of which may be designated
by the board of directors of the Company in a certificate of designations and (y) any capital stock into which such preferred stock shall
have been changed or any share capital resulting from a reclassification of such preferred stock (other than a conversion of such preferred
stock into Common Stock in accordance with the terms of such certificate of designations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Authorized
and Outstanding Capital Stock</U>. As of the date hereof, the authorized capital stock of the Company consists of (A) 800,000,000 shares
of Common Stock, of which, 385,766,027 are issued and outstanding and 130,908,626 shares are reserved for issuance pursuant to Common
Stock Equivalents (as defined below) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares
of Preferred Stock, none of which are issued and outstanding. No shares of Common Stock are held in the treasury of the Company. &ldquo;<B>Common
Stock Equivalents</B>&rdquo; means any capital stock or other security of the Company or any of its Subsidiaries that is at any time and
under any circumstances directly or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder
thereof to acquire, any capital stock or other security of the Company (including, without limitation, Common Stock) or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Valid
Issuance; Available Shares; Affiliates</U>. All of such outstanding shares are duly authorized and have been, or upon issuance will be,
validly issued and are fully paid and nonassessable. Except as disclosed in the SEC Documents, to the Company&rsquo;s knowledge, no Person
owns 10% or more of the Company&rsquo;s issued and outstanding shares of Common Stock (calculated based on the assumption that all Common
Stock Equivalents (as defined below), whether or not presently exercisable or convertible, have been fully exercised&nbsp;or converted&nbsp;(as
the case may be) taking account of any limitations on exercise or conversion (including &ldquo;blockers&rdquo;) contained therein without
conceding that such identified Person is a 10% stockholder for purposes of federal securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<U>Existing
Securities; Obligations</U>. Except as disclosed in the SEC Documents: (A) none of the Company&rsquo;s or any Subsidiary&rsquo;s shares,
interests or capital stock is subject to preemptive rights or any other similar rights or Liens suffered or permitted by the Company or
any Subsidiary; (B) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares, interests or capital stock of the
Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries
is or may become bound to issue additional shares, interests or capital stock of the Company or any of its Subsidiaries or options, warrants,
scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into,
or exercisable or exchangeable for, any shares, interests or capital stock of the Company or any of its Subsidiaries; (C) there are no
agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities
under the 1933 Act (except pursuant to this Agreement); (D) there are no outstanding securities or instruments of the Company or any of
its Subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements
by which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries;
(E) there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the
Securities; and (F) neither the Company nor any Subsidiary has any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Organizational
Documents</U>. The Company has furnished to the Buyers true, correct and complete copies of the Company&rsquo;s articles of incorporation,
as amended and as in effect on the date hereof (the &ldquo;<B>Articles of Incorporation</B>&rdquo;), and the Company&rsquo;s bylaws, as
amended and as in effect on the date hereof (the &ldquo;<B>Bylaws</B>&rdquo;), and the terms of all Common Stock Equivalents and the material
rights of the holders thereof in respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;<U>Indebtedness
and Other Contracts</U>. Neither the Company nor any of its Subsidiaries, (i) except as disclosed in the SEC Documents, has any outstanding
debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments evidencing Indebtedness of
the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries is or may become bound, (ii) is a party to any
contract, agreement or instrument, the violation of which, or default under which, by the other party(ies) to such contract, agreement
or instrument could reasonably be expected to result in a Material Adverse Effect, (iii) has any financing statements securing obligations
in any amounts filed in connection with the Company or any of its Subsidiaries; (iv) is in violation of any term of, or in default under,
any contract, agreement or instrument relating to any Indebtedness, except where such violations and defaults would not result, individually
or in the aggregate, in a Material Adverse Effect, or (v) is a party to any contract, agreement or instrument relating to any Indebtedness,
the performance of which, in the judgment of the Company&rsquo;s officers, has or is expected to have a Material Adverse Effect. Neither
the Company nor any of its Subsidiaries have any liabilities or obligations required to be disclosed in the SEC Documents which are not
so disclosed in the SEC Documents, other than those incurred in the ordinary course of the Company&rsquo;s or its Subsidiaries&rsquo;
respective businesses and which, individually or in the aggregate, do not or could not have a Material Adverse Effect. For purposes of
this Agreement: (x) &ldquo;<B>Indebtedness</B>&rdquo; of any Person means, without duplication (A) all indebtedness for borrowed money,
(B) all obligations issued, undertaken or assumed as the deferred purchase price of property or services (including, without limitation,
&ldquo;capital leases&rdquo; in accordance with GAAP) (other than trade payables entered into in the ordinary course of business consistent
with past practice), (C) all reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments,
(D) all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection
with the acquisition of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or other title
retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds of such
indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default are limited to repossession
or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which, in connection with GAAP, consistently
applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F)
above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien
upon or in any property or assets (including accounts and contract rights) owned by any Person, even though the Person which owns such
assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect
of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above; (y) &ldquo;<B>Contingent Obligation</B>&rdquo;
means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to any Indebtedness, lease,
dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary
effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged, or that any agreements
relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with
respect thereto; and (z) &ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture,
a corporation, a trust, an unincorporated organization, any other entity and any Governmental Entity or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)&nbsp;<U>Litigation</U>.
There is no action, suit, arbitration, proceeding, inquiry or investigation before or by the Principal Market, any court, public board,
other Governmental Entity, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting
the Company or any of its Subsidiaries, the Common Stock or any of the Company&rsquo;s or its Subsidiaries&rsquo; officers or directors,
whether of a civil or criminal nature or otherwise, in their capacities as such, which is outside of the ordinary course of business or
individually or in the aggregate material to the Company or any of its Subsidiaries, except as set forth in the SEC Documents. No director,
officer or employee of the Company or any of its subsidiaries has willfully violated 18 U.S.C. &sect;1519 or engaged in spoliation in
reasonable anticipation of litigation. Without limitation of the foregoing, there has not been, and to the knowledge of the Company, there
is not pending or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries or any current or former director
or officer of the Company or any of its Subsidiaries. The SEC has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company under the 1933 Act or the 1934 Act, including, without limitation, the Registration
Statement. After reasonable inquiry of its employees, the Company is not aware of any fact which might result in or form the basis for
any such action, suit, arbitration, investigation, inquiry or other proceeding. Neither the Company nor any of its Subsidiaries is subject
to any order, writ, judgment, injunction, decree, determination or award of any Governmental Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)&nbsp;<U>Insurance</U>.
The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries
are engaged. Neither the Company nor any such Subsidiary has been refused any insurance coverage sought or applied for, and neither the
Company nor any such Subsidiary has any reason to believe that it will be unable to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that
would not have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Employee
Relations</U>. Neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement or employs any member
of a union. The Company and its Subsidiaries believe that their relations with their employees are good. No executive officer (as defined
in Rule 501(f) promulgated under the 1933 Act) or other key employee of the Company or any of its Subsidiaries has notified the Company
or any such Subsidiary that such officer intends to leave the Company or any such Subsidiary or otherwise terminate such officer&rsquo;s
employment with the Company or any such Subsidiary. No executive officer or other key employee of the Company or any of its Subsidiaries
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement, non-competition agreement, or any other contract or agreement or any restrictive covenant, and the continued employment
of each such executive officer or other key employee (as the case may be) does not subject the Company or any of its Subsidiaries to any
liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all federal, state, local
and foreign laws and regulations respecting labor, employment and employment practices and benefits, terms and conditions of employment
and wages and hours, except where failure to be in compliance would not, either individually or in the aggregate, reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w)&nbsp;<U>Title</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;<U>Real
Property</U>. Each of the Company and its Subsidiaries holds good title to all real property, leases in real property, facilities or other
interests in real property owned or held by the Company or any of its Subsidiaries (the &ldquo;<B>Real Property</B>&rdquo;) owned by the
Company or any of its Subsidiaries (as applicable). The Real Property is free and clear of all Liens and is not subject to any rights
of way, building use restrictions, exceptions, variances, reservations, or limitations of any nature except for (a) Liens for current
taxes not yet due and (b) zoning laws and other land use restrictions that do not impair the present or anticipated use of the property
subject thereto. Any Real Property held under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting
and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such
property and buildings by the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&nbsp;<U>Fixtures
and Equipment</U>. Each of the Company and its Subsidiaries (as applicable) has good title to, or a valid leasehold interest in, the tangible
personal property, equipment, improvements, fixtures, and other personal property and appurtenances that are used by the Company or its
Subsidiary in connection with the conduct of its business (the &ldquo;<B>Fixtures and Equipment</B>&rdquo;). The Fixtures and Equipment
are structurally sound, are in good operating condition and repair, are adequate for the uses to which they are being put, are not in
need of maintenance or repairs except for ordinary, routine maintenance and repairs and are sufficient for the conduct of the Company&rsquo;s
and/or its Subsidiaries&rsquo; businesses (as applicable) in the manner as conducted prior to the Closing. Each of the Company and its
Subsidiaries owns all of its Fixtures and Equipment free and clear of all Liens except for (a) Liens for current taxes not yet due and
(b) zoning laws and other land use restrictions that do not impair the present or anticipated use of the property subject thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)&nbsp;<U>Intellectual
Property Rights</U>. The Company and its Subsidiaries own or possess adequate rights or licenses to use all trademarks, trade names, service
marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications and registrations therefor
(&ldquo;<B>Intellectual Property Rights</B>&rdquo;) necessary to conduct their respective businesses as now conducted and presently proposed
to be conducted. The Company does not have any knowledge of any infringement by the Company or its Subsidiaries of Intellectual Property
Rights of others. There is no claim, action or proceeding being made or brought, or to the knowledge of the Company or any of its Subsidiaries,
being threatened, against the Company or any of its Subsidiaries regarding its Intellectual Property Rights. The Company and its Subsidiaries
have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their Intellectual Property Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y)&nbsp;<U>Environmental
Laws</U>. (i) The Company and its Subsidiaries (A) are in compliance with any and all Environmental Laws (as defined below), (B) have
received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses
and (C) are in compliance with all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses
(A), (B) and (C), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse
Effect. The term &ldquo;Environmental Laws&rdquo; means all federal, state, local or foreign laws relating to pollution or protection
of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface
strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<B>Hazardous Materials</B>&rdquo;) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous
Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice
letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;No
Hazardous Materials:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(A) (A) have
been disposed of or otherwise released from any Real Property of the Company or any of its Subsidiaries in violation of any Environmental
Laws; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(B)&nbsp;are
present on, over, beneath, in or upon any Real Property or any portion thereof in quantities that would constitute a violation of any
Environmental Laws. No prior use by the Company or any of its Subsidiaries of any Real Property has occurred that violates any Environmental
Laws, which violation would have a material adverse effect on the business of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;Neither
the Company nor any of its Subsidiaries knows of any other person who or entity which has stored, treated, recycled, disposed of or otherwise
located on any Real Property any Hazardous Materials, including, without limitation, such substances as asbestos and polychlorinated biphenyls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;None
of the Real Properties are on any federal or state &ldquo;Superfund&rdquo; list or Liability Information System (&ldquo;<B>CERCLIS</B>&rdquo;)
list or any state environmental agency list of sites under consideration for CERCLIS, nor subject to any environmental related Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z)&nbsp;<U>Subsidiary
Rights</U>. The Company or one of its Subsidiaries has the unrestricted right to vote, and (subject to limitations imposed by applicable
law) to receive dividends and distributions on, all capital securities of its Subsidiaries as owned by the Company or such Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) <U>Tax Status</U>.
The Company and each of its Subsidiaries (i) has timely made or filed all foreign, federal and state income and all other tax returns,
reports and declarations required by any jurisdiction to which it is subject, (ii) has timely paid all taxes and other governmental assessments
and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested
in good faith and (iii) has set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent to
the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by
the taxing authority of any jurisdiction, and the officers of the Company and its Subsidiaries know of no basis for any such claim. The
Company is not operated in such a manner as to qualify as a passive foreign investment company, as defined in Section 1297 of the U.S.
Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;). The net operating loss carryforwards (&ldquo;<B>NOLs</B>&rdquo;)
for United States federal income tax purposes of the consolidated group of which the Company is the common parent, if any, shall not be
adversely effected by the transactions contemplated hereby. The transactions contemplated hereby do not constitute an &ldquo;ownership
change&rdquo; within the meaning of Section 382 of the Code, thereby preserving the Company&rsquo;s ability to utilize such NOLs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Internal Accounting
and Disclosure Controls</U>. The Company and each of its Subsidiaries maintains internal control over financial reporting (as such term
is defined in Rule 13a-15(f) under the 1934 Act) that is effective to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles,
including that (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset and liability accountability,
(iii) access to assets or incurrence of liabilities is permitted only in accordance with management&rsquo;s general or specific authorization
and (iv) the recorded accountability for assets and liabilities is compared with the existing assets and liabilities at reasonable intervals
and appropriate action is taken with respect to any difference. The Company maintains disclosure controls and procedures (as such term
is defined in Rule 13a-15(e) under the 1934 Act) that are effective in ensuring that information required to be disclosed by the Company
in the reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported, within the time periods specified
in the rules and forms of the SEC, including, without limitation, controls and procedures designed to ensure that information required
to be disclosed by the Company in the reports that it files or submits under the 1934 Act is accumulated and communicated to the Company&rsquo;s
management, including its principal executive officer or officers and its principal financial officer or officers, as appropriate, to
allow timely decisions regarding required disclosure. Neither the Company nor any of its Subsidiaries has received any notice or correspondence
from any accountant, Governmental Entity or other Person relating to any potential material weakness or significant deficiency in any
part of the internal controls over financial reporting of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Off Balance Sheet
Arrangements</U>. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated
or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that
otherwise could be reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>Investment Company
Status</U>. The Company is not, and upon consummation of the sale of the Securities will not be, an &ldquo;investment company,&rdquo;
an affiliate of an &ldquo;investment company,&rdquo; a company controlled by an &ldquo;investment company&rdquo; or an &ldquo;affiliated
person&rdquo; of, or &ldquo;promoter&rdquo; or &ldquo;principal underwriter&rdquo; for, an &ldquo;investment company&rdquo; as such terms
are defined in the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>Acknowledgement
Regarding Buyers&rsquo; Trading Activity</U>. It is understood and acknowledged by the Company that (i) following the public disclosure
of the transactions contemplated by the Transaction Documents, in accordance with the terms thereof, none of the Buyers have been asked
by the Company or any of its Subsidiaries to agree, nor has any Buyer agreed with the Company or any of its Subsidiaries, to desist from
effecting any transactions in or with respect to (including, without limitation, purchasing or selling, long and/or short) any securities
of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold any of the Securities for
any specified term; (ii) any Buyer, and counterparties in &ldquo;derivative&rdquo; transactions to which any such Buyer is a party, directly
or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock which was established prior to such Buyer&rsquo;s
knowledge of the transactions contemplated by the Transaction Documents; (iii) each Buyer shall not be deemed to have any affiliation
with or control over any arm&rsquo;s length counterparty in any &ldquo;derivative&rdquo; transaction; and (iv) each Buyer may rely on
the Company&rsquo;s obligation to timely deliver shares of Common Stock upon exercise or exchange, as applicable, of the Securities as
and when required pursuant to the Transaction Documents for purposes of effecting trading in the Common Stock of the Company. The Company
further understands and acknowledges that following the public disclosure of the transactions contemplated by the Transaction Documents
pursuant to the Press Release (as defined below) one or more Buyers may engage in hedging and/or trading activities (including, without
limitation, the location and/or reservation of borrowable shares of Common Stock) at various times during the period that the Securities
are outstanding, including, without limitation, during the periods that the value and/or number of the Warrant Shares deliverable with
respect to the Securities are being determined and such hedging and/or trading activities (including, without limitation, the location
and/or reservation of borrowable shares of Common Stock), if any, can reduce the value of the existing stockholders&rsquo; equity interest
in the Company both at and after the time the hedging and/or trading activities are being conducted. The Company acknowledges that such
aforementioned hedging and/or trading activities do not constitute a breach of this Agreement, the Warrants or any other Transaction Document
or any of the documents executed in connection herewith or therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Manipulation of
Price</U>. Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company, no Person acting on their behalf
has, directly or indirectly, (i) taken any action designed to cause or to result in the stabilization or manipulation of the price of
any security of the Company or any of its Subsidiaries to facilitate the sale or resale of any of the Securities, (ii) sold, bid for,
purchased, or paid any compensation for soliciting purchases of, any of the Securities (other than the Placement Agents), (iii) paid or
agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company or any of its Subsidiaries
or (iv) paid or agreed to pay any Person for research services with respect to any securities of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) <U>U.S. Real Property
Holding Corporation</U>. Neither the Company nor any of its Subsidiaries is, or has ever been, and so long as any of the Securities are
held by any of the Buyers, shall become, a U.S. real property holding corporation within the meaning of Section 897 of the Code, and the
Company and each Subsidiary shall so certify upon any Buyer&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>Registration Eligibility</U>.
The Company is eligible to register the issuance of the Securities by the Company using Form S-3 promulgated under the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Transfer
Taxes</U>. On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required to be paid in
connection with the issuance, sale and transfer of the Securities to be sold to each Buyer hereunder will be, or will have been, fully
paid or provided for by the Company, and all laws imposing such taxes will be or will have been complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956, as amended (the &ldquo;<B>BHCA</B>&rdquo;)
and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<B>Federal Reserve</B>&rdquo;). Neither the Company
nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares
of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to
the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or affiliates exercises a controlling
influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>Shell Company Status</U>.
The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll) <U>Illegal or Unauthorized
Payments; Political Contributions</U>. Neither the Company nor any of its Subsidiaries nor, to the best of the Company&rsquo;s knowledge
(after reasonable inquiry of its officers and directors), any of the officers, directors, employees, agents or other representatives of
the Company or any of its Subsidiaries or any other business entity or enterprise with which the Company or any Subsidiary is or has been
affiliated or associated, has, directly or indirectly, made or authorized any payment, contribution or gift of money, property, or services,
whether or not in contravention of applicable law, (i) as a kickback or bribe to any Person or (ii) to any political organization, or
the holder of or any aspirant to any elective or appointive public office except for personal political contributions not involving the
direct or indirect use of funds of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Money Laundering</U>.
The Company and its Subsidiaries are in compliance with, and have not previously violated, the USA Patriot Act of 2001 and all other applicable
U.S. and non-U.S. anti-money laundering laws and regulations, including, without limitation, the laws, regulations and Executive Orders
and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, but not limited, to (i) Executive Order 13224
of September 23, 2001 entitled, &ldquo;Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or
Support Terrorism&rdquo; (66 Fed. Reg. 49079 (2001)); and (ii) any regulations contained in 31 CFR, Subtitle B, Chapter V.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(nn) [Intentionally Omitted].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(oo)&nbsp;<U>Stock
Option Plans</U>. Each stock option granted by the Company was granted (i) in accordance with the terms of the applicable stock option
plan of the Company and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock
option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option plan
has been backdated. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company to knowingly
grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement
of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(pp) <U>No Disagreements
with Accountants and Lawyers</U>. There are no material disagreements of any kind presently existing, or reasonably anticipated by the
Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is
current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of
its obligations under any of the Transaction Documents. In addition, on or prior to the date hereof, the Company had discussions with
its accountants about its financial statements previously filed with the SEC. Based on those discussions, the Company has no reason to
believe that it will need to restate any such financial statements or any part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(qq) <U>No Additional Agreements.</U>
The Company does not have any agreement or understanding with any Buyer with respect to the transactions contemplated by the Transaction
Documents other than as specified in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(rr) <U>Public Utility
Holding Act</U> None of the Company nor any of its Subsidiaries is a &ldquo;holding company,&rdquo; or an &ldquo;affiliate&rdquo; of a
&ldquo;holding company,&rdquo; as such terms are defined in the Public Utility Holding Act of 2005.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ss) <U>Federal Power Act.</U>
None of the Company nor any of its Subsidiaries is subject to regulation as a &ldquo;public utility&rdquo; under the Federal Power Act,
as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(tt) <U>Cybersecurity</U>.
The Company and its Subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications, and databases (collectively, &ldquo;<B>IT Systems</B>&rdquo;) are adequate for, and operate and perform in all
material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted,
free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants that would reasonably be
expected to have a Material Adverse Effect on the Company&rsquo;s business. The Company and its Subsidiaries have implemented and maintained
commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to maintain and protect
their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data, including
&ldquo;Personal Data,&rdquo; used in connection with their businesses. &ldquo;<B>Personal Data</B>&rdquo; means (i) a natural person&rsquo;s
name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver&rsquo;s
license number, passport number, credit card number, bank information, or customer or account number; (ii) any information which would
qualify as &ldquo;personally identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal
data&rdquo; as defined by the European Union General Data Protection Regulation (&ldquo;<B>GDPR</B>&rdquo;) (EU 2016/679); (iv) any information
which would qualify as &ldquo;protected health information&rdquo; under the Health Insurance Portability and Accountability Act of 1996,
as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, &ldquo;<B>HIPAA</B>&rdquo;); and (v)
any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection
or analysis of any data related to an identified person&rsquo;s health or sexual orientation. There have been no breaches, violations,
outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the
duty to notify any other person or such, nor any incidents under internal review or investigations relating to the same except in each
case, where such would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. The
Company and its Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access,
misappropriation or modification except in each case, where such would not, either individually or in the aggregate, reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(uu) <U>Compliance with
Data Privacy Laws</U>. The Company and its Subsidiaries are, and at all prior times were, in compliance with all applicable state and
federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company and its Subsidiaries have
taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, have been and currently are in compliance with,
the General Data Protection Regulation of the European Union (GDPR) (Regulation EU 2016/679) (collectively, the &ldquo;<B>Privacy Laws</B>&rdquo;)
except in each case, where such would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse
Effect. To ensure compliance with the Privacy Laws, the Company and its Subsidiaries have in place, comply with, and take appropriate
steps reasonably designed to ensure compliance in all material respects with their policies and procedures relating to data privacy and
security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the &ldquo;<B>Policies</B>&rdquo;). The
Company and its Subsidiaries have at all times made all disclosures to users or customers required by applicable laws and regulatory rules
or requirements, and none of such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or
in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further certifies that neither
it nor any Subsidiary: (i) has received notice of any actual or potential liability under or relating to, or actual or potential violation
of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice;
(ii) is currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to
any Privacy Law; or (iii) is a party to any order, decree, or agreement that imposes any obligation or liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vv) <U>Registration Rights</U>.
No holder of securities of the Company has rights to the registration of any securities of the Company because of the filing of the Registration
Statement or the issuance of the Securities hereunder that could expose the Company to material liability or any Buyer to any liability
or that could impair the Company&rsquo;s ability to consummate the issuance and sale of the Securities in the manner, and at the times,
contemplated hereby, which rights have not been waived by the holder thereof as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ww) <U>Compliance With
FINRA Rule 5110</U>. At the time the Registration Statement was declared effective by the SEC, and as of the date hereof and as of the
Closing Date, the Company has (i) a 1934 Act reporting history in excess of 36 months and (ii) a non-affiliate, public common float of
at least $100 million and annual trading volume of at least three million shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xx)&nbsp;<U>Disclosure</U>.
The Company confirms that neither it nor any other Person acting on its behalf has provided any of the Buyers or their agents or counsel
with any information that constitutes or could reasonably be expected to constitute material, non-public information concerning the Company
or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the other Transaction Documents.
The Company understands and confirms that each of the Buyers will rely on the foregoing representations in effecting transactions in securities
of the Company. All disclosure provided to the Buyers regarding the Company and its Subsidiaries, their businesses and the transactions
contemplated hereby, including the schedules to this Agreement, furnished by or on behalf of the Company or any of its Subsidiaries is
true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements made therein, in the light of the circumstances under which they were made, not misleading. All of the written information
furnished after the date hereof by or on behalf of the Company or any of its Subsidiaries to each Buyer pursuant to or in connection with
this Agreement and the other Transaction Documents, taken as a whole, will be true and correct in all material respects as of the date
on which such information is so provided and will not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
Each press release issued by the Company or any of its Subsidiaries during the twelve (12) months preceding the date of this Agreement
did not at the time of release contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they are made, not misleading.
No event or circumstance has occurred or information exists with respect to the Company or any of its Subsidiaries or its or their business,
properties, liabilities, prospects, operations (including results thereof) or conditions (financial or otherwise), which, under applicable
law, rule or regulation, requires public disclosure at or before the date hereof or announcement by the Company but which has not been
so publicly disclosed. All financial projections and forecasts that have been prepared by or on behalf of the Company or any of its Subsidiaries
and made available to you have been prepared in good faith based upon reasonable assumptions and represented, at the time each such financial
projection or forecast was delivered to each Buyer, the Company&rsquo;s best estimate of future financial performance (it being recognized
that such financial projections or forecasts are not to be viewed as facts and that the actual results during the period or periods covered
by any such financial projections or forecasts may differ from the projected or forecasted results). The Company acknowledges and agrees
that no Buyer makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those
specifically set forth in Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><B>COVENANTS.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Best
Efforts</U>. Each Buyer shall use its best efforts to timely satisfy each of the covenants hereunder and conditions to be satisfied by
it as provided in Section 6 of this Agreement. The Company shall use its best efforts to timely satisfy each of the covenants hereunder
and conditions to be satisfied by it as provided in Section 7 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Amendments
to the Registration Statement; Prospectus Supplements; Free Writing Prospectuses</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<U>Amendments
to the Registration Statement; Prospectus Supplements; Free Writing Prospectuses</U>. Except as provided in this Agreement and other than
periodic reports required to be filed pursuant to the 1934 Act, the Company shall not file with the SEC any amendment to the Registration
Statement that relates to the Buyer, this Agreement or any other Transaction Document or the transactions contemplated hereby or thereby
or file with the SEC any Prospectus Supplement that relates to the Buyer, this Agreement or any other Transaction Document or the transactions
contemplated hereby or thereby with respect to which (a) the Buyer shall not previously have been advised, (b) the Company shall not have
given due consideration to any comments thereon received from the Buyer or its counsel, or (c) the Buyer shall reasonably object after
being so advised, unless the Company reasonably has determined that it is necessary to amend the Registration Statement or make any supplement
to the Prospectus to comply with the 1933 Act or any other applicable law or regulation, in which case the Company shall promptly (but
in no event later than 24 hours) so inform the Buyer, the Buyer shall be provided with a reasonable opportunity to review and comment
upon any disclosure relating to the Buyer and the Company shall expeditiously furnish to the Buyer an electronic copy thereof. In addition,
for so long as, in the reasonable opinion of counsel for the Buyer, the Prospectus (or in lieu thereof, the notice referred to in Rule
173(a) under the 1933 Act) is required to be delivered in connection with any acquisition or sale of Securities by the Buyer, the Company
shall not file any Prospectus Supplement with respect to the Securities without delivering or making available a copy of such Prospectus
Supplement, together with the Prospectus, to the Buyer promptly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;The
Company has not made, and agrees that unless it obtains the prior written consent of the Buyer it will not make, an offer relating to
the Securities that would constitute an &ldquo;issuer free writing prospectus&rdquo; as defined in Rule 433 promulgated under the 1933
Act (an &ldquo;<B>Issuer Free Writing Prospectus</B>&rdquo;) or that would otherwise constitute a &ldquo;free writing prospectus&rdquo;
as defined in Rule 405 promulgated under the 1933 Act (a &ldquo;<B>Free Writing Prospectus</B>&rdquo;) required to be filed by the Company
or the Buyer with the SEC or retained by the Company or the Buyer under Rule 433 under the 1933 Act. The Buyer has not made, and agrees
that unless it obtains the prior written consent of the Company it will not make, an offer relating to the Securities that would constitute
a Free Writing Prospectus required to be filed by the Company with the SEC or retained by the Company under Rule 433 under the 1933 Act.
Any such Issuer Free Writing Prospectus or other Free Writing Prospectus consented to by the Buyer or the Company is referred to in this
Agreement as a &ldquo;<B>Permitted Free Writing Prospectus</B>.&rdquo; The Company agrees that (x) it has treated and will treat, as the
case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y) it has complied and will comply, as the
case may be, with the requirements of Rules 164 and 433 under the 1933 Act applicable to any Permitted Free Writing Prospectus, including
in respect of timely filing with the SEC, legending and record keeping.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Prospectus
Delivery</U>. Immediately prior to execution of this Agreement, the Company shall have delivered to the Buyer, and as soon as practicable
after execution of this Agreement the Company shall file, Prospectus Supplements with respect to the Securities to be issued on the Closing
Date, as required under, and in conformity with, the 1933 Act, including Rule 424(b) thereunder. The Company shall provide the Buyer a
reasonable opportunity to comment on a draft of each Prospectus Supplement and any Issuer Free Writing Prospectus, shall give due consideration
to all such comments and, subject to the provisions of Section 4(b) hereof, shall deliver or make available to the Buyer, without charge,
an electronic copy of each form of Prospectus Supplement, together with the Prospectus, and any Permitted Free Writing Prospectus on the
Closing Date. The Company consents to the use of the Prospectus (and of any Prospectus Supplements thereto) in accordance with the provisions
of the 1933 Act and with the securities or &ldquo;blue sky&rdquo; laws of the jurisdictions in which the Securities may be sold by the
Buyer, in connection with the offering and sale of the Securities and for such period of time thereafter as the Prospectus (or in lieu
thereof, the notice referred to in Rule 173(a) under the 1933 Act) is required by the 1933 Act to be delivered in connection with sales
of the Securities. If during such period of time any event shall occur that in the judgment of the Company and its counsel is required
to be set forth in the Registration Statement or the Prospectus or any Permitted Free Writing Prospectus or should be set forth therein
in order to make the statements made therein (in the case of the Prospectus, in light of the circumstances under which they were made)
not misleading, or if it is necessary to amend the Registration Statement or supplement or amend the Prospectus or any Permitted Free
Writing Prospectus to comply with the 1933 Act or any other applicable law or regulation, the Company shall forthwith prepare and, subject
to Section 4(b) above, file with the SEC an appropriate amendment to the Registration Statement or Prospectus Supplement to the Prospectus
(or supplement to the Permitted Free Writing Prospectus) and shall expeditiously furnish or make available to the Buyer an electronic
copy thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Stop
Orders</U>. The Company shall advise the Buyer promptly (but in no event later than 24 hours) and shall confirm such advice in writing:
(i) of the Company&rsquo;s receipt of notice of any request by the SEC for amendment of or a supplement to the Registration Statement,
the Prospectus, any Permitted Free Writing Prospectus or for any additional information; (ii) of the Company&rsquo;s receipt of notice
of the issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement or prohibiting or suspending the
use of the Prospectus or any Prospectus Supplement, or of the suspension of qualification of the Securities for offering or sale in any
jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose; (iii) of the Company becoming aware of
the happening of any event, which makes any statement of a material fact made in the Registration Statement, the Prospectus or any Permitted
Free Writing Prospectus untrue or which requires the making of any additions to or changes to the statements then made in the Registration
Statement, the Prospectus or any Permitted Free Writing Prospectus in order to state a material fact required by the 1933 Act to be stated
therein or necessary in order to make the statements then made therein (in the case of the Prospectus, in light of the circumstances under
which they were made) not misleading, or of the necessity to amend the Registration Statement or supplement the Prospectus or any Permitted
Free Writing Prospectus to comply with the 1933 Act or any other law or (iv) if at any time following the date hereof the Registration
Statement is not effective or is not otherwise available for the issuance of the Securities or any Prospectus contained therein is not
available for use for any other reason. Thereafter, the Company shall promptly notify such holders when the Registration Statement, the
Prospectus, any Permitted Free Writing Prospectus and/or any amendment or supplement thereto, as applicable, is effective and available
for the issuance of the Securities. If at any time the SEC shall issue any stop order suspending the effectiveness of the Registration
Statement or prohibiting or suspending the use of the Prospectus or any Prospectus Supplement, the Company shall use best efforts to obtain
the withdrawal of such order at the earliest possible time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Blue
Sky</U>. The Company shall, on or before the Closing Date, take such action as the Company shall reasonably determine is necessary in
order to obtain an exemption for, or to, qualify the Securities for sale to the Buyers at the Closing pursuant to this Agreement under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States (or to obtain an exemption from such qualification),
and shall provide evidence of any such action so taken to the Buyers on or prior to the Closing Date. Without limiting any other obligation
of the Company under this Agreement, the Company shall timely make all filings and reports relating to the offer and sale of the Securities
required under all applicable securities laws (including, without limitation, all applicable federal securities laws and all applicable
&ldquo;Blue Sky&rdquo; laws), and the Company shall comply with all applicable foreign, federal, state and local laws, statutes, rules,
regulations and the like relating to the offering and sale of the Securities to the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Reporting
Status</U>. Until the date on which the Buyers shall have sold all of the Securities (the &ldquo;<B>Reporting Period</B>&rdquo;), the
Company shall timely file all reports required to be filed with the SEC pursuant to the 1934 Act, and the Company shall not terminate
its status as an issuer required to file reports under the 1934 Act even if the 1934 Act or the rules and regulations thereunder would
no longer require or otherwise permit such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Use
of Proceeds</U>. The Company will use the proceeds from the sale of the Securities as described in the Prospectus Supplement,.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;[Intentionally
Omitted]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Listing</U>.
The Company shall promptly secure the listing or designation for quotation (as the case may be) of all of the Underlying Securities (as
defined below) upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed
or designated for quotation (as the case may be) (subject to official notice of issuance) and shall maintain such listing or designation
for quotation (as the case may be) of all Underlying Securities from time to time issuable under the terms of the Transaction Documents
on such national securities exchange or automated quotation system. The Company shall maintain the Common Stock&rsquo;s listing or authorization
for quotation (as the case may be) on the Principal Market, The New York Stock Exchange, the NYSE American, the Nasdaq Capital Market,
the Nasdaq Global Market or the Nasdaq Global Select Market (each, an &ldquo;<B>Eligible Market</B>&rdquo;). Neither the Company nor any
of its Subsidiaries shall take any action which could be reasonably expected to result in the delisting or suspension of the Common Stock
on an Eligible Market. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section 4(i).
&ldquo;<B>Underlying Securities</B>&rdquo; means the (i) the Common Shares, (ii) the Warrant Shares and (iii) any capital stock of the
Company issued or issuable with respect to the Common Shares, the Warrant Shares, or the Warrants, respectively, including, without limitation,
(1) as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise and (2) shares of capital
stock of the Company into which the shares of Common Stock are converted or exchanged and shares of capital stock of a Successor Entity
(as defined in the Warrants) into which the shares of Common Stock are converted or exchanged, in each case, without regard to any limitations
on exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Fees</U>.
The Company shall be responsible for the payment of any placement agent&rsquo;s fees, financial advisory fees, transfer agent fees, DTC
fees or broker&rsquo;s commissions (other than for Persons engaged by any Buyer) relating to or arising out of the transactions contemplated
hereby (including, without limitation, any fees or commissions payable to the Placement Agents, who are the Company&rsquo;s sole placement
agents in connection with the transactions contemplated by this Agreement). The Company shall pay, and hold each Buyer harmless against,
any liability, loss or expense (including, without limitation, reasonable attorneys&rsquo; fees and out-of-pocket expenses) arising in
connection with any claim relating to any such payment. Except as otherwise set forth in the Transaction Documents, each party to this
Agreement shall bear its own expenses in connection with the sale of the Securities to the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Pledge
of Securities</U>. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges and agrees that the
Securities may be pledged by a holder of Warrants (each, an &ldquo;<B>Investor</B>&rdquo;) in connection with a bona fide margin agreement
or other loan or financing arrangement that is secured by the Securities. The Company hereby agrees to execute and deliver such documentation
as a pledgee of the Securities may reasonably request in connection with a pledge of the Securities to such pledgee by a Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Disclosure
of Transactions and Other Material Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Disclosure
of Transaction</U>. The Company shall, on or before 9:30&nbsp;a.m., New York time, on the date of this Agreement, issue a press release
(the &ldquo;<B>Press Release</B>&rdquo;) reasonably acceptable to the Buyers disclosing all the material terms of the transactions contemplated
by the Transaction Documents. On or before 9:30 a.m., New York time, on the first (1<SUP>st</SUP>) Business Day after the date of this
Agreement, the Company shall file a Current Report on Form 8-K describing all the material terms of the transactions contemplated by the
Transaction Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including, without limitation,
this Agreement (and all schedules to this Agreement), and the form of the Warrants) (including all attachments, the &ldquo;<B>8-K Filing</B>&rdquo;).
From and after the issuance of the press release, the Company shall have disclosed all material, non-public information (if any) provided
to any of the Buyers by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents in
connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of the press release,
the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral,
between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one
hand, and any of the Buyers or any of their affiliates, on the other hand, shall terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Limitations
on Disclosure</U>. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective
officers, directors, employees and agents not to, provide any Buyer with any material, non-public information regarding the Company
or any of its Subsidiaries from and after the date hereof without the express prior written consent of such Buyer (which may be
granted or withheld in such Buyer&rsquo;s sole discretion). In the event of a breach of any of the foregoing covenants, including,
without limitation, Section&nbsp;4(q)<B> </B>of this Agreement, or any of the covenants or agreements contained in any other
Transaction Document, by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees and
agents (as determined in the reasonable good faith judgment of such Buyer), in addition to any other remedy provided herein or in
the Transaction Documents, such Buyer shall have the right to make a public disclosure, in the form of a press release, public
advertisement or otherwise, of such breach or such material, non-public information, as applicable, without the prior approval by
the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees or agents. No Buyer shall
have any liability to the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees,
affiliates, stockholders or agents, for any such disclosure. To the extent that the Company delivers any material, non-public
information to a Buyer without such Buyer&rsquo;s consent, the Company hereby covenants and agrees that such Buyer shall not have
any duty of confidentiality with respect to, or a duty not to trade on the basis of, such material, non-public information. Subject
to the foregoing, neither the Company, its Subsidiaries nor any Buyer shall issue any press releases or any other public statements
with respect to the transactions contemplated hereby; provided, however, the Company shall be entitled, without the prior approval
of any Buyer, to make the Press Release and any press release or other public disclosure with respect to such transactions (i) in
substantial conformity with the 8-K Filing and contemporaneously therewith and (ii) as is required by applicable law and regulations
(provided that in the case of clause (i) each Buyer shall be consulted by the Company in connection with any such press release or
other public disclosure prior to its release). Without the prior written consent of the applicable Buyer (which may be granted or
withheld in such Buyer&rsquo;s sole discretion), the Company shall not (and shall cause each of its Subsidiaries and affiliates to
not) disclose the name of such Buyer in any filing, announcement, release or otherwise. Notwithstanding anything contained in this
Agreement to the contrary and without implication that the contrary would otherwise be true, the Company expressly acknowledges and
agrees that no Buyer shall have (unless expressly agreed to by a particular Buyer after the date hereof in a written definitive and
binding agreement executed by the Company and such particular Buyer (it being understood and agreed that no Buyer may bind any other
Buyer with respect thereto)), any duty of confidentiality with respect to, or a duty not to trade on the basis of, any material,
non-public information regarding the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;[Intentionally
Omitted]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Reservation
of Shares</U>. So long as any of the Warrants remain outstanding, the Company shall take all action necessary to at all times have authorized,
and reserved for the purpose of issuance, no less than 100% of the sum of the maximum number of Warrant Shares issuable upon exercise
of all the Warrants then outstanding (without regard to any limitations on the exercise of the Warrants set forth therein) (collectively,
the &ldquo;<B>Required Reserve Amount</B>&rdquo;); provided that at no time shall the number of shares of Common Stock reserved pursuant
to this Section 4(n) be reduced other than proportionally in connection with any exercise of the Warrants. If at any time the number of
shares of Common Stock authorized and reserved for issuance is not sufficient to meet the Required Reserve Amount, the Company will promptly
take all corporate action necessary to authorize and reserve a sufficient number of shares, including, without limitation, calling a special
meeting of stockholders to authorize additional shares to meet the Company&rsquo;s obligations pursuant to the Transaction Documents,
in the case of an insufficient number of authorized shares, obtain stockholder approval of an increase in such authorized number of shares,
and voting the management shares of the Company in favor of an increase in the authorized shares of the Company to ensure that the number
of authorized shares is sufficient to meet the Required Reserve Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Conduct
of Business</U>. The business of the Company and its Subsidiaries shall not be conducted in violation of any law, ordinance or regulation
of any Governmental Entity, except where such violations would not reasonably be expected to result, either individually or in the aggregate,
in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;[Intentionally
Omitted]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;[Intentionally
Omitted]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;[Intentionally
Omitted]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;<U>Passive
Foreign Investment Company</U>. The Company shall conduct its business, and shall cause its Subsidiaries to conduct their respective businesses,
in such a manner as will ensure that the Company will not be deemed to constitute a passive foreign investment company within the meaning
of Section 1297 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)&nbsp;<U>Corporate
Existence</U>. So long as any Buyer beneficially owns any Warrants, the Company shall not be party to any Fundamental Transaction (as
defined in the Warrants) unless the Company is in compliance with the applicable provisions governing Fundamental Transactions set forth
in the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)&nbsp;[Intentionally
Omitted]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Exercise
Procedures</U>. The form of Exercise Notice (as defined in the Warrants) included in the Warrants sets forth the totality of the procedures
required of the Buyers in order to exercise the Warrants. No legal opinion or other information or instructions shall be required of the
Buyers to exercise their Warrants. The Company shall honor exercises of the Warrants and shall deliver the Warrant Shares in accordance
with the terms, conditions and time periods set forth in the Warrants. Without limiting the preceding sentences, no ink-original Exercise
Notice shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Exercise Notice form be
required in order to exercise the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w)&nbsp;<U>Regulation
M</U>. The Company will not take any action prohibited by Regulation M under the 1934 Act, in connection with the distribution of the
Securities contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)&nbsp;<U>Closing
Documents.</U> On or prior to fourteen (14) calendar days after the Closing Date, the Company agrees to deliver, or cause to be delivered,
to each Buyer and Kelley Drye &amp; Warren, LLP a complete closing set of the executed Transaction Documents, Securities and any other
document required to be delivered to any party pursuant to Section&nbsp;7 hereof or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>5.</B></FONT></TD><TD STYLE="text-align: justify"><B>REGISTER; TRANSFER AGENT INSTRUCTIONS; NO LEGEND.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Register</U>.
The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice
to each holder of Securities), a register for the Common Shares and the Warrants in which the Company shall record the name and address
of the Person in whose name the Common Shares and the Warrants have been issued (including the name and address of each transferee), the
number of Common Shares held by such Person and the number of Warrant Shares issuable upon exercise of the Warrants held by such Person.
The Company shall keep the register open and available at all times during business hours for inspection of any Buyer or its legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Transfer
Agent Instructions</U>. The Company shall issue irrevocable instructions to its Transfer Agent and any subsequent transfer agent in a
form acceptable to each of the Buyers (the &ldquo;<B>Irrevocable Transfer Agent Instructions</B>&rdquo;) to issue certificates or credit
shares to the applicable balance accounts at DTC, registered in the name of each Buyer or its respective nominee(s), for the Common Shares
and the Warrant Shares in such amounts as specified from time to time by each Buyer to the Company upon the exercise of the Warrants (as
the case may be). The Company represents and warrants that no instruction other than the Irrevocable Transfer Agent Instructions referred
to in this Section&nbsp;5(b) will be given by the Company to its Transfer Agent with respect to the Securities, and that the Securities
shall otherwise be freely transferable on the books and records of the Company, as applicable, to the extent provided in this Agreement
and the other Transaction Documents. If a Buyer effects a sale, assignment or transfer of the Securities, the Company shall permit the
transfer and shall promptly instruct its Transfer Agent to issue one or more certificates or credit shares to the applicable balance accounts
at DTC in such name and in such denominations as specified by such Buyer to effect such sale, transfer or assignment. The Company acknowledges
that a breach by it of its obligations hereunder will cause irreparable harm to a Buyer. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Section&nbsp;5(b) will be inadequate and agrees, in the event of a breach or
threatened breach by the Company of the provisions of this Section&nbsp;5(b), that a Buyer shall be entitled, in addition to all other
available remedies, to an order and/or injunction restraining any breach and requiring immediate issuance and transfer, without the necessity
of showing economic loss and without any bond or other security being required. The Company shall cause its counsel to issue each legal
opinion referred to in the Irrevocable Transfer Agent Instructions to the Transfer Agent as follows: (i) at the Closing with respect to
the Common Shares, (ii) upon each exercise of the Warrants (unless such issuance covered by a prior legal opinion previously delivered
to the Transfer Agent), and (iii) on each date a registration statement with respect to the issuance or resale of any of the Securities
is declared effective by the SEC. Any fees (with respect to the Transfer Agent, counsel to the Company or otherwise) associated with the
issuance of such opinions or the removal of any legends on any of the Securities shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Legends</U>.
Certificates and any other instruments evidencing the Securities shall not bear any restrictive or other legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>FAST
Compliance</U>. While any Warrants remain outstanding, the Company shall maintain a transfer agent that participates in the DTC Fast Automated
Securities Transfer Program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><B>CONDITIONS TO THE COMPANY&rsquo;S OBLIGATION TO SELL. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligation of the Company
hereunder to issue and sell the Common Shares and the Warrants to each Buyer at the Closing is subject to the satisfaction, at or before
the Closing Date, of each of the following conditions, provided that these conditions are for the Company&rsquo;s sole benefit and may
be waived by the Company at any time in its sole discretion by providing each Buyer with prior written notice thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;Such
Buyer shall have executed each of the other Transaction Documents to which it is a party and delivered the same to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Such
Buyer and each other Buyer shall have delivered to the Company the Purchase Price (less, in the case of the lead Buyer, the amounts withheld
pursuant to Section 4(j)) for the Common Shares and the related Warrants being purchased by such Buyer at the Closing by wire transfer
of immediately available funds in accordance with the Flow of Funds Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The
representations and warranties of such Buyer shall be true and correct in all material respects as of the date when made and as of the
Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date, which
shall be true and correct as of such specific date), and such Buyer shall have performed, satisfied and complied in all material respects
with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Buyer at
or prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><B>CONDITIONS TO EACH BUYER&rsquo;S OBLIGATION TO PURCHASE. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligation of each Buyer
hereunder to purchase its Common Shares and its related Warrants at the Closing is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions, provided that these conditions are for each Buyer&rsquo;s sole benefit and may be waived by
such Buyer at any time in its sole discretion by providing the Company with prior written notice thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The
Company shall have duly executed and delivered to such Buyer each of the Transaction Documents and the Company shall have duly executed
and delivered to such Buyer (x) such aggregate number of Common Shares set forth across from such Buyer&rsquo;s name in column (3) of
the Schedule of Buyers, (y) Pre-Funded Warrants (initially for such aggregate number of Pre-Funded Warrant Shares as is set forth across
from such Buyer&rsquo;s name in column (4) of the Schedule of Buyers) and (z) Common Warrant (initially for such aggregate number of Common
Warrant Share as is set forth across from such Buyer&rsquo;s name in column (5) of the Schedule of Buyers), in each case, as being purchased
by such Buyer at the Closing pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Such
Buyer shall have received the opinion of Akerman LLP, the Company&rsquo;s counsel, dated as of the Closing Date, and the opinion of Snell
&amp; Wilmer LLP, the Company&rsquo;s special Nevada counsel, dated as of the Closing Date, in each case, in the form acceptable to such
Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The
Company shall have delivered to such Buyer a copy of the Irrevocable Transfer Agent Instructions, in the form acceptable to such Buyer,
which instructions shall have been delivered to and acknowledged in writing by the Company&rsquo;s transfer agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;The
Company shall have delivered to such Buyer a certificate evidencing the formation and good standing of the Company and each of its Subsidiaries
in each such entity&rsquo;s jurisdiction of formation issued by the Secretary of State (or comparable office) of such jurisdiction of
formation as of a date within ten (10) days of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;The
Company shall have delivered to such Buyer a certificate evidencing the Company&rsquo;s qualification as a foreign corporation and good
standing issued by the Secretary of State (or comparable office) of each jurisdiction in which the Company conducts business and is required
to so qualify, as of a date within ten (10) days of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;The
Company shall have delivered to such Buyer a certificate, in the form acceptable to such Buyer, executed by the Secretary of the Company
and dated as of the Closing Date, as to (i) the resolutions consistent with Section&nbsp;3(b) as adopted by the Company&rsquo;s board
of directors in a form reasonably acceptable to such Buyer, (ii) the Articles of Incorporation of the Company and (iii)&nbsp;the Bylaws
of the Company, each as in effect at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;Each
and every representation and warranty of the Company shall be true and correct as of the date when made and as of the Closing Date as
though originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true and
correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects with the covenants, agreements
and conditions required to be performed, satisfied or complied with by the Company at or prior to the Closing Date. Such Buyer shall have
received a certificate, duly executed by the Chief Executive Officer of the Company, dated as of the Closing Date, to the foregoing effect
and as to such other matters as may be reasonably requested by such Buyer in the form acceptable to such Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;The
Company shall have delivered to such Buyer a letter from the Company&rsquo;s transfer agent certifying the number of shares of Common
Stock outstanding on the Closing Date immediately prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;The
Common Stock (A) shall be designated for quotation or listed (as applicable) on the Principal Market and (B) shall not have been suspended,
as of the Closing Date, by the SEC or the Principal Market from trading on the Principal Market nor shall suspension by the SEC or the
Principal Market have been threatened, as of the Closing Date, either (I) in writing by the SEC or the Principal Market or (II) by falling
below the minimum maintenance requirements of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;The
Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale of the
Securities, including without limitation, those required by the Principal Market, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by
any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by
the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;Since
the date of execution of this Agreement, no event or series of events shall have occurred that reasonably would have or result in a Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;The
Company shall have obtained approval of the Principal Market to list or designate for quotation (as the case may be) the Common Shares
and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;Such
Buyer shall have received a letter on the letterhead of the Company, duly executed by the Chief Executive Officer of the Company, setting
forth the wire amounts of each Buyer and the wire transfer instructions of the Company (the &ldquo;<B>Flow of Funds Letter</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;From
the date hereof to the Closing Date, (i) trading in the Common Stock shall not have been suspended by the SEC or the Principal Market
(except for any suspension of trading of limited duration agreed to by the Company, which suspension shall be terminated prior to the
Closing), and, (ii) at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have
been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service,
or on the Principal Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of each Buyer,
makes it impracticable or inadvisable to purchase the Securities at the Closing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;The
Registration Statement shall be effective and available for the issuance and sale of the Securities hereunder and the Company shall have
delivered to such Buyer the Prospectus and the Prospectus Supplement as required thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;The
Company and its Subsidiaries shall have delivered to such Buyer such other documents, instruments or certificates relating to the transactions
contemplated by this Agreement as such Buyer or its counsel may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>8.</B></FONT></TD><TD STYLE="text-align: justify"><B>TERMINATION. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Closing
shall not have occurred with respect to a Buyer within five (5) days of the date hereof, then such Buyer shall have the right to terminate
its obligations under this Agreement with respect to itself at any time on or after the close of business on such date without liability
of such Buyer to any other party; provided, however, (i) the right to terminate this Agreement under this Section&nbsp;8 shall not be
available to such Buyer if the failure of the transactions contemplated by this Agreement to have been consummated by such date is the
result of such Buyer&rsquo;s breach of this Agreement and (ii) the abandonment of the sale and purchase of the Common Shares and the Warrants
shall be applicable only to such Buyer providing such written notice, provided further that no such termination shall affect any obligation
of the Company under this Agreement to reimburse such Buyer for the expenses described in Section&nbsp;4(j) above. Nothing contained in
this Section&nbsp;8 shall be deemed to release any party from any liability for any breach by such party of the terms and provisions of
this Agreement or the other Transaction Documents or to impair the right of any party to compel specific performance by any other party
of its obligations under this Agreement or the other Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><B>MISCELLANEOUS.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Governing
Law; Jurisdiction; Jury Trial</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement
shall be governed by the internal laws of the State of New York, without giving effect to any provision or rule (whether of the State
of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New
York. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New
York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or under any of the other Transaction
Documents or with any transaction contemplated hereby or thereby, and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding
is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such
party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law. Nothing contained herein shall be deemed or operate to preclude any Buyer from bringing suit or taking other legal action against
the Company in any other jurisdiction to collect on the Company&rsquo;s obligations to such Buyer or to enforce a judgment or other court
ruling in favor of such Buyer. <B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL
FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT,
ANY OTHER TRANSACTION DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Counterparts</U>.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature
is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature
page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Headings;
Gender</U>. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of,
this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine,
neuter, singular and plural forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words
of like import shall be construed broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo;
&ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo; and words of like import refer to this entire Agreement instead of just the provision in
which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Severability;
Maximum Payment Amounts</U>. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable
by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s). Notwithstanding anything to the contrary contained
in this Agreement or any other Transaction Document (and without implication that the following is required or applicable), it is the
intention of the parties that in no event shall amounts and value paid by the Company and/or any of its Subsidiaries (as the case may
be), or payable to or received by any of the Buyers, under the Transaction Documents (including without limitation, any amounts that would
be characterized as &ldquo;interest&rdquo; under applicable law) exceed amounts permitted under any applicable law. Accordingly, if any
obligation to pay, payment made to any Buyer, or collection by any Buyer pursuant the Transaction Documents is finally judicially determined
to be contrary to any such applicable law, such obligation to pay, payment or collection shall be deemed to have been made by mutual mistake
of such Buyer, the Company and its Subsidiaries and such amount shall be deemed to have been adjusted with retroactive effect to the maximum
amount or rate of interest, as the case may be, as would not be so prohibited by the applicable law. Such adjustment shall be effected,
to the extent necessary, by reducing or refunding, at the option of such Buyer, the amount of interest or any other amounts which would
constitute unlawful amounts required to be paid or actually paid to such Buyer under the Transaction Documents. For greater certainty,
to the extent that any interest, charges, fees, expenses or other amounts required to be paid to or received by such Buyer under any of
the Transaction Documents or related thereto are held to be within the meaning of &ldquo;interest&rdquo; or another applicable term to
otherwise be violative of applicable law, such amounts shall be pro-rated over the period of time to which they relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Entire
Agreement; Amendments</U>. This Agreement, the other Transaction Documents and the schedules and exhibits attached hereto and thereto
and the instruments referenced herein and therein supersede all other prior oral or written agreements between the Buyers, the Company,
its Subsidiaries, their affiliates and Persons acting on their behalf, including, without limitation, any transactions by any Buyer with
respect to Common Stock or the Securities, and the other matters contained herein and therein, and this Agreement, the other Transaction
Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein contain the entire
understanding of the parties solely with respect to the matters covered herein and therein; provided, however, nothing contained in this
Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect on any agreements any Buyer has entered
into with, or any instruments any Buyer has received from, the Company or any of its Subsidiaries prior to the date hereof with respect
to any prior investment made by such Buyer in the Company or (ii) waive, alter, modify or amend in any respect any obligations of the
Company or any of its Subsidiaries, or any rights of or benefits to any Buyer or any other Person, in any agreement entered into prior
to the date hereof between or among the Company and/or any of its Subsidiaries and any Buyer, or any instruments any Buyer received from
the Company and/or any of its Subsidiaries prior to the date hereof, and all such agreements and instruments shall continue in full force
and effect. Except as specifically set forth herein or therein, neither the Company nor any Buyer makes any representation, warranty,
covenant or undertaking with respect to such matters. For clarification purposes, the Recitals are part of this Agreement. No provision
of this Agreement may be amended other than by an instrument in writing signed by the Company and the Required Holders (as defined below),
and any amendment to any provision of this Agreement made in conformity with the provisions of this Section&nbsp;9(e) shall be binding
on all Buyers and holders of Securities, as applicable, provided that no such amendment shall be effective to the extent that it (A) applies
to less than all of the holders of the Securities then outstanding or (B) imposes any obligation or liability on any Buyer without such
Buyer&rsquo;s prior written consent (which may be granted or withheld in such Buyer&rsquo;s sole discretion). No waiver shall be effective
unless it is in writing and signed by an authorized representative of the waiving party, provided that the Required Holders may waive
any provision of this Agreement, and any waiver of any provision of this Agreement made in conformity with the provisions of this Section&nbsp;9(e)
shall be binding on all Buyers and holders of Securities, as applicable, provided that no such waiver shall be effective to the extent
that it (1) applies to less than all of the holders of the Securities then outstanding (unless a party gives a waiver as to itself only)
or (2) imposes any obligation or liability on any Buyer without such Buyer&rsquo;s prior written consent (which may be granted or withheld
in such Buyer&rsquo;s sole discretion). No consideration (other than reimbursement of legal fees) shall be offered or paid to any Person
to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration also
is offered to all of the parties to the Transaction Documents, all holders of the Common Shares, or all holders of the Warrants (as the
case may be). From the date hereof and while any Warrants are outstanding, the Company shall not be permitted to receive any consideration
from a Buyer or a holder of Warrants that is not otherwise contemplated by the Transaction Documents in order to, directly or indirectly,
induce the Company or any Subsidiary (i) to treat such Buyer or holder of Warrants in a manner that is more favorable than to other similarly
situated Buyers or holders of Warrants, as applicable, or (ii) to treat any Buyer(s) or holder(s) of Warrants in a manner that is less
favorable than the Buyer or holder of Warrants that is paying such consideration; provided, however, that the determination of whether
a Buyer has been treated more or less favorably than another Buyer shall disregard any securities of the Company purchased or sold by
any Buyer. The Company has not, directly or indirectly, made any agreements with any Buyers relating to the terms or conditions of the
transactions contemplated by the Transaction Documents except as set forth in the Transaction Documents. Without limiting the foregoing,
the Company confirms that, except as set forth in this Agreement, no Buyer has made any commitment or promise or has any other obligation
to provide any financing to the Company, any Subsidiary or otherwise. As a material inducement for each Buyer to enter into this Agreement,
the Company expressly acknowledges and agrees that (x) no due diligence or other investigation or inquiry conducted by a Buyer, any of
its advisors or any of its representatives shall affect such Buyer&rsquo;s right to rely on, or shall modify or qualify in any manner
or be an exception to any of, the Company&rsquo;s representations and warranties contained in this Agreement or any other Transaction
Document and (y) unless a provision of this Agreement or any other Transaction Document is expressly preceded by the phrase &ldquo;except
as disclosed in the SEC Documents,&rdquo; nothing contained in any of the SEC Documents shall affect such Buyer&rsquo;s right to rely
on, or shall modify or qualify in any manner or be an exception to any of, the Company&rsquo;s representations and warranties contained
in this Agreement or any other Transaction Document. &ldquo;<B>Required Holders</B>&rdquo; means (I) prior to the Closing Date, Buyers
entitled to purchase, in the aggregate, at least a majority of the number of Common Shares at the Closing and (II) on or after the Closing
Date, holders of, in the aggregate, at least a majority of the Underlying Securities as of such time (excluding any Underlying Securities
held by the Company or any of its Subsidiaries as of such time) issued or issuable hereunder or pursuant to the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Notices</U>.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic
mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party does
not receive an automatically generated message from the recipient&rsquo;s email server that such e-mail could not be delivered to such
recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each case,
properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Ondas Holdings Inc.<BR>
222 Lakeview Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Suite 800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">West Palm Beach, FL 33401<BR>
Telephone: (888) 350-9994<BR>
Attention: Eric A. Brock, Chief Executive Officer<BR>
E-Mail: [***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">With a copy (for informational purposes only) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Akerman LLP<BR>
Three Brickell City Centre</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">98 Southeast Seventh Street, Suite 1100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Miami, FL 33131<BR>
Telephone: (954) 463-2700<BR>
Attention: Christina Russo<BR>
E-Mail: [***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">If to the Transfer Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Broadridge Corporate Issuer Solutions, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">51 Mercedes Way, Edgewood, NY 11717</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Telephone: 212-973-6195</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Attention: Bri Maikranz</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Email: Brianna.Maikranz@broadridge.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to a Buyer, to its mailing address and e-mail
address set forth on the Schedule of Buyers, with copies to such Buyer&rsquo;s representatives as set forth on the Schedule of Buyers,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">with a copy (for informational purposes only) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Kelley Drye &amp; Warren LLP<BR>
3 World Trade Center<BR>
175 Greenwich Street<BR>
New York, NY 10007<BR>
Telephone: (212) 808-7540<BR>
Attention: Michael A. Adelstein, Esq.<BR>
E-mail: madelstein@kelleydrye.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or to such other mailing address and/or e-mail
address and/or to the attention of such other Person as the recipient party has specified by written notice given to each other party
five (5) days prior to the effectiveness of such change, provided that Kelley Drye &amp; Warren LLP shall only be provided copies of notices
sent to the lead Buyer. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication,
(B) mechanically or electronically generated by the sender&rsquo;s e-mail containing the time, date and recipient&rsquo;s e-mail or (C)
provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by e-mail or receipt from an overnight
courier service in accordance with clause (i), (ii) or (iii) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns,
including any purchasers of any of the Warrants (but excluding any purchasers of Underlying Securities, unless pursuant to a written assignment
by such Buyer). The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of
the Required Holders, including, without limitation, by way of a Fundamental Transaction (as defined in the Warrants) (unless the Company
is in compliance with the applicable provisions governing Fundamental Transactions set forth in the Warrants). A Buyer may assign some
or all of its rights hereunder in connection with any transfer of any of its Securities without the consent of the Company, in which event
such assignee shall be deemed to be a Buyer hereunder with respect to such assigned rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>No
Third Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than the Indemnitees
referred to in Section&nbsp;9(k). For the avoidance of doubt, the Company and the Buyers further acknowledges and agrees that the Placement
Agents are third-party beneficiaries of the representations and warranties of the Company and of the Buyers contained in this Agreement;
provided, that the Company and the Buyers shall have no liability to the Placement Agents with respect to the representations and warranties
of the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Survival</U>.
The representations, warranties, agreements and covenants shall survive the Closing. Each Buyer shall be responsible only for its own
representations, warranties, agreements and covenants hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Further
Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;In
consideration of each Buyer&rsquo;s execution and delivery of the Transaction Documents and acquiring the Securities thereunder and in
addition to all of the Company&rsquo;s other obligations under the Transaction Documents, the Company shall defend, protect, indemnify
and hold harmless each Buyer and each holder of any Securities and all of their stockholders, partners, members, officers, directors,
employees and direct or indirect investors and any of the foregoing Persons&rsquo; agents or other representatives (including, without
limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the &ldquo;<B>Indemnitees</B>&rdquo;)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses
in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought),
and including reasonable attorneys&rsquo; fees and disbursements (the &ldquo;<B>Indemnified Liabilities</B>&rdquo;), incurred by any Indemnitee
as a result of, or arising out of, or relating to (i) any misrepresentation or breach of any representation or warranty made by the Company
or any Subsidiary in any of the Transaction Documents, (ii) any breach of any covenant, agreement or obligation of the Company or any
Subsidiary contained in any of the Transaction Documents or (iii) any cause of action, suit, proceeding or claim brought or made against
such Indemnitee by a third party (including for these purposes a derivative action brought on behalf of the Company or any Subsidiary)
or which otherwise involves such Indemnitee that arises out of or results from (A) the execution, delivery, performance or enforcement
of any of the Transaction Documents, (B) any transaction financed or to be financed in whole or in part, directly or indirectly, with
the proceeds of the issuance of the Securities, (C) any disclosure properly made by such Buyer pursuant to Section&nbsp;4(l), or (D) the
status of such Buyer or holder of the Securities either as an investor in the Company pursuant to the transactions contemplated by the
Transaction Documents or as a party to this Agreement (including, without limitation, as a party in interest or otherwise in any action
or proceeding for injunctive or other equitable relief). To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
which is permissible under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;Promptly
after receipt by an Indemnitee under this Section 9(k) of notice of the commencement of any action or proceeding (including any governmental
action or proceeding) involving an Indemnified Liability, such Indemnitee shall, if a claim in respect thereof is to be made against the
Company under this Section 9(k), deliver to the Company a written notice of the commencement thereof, and the Company shall have the right
to participate in, and, to the extent the Company so desires, to assume control of the defense thereof with counsel mutually satisfactory
to the Company and the Indemnitee; provided, however, that an Indemnitee shall have the right to retain its own counsel with the fees
and expenses of such counsel to be paid by the Company if: (A) the Company has agreed in writing to pay such fees and expenses; (B) the
Company shall have failed promptly to assume the defense of such Indemnified Liability and to employ counsel reasonably satisfactory to
such Indemnitee in any such Indemnified Liability; or (C) the named parties to any such Indemnified Liability (including any impleaded
parties) include both such Indemnitee and the Company, and such Indemnitee shall have been advised by counsel that a conflict of interest
is likely to exist if the same counsel were to represent such Indemnitee and the Company (in which case, if such Indemnitee notifies the
Company in writing that it elects to employ separate counsel at the expense of the Company, then the Company shall not have the right
to assume the defense thereof and such counsel shall be at the expense of the Company), provided further, that in the case of clause (C)
above the Company shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for the Indemnitees.
The Indemnitee shall reasonably cooperate with the Company in connection with any negotiation or defense of any such action or Indemnified
Liability by the Company and shall furnish to the Company all information reasonably available to the Indemnitee which relates to such
action or Indemnified Liability. The Company shall keep the Indemnitee reasonably apprised at all times as to the status of the defense
or any settlement negotiations with respect thereto. The Company shall not be liable for any settlement of any action, claim or proceeding
effected without its prior written consent, provided, however, that the Company shall not unreasonably withhold, delay or condition its
consent. The Company shall not, without the prior written consent of the Indemnitee, consent to entry of any judgment or enter into any
settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
Indemnitee of a release from all liability in respect to such Indemnified Liability or litigation, and such settlement shall not include
any admission as to fault on the part of the Indemnitee. Following indemnification as provided for hereunder, the Company shall be subrogated
to all rights of the Indemnitee with respect to all third parties, firms or corporations relating to the matter for which indemnification
has been made. The failure to deliver written notice to the Company within a reasonable time of the commencement of any such action shall
not relieve the Company of any liability to the Indemnitee under this Section 9(k), except to the extent that the Company is materially
and adversely prejudiced in its ability to defend such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;The
indemnification required by this Section 9(k) shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, within ten (10) days after bills are received or Indemnified Liabilities are incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;The
indemnity agreement contained herein shall be in addition to (A) any cause of action or similar right of the Indemnitee against the Company
or others, and (B) any liabilities the Company may be subject to pursuant to the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Construction</U>.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules
of strict construction will be applied against any party. No specific representation or warranty shall limit the generality or applicability
of a more general representation or warranty. Each and every reference to share prices, shares of Common Stock and any other numbers in
this Agreement that relate to the Common Stock shall be automatically adjusted for any stock splits, stock dividends, stock combinations,
recapitalizations or other similar transactions that occur with respect to the Common Stock after the date of this Agreement. Notwithstanding
anything in this Agreement to the contrary, for the avoidance of doubt, nothing contained herein shall constitute a representation or
warranty against, or a prohibition of, any actions with respect to the borrowing of, arrangement to borrow, identification of the availability
of, and/or securing of, securities of the Company in order for such Buyer (or its broker or other financial representative) to effect
short sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Remedies</U>.
Each Buyer and in the event of assignment by Buyer of its rights and obligations hereunder, each holder of Securities, shall have all
rights and remedies set forth in the Transaction Documents and all rights and remedies which such holders have been granted at any time
under any other agreement or contract and all of the rights which such holders have under any law. Any Person having any rights under
any provision of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security), to recover
damages by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore, the Company
recognizes that in the event that it or any Subsidiary fails to perform, observe, or discharge any or all of its or such Subsidiary&rsquo;s
(as the case may be) obligations under the Transaction Documents, any remedy at law would inadequate relief to the Buyers. The Company
therefore agrees that the Buyers shall be entitled to specific performance and/or temporary, preliminary and permanent injunctive or other
equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and without
posting a bond or other security. The remedies provided in this Agreement and the other Transaction Documents shall be cumulative and
in addition to all other remedies available under this Agreement and the other Transaction Documents, at law or in equity (including a
decree of specific performance and/or other injunctive relief).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction Documents,
whenever any Buyer exercises a right, election, demand or option under a Transaction Document and the Company or any Subsidiary does not
timely perform its related obligations within the periods therein provided, then such Buyer may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company or such Subsidiary (as the case may be), any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Payment
Set Aside; Currency</U>. To the extent that the Company makes a payment or payments to any Buyer hereunder or pursuant to any of the other
Transaction Documents or any of the Buyers enforce or exercise their rights hereunder or thereunder, and such payment or payments or the
proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential,
set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver
or any other Person under any law (including, without limitation, any bankruptcy law, foreign, state or federal law, common law or equitable
cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall
be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.
Unless otherwise expressly indicated, all dollar amounts referred to in this Agreement and the other Transaction Documents are in United
States Dollars (&ldquo;<B>U.S. Dollars</B>&rdquo;), and all amounts owing under this Agreement and all other Transaction Documents shall
be paid in U.S. Dollars. All amounts denominated in other currencies (if any) shall be converted into the U.S. Dollar equivalent amount
in accordance with the Exchange Rate on the date of calculation. &ldquo;<B>Exchange Rate</B>&rdquo; means, in relation to any amount of
currency to be converted into U.S. Dollars pursuant to this Agreement, the U.S. Dollar exchange rate as published in the Wall Street Journal
on the relevant date of calculation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Judgment
Currency</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;If
for the purpose of obtaining or enforcing judgment against the Company in connection with this Agreement or any other Transaction Document
in any court in any jurisdiction it becomes necessary to convert into any other currency (such other currency being hereinafter in this
Section&nbsp;9(p) referred to as the &ldquo;<B>Judgment Currency</B>&rdquo;) an amount due in US Dollars under this Agreement, the conversion
shall be made at the Exchange Rate prevailing on the Trading Day immediately preceding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(1)&nbsp;the
date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction
that will give effect to such conversion being made on such date: or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(2)&nbsp;the
date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of which
such conversion is made pursuant to this Section&nbsp;9(p)(i)(1) being hereinafter referred to as the &ldquo;<B>Judgment Conversion Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;If
in the case of any proceeding in the court of any jurisdiction referred to in Section&nbsp;9(p)(i)(1) above, there is a change in the
Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party shall
pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange Rate
prevailing on the date of payment, will produce the amount of US Dollars which could have been purchased with the amount of Judgment Currency
stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;Any
amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained
for any other amounts due under or in respect of this Agreement or any other Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Independent
Nature of Buyers&rsquo; Obligations and Rights</U>. The obligations of each Buyer under the Transaction Documents are several and not
joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance of the obligations of
any other Buyer under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by
any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company acknowledges that the Buyers do not
so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Buyers
are in any way acting in concert or as a group or entity, and the Company shall not assert any such claim with respect to such obligations
or the transactions contemplated by the Transaction Documents or any matters, and the Company acknowledges that the Buyers are not acting
in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or the transactions contemplated
by the Transaction Documents. The decision of each Buyer to purchase Securities pursuant to the Transaction Documents has been made by
such Buyer independently of any other Buyer. Each Buyer acknowledges that no other Buyer has acted as agent for such Buyer in connection
with such Buyer making its investment hereunder and that no other Buyer will be acting as agent of such Buyer in connection with monitoring
such Buyer&rsquo;s investment in the Securities or enforcing its rights under the Transaction Documents. The Company and each Buyer confirms
that each Buyer has independently participated with the Company and its Subsidiaries in the negotiation of the transaction contemplated
hereby with the advice of its own counsel and advisors. Each Buyer shall be entitled to independently protect and enforce its rights,
including, without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be
necessary for any other Buyer to be joined as an additional party in any proceeding for such purpose. The use of a single agreement to
effectuate the purchase and sale of the Securities contemplated hereby was solely in the control of the Company, not the action or decision
of any Buyer, and was done solely for the convenience of the Company and its Subsidiaries and not because it was required or requested
to do so by any Buyer. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction
Document is between the Company, each Subsidiary and a Buyer, solely, and not between the Company, its Subsidiaries and the Buyers collectively
and not between and among the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>signature pages follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>COMPANY:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>ONDAS HOLDINGS INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 37%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>BUYER:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ]</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 37%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: justify">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD>
    <TD STYLE="text-align: left">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE OF BUYERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(1)</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 16%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(2)</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(3)</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(4)</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(5)</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(6)</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 30%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(7)</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Buyer</B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Mailing Address
    and E-mail Address</B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aggregate<BR>
    Number of<BR>
    Common Shares</B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aggregate<BR>
    Number of<BR>
    Pre-Funded Warrant Shares</B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aggregate<BR>
    Number of<BR>
    Common Warrant Shares </B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Purchase
    Price </B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Legal Representative&rsquo;s<BR>
    Mailing Address and E-mail Address</B></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>7
<FILENAME>ea027241901ex10-2_ondas.htm
<DESCRIPTION>PLACEMENT AGENT AGREEMENT, DATED JANUARY 9, 2026, BETWEEN ONDAS HOLDINGS INC. AND OPPENHEIMER & CO. INC., AS REPRESENTATIVE OF THE PLACEMENT AGENTS NAMED IN SCHEDULE I THERETO
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><I>Execution Version</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ONDAS HOLDINGS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>PLACEMENT AGENT AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">January 9, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Oppenheimer &amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">as Representative of the several</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Placement Agents named herein</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o Oppenheimer &amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">85 Broad Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Ondas Holdings Inc., a Nevada
corporation (the &#8220;<B>Company</B>&#8221;), proposes, subject to the terms and conditions contained herein, to sell directly to various
investors (each, an &#8220;<B>Investor</B>&#8221; and collectively, the &#8220;<B>Investors</B>&#8221;), pursuant to the terms of this
Placement Agent Agreement (this &#8220;<B>Agreement</B>&#8221;) and the Securities Purchase Agreement in the form of <U>Exhibit A</U>
attached hereto (the &#8220;<B>Securities Purchase Agreement</B>&#8221;) entered into with such Investors, (i) 19,000,000 shares (the
&#8220;<B>Shares</B>&#8221;) of the Company&#8217;s common stock, $0.0001 par value per share (the &#8220;<B>Common Stock</B>&#8221;),
(ii) pre-funded warrants to purchase up to 41,790,274 shares of Common Stock (the &#8220;<B>Pre-Funded Warrants</B>&#8221;) and (iii)
common warrants to purchase up to 121,580,548 shares of Common Stock (the &#8220;<B>Common Warrants</B>&#8221; and together with the Pre-Funded
Warrants, the &#8220;<B>Warrants</B>&#8221;). The aggregate number of shares of Common Stock issuable upon exercise of the Pre-Funded
Warrants is hereinafter referred to as the &#8220;<B>Pre-Funded Warrant Shares</B>&#8221;, and the aggregate number of shares of Common
Stock issuable upon exercise of the Common Warrants is hereinafter referred to as the &#8220;<B>Common Warrant Shares</B>.&#8221; The
Pre-Funded Warrant Shares and the Common Warrant Shares are collectively hereinafter referred to as the &#8220;<B>Warrant Shares</B>.&#8221;
The Shares, the Warrants and the Warrant Shares are collectively called the &#8220;<B>Securities</B>.&#8221; The Securities in the transaction
will be sold as (i)&nbsp;one Share and one accompanying Common Warrant to purchase two Common Warrant Shares or (ii)&nbsp;one Pre-Funded
Warrant to purchase one Pre-Funded Warrant Share and one accompanying Common Warrant to purchase two Common Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The terms of the Pre-Funded
Warrants are set forth in the form of Pre-Funded Warrant attached hereto as <U>Exhibit B</U>. The terms of the Common Warrants are set
forth in the form of Common Warrant attached hereto as <U>Exhibit C</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company has prepared
and filed in conformity with the requirements of the Securities Act of 1933, as amended (the &#8220;<B>Securities Act</B>&#8221;), and
the published rules and regulations thereunder (the &#8220;<B>Rules</B>&#8221;) adopted by the Securities and Exchange Commission (the
&#8220;<B>Commission</B>&#8221;), a registration statement on Form S-3ASR (No. 333-290121), including a related prospectus dated September
9, 2025 (the &#8220;<B>Base Prospectus</B>&#8221;) relating to common stock, preferred stock, debt securities, units and warrants to purchase
common stock, preferred stock or debt securities of the Company that may be sold from time to time by the Company in accordance with Rule
415 of the Securities Act, and such amendments thereof as may have been required to the date of this Agreement. Copies of such Registration
Statement (including all amendments thereof and all documents deemed incorporated by reference therein) and of the related Base Prospectus
have heretofore been delivered by the Company or are otherwise available to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The term &#8220;<B>Registration
Statement</B>&#8221; as used in this Agreement means the registration statement, including all exhibits, financial schedules and all documents
and information deemed to be part of the Registration Statement by incorporation by reference or otherwise, as amended from time to time,
including the information (if any) contained in the form of final prospectus filed with the Commission pursuant to Rule 424(b) of the
Rules and deemed to be part thereof at the time of effectiveness pursuant to Rule 430A or Rule 430B of the Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If the Company has filed
an abbreviated registration statement to register additional Securities pursuant to Rule 462(b) under the Rules (the &#8220;<B>462(b)
Registration Statement</B>&#8221;), then any reference herein to the Registration Statement shall also be deemed to include such 462(b)
Registration Statement. The term &#8220;<B>Preliminary Prospectus</B>&#8221; means the Base Prospectus, together with any preliminary
prospectus supplement used or filed with the Commission pursuant to Rule 424 of the Rules, in the form provided to the Placement Agents
by the Company for use in connection with the offering of the Securities. The term &#8220;<B>Prospectus</B>&#8221; means the Base Prospectus,
any Preliminary Prospectus and any amendments or further supplements to such prospectus, and including, without limitation, the final
prospectus supplement filed pursuant to and within the limits described in Rule 424(b) with the Commission in connection with the proposed
sale of the Securities to the Investors contemplated by this Agreement and the Securities Purchase Agreement through the date of such
Prospectus Supplement. The term &#8220;<B>Effective Date</B>&#8221; shall mean each date that the Registration Statement and any post-effective
amendment or amendments thereto became or become effective. Unless otherwise stated herein, any reference herein to the Registration Statement,
any Preliminary Prospectus, the Statutory Prospectus (as hereinafter defined) and the Prospectus shall be deemed to refer to and include
the documents incorporated by reference therein, including pursuant to Item 12 of Form S-3 under the Securities Act, which were filed
under the Securities Exchange Act of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;) on or before the date hereof or are so filed
hereafter. Any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to
the Registration Statement, any Preliminary Prospectus, the Statutory Prospectus or the Prospectus shall be deemed to refer to and include
any such document filed or to be filed under the Exchange Act after the date of the Registration Statement, any Preliminary Prospectus,
the Statutory Prospectus or Prospectus, as the case may be, and deemed to be incorporated therein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company hereby confirms
its agreement with Oppenheimer &amp; Co. Inc. to act as representative (the &#8220;<B>Representative</B>&#8221;) of the placement agents
named in <U>Schedule I</U> hereto (the &#8220;<B>Placement Agents</B>&#8221;) in accordance with the terms and conditions hereof. The
Placement Agents may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Offering.
The Company hereby confirms that the Placement Agents and dealers have been authorized to distribute or cause to be distributed the Prospectus,
and each Issuer Free Writing Prospectus (as hereinafter defined) and are authorized to distribute the Prospectus (as from time to time
amended or supplemented if the Company furnishes amendments or supplements thereto to the Placement Agents).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Agreement to Act
as Placement Agents; Placement of Securities</U>. On the basis of the representations, warranties and agreements of the Company
contained in, and subject to the terms and conditions of, this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Placement Agents shall be the exclusive Placement Agents in connection with the offering and sale by the Company of the Securities
from time to time pursuant to the Registration Statement (such offering, the &#8220;<B>Offering</B>&#8221;), to be subject to market conditions
and negotiations between the Company and the prospective Investors. The Placement Agents will act on a reasonable best efforts basis and
the Company agrees and acknowledges that there is no guarantee of the successful placement of the Securities, or any portion thereof,
in the prospective Offering. Under no circumstances will the Placement Agents or any of their affiliates be obligated to underwrite or
purchase any of the Securities for its own account or otherwise provide any financing. The Placement Agents shall act solely as the Company&#8217;s
agent and not as principal. The Placement Agents shall have no authority to bind the Company with respect to any prospective offer to
purchase Securities and the Company shall have the sole right to accept offers to purchase Securities and may reject any such offer, in
whole or in part. Subject to the terms and conditions hereof, payment of the purchase price for, and delivery of, the Securities shall
be made at the Closing (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Until the Closing Date or earlier upon termination of this Agreement pursuant to Section 8, the Company shall not, without the
prior written consent of the Representative, solicit or accept offers to purchase the Securities otherwise than through the Placement
Agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Subject to the provisions of this Section 1, offers for the purchase of Securities may be solicited by the Placement Agents, as
agent for the Company at such times and in such amounts as the Placement Agents deem advisable. The Placement Agents shall communicate
to the Company, orally or in writing, each reasonable offer to purchase Securities received by it as agent of the Company. The Company
shall have the sole right to accept offers to purchase Securities and may reject any such offer, in whole or in part. The Placement Agents
shall have the right, in its discretion reasonably exercised, without notice to the Company, to reject any offer to purchase Securities
received by it, in whole or in part, and any such rejection shall not be deemed a breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) The Shares are being sold to the Investors at an offering price of $16.4500 per Share and accompanying Common Warrant, and
(ii) the Pre-Funded Warrants are being sold to the Investors at an offering price of $16.4499 per Pre-Funded Warrant and accompanying
Common Warrant. The purchase of Securities by the Investors shall be evidenced by the execution of (i) a Securities Purchase Agreement
in form and substance consistent with Exhibit A hereto by each of the Investors and the Company, (ii) the Pre-Funded Warrants in form
and substance consistent with Exhibit B hereto by the Company and (ii) the Common Warrants in form and substance consistent with Exhibit
C hereto by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>As compensation for services rendered, on the Closing Date, the Company shall pay to the Representative by wire transfer of immediately
available funds to an account or accounts designated by the Representative, an aggregate amount equal to 4.0% of the gross proceeds received
by the Company (the &#8220;<B>Placement&nbsp;Fee</B>&#8221;) from the sale of the Securities on the Closing Date. The Placement Agents
may retain other brokers or dealers to act as sub-agents or selected-dealers on their behalf in connection with the Offering, the fees
of which shall be paid out of the Placement Fee paid to such Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No Securities which the Company has agreed to sell pursuant to this Agreement and the Securities Purchase Agreement shall be deemed
to have been purchased and paid for, or sold by the Company, until such securities shall have been delivered to the Investor thereof against
payment by such Investor. If the Company shall default in its obligations to deliver such securities to an Investor whose offer it has
accepted, the Company shall indemnify and hold the Placement Agents harmless against any loss, claim, damage or expense arising from or
as a result of such default by the Company in accordance with the procedures set forth in Section 6(c) herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Representations
and Warranties of the Company</U>. The Company represents and warrants to the Placement Agents as of the date hereof and as of the
Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. As of the date of this Agreement,
the Company is eligible to use Form S-3 under the Securities Act, including the transaction requirements set forth in General Instruction
I.B.1 of such form, and is not subject to the limitations of General Instruction I.B.6 of such form. The Company is not, and has not been
for at least 12 calendar months prior to the filing of the Registration Statement, a shell company. The Company filed with the Commission
the Registration Statement on Form S-3, including a Base Prospectus, for registration under the Securities Act of the offering and sale
of the Securities, and the Company has prepared and used a Prospectus in connection with the offer and sale of the Securities. When the
Registration Statement or any amendment thereof or supplement thereto was or is declared effective, and as of the date of the most recent
Amendment to the Registration Statement, it (i) complied or will comply, in all material respects, with the requirements of the Securities
Act and the Rules, the Exchange Act and the rules and regulations of the Commission thereunder, and (ii) did not or will not, contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make
the statements therein not misleading. When the Prospectus was first filed with the Commission (whether filed as part of the Registration
Statement or any amendment thereto or pursuant to Rule 424 of the Rules) and when any amendment thereof or supplement thereto was first
filed with the Commission, such Prospectus as amended or supplemented complied in all material respects with the applicable provisions
of the Securities Act and the Rules and did not or will not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. If applicable, the Prospectus delivered to the Placement Agents for use in connection with this offering
was identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted
by Regulation S-T. Notwithstanding the foregoing, none of the representations and warranties in this paragraph 2(a) shall apply to statements
in, or omissions from, the Prospectus made in reliance upon, and in conformity with, information herein or otherwise furnished in writing
by the Placement Agents specifically for use in the Prospectus. With respect to the preceding sentence, the Company acknowledges that
the only information furnished in writing by the Placement Agents for use in the Prospectus is their names in the Prospectus (the &#8220;<B>Placement
Agent Information</B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>As of the Applicable Time (as hereinafter defined), none of (i) the price and the number of Securities offered and sold, as indicated
on the cover page of the Prospectus, (ii) the Statutory Prospectus, or (iii) any individual Issuer Free Writing Prospectus listed on <U>Schedule
III</U> hereto, all considered together (collectively, the &#8220;<B>General Disclosure Package</B>&#8221;), included, includes or will
include any untrue statement of a material fact or omitted, omits or will omit to state any material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading&#894;
<I>provided</I>, <I>however</I>, that this representation and warranty shall not apply to statements in or omissions in the General Disclosure
Package made in reliance upon and in conformity with the Placement Agent Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each Issuer Free Writing
Prospectus (as hereinafter defined), including any electronic road show (including without limitation any &#8220;bona fide electronic
road show&#8221; as defined in Rule 433(h)(5) under the Securities Act) (each, a &#8220;<B>Road Show</B>&#8221;) (i) is identified in
<U>Schedule III</U> hereto and (iii) complied when issued, and complies, in all material respects with the requirements of the Securities
Act and the Rules and the Exchange Act and the rules and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As used in this Section and
elsewhere in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<B>Applicable Time</B>&#8221;
means 7:30 a.m. (Eastern Standard Time) on the date of this Placement Agent Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<B>subsidiaries</B>&#8221;
means Ondas Networks Inc., Ondas Autonomous Systems Inc., American Robotics, Inc., Airobotics Ltd., Airobotics Pte. Ltd., Airobotics,
Inc., Airobotics Gulf DMCC, Zickel Engineering Consulting &amp; Training Ltd, Apeiro Motion Ltd., Sentry CS Ltd. (&#8220;Sentry&#8221;),
Robo-Team Holdings Ltd. and Ondas Capital Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<B>Statutory Prospectus</B>&#8221;
as of any time means the Preliminary Prospectus, if any, and the Base Prospectus, each as amended and supplemented immediately prior to
the Applicable Time, including any document incorporated by reference therein and any prospectus supplement deemed to be a part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<B>Issuer Free Writing
Prospectus</B>&#8221; means each &#8220;free writing prospectus&#8221; (as defined in Rule 405 of the Rules) prepared by or on behalf
of the Company or used or referred to by the Company in connection with the offering of the Securities, including, without limitation,
each Road Show.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of
the Registration Statement or suspending or preventing the use of any Preliminary Prospectus, the Prospectus or any &#8220;free writing
prospectus&#8221;, as defined in Rule 405 under the Rules, has been issued by the Commission and no proceedings for that purpose have
been instituted or are threatened under the Securities Act. Any required filing of any Preliminary Prospectus and/or the Prospectus and
any supplement thereto pursuant to Rule 424(b) of the Rules has been or will be made in the manner and within the time period required
by such Rule 424(b). Any material required to be filed by the Company pursuant to Rule 433(d) or Rule 163(b)(2) of the Rules has been
or will be made in the manner and within the time period required by such Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The documents incorporated by reference in the Registration Statement, any Preliminary Prospectus and the Prospectus, at the time
they became effective or were filed with the Commission, as the case may be, complied in all material respects with the requirements of
the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder, and none of such documents
contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading, and any further documents
so filed and incorporated by reference in the Registration Statement, any Preliminary Prospectus and the Prospectus, when such documents
become effective or are filed with the Commission, as the case may be, will conform in all material respects to the requirements of the
Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder and will not contain an
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they are made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company has not, directly or indirectly, prepared, used or referred to any &#8220;free writing prospectus&#8221; (as defined
in Rule 405 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The consolidated financial statements of the Company (including all notes and schedules thereto) included or incorporated by reference
in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and Prospectus present fairly the financial position
of the Company and its consolidated subsidiaries at the dates indicated and the statement of operations, stockholders&#8217; equity and
cash flows of the Company and its consolidated subsidiaries for the periods specified&#894; and such financial statements and related
schedules and notes thereto, and the unaudited financial information filed with the Commission as part of the Registration Statement,
have been prepared in conformity with generally accepted accounting principles, consistently applied throughout the periods involved.
The summary and selected financial data included in the Statutory Prospectus and Prospectus present fairly the information shown therein
as at the respective dates and for the respective periods specified and have been presented on a basis consistent with the consolidated
financial statements set forth in the Prospectus and other financial information. There are no financial statements (historical or pro
forma) that are required to be included or incorporated by reference in the Registration Statement, the General Disclosure Package or
the Prospectus that are not included or incorporated by reference as required..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Rosenberg Rich Baker Berman, P.A. (the &#8220;<B>Auditor</B>&#8221;), whose reports are filed with the Commission as part of the
Registration Statement, the General Disclosure Package, the Statutory Prospectus or the Prospectus, as applicable, is and, during the
periods covered by their reports, was, (x) an independent public accounting firm as required by the Securities Act and the Rules, (y)
a registered public accounting firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act of 2002, as amended (the &#8220;<B>Sarbanes-Oxley
Act</B>&#8221;)) and (z) not in violation of the auditor independence requirements of the Sarbanes-Oxley Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and the subsidiaries are duly organized, validly existing and in good standing under the laws of their respective jurisdictions
of incorporation or organization and each such entity has all requisite power and authority to carry on its business as is currently being
conducted as described in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus, and
to own, lease and operate its properties. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus,
all of the issued shares of capital stock of, or other ownership interests in, each subsidiary have been duly and validly authorized and
issued and are fully paid and non-assessable and are owned, directly or indirectly, by the Company, free and clear of any lien, charge,
mortgage, pledge, security interest, claim, limitation on voting rights, equity, trust or other encumbrance, preferential arrangement,
defect or restriction of any kind whatsoever. The Company and each of its subsidiaries is duly qualified to do business and is in good
standing as a foreign corporation in each jurisdiction in which the nature of the business conducted by it or location of the assets or
properties owned, leased or licensed by it requires such qualification, except for such jurisdictions where the failure to so qualify
individually or in the aggregate would not have a material adverse effect on the assets, properties, condition, financial or otherwise,
or in the results of operations, business affairs or business prospects of the Company and its subsidiaries considered as a whole (a &#8220;<B>Material
Adverse Effect</B>&#8221;); and to the Company&#8217;s knowledge, no proceeding has been instituted in any such jurisdiction revoking,
limiting or curtailing, or seeking to revoke, limit or curtail, such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Registration Statement initially became effective within three years of the date hereof. If, immediately prior to the third
anniversary of the initial effective date of the Registration Statement, any of the Securities remain unsold by the Placement Agents,
the Company will, prior to that third anniversary file, if it has not already done so, a new shelf registration statement relating to
the Securities, in a form satisfactory to the Placement Agents, will use its best efforts to cause such registration statement to be declared
effective within 180 days after that third anniversary, and will take all other action necessary or appropriate to permit the offering
and sale of the Securities to continue as contemplated in the expired Registration Statement. References herein to the registration statement
relating to the Securities shall include such new shelf registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and each of its subsidiaries has all requisite corporate power and authority, and all necessary authorizations, approvals,
consents, orders, licenses, certificates and permits of and from all governmental or regulatory bodies or any other person or entity (collectively,
the &#8220;<B>Permits</B>&#8221;), to own, lease and license its assets and properties and conduct its business, all of which are valid
and in full force and effect, except where the lack of such Permits, individually or in the aggregate, would not have a Material Adverse
Effect. The Company and each of its subsidiaries has fulfilled and performed in all material respects all of its obligations with respect
to such Permits and no event has occurred that allows, or after notice or lapse of time would allow, revocation or termination thereof
or results in any other material impairment of the rights of the Company thereunder. Except as may be required under the Securities Act
and state and foreign Blue Sky laws, no other Permits are required to enter into, deliver and perform this Agreement and the Warrants
and to issue and sell the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) At the earliest time after the filing of the Registration Statement that the Company or another offering participant made a
<I>bona fide </I>offer (within the meaning of Rule 164(h)(2) of the Rules) of the Securities and (ii) at the date hereof, the Company
was and is not an &#8220;ineligible issuer,&#8221; as defined in Rule 405 of the Rules. (i) At the original effectiveness of the Registration
Statement, (ii) at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Securities
Act (whether such amendment was by post-effective amendment or incorporated report filed pursuant to Section 13 or 15(d) of the Exchange
Act or in the form of a prospectus), and (iii) at the time the Company or any person acting on its behalf (within the meaning, for this
clause only, of Rule 163(c) under the Securities Act) made any offer relating to the Shares in reliance on the exemption of Rule 163 under
the Securities Act, the Company was and is a &#8220;well-known seasoned issuer&#8221; (as defined in Rule 405 of the Rules).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company or its subsidiaries own or possess the valid right to use all (i) valid and enforceable patents, patent applications,
trademarks, trademark registrations, service marks, service mark registrations, Internet domain name registrations, copyrights, copyright
registrations, licenses, trade secret rights (&#8220;<B>Intellectual Property Rights</B>&#8221;) and (ii) inventions, software, works
of authorships, trademarks, service marks, trade names, databases, formulae, know how, Internet domain names and other intellectual property
(including trade secrets and other unpatented and/or unpatentable proprietary confidential information, systems, or procedures) (collectively,
&#8220;<B>Intellectual Property Assets</B>&#8221;) necessary to conduct its business as currently conducted, and as proposed to be conducted
and described in the Registration Statement, the General Disclosure Package and the Prospectus. The Company has not received any notice
of, nor is aware of, any infringement of or conflict with asserted rights of others with respect to any Intellectual Property Rights or
Intellectual Property Assets. Further, the Company has not received any opinion from its legal counsel concluding that any activities
of its business infringe, misappropriate, or otherwise violate, valid and enforceable Intellectual Property Rights of any other person.
To the Company&#8217;s knowledge, the Company&#8217;s business as now conducted does not give rise to any infringement of, any misappropriation
of, or other violation of, any valid and enforceable Intellectual Property Rights of any other person. All licenses for the use of the
Intellectual Property Rights described in the Registration Statement, the General Disclosure Package and the Prospectus are valid, binding
upon, and enforceable by or against the parties thereto in accordance to its terms. The Company has complied in all material respects
with, and is not in breach nor has received any asserted or threatened claim of breach of any Intellectual Property license, and the Company
has no knowledge of any breach or anticipated breach by any other person to any Intellectual Property license. No claim has been made
against the Company alleging the infringement by the Company of any patent, trademark, service mark, trade name, copyright, trade secret,
license in or other intellectual property right or franchise right of any person. The Company has taken all reasonable steps to protect,
maintain and safeguard its Intellectual Property Rights, including the execution of appropriate nondisclosure and confidentiality agreements.
The consummation of the transactions contemplated by this Agreement and the Warrants will not result in the loss or impairment of or payment
of any additional amounts with respect to, nor require the consent of any other person in respect of, the Company&#8217;s right to own,
use, or hold for use any of the Intellectual Property Rights as owned, used or held for use in the conduct of the business as currently
conducted. The Company has at all times complied with all applicable laws relating to privacy, data protection, and the collection and
use of personal information collected, used, or held for use by the Company in the conduct of the Company&#8217;s business. No claims
have been asserted or threatened against the Company alleging a violation of any person&#8217;s privacy or personal information or data
rights and the consummation of the transactions contemplated hereby and in the Warrants will not breach or otherwise cause any violation
of any law related to data privacy, data protection, or the collection and use of personal information collected, used, or held for use
by the Company in the conduct of the Company&#8217;s business. The Company takes reasonable measures to ensure that such information is
protected against unauthorized access, use, modification, or other misuse. The Company has taken all necessary actions to obtain ownership
of all works of authorship and inventions made by its employees, consultants and contractors during the time they are or were employed
by or under contract with the Company and which relate to the Company&#8217;s business. All founders and key employees have signed confidentiality,
non-disclosure and invention assignment agreements with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and its subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications, and databases (collectively, &#8220;<B>IT&nbsp;Systems</B>&#8221;) are adequate for, and operate and perform in
all material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted,
free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries
have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards
to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and data, including &#8220;Personal Data,&#8221; used in connection with their businesses. &#8220;<B>Personal Data</B>&#8221;
means (i)&nbsp;a natural person&#8217;s name, street address, telephone number, e-mail address, photograph, social security number or
tax identification number, driver&#8217;s license number, passport number, credit card number, bank information, or customer or account
number; (ii)&nbsp;any information which would qualify as &#8220;personally identifying information&#8221; under the Federal Trade Commission
Act, as amended; (iii)&nbsp;&#8220;personal data&#8221; as defined by GDPR; (iv)&nbsp;any information which would qualify as &#8220;protected
health information&#8221; under the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information
Technology for Economic and Clinical Health Act (collectively, &#8220;<B>HIPAA</B>&#8221;); and (v)&nbsp;any other piece of information
that allows the identification of such natural person, or his or her family, or permits the collection or analysis of any data related
to an identified person&#8217;s health or sexual orientation. To the knowledge of the Company, there have been no breaches, violations,
outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the
duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and its subsidiaries
are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules&nbsp;and regulations of any
court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and
security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation
or modification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and its subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal
data privacy and security laws and regulations, including without limitation HIPAA, and the Company and its subsidiaries have taken commercially
reasonable actions to prepare to comply with, and have been and currently are in compliance with, the European Union General Data Protection
Regulation (&#8220;<B>GDPR</B>&#8221;) (EU 2016/679) (collectively, the &#8220;<B>Privacy Laws</B>&#8221;). To ensure compliance with
the Privacy Laws, the Company and its subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure
compliance in all material respects with their policies and procedures relating to data privacy and security and the collection, storage,
use, disclosure, handling, and analysis of Personal Data (the &#8220;<B>Policies</B>&#8221;). The Company and its subsidiaries have at
all times made all disclosures to users or customers required by applicable laws and regulatory rules&nbsp;or requirements, and none of
such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or in violation of any applicable
laws and regulatory rules&nbsp;or requirements in any material respect. The Company further certifies that neither it nor any subsidiary:
(i)&nbsp;has received notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the
Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii)&nbsp;is
currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy
Law; or (iii)&nbsp;is a party to any order, decree, or agreement that imposes any obligation or liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as described in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus,
the Company and each of its subsidiaries has good and marketable title in fee simple to all real property, and good and marketable title
to all other property owned by it, in each case free and clear of all liens, encumbrances, claims, security interests and defects, except
such as do not materially affect the value of such property and do not materially interfere with the use made or proposed to be made of
such property by the Company and its subsidiaries. All property held under lease by the Company and its subsidiaries is held by them under
valid, existing and enforceable leases, free and clear of all liens, encumbrances, claims, security interests and defects, except such
as are not material and do not materially interfere with the use made or proposed to be made of such property by the Company and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Subsequent to the respective dates as of which information is given in the Registration Statement, the General Disclosure Package,
the Statutory Prospectus and the Prospectus, (i) there has not been any event which could have a Material Adverse Effect; (ii) neither
the Company nor any of its subsidiaries has sustained any loss or interference with its assets, businesses or properties (whether owned
or leased) from fire, explosion, earthquake, flood or other calamity, including a health epidemic or pandemic outbreak of infectious disease,
whether or not covered by insurance, or from any labor dispute or any court or legislative or other governmental action, order or decree
which would have a Material Adverse Effect; and (iii) since the date of the latest balance sheet included in the Registration Statement,
the General Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has (A) issued any securities (other than
plans disclosed in the Registration Statement, the General Disclosure Package and the Prospectus for securities issued pursuant to employee
benefit plans, qualified stock option plans or other employee compensation plans or pursuant to plans disclosed in the Registration Statement,
the General Disclosure Package and the Prospectus for outstanding options, rights or warrants) or incurred any liability or obligation,
direct or contingent, for borrowed money, except such liabilities or obligations incurred in the ordinary course of business, (B) entered
into any transaction (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as
a whole or (C) declared or paid any dividend or made any distribution on any shares of its stock or redeemed, purchased or otherwise acquired
or agreed to redeem, purchase or otherwise acquire any shares of its capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>There is no document, contract or other agreement required to be described in the Registration Statement, the General Disclosure
Package, the Statutory Prospectus or the Prospectus or to be filed as an exhibit to the Registration Statement which is not described
or filed as required by the Securities Act or Rules. Each description of a contract, document or other agreement in the Registration Statement,
the General Disclosure Package, the Statutory Prospectus or the Prospectus accurately reflects in all material respects the terms of the
underlying contract, document or other agreement. Each contract, document or other agreement described in the Registration Statement,
the General Disclosure Package, the Statutory Prospectus or the Prospectus or listed in the exhibits to the Registration Statement or
incorporated by reference is in full force and effect and is valid and enforceable by and against the Company or its subsidiaries, as
the case may be, in accordance with its terms. Neither the Company nor any of its subsidiaries, if a subsidiary is a party, nor to the
Company&#8217;s knowledge, any other party is in default in the observance or performance of any term or obligation to be performed by
it under any such agreement, and no event has occurred which with notice or lapse of time or both would constitute such a default, in
any such case which default or event, individually or in the aggregate, would have a Material Adverse Effect. No default exists, and no
event has occurred which with notice or lapse of time or both would constitute a default, in the due performance and observance of any
term, covenant or condition, by the Company or its subsidiaries, if a subsidiary is a party thereto, of any other agreement or instrument
to which the Company or any of its subsidiaries is a party or by which Company or its properties or business or a subsidiary or its properties
or business may be bound or affected which default or event, individually or in the aggregate, would have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The statistical and market related data included in the Registration Statement, the General Disclosure Package, the Statutory Prospectus
or the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Neither the Company nor any subsidiary (i) is in violation of its certificate or articles of incorporation, by-laws, certificate
of formation, limited liability company agreement, partnership agreement or other organizational documents, (ii) is in default under,
and no event has occurred which, with notice or lapse of time, or both, would constitute a default under, or result in the creation or
imposition of any lien, charge, mortgage, pledge, security interest, claim, limitation on voting rights, equity, trust or other encumbrance,
preferential arrangement, defect or restriction of any kind whatsoever, upon, any property or assets of the Company or any subsidiary
pursuant to, any bond, debenture, note, indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which it
is a party or by which it is bound or to which any of its properties or assets is subject or (iii) is in violation of any statute, law,
rule, regulation, ordinance, directive, judgment, decree or order of any judicial, regulatory or other legal or governmental agency or
body, foreign or domestic, except (in the case of clauses (ii) and (iii) above) for violations or defaults that could not (individually
or in the aggregate) reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>This Agreement has been duly authorized, executed and delivered by the Company. The Securities Purchase Agreement has been duly
authorized by the Company, and, upon its execution and delivery, will be valid and binding obligations of the Company enforceable against
it in accordance with its terms, except as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance and other laws of general application affecting enforcement of creditors&#8217; rights generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Shares and Warrant Shares, when issued, paid for and delivered by the Company to the Investors pursuant to the Securities Purchase
Agreement or upon exercise of the Warrants, will be duly authorized and validly issued, fully paid and non-assessable and will conform
to the descriptions thereof in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus;
the Shares and Warrant Shares have been reserved for issuance pursuant to the terms of the Securities Purchase Agreement and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company has entered into a Securities Purchase Agreement with the Investors that contains certain representations, warranties
and covenants of the Company. Such representations, warranties, covenants and agreements may be relied upon by the Placement Agents as
a third-party beneficiary thereof. The Securities Purchase Agreement has been executed and delivered by the Company and the Investors
and is enforceable against the Investors in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(w)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Neither the execution, delivery and performance of this Agreement, the Securities Purchase Agreement, and the Warrants by the Company
nor the consummation of any of the transactions contemplated hereby (including, without limitation, the issuance and sale by the Company
of the Securities) will give rise to a right to terminate or accelerate the due date of any payment due under, or conflict with or result
in the breach of any term or provision of, or constitute a default (or an event which with notice or lapse of time or both would constitute
a default) under, or require any consent or waiver under, or result in the execution or imposition of any lien, charge or encumbrance
upon any properties or assets of the Company or its subsidiaries pursuant to the terms of, any indenture, mortgage, deed of trust or other
agreement or instrument to which the Company or any of its subsidiaries is a party or by which either the Company or its subsidiaries
or any of their properties or businesses is bound, or any franchise, license, permit, judgment, decree, order, statute, rule or regulation
applicable to the Company or any of its subsidiaries or violate any provision of the charter or by-laws of the Company or any of its subsidiaries,
except for such consents or waivers which have already been obtained and are in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company has authorized and outstanding capital stock as set forth under the captions &#8220;Capitalization&#8221; and &#8220;Description
of Capital Stock&#8221; in the Registration Statement, the General Disclosure Package and the Prospectus. The certificates or book entry
statements evidencing the Shares and the Warrants are in due and proper legal form and have been duly authorized for issuance by the Company.
All of the issued and outstanding shares of Common Stock have been duly and validly issued and are fully paid and nonassessable. There
are no statutory preemptive or other similar rights to subscribe for or to purchase or acquire any shares of Common Stock of the Company
or any of its subsidiaries or any such rights pursuant to its Certificate of Incorporation or by-laws or any agreement or instrument to
or by which the Company or any of its subsidiaries is a party or bound. The Company will reserve and keep available for the exercise of
the Warrants such number of authorized but unissued shares as is sufficient to permit the exercise in full of the Warrants. The Shares,
when issued and sold pursuant to this Agreement, the Pre-Funded Warrant Shares, when issued and sold pursuant to the Pre-Funded Warrants,
and the Common Warrant Shares, when issued and sold pursuant to the Common Warrants, will be duly and validly issued, fully paid and nonassessable
and none of them will be issued in violation of any preemptive or other similar right. Neither the filing of the Registration Statement
nor the offering or sale of the Securities as contemplated by this Agreement and the Warrants gives rise to any rights for or relating
to the registration of any shares of Common Stock or other securities of the Company. Except as disclosed in the Registration Statement,
the General Disclosure Package, the Statutory Prospectus and the Prospectus, there is no outstanding option, warrant or other right calling
for the issuance of, and there is no commitment, plan or arrangement to issue, any share of stock of the Company or any of its subsidiaries
or any security convertible into, or exercisable or exchangeable for, such stock. The exercise price of each option to acquire Common
Stock, stock bonus and other stock plans or arrangements (each, a &#8220;<B>Company Stock Option</B>&#8221;) is no less than the fair
market value of a share of Common Stock as determined on the date of grant of such Company Stock Option. All grants of Company Stock Options
were validly issued and properly approved by the Board of Directors of the Company in material compliance with all applicable laws and
regulatory rules or requirements, including all applicable federal securities laws, and the terms of the plans under which such Company
Stock Options were issued and were recorded on the Company&#8217;s financial statements in accordance with GAAP, and no such grants involved
any &#8220;back dating&#8221;, &#8220;forward dating,&#8221; &#8220;spring loading&#8221; or similar practices with respect to the effective
date of grant. The description of the Company Stock Options and the options or other rights granted thereunder set forth in the Registration
Statement, the General Disclosure Package and the Prospectus accurately and fairly presents in all material respects the information required
to be shown with respect to such plans, arrangements and awards. The Common Stock, the Shares and the Warrants conform in all material
respects to all statements in relation thereto contained in the Registration Statement, the General Disclosure Package, the Statutory
Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(y)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No holder of any security of the Company has any right, which has not been waived, to have any security owned by such holder included
in the Registration Statement or to demand registration of any security owned by such holder for a period of 60 days after the date of
this Agreement, except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus. Each director and
executive officer of the Company and each stockholder of the Company listed on <U>Schedule II</U> hereto has delivered to the Representative
her, his or their enforceable written lock-up agreement in the form attached to this Agreement as <U>Exhibit D</U> hereto (&#8220;<B>Lock-Up
Agreement</B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(z)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>There are no legal or governmental proceedings pending to which the Company or any of its subsidiaries is a party or of which any
property of the Company or any of its subsidiaries is the subject which, if determined adversely to the Company or any of its subsidiaries
could individually or in the aggregate have a Material Adverse Effect; and, to the knowledge of the Company, no such proceedings are threatened
or contemplated by governmental authorities or threatened by others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aa)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>All necessary corporate action has been duly and validly taken by the Company and to authorize the execution, delivery and performance
of this Agreement, the Securities Purchase Agreement and the Warrants and the issuance and sale of the Securities by the Company, as applicable.
The Warrants have been duly and validly authorized and, upon the execution and delivery thereof by the Company on the Closing Date, will
constitute legal, valid and binding obligations of the Company enforceable against the Company in accordance with their respective terms,
except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws
of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions
may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bb)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Neither the Company nor any of its subsidiaries is involved in any labor dispute nor, to the knowledge of the Company, is any such
dispute threatened, which dispute would have a Material Adverse Effect. The Company is not aware of any existing or imminent labor disturbance
by the employees of any of its principal suppliers or contractors which would have a Material Adverse Effect. The Company is not aware
of any threatened or pending litigation between the Company or its subsidiaries and any of its executive officers which, if adversely
determined, could have a Material Adverse Effect and has no reason to believe that such officers will not remain in the employment of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(cc)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No supplier, customer or distributor of the Company has notified the Company that it intends to discontinue or decrease the rate
of business done with the Company, except where such discontinuation or decrease has not resulted in and could not reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(dd)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No transaction has occurred between or among the Company or any of its subsidiaries and any of the Company&#8217;s officers or
directors, stockholders or five percent stockholders or any affiliate or affiliates of any such officer or director or stockholder or
five percent stockholders that is required to be described in and is not described in the Registration Statement, the General Disclosure
Package, the Statutory Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ee)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company has not taken, nor will it take, directly or indirectly, any action designed to or which might reasonably be expected
to cause or result in, or which has constituted or which might reasonably be expected to constitute, the stabilization or manipulation
of the price of the Common Stock or any security of the Company, within the meaning of Regulation M of the Exchange Act, to facilitate
the sale or resale of any of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ff)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and each of its subsidiaries has filed all Federal, state, local and foreign tax returns which are required to be filed
through the date hereof, which returns are true and correct in all material respects or has received timely extensions thereof, and has
paid all taxes shown on such returns and all assessments received by it to the extent that the same are material and have become due.
There are no tax audits or investigations pending, which if adversely determined would have a Material Adverse Effect; nor are there any
material proposed additional tax assessments against the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(gg)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Shares and Warrant Shares have been duly authorized for listing on The Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hh)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock
under the Exchange Act or the listing of the Common Stock on The Nasdaq Capital Market, nor has the Company received any notification
that the Commission or The Nasdaq Capital Market is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The books, records and accounts of the Company and its subsidiaries accurately and fairly reflect, the transactions in, and dispositions
of, the assets of, and the results of operations of, the Company and its subsidiaries. Except as described in the Registration Statement,
the General Disclosure Package, the Statutory Prospectus and the Prospectus, the Company and each of its subsidiaries maintains a system
of &#8220;internal control over financial reporting&#8221; sufficient to provide reasonable assurances that (i) transactions are executed
in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation
of financial statements in accordance with generally accepted accounting principles and to maintain asset accountability, (iii) access
to assets is permitted only in accordance with management&#8217;s general or specific authorization, (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences
and (v) interactive data in eXtensible Business Reporting Language included in the Registration Statement fairly presents the information
called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jj)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as described in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus,
the Company has established and maintains disclosure controls and procedures (as such term is defined in Rule 13a-15 under the Exchange
Act), which: (i) are designed to ensure that material information relating to the Company is made known to the Company&#8217;s principal
executive officer and its principal financial officer by others within the Company, particularly during the periods in which the periodic
reports required under the Exchange Act are required to be prepared&#894; (ii) provide for the periodic evaluation of the effectiveness
of such disclosure controls and procedures at the end of the periods in which the periodic reports are required to be prepared&#894; and
(iii) are effective in all material respects to perform the functions for which they were established.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(kk)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as described in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus,
based on the Company&#8217;s most recent evaluation of its internal controls over financial reporting pursuant to Rule 13a-15(c) of the
Exchange Act, the Company is not aware of (i) any material weakness or significant deficiency in the design or operation of internal controls
which could adversely affect the Company&#8217;s ability to record, process, summarize and report financial data or any material weaknesses
in internal controls; or (ii) any fraud, whether or not material, that involves management or other employees who have a role in the Company&#8217;s
internal controls over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ll)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as described in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus
and as preapproved in accordance with the requirements set forth in Section 10A of the Exchange Act, the Auditor has not been engaged
by the Company to perform any &#8220;prohibited activities&#8221; (as defined in Section 10A of the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(mm)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as described in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus,
there are no material off-balance sheet arrangements (as defined in Item 303 of Regulation S-K) that have or are reasonably likely to
have a material current or future effect on the Company&#8217;s financial condition, revenues or expenses, changes in financial condition,
results of operations, liquidity, capital expenditures or capital resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(nn)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Company&#8217;s Board of Directors has, subject to the exceptions, cure periods and phase in periods specified in the applicable
stock exchange rules (&#8220;<B>Exchange Rules</B>&#8221;), validly appointed an audit committee to oversee internal accounting controls
whose composition satisfies the requirements of Listing Rule 5605 of The Nasdaq Stock Market and the Board of Directors and/or the audit
committee has adopted a charter that satisfies the requirements of Listing Rule 5605 of The Nasdaq Stock Market. The audit committee has
adopted a charter that complies in all material respects with the requirements of the Exchange Rules and has reviewed the adequacy of
its charter within the past twelve months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(oo)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>There is and has been no failure on the part of the Company or any of its directors or officers, in their capacities as such, to
comply with any provision of the Sarbanes-Oxley Act, including, without limitation, Section 402 related to loans and Sections 302 and
906 related to certifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(pp)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and
in such amounts as are customary in the businesses in which they are engaged or propose to engage after giving effect to the transactions
described in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus&#894; all policies
of insurance and fidelity or surety bonds insuring the Company or any of its subsidiaries or the Company&#8217;s or its subsidiaries&#8217;
respective businesses, assets, employees, officers and directors are in full force and effect&#894; the Company and each of its subsidiaries
are in compliance with the terms of such policies and instruments in all material respects&#894; and neither the Company nor any subsidiary
of the Company has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that is not materially greater
than the current cost. Neither the Company nor any of its subsidiaries has been denied any insurance coverage which it has sought or for
which it has applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(qq)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each approval, consent, order, authorization, designation, declaration or filing of, by or with any regulatory, administrative
or other governmental body necessary in connection with the execution and delivery by the Company of this Agreement, the Securities Purchase
Agreement and the Warrants and the consummation of the transactions herein and therein contemplated required to be obtained or performed
by the Company (except such additional steps as may be required by the Financial Industry Regulatory Authority (&#8220;<B>FINRA</B>&#8221;)
or may be necessary to qualify the Securities for offering by the Placement Agents under the state securities or Blue Sky laws) has been
obtained or made and is in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(rr)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>There are no affiliations with FINRA among the Company&#8217;s officers, directors or, to the knowledge of the Company, any five
percent or greater stockholder of the Company, except as set forth in the Registration Statement, the General Disclosure Package and the
Prospectus or otherwise disclosed in writing to the Placement Agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ss)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>All of the information provided to the Placement Agents or to counsel for the Placement Agents by the Company, its counsel, its
officers and directors and the holders of any securities (debt or equity) or options to acquire any securities of the Company in connection
with the offering of the Securities is true, complete, correct and compliant in all material respects with FINRA&#8217;s rules, and any
letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules or NASD Conduct Rules is true, complete,
correct and compliant in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(tt)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) Each of the Company and each of its subsidiaries is in compliance in all material respects with all rules, laws and regulations
relating to the use, treatment, storage and disposal of toxic substances and protection of health or the environment (&#8220;<B>Environmental
Law</B>&#8221;) which are applicable to its business; (ii) neither the Company nor its subsidiaries has received any notice from any governmental
authority or third party of an asserted claim under Environmental Laws; (iii) each of the Company and each of its subsidiaries has received
all permits, licenses or other approvals required of it under applicable Environmental Laws to conduct its business, except where the
lack of such permits, licenses or other approvals, individually or in the aggregate, would not have a Material Adverse Effect, and is
in compliance, in all material respects, with all terms and conditions of any such permit, license or approval; (iv) to the Company&#8217;s
knowledge, no facts currently exist that will require the Company or any of its subsidiaries to make future material capital expenditures
to comply with Environmental Laws; and (v) no property which is or has been owned, leased or occupied by the Company or its subsidiaries
has been designated as a Superfund site pursuant to the Comprehensive Environmental Response, Compensation of Liability Act of 1980, as
amended (42 U.S.C. Section 9601, et. seq.) (&#8220;<B>CERCLA</B>&#8221;) or otherwise designated as a contaminated site under applicable
state or local law. Neither the Company nor any of its subsidiaries has been named as a &#8220;potentially responsible party&#8221; under
CERCLA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(uu)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In the ordinary course of its business, the Company periodically reviews the effect of Environmental Laws on the business, operations
and properties of the Company and its subsidiaries, in the course of which the Company identifies and evaluates associated costs and liabilities
(including, without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with
Environmental Laws, or any permit, license or approval, any related constraints on operating activities and any potential liabilities
to third parties). On the basis of such review, the Company has reasonably concluded that such associated costs and liabilities would
not, singly or in the aggregate, have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and each of its subsidiaries (i) is in compliance, in all material respects, with any and all applicable foreign, federal,
state and local laws, rules, regulations, treaties, statutes and codes promulgated by any and all governmental authorities (including
pursuant to the Occupational Health and Safety Act) relating to the protection of human health and safety in the workplace (&#8220;<B>Occupational
Laws</B>&#8221;); (ii) has received all material permits, licenses or other approvals required of it under applicable Occupational Laws
to conduct its business as currently conducted; and (iii) is in compliance, in all material respects, with all terms and conditions of
any such permits, licenses or approvals. No action, proceeding, revocation proceeding, writ, injunction or claim is pending or, to the
Company&#8217;s knowledge, threatened against the Company or any of its subsidiaries relating to Occupational Laws, and the Company does
not have knowledge of any facts, circumstances or developments relating to its operations or cost accounting practices that could reasonably
be expected to form the basis for or give rise to such actions, suits, investigations or proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ww)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company is not and, after giving effect to the offering and sale of the Securities and the application of proceeds thereof
(including any cash exercise of the Warrants) as described in the Registration Statement, General Disclosure Package, Statutory Prospectus
and the Prospectus, will not be required to register as an &#8220;investment company&#8221; or an entity &#8220;controlled&#8221; by an
&#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended (the &#8220;<B>Investment Company
Act</B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xx)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Neither the Company nor any of its subsidiaries nor any director, officer or employee of the Company or any of its subsidiaries
nor any director, officer, agent, employee, affiliate or other person associated with or acting on behalf of the Company or any of its
subsidiaries has, directly or indirectly, (i) used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful
expenses relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct
or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned
or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of
the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of any anti-bribery
laws, including but not limited to, any applicable law, rule or regulation of any locality, including but not limited to any law, rule
or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International Business
Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010,
or any other applicable law, rule or regulation of similar purpose and scope or anti-corruption law; or (iv) made, offered, agreed, requested
or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence
payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintained and enforced,
and will continue to maintain and enforce, policies and procedures designed to promote and ensure compliance with all applicable anti-bribery
and anti-corruption laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(yy)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering
statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued,
administered or enforced by any governmental agency (collectively, the &#8220;<B>Anti-Money Laundering Laws</B>&#8221;) and no action,
suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of
its subsidiaries with respect to the Anti-Money Laundering Laws is pending, or to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(zz)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) Neither the Company, nor any of its subsidiaries, directors, officers, or employees, nor, to the knowledge of the Company,
any agent or affiliate of the Company or any of its subsidiaries, or other person associated with or acting on behalf of the Company or
any of its subsidiaries is (y) currently the subject or the target of any sanctions administered or enforced by the U.S. government (including,
without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#8220;<B>OFAC</B>&#8221;) or the U.S.
Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked
person&#8221;), the United Nations Security Council, the European Union, Her Majesty&#8217;s Treasury, or other relevant sanctions authority
(collectively, &#8220;<B>Sanctions</B>&#8221;), nor is (z) located, organized or resident in a country or territory that is the subject
or the target of Sanctions, including, without limitation, the Crimea region, the non-government controlled areas of the Zaporizhzhia
and Kherson Regions of Ukraine (or any other Covered Region of Ukraine identified pursuant to Executive Order 14065), the so-called Donetsk
People&#8217;s Republic, the so-called Luhansk People&#8217;s Republic, Cuba, Iran, North Korea and Syria (each, a &#8220;<B>Sanctioned
Country</B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company will not, directly or indirectly, use the proceeds of the offering of the Securities hereunder, or lend, contribute
or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate
any activities or business of or with any person that, at the time of such funding or facilitation, is the subject or the target of Sanctions,
(ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a
violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise)
of Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Since the more recent of (i) April 24, 2019 and (ii) ten (10) years prior to the date of this Agreement, the Company and its subsidiaries
have not engaged in and are not now engaged in, and will not engage in, any dealings or transactions with any person that at the time
of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company has implemented and maintains in effect policies and procedures designed to ensure compliance by the Company, and the
Company and its subsidiaries, and their respective directors, officers and employees, and to the knowledge of the Company, the agents
of the Company and its subsidiaries, are in compliance with all applicable Sanctions, and are not knowingly engaged in any activity that
would reasonably be expected to result in the Company being designated as the subject or target of Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aaa)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as described in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus,
the Company has not sold or issued any shares of Common Stock during the six-month period preceding the date of the Prospectus, including
any sales pursuant to Rule 144A under, or Regulations D or S of, the Securities Act, other than shares issued pursuant to employee benefit
plans, qualified stock options plans or other employee compensation plans or pursuant to outstanding options, rights or warrants. For
the avoidance of doubt, the Company has not sold or issued any securities that would be integrated with the offering of the Securities
contemplated by this Agreement, the Securities Purchase Agreement and the Warrants pursuant to the Securities Act, the Rules or any interpretations
thereof by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bbb)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended
(&#8220;<B>ERISA</B>&#8221;), for which the Company or any member of its &#8220;<B>Controlled Group</B>&#8221; (defined as any entity,
whether or not incorporated, that is under common control with the Company within the meaning of Section 4001(a)(14) of ERISA or any entity
that would be regarded as a single employer with the Company under Section 414(b), (c), (m) or (o) of the Code would have any liability
(each, a &#8220;<B>Plan</B>&#8221;) has been maintained in compliance with its terms and the requirements of any applicable statutes,
orders, rules and regulations, including but not limited to, ERISA and the Code; (ii) no prohibited transaction, within the meaning of
Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a
statutory or administrative exemption; (iii) for each Plan that is subject to the funding rules of Section 412 of the Code or Section
302 of ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail, to satisfy the minimum funding standards
(within the meaning of Section 302 of ERISA or Section 412 of the Code) applicable to such Plan; (iv) no Plan is, or is reasonably expected
to be, in &#8220;at risk status&#8221; (within the meaning of Section 303(i) of ERISA) and no Plan that is a &#8220;multiemployer plan&#8221;
within the meaning of Section 4001(a)(3) of ERISA is in &#8220;endangered status&#8221; or &#8220;critical status&#8221; (within the meaning
of Sections 304 and 305 of ERISA); (v) the fair market value of the assets of each Plan exceeds the present value of all benefits accrued
under such Plan (determined based on those assumptions used to fund such Plan); (vi) no &#8220;reportable event&#8221; (within the meaning
of Section 4043(c) of ERISA and the regulations promulgated thereunder) has occurred or is reasonably expected to occur; (vii) each Plan
that is intended to be qualified under Section 401(a) of the Code is so qualified, and nothing has occurred, whether by action or by failure
to act, which would cause the loss of such qualification; (viii) neither the Company nor any member of the Controlled Group has incurred,
nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension
Benefit Guarantee Corporation, in the ordinary course and without default) in respect of a Plan (including a &#8220;multiemployer plan&#8221;,
within the meaning of Section 4001(a)(3) of ERISA); and (ix) none of the following events has occurred or is reasonably likely to occur:
(A) a material increase in the aggregate amount of contributions required to be made to all Plans by the Company or its Controlled Group
affiliates in the current fiscal year of the Company and its Controlled Group affiliates compared to the amount of such contributions
made in the Company&#8217;s and its Controlled Group affiliates&#8217; most recently completed fiscal year; or (B) a material increase
in the Company and its subsidiaries&#8217; &#8220;accumulated post-retirement benefit obligations&#8221; (within the meaning of Accounting
Standards Codification Topic 715-60) compared to the amount of such obligations in the Company and its subsidiaries&#8217; most recently
completed fiscal year, except in each case with respect to the events or conditions set forth in (i) through (ix) hereof, as would not,
individually or in the aggregate, have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ccc)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>None of the Company, its directors or its officers has distributed nor will distribute prior to the later of (i) the Closing Date,
and (ii) completion of the distribution of the Shares and the Warrants, any offering material in connection with the offering and sale
of the Securities other than any Preliminary Prospectus, the Prospectus, the Registration Statement and other materials, if any, permitted
by the Securities Act and consistent with Section 4(d) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ddd)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company (a) has not alone engaged in any Testing-the-Waters Communication (as defined below) other than Testing-the-Waters
Communications with the consent of the Placement Agents with entities that are qualified institutional buyers within the meaning of Rule
144A under the Securities Act or institutions that are accredited investors within the meaning of Rule&nbsp;501 under the Securities Act
and (b) has not authorized anyone other than the Placement Agents to engage in Testing-the-Waters Communications. The Company reconfirms
that the Placement Agents have been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The Company has
not distributed any Written Testing-the-Waters Communications (as defined herein). &#8220;<B>Testing-the-Waters Communication</B>&#8221;
means any oral or written communication with potential investors undertaken in reliance on Section 5(d) or Rule 163B of the Securities
Act. &#8220;<B>Written Testing-the-Waters Communication</B>&#8221; means any Testing-the-Waters Communication that is a written communication
within the meaning of Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(eee)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained
in the Registration Statement, the General Disclosure Package, or the Prospectus has been made or reaffirmed without a reasonable basis
or has been disclosed other than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(fff)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Other than as contemplated by this Agreement and the Warrants, the Company has not incurred any liability for any finder&#8217;s
or broker&#8217;s fee or agent&#8217;s commission in connection with the execution and delivery of this Agreement and the Warrants or
the consummation of the transactions contemplated hereby or thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ggg)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Neither the issuance, sale and delivery of the Securities nor the application of the proceeds thereof by the Company as described
in each of the Registration Statement, the General Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board
of Governors of the Federal Reserve System or any other regulation of such Board of Governors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hhh)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>There are (and prior to the Closing Date, will be) no debt securities, convertible securities or preferred stock issued or guaranteed
by the Company or any of its subsidiaries that are rated by a &#8220;nationally recognized statistical rating organization,&#8221; as
such term is defined in Section 3(a)(62) under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company (i) does not have any material lending or other relationship with any banking or lending affiliate of the Placement
Agents and (ii) does not intend to use any of the proceeds from the sale of the Securities to repay any outstanding debt owed to any affiliate
of the Placement Agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jjj)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which
it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiary&#8217;s capital
stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring
any of such subsidiary&#8217;s properties or assets to the Company or any other subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>The Closing</U>.
The time and date of closing (the &#8220;<B>Closing</B>&#8221;) and delivery of the documents required to be delivered to the
Placement Agents pursuant to terms hereof, shall be at 10:00 A.M., New York time, on the first (second, if pricing occurs after 4:30
p.m., New York City time, on any given day) business day following the date of this Agreement or at such time on such other date,
not later than ten (10) business days after the date of this Agreement, as shall be agreed upon by the Company and the
Representative (such time and date of delivery and payment are called the &#8220;<B>Closing Date</B>&#8221;) at the office of
Oppenheimer &amp; Co. Inc., 85 Broad Street, New York, New York 10004.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Conditions of the
Placement Agents&#8217; Obligations and the Investors and the Sale of the Securities</U>. The respective obligations of the
Placement Agents hereunder and the Investors under the Securities Purchase Agreement, and the Closing of the sale of the Securities,
are subject to the accuracy, when made and as of the Applicable Time and on the Closing Date, of the representations and warranties
of the Company contained herein, to the accuracy of the statements of the Company made in any certificates pursuant to the
provisions hereof, to the performance by the Company of its obligations hereunder, and to each of the following additional terms and
conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notification that the Registration Statement has become effective shall have been received by the Representative, and the Prospectus
shall have been timely filed with the Commission in accordance with Section 4(a) of this Agreement and any material required to be filed
by the Company pursuant to Rule 433(d) of the Rules shall have been timely filed with the Commission in accordance with such rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No order preventing or suspending the use of any Preliminary Prospectus or the Prospectus, shall have been or shall be in effect
and no order suspending the effectiveness of the Registration Statement shall be in effect and no proceedings for such purpose shall be
pending before or threatened by the Commission, and any requests for additional information on the part of the Commission (to be included
in the Registration Statement or the Prospectus or otherwise) shall have been complied with to the satisfaction of the Commission and
the Placement Agents. If the Company has elected to rely upon Rule 430B, Rule 430B information previously omitted from the effective Registration
Statement pursuant to Rule 430B shall have been transmitted to the Commission for filing pursuant to Rule 424(b) within the prescribed
time period and the Company shall have provided evidence satisfactory to the Placement Agents of such timely filing, or a post-effective
amendment providing such information shall have been promptly filed and declared effective in accordance with the requirements of Rule
430B.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The representations and warranties of the Company contained in this Agreement and in the certificates delivered pursuant to Section
4(d) shall be true and correct when made and on and as of the Closing Date as if made on such date. The Company shall have performed all
covenants and agreements and satisfied all the conditions contained in this Agreement, the Securities Purchase Agreement and the Warrants
required to be performed or satisfied by it at or before the Closing Date, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Representative shall have received on the Closing Date a certificate, addressed to the Placement Agents and dated the Closing
Date, of the chief executive and the chief financial officer of the Company to the effect that: (i) the representations, warranties and
agreements of the Company in this Agreement were true and correct when made and are true and correct as of the Closing Date&#894; (ii)
the Company has performed all covenants and agreements and satisfied all conditions contained herein&#894; (iii) they have carefully examined
the Registration Statement, the Prospectus, and the General Disclosure Package and, in their opinion (A) as of the Effective Date the
Registration Statement and Prospectus did not include, and as of the Applicable Time, the General Disclosure Package, did not include
any untrue statement of a material fact and did not omit to state a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading, and (B) since the Effective Date no
event has occurred which should have been set forth in a supplement or otherwise required an amendment to the Registration Statement,
the Statutory Prospectus or the Prospectus&#894; (iv) no stop order suspending the effectiveness of the Registration Statement has been
issued and, to their knowledge, no proceedings for that purpose have been instituted or are pending under the Securities Act and (v) there
has not occurred any material adverse change in the assets, properties, condition, financial or otherwise, or in the results of operations,
business affairs or business prospects of the Company and its subsidiaries considered as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Representative shall have received: (i) simultaneously with the execution of this Agreement a signed letter from the Auditor
addressed to the Placement Agents and dated the date of this Agreement, in form and substance reasonably satisfactory to the Representative,
containing statements and information of the type ordinarily included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters
with respect to the financial statements and certain financial information contained in the Registration Statement, the General Disclosure
Package, and the Prospectus and (ii) on the Closing Date, a signed letter from the Auditor addressed to the Placement Agents and dated
the date of the Closing Date, in form and substance reasonably satisfactory to the Representative containing statements and information
of the type ordinarily included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with respect to the financial statements
and certain financial information contained in the Registration Statement, the General Disclosure Package and the Prospectus, <I>provided</I>,
that such letter delivered on the Closing Date shall use a &#8220;cut-off&#8221; date no more than two business days prior to the Closing
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Representative shall have received on the Closing Date from Akerman LLP, counsel for the Company, an opinion and a negative
assurance letter, addressed to the Placement Agents and dated as of the Closing Date, in form and substance reasonably satisfactory to
the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Representative shall have received on the Closing Date from Snell &amp; Wilmer L.L.P., Nevada local counsel for the Company,
an opinion, addressed to the Placement Agents and dated as of the Closing Date, in form and substance reasonably satisfactory to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Representative shall have received on the Closing Date from Akerman LLP, intellectual property counsel for Ondas Autonomous
Systems Inc., a Nevada corporation, an opinion, addressed to the Placement Agents and dated as of the Closing Date, in form and substance
reasonably satisfactory to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Representative shall have received on the Closing Date from Pearl Cohen Zedek Latzer Baratz LLP, intellectual property counsel
for the Company, an opinion, addressed to the Placement Agents and dated as of the Closing Date, in form and substance reasonably satisfactory
to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Representative shall have received on the Closing Date from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel for
the Placement Agents, an opinion and negative assurance letter, addressed to the Placement Agents and dated the Closing Date , in form
and substance reasonably satisfactory to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Representative shall have received on and as of (i) the date hereof and (ii) the Closing Date, a certificate of the chief financial
officer of the Company, addressed to the Placement Agents, confirming certain financial information included in the General Disclosure
Package and the Prospectus, in form and substance reasonably satisfactory to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>All proceedings taken in connection with the sale of the Securities as herein contemplated shall be reasonably satisfactory in
form and substance to the Placement Agents, and their counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Representative shall have received copies of the Lock-up Agreements executed by each entity or person listed on <U>Schedule
II</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Shares and Warrant Shares shall have been approved for listing on The Nasdaq Capital Market, subject only to official notice
of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Placement Agents shall be reasonably satisfied that since the respective dates as of which information is given in the Registration
Statement, the Statutory Prospectus, the General Disclosure Package and the Prospectus, (i) there shall not have been any material change
in the capital stock of the Company or any material change in the indebtedness (other than in the ordinary course of business) of the
Company, (ii) except as set forth or contemplated by the Registration Statement, the Statutory Prospectus, the General Disclosure Package
or the Prospectus, no material oral or written agreement or other transaction shall have been entered into by the Company that is not
in the ordinary course of business or that could reasonably be expected to result in a material reduction in the future earnings of the
Company, (iii) no loss or damage (whether or not insured) to the property of the Company shall have been sustained that had or could reasonably
be expected to have a Material Adverse Effect, (iv) no legal or governmental action, suit or proceeding affecting the Company or any of
its properties that is material to the Company or that affects or could reasonably be expected to affect the transactions contemplated
by this Agreement shall have been instituted or threatened and (v) there shall not have been any material change in the assets, properties,
condition (financial or otherwise), or in the results of operations, business affairs or business prospects of the Company or its subsidiaries
considered as a whole that makes it impractical or inadvisable in the Placement Agents&#8217; judgment to proceed with the purchase or
offering of the Securities as contemplated by this Agreement, the Securities Purchase Agreement, Warrants and the General Disclosure Package.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On or before the Closing Date, FINRA shall have confirmed that it has not raised any objection with respect to the fairness and
reasonableness of the terms and agreements in connection with the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Subsequent to the execution and delivery of this Agreement, there shall not have occurred any of the following: (i) trading in
any of the Company&#8217;s securities shall have been suspended or materially limited by the Commission or the Exchange, or trading in
securities generally on the New York Stock Exchange, Nasdaq Global Select Market, Nasdaq Global Market, Nasdaq Capital Market or the NYSE
MKT LLC or in the over-the-counter market, or trading in any securities of the Company on any exchange or in the over-the-counter market,
shall have been suspended or materially limited, or minimum or maximum prices or maximum range for prices shall have been established
on any such exchange or such market by the Commission, by such exchange or market or by any other regulatory body or governmental authority
having jurisdiction, (ii) a banking moratorium shall have been declared by Federal or state authorities or a material disruption has occurred
in commercial banking or securities settlement or clearance services in the United States, (iii) the United States shall have become engaged
in hostilities, or the subject of an act of terrorism, or there shall have been an outbreak of or escalation in hostilities involving
the United States, or there shall have been a declaration of a national emergency or war by the United States or (iv) there shall have
occurred such a material adverse change in general economic, political or financial conditions (or the effect of international conditions
on the financial markets in the United States shall be such) as to make it, in the judgment of the Placement Agents, impracticable or
inadvisable to proceed with the sale of or payment for the Securities on the terms and in the manner contemplated in the General Disclosure
Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal,
state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities;
and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the
issuance or sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On or before the Closing Date, FINRA shall have confirmed that it has not raised any objection with respect to the fairness and
reasonableness of the terms and arrangements of this Agreement or the transactions contemplated hereby in connection with issuance and
sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Placement Agents shall have received on or prior to the Closing Date satisfactory evidence of the good standing of the Company
in its jurisdiction of organization and its good standing as a foreign entity in such other jurisdictions as the Placement Agents may
reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of
such jurisdictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On the Closing Date, the Placement Agent shall have received electronic copies of the Warrants executed by the Company. As of the
date hereof, the Company shall have entered into the Securities Purchase Agreement, substantially in the form of <U>Exhibit A</U> hereto,
with each of the Investors. The Securities Purchase Agreement and the Warrants shall be in full force and effect, and the Company shall
have satisfied all of the conditions to closing in such Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall have furnished or caused to be furnished to the Representative such further certificates or documents (including
a Secretary&#8217;s Certificate) as the Representative shall have reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Covenants and
other Agreements of the Company and the Placement Agents</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company covenants and agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company will use its best efforts to cause the Registration Statement, if not effective at the time of execution of this Agreement,
and any amendments thereto, to become effective as promptly as possible. The Company shall prepare the Prospectus in a form approved by
the Placement Agents and file such Prospectus pursuant to Rule 424(b) under the Securities Act not later than the Commission&#8217;s close
of business on the second business day following execution and delivery of this Agreement, or, if applicable, such earlier time as may
be required by the Rules. The Company also agrees to pay the registration fee for this offering within the time period required by Rule
456(b)(1) of the Rules (without giving effect to the proviso therein) and in any event prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall promptly advise the Placement Agents in writing (A) when any post-effective amendment to the Registration Statement
shall have become effective or any supplement to the Prospectus shall have been filed, (B) of any request by the Commission for any amendment
of the Registration Statement or the Prospectus or for any additional information, (C) of the issuance by the Commission of any stop order
suspending the effectiveness of the Registration Statement or of any order preventing or suspending the use of any preliminary prospectus,
or the institution or threatening of any proceeding for that purpose and (D) of the receipt by the Company of any notification with respect
to the suspension of the qualification of the Securities for sale in any jurisdiction or the initiation or threatening of any proceeding
for such purpose. The Company shall not file any amendment of the Registration Statement or supplement to the Prospectus or any document
incorporated by reference in the Registration Statement unless the Company has furnished the Placement Agents a copy for its review prior
to filing and shall not file any such proposed amendment or supplement to which the Placement Agents reasonably object. The Company shall
use its best efforts to prevent the issuance of any such stop order and, if issued, to obtain as soon as possible the withdrawal thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If, at any time when a prospectus relating to the Securities (or, in lieu thereof, the notice referred to in Rule 173(a) of the
Rules) is required to be delivered under the Securities Act and, any event occurs as a result of which the Prospectus as then amended
or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements
therein in the light of the circumstances under which they were made not misleading, or if it shall be necessary to amend or supplement
the Prospectus to comply with the Securities Act or the Rules, the Company promptly shall prepare and file with the Commission, subject
to the second sentence of paragraph (ii) of this Section 5(a), an amendment or supplement which shall correct such statement or omission
or an amendment which shall effect such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If at any time following issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which
such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement or would include an untrue
statement of a material fact or would omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances prevailing at the subsequent time, not misleading, the Company will promptly notify the Placement
Agents and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict,
untrue statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Registration Statement initially became effective within three years of the date hereof and immediately prior to the third
anniversary of the initial effective date of the Registration Statement, the Company will, prior to the third anniversary, file a new
shelf registration statement relating to the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall deliver copies of all closing documents to the Investors pursuant to the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall make generally available to its security holders and to the Placement Agents as soon as practicable, but not
later than 45 days after the end of the 12-month period beginning at the end of the fiscal quarter of the Company during which the Effective
Date occurs (or 90 days if such 12-month period coincides with the Company&#8217;s fiscal year), an earning statement (which need not
be audited) of the Company, covering such 12-month period, which shall satisfy the provisions of Section 11(a) of the Securities Act or
Rule 158 of the Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall furnish to the Placement Agents and counsel for the Placement Agents, without charge, signed copies of the Registration
Statement (including all exhibits thereto and amendments thereof) and all amendments thereof and, so long as delivery of a prospectus
by the Placement Agents or dealer may be required by the Securities Act or the Rules, as many copies of any Preliminary Prospectus and
the Prospectus and any amendments thereof and supplements thereto as the Placement Agents may reasonably request. If applicable, the copies
of the Registration Statement, Preliminary Prospectus and Prospectus and each amendment and supplement thereto furnished to the Placement
Agents will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent
permitted by Regulation S-T.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall cooperate with the Placement Agents and its counsel in endeavoring to qualify the Securities for offer and sale
in connection with the offering under the laws of such jurisdictions as the Placement Agents may designate and shall maintain such qualifications
in effect so long as required for the distribution of the Securities&#894; provided, however, that the Company shall not be required in
connection therewith, as a condition thereof, to qualify as a foreign corporation or to execute a general consent to service of process
in any jurisdiction or subject itself to taxation as doing business in any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company, during the period when the Prospectus (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules) is
required to be delivered under the Securities Act and the Rules or the Exchange Act, will file all reports and other documents required
to be filed with the Commission pursuant to Section 13, 14 or 15 of the Exchange Act within the time periods required by the Exchange
Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Without the prior written consent of the Representative, for a period of 60 days after the date of this Agreement (the &#8220;<B>Lock-Up
Period</B>&#8221;), the Company shall not issue, sell or register with the Commission (other than on Form S-8 or on any successor form),
or otherwise dispose of, directly or indirectly, any equity securities of the Company (or any securities convertible into, exercisable
for or exchangeable for equity securities of the Company), except for (i) the issuance of the Securities pursuant to the Prospectus; (ii)
the exercise of the Company&#8217;s outstanding warrants into shares of Common Stock; (iii) securities issued pursuant to acquisitions
or strategic transactions approved by a majority of the disinterested directors of the Company, provided that (A) such securities are
issued as &#8220;restricted securities&#8221; (as defined in Rule 144) and carry no registration rights that require or permit the filing
of any registration statement in connection therewith within 60 days after the date of this Agreement, (B) any such issuance shall only
be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of
an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to
the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising
capital or to an entity whose primary business is investing in securities, and (C)&nbsp;the aggregate number of shares of Common Stock
issued pursuant to this clause (iii)&nbsp;shall not exceed 2.5% of the total number of outstanding shares of Common Stock immediately
prior to the issuance and sale of the Shares pursuant hereto; (iv) the issuance of shares pursuant to the Company&#8217;s existing stock
incentive plan as described in the Registration Statement, the General Disclosure Package and the Prospectus, and (v) the issuance and
registration for resale of the shares of Common Stock to be issued in connection with the acquisition of Sentry as described in the Registration
Statement, the General Disclosure Package and the Prospectus. &#8220;<B>Person</B>&#8221; means an individual or corporation, partnership,
trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency
or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On or before completion of this offering, the Company shall make all filings required under applicable securities laws and by The
Nasdaq Capital Market (including any required registration under the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Prior to the Closing Date, the Company will issue no press release or other communications directly or indirectly and hold no press
conference with respect to the Company, the condition, financial or otherwise, or the earnings, business affairs or business prospects
of any of them, or the offering of the Securities without the prior written consent of the Representative, unless in the judgment of the
Company and its counsel, and after notification to the Representative, such press release or communication is required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company will apply the net proceeds from the offering of the Securities in the manner set forth under &#8220;Use of Proceeds&#8221;
in the Registration Statement, the General Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Until the Placement Agents have notified the Company of the completion of the offering of the Securities the Company will not,
and will use its reasonable efforts to cause its affiliated purchasers (as defined in Regulation M under the Exchange Act) not to, either
alone or with one or more other persons, bid for or purchase, for any account in which it or any of its affiliated purchasers has a beneficial
interest, any Securities, or attempt to induce any person to purchase Securities, and not to, and to use its reasonable best efforts to
cause its affiliated purchasers not to, make bids or purchase for the purpose of creating actual or apparent active trading in or of raising
the price of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xvi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company will maintain, at its expense, a transfer agent and registrar for the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xvii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company will reserve and keep available for the exercise of the Warrants such number of authorized but unissued shares of Common
Stock as are sufficient to permit the exercise in full of the Warrants for the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xviii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If at any time following the distribution of any Written Testing-the-Waters Communication there occurred or occurs an event or
development as a result of which such Written Testing-the-Waters Communication included or would include an untrue statement of a material
fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
existing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement,
at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such untrue statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company agrees to pay, or reimburse if paid by the Placement Agents, whether or not the transactions contemplated hereby are
consummated or this Agreement is terminated, all costs and expenses incident to the offering of the Securities and the performance of
the obligations of the Company under this Agreement including those relating to: (i) the preparation, printing, reproduction, filing and
distribution of the Registration Statement including all exhibits thereto, the Prospectus, any Issuer Free Writing Prospectus, all amendments
and supplements thereto and any document incorporated by reference therein, and the printing, filing and distribution of this Agreement
and the Securities Purchase Agreement&#894; (ii) the registration or qualification of the Securities for offer and sale under the securities
or Blue Sky laws of the various jurisdictions referred to in Section 5(a)(ix), including the reasonable fees and disbursements of counsel
for the Placement Agents in connection with such registration and qualification and the preparation, printing, distribution and shipment
of preliminary and supplementary Blue Sky memoranda&#894; (iii) the furnishing (including costs of shipping and mailing) to the Placement
Agents of copies of the Prospectus and all amendments or supplements to the Prospectus, any Issuer Free Writing Prospectus, and of the
several documents required by this Section to be so furnished, as may be reasonably requested for use in connection with the offering
and sale of the Securities by the Placement Agents or by dealers to whom Securities may be sold&#894; (iv) the filing fees of FINRA in
connection with its review of the terms of the offering and reasonable fees and disbursements of counsel for the Placement Agents in connection
with such review&#894; (v) inclusion of the Shares and Warrant Shares for listing on The Nasdaq Capital Market&#894; and (vi) all transfer
taxes, if any, with respect to the sale and delivery of the Securities by the Company to the Placement Agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company hereby engages the Representative as its exclusive agent for the solicitation of the exercise or conversion of the
Common Warrants. The Company will (i) assist the Representative with respect to the solicitation, if requested by the Representative,
and (ii) provide the Representative lists of the record and, to the extent known, beneficial owners of the Common Warrants. For each Common
Warrant exercised or converted, the Company will pay the Representative a solicitation fee (the &#8220;<B>Solicitation Fee</B>&#8221;)
of three percent (3.0%) of the exercise or conversion price of the Common Warrants. The Company shall provide the Representative with
written notice of each exercise or conversion of Common Warrants within twenty-four (24) hours of the applicable exercise or conversion
date of such Common Warrants. Any such Solicitation Fee shall be paid to the Representative not less than two (2) business days after
the exercise or conversion payment giving rise to such Solicitation Fee and shall be paid by wire transfer of immediately available funds
to an account previously specified by the Representative. The Company agrees to disclose the arrangement to pay solicitation fees to the
Representative in the Prospectus. Notwithstanding the foregoing, as required by FINRA Rule 5110(g)(10), no Solicitation Fee shall be payable
to the Representative hereunder in respect of the exercise or conversion of a Common Warrant if: (i) the market price of the underlying
shares of&nbsp;Common
Stock&nbsp;is lower than the exercise or conversion price of the Common Warrant at the time of exercise or conversion; (ii) the Common
Warrant is held in a discretionary account of the Representative at the time of exercise or conversion, unless prior specific written
approval for the exercise or conversion is received from the holder; (iii) the arrangement to pay the Solicitation Fee is not disclosed
in the Prospectus or in any prospectus provided to the holder of the Common Warrant at the time of exercise or conversion; or (iv) the
Common Warrant is exercised or converted in an unsolicited transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company acknowledges and agrees that each Placement Agent has acted and is acting solely in the capacity of a placement agent,
with respect to the offering of Securities contemplated hereby and not as a financial advisor, agent or fiduciary to the Company or any
other person. Additionally, the Company acknowledges and agrees that each Placement Agent has not and will not advise the Company or any
other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company has consulted with its
own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions
contemplated hereby, and each Placement Agent shall have no responsibility or liability to the Company or any other person with respect
thereto, whether arising prior to or after the date hereof. Any review by each Placement Agent of the Company, the transactions contemplated
hereby or other matters relating to such transactions have been and will be performed solely for the benefit of the Placement Agents and
shall not be on behalf of the Company. The Company agrees that it will not claim that each Placement Agent, or any of them, has rendered
advisory services of any nature or respect, or owes a fiduciary duty to the Company or any other person in connection with any such transaction
or the process leading thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company represents and agrees that it, its directors or officers have not made and will not make any offer relating to the
Securities that would constitute an &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433, or that would otherwise constitute
a &#8220;free writing prospectus,&#8221; as defined in Rule 405, required to be filed with the Commission. The Company has complied and
will comply with the requirements of Rule 433 under the Securities Act applicable to any Issuer Free Writing Prospectus, including timely
filing with the Commission where required, legending and record keeping. The Company represents that it has satisfied and agrees that
it will satisfy the conditions set forth in Rule 433 of the Rules to avoid a requirement to file with the Commission any Road Show.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company agrees to indemnify and hold harmless each Placement Agent, its officers and employees and each person, if any, who
controls each Placement Agent within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any and
all losses, claims, damages and liabilities, joint or several (including any reasonable investigation, legal and other expenses incurred
in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted), to which they, or any
of them, may become subject under the Securities Act, the Exchange Act or other Federal or state law or regulation, at common law or otherwise,
insofar as such losses, claims, damages or liabilities arise out of or are based upon any untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement, the Statutory Prospectus, the Prospectus, any Issuer Free Writing Prospectus
or any &#8220;issuer-information&#8221; filed or required to be filed pursuant to Rule 433(d) of the Rules, any amendment thereof or supplement
thereto, or in any Blue Sky application or other information or other documents executed by the Company filed in any state or other jurisdiction
to qualify any or all of the Securities under the securities laws thereof (any such application, document or information being hereinafter
referred to as a &#8220;<B>Blue Sky Application</B>&#8221;) or arise out of or are based upon any omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein, with respect to the Statutory Prospectus
and the Prospectus, in the light of the circumstances under which they were made, not misleading&#894; provided, however, that such indemnity
shall not inure to the benefit of each Placement Agent (or any person controlling each Placement Agent) on account of any losses, claims,
damages or liabilities arising from the sale of the Securities to any person by such Placement Agent if such untrue statement or omission
or alleged untrue statement or omission was made in the Registration Statement, the Prospectus, the Statutory Prospectus, any Issuer Free
Writing Prospectus or such amendment or supplement thereto, or in any Blue Sky Application in reliance upon and in conformity with the
Placement Agent Information. This indemnity agreement will be in addition to any liability which the Company may otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each Placement Agent, severally and not jointly, agrees to indemnify and hold harmless the Company, and each person, if any, who
controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, each director of the Company,
and each officer of the Company who signs the Registration Statement, against any losses, claims, damages or liabilities to which such
party may become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement, the Statutory Prospectus or the Prospectus, or any amendment or supplement thereto, or arise out of or are based upon the omission
or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, with respect
to the Statutory Prospectus and the Prospectus, in the light of the circumstances under which they were made, not misleading, in each
case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was
made in the Registration Statement, the Statutory Prospectus or the Prospectus or any such amendment or supplement in reliance upon and
in conformity with the Placement Agent Information&#894; provided, however, that the obligation of each Placement Agent to indemnify the
Company (including any controlling person, director or officer thereof) shall be limited to the amount of the placement agent discount
and commissions applicable to the Securities to be purchased by such Placement Agent hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Any party that proposes to assert the right to be indemnified under this Section will, promptly after receipt of notice of commencement
of any action, suit or proceeding against such party in respect of which a claim is to be made against an indemnifying party or parties
under this Section, notify each such indemnifying party of the commencement of such action, suit or proceeding, enclosing a copy of all
papers served. No indemnification provided for in Section 6(a) or 6(b) shall be available to any party who shall fail to give notice as
provided in this Section 6(c) if the party to whom notice was not given was unaware of the proceeding to which such notice would have
related and was prejudiced by the failure to give such notice but the omission so to notify such indemnifying party of any such action,
suit or proceeding shall not relieve it from any liability that it may have to any indemnified party for contribution or otherwise than
under this Section. In case any such action, suit or proceeding shall be brought against any indemnified party and it shall notify the
indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it
shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory
to such indemnified party, and after notice from the indemnifying party to such indemnified party of its election so to assume the defense
thereof and the approval by the indemnified party of such counsel, the indemnifying party shall not be liable to such indemnified party
for any legal or other expenses, except as provided below and except for the reasonable costs of investigation subsequently incurred by
such indemnified party in connection with the defense thereof. The indemnified party shall have the right to employ its counsel in any
such action, but the reasonable and documented fees and expenses of such counsel shall be at the expense of such indemnified party unless
(i) the employment of counsel by such indemnified party has been authorized in writing by the indemnifying parties, (ii) the indemnified
party shall have been advised by counsel that there may be one or more legal defenses available to it which are different from or in addition
to those available to the indemnifying party (in which case the indemnifying parties shall not have the right to direct the defense of
such action on behalf of the indemnified party) or (iii) the indemnifying parties shall not have employed counsel to assume the defense
of such action within a reasonable time after notice of the commencement thereof, in each of which cases the reasonable and documented
fees and expenses of counsel shall be at the expense of the indemnifying parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The indemnifying party under this Section 6 shall not be liable for any settlement of any proceeding effected without its written
consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify
the indemnified party against any loss, claim, damage, liability or expense by reason of such settlement or judgment. No indemnifying
party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of
judgment in any pending or threatened action, suit or proceeding in respect of which any indemnified party is a party or could be named
and indemnity was or would be sought hereunder by such indemnified party, unless such settlement, compromise or consent (a) includes an
unconditional release of such indemnified party from all liability for claims that are the subject matter of such action, suit or proceeding
and (b) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified
party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>Contribution</U>.
In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in Section 6(a)
or 6(b) is due in accordance with its terms but for any reason is unavailable to or insufficient to hold harmless an indemnified
party in respect to any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall
contribute to the aggregate losses, liabilities, claims, damages and expenses (including any investigation, legal and other expenses
reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claims asserted,
but after deducting any contribution received by any person entitled hereunder to contribution from any person who may be liable for
contribution) incurred by such indemnified party, as incurred, in such proportion as is appropriate to reflect the relative benefits
received by the Company on the one hand and each Placement Agent on the other hand from the offering of the Securities pursuant to
this Agreement or, if such allocation is not permitted by applicable law, in such proportion as is appropriate to reflect not only
the relative benefits referred to above but also the relative fault of the Company on the one hand and each Placement Agent on the
other hand in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses,
as well as any other relevant equitable considerations. The Company and each Placement Agent agree that it would not be just and
equitable if contribution pursuant to this Section 7 were determined by pro rata allocation or by any other method of allocation
which does not take account of the equitable considerations referred to above. The aggregate amount of losses, liabilities, claims,
damages and expenses incurred by an indemnified party and referred to above shall be deemed to include any legal or other expenses
reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation, or any investigation
or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or
alleged untrue statement or omission or alleged omission. Notwithstanding the provisions of this Section 7, each Placement Agent
shall not be required to contribute any amount in excess of the placement agent discounts and commissions applicable to the
Securities purchased by such Placement Agent. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
For purposes of this Section 7, each person, if any, who controls each Placement Agent within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as each Placement Agent, and each
director of the Company including any person who, with his or her consent, is named in the Registration Statement as about to become
a director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls
the Company within the meaning of the Section 15 of the Securities Act or Section 20 of the Exchange Act, shall have the same rights
to contribution as the Company, as the case may be. Any party entitled to contribution will, promptly after receipt of notice of
commencement of any action, suit or proceeding against such party in respect of which a claim for contribution may be made against
another party or parties under this Section 7, notify such party or parties from whom contribution may be sought, but the omission
so to notify such party or parties from whom contribution may be sought shall not relieve the party or parties from whom
contribution may be sought from any other obligation it or they may have hereunder or otherwise than under this Section 7. No party
shall be liable for contribution with respect to any action, suit, proceeding or claim settled without its written consent. Such
Placement Agent&#8217;s obligations to contribute pursuant to this Section 7 are several in proportion to their respective placement
agent commitments and not joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Termination</U>.
The obligations of each Placement Agent hereunder may be terminated by each Placement Agent, in its absolute discretion, by notice
given to the Company prior to delivery of and payment for the Securities if, prior to that time, any of the events described in
Sections 4(p), 4(q) or 4(r) have occurred or if the Investors shall decline to purchase the Securities for any reason permitted
under this Agreement or the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9. <U>Miscellaneous</U>.
The respective agreements, representations, warranties, indemnities and other statements of the Company and each Placement Agent, as
set forth in this Agreement or made by or on behalf of them pursuant to this Agreement, shall remain in full force and effect,
regardless of any investigation (or any statement as to the results thereof) made by or on behalf of each Placement Agent or the
Company or any of their respective officers, directors or controlling persons referred to in Sections 6 and 7 hereof, and shall
survive delivery of and payment for the Securities. In addition, the provisions of Sections 5(b), 6, 7 and 8 shall survive the
termination or cancellation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Notwithstanding anything
herein or otherwise to the contrary, the Placement Agents shall have no liability to the Company with respect to any failure by an Investor
to purchase any Securities it agreed to purchase pursuant to the Securities Purchase Agreement, or any other breach by a purchaser of
Securities pursuant to the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This Agreement has been and
is made for the benefit of the Placement Agents, the Company and their respective successors and assigns, and, to the extent expressed
herein, for the benefit of persons controlling any of the Placement Agents, or the Company, and directors and officers of the Company,
and their respective successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement.
The term &#8220;successors and assigns&#8221; shall not include any purchaser of Securities from the Placement Agents merely because of
such purchase. The invalidity or unenforceability of any Section, paragraph or provision of this Agreement shall not affect the validity
or enforceability of any other Section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for
any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes)
as are necessary to make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No amendment or waiver of
any provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless and until
the same shall be in writing and signed by the Company and the Placement Agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All notices and communications
hereunder shall be in writing and mailed or delivered or by telephone or telegraph if subsequently confirmed in writing, (a) if to the
Placement Agents, c/o Oppenheimer &amp; Co. Inc., 85 Broad Street, New York, New York 10004 Attention: Equity Capital Markets, with a
copy to Oppenheimer &amp; Co. Inc., 85 Broad Street, New York, New York 10004 Attention: General Counsel, and to Mintz, Levin, Cohn, Ferris,
Glovsky and Popeo, P.C., 919 Third Avenue, New York, New York 10022, Attention: Alok A. Choksi, and (b) if to the Company, to its agent
for service as such agent&#8217;s address appears on the cover page of the Registration Statement with a copy to Ondas Holdings Inc.,
222 Lakeview Avenue, Suite 800, West Palm Beach, FL 33401, Attention: Eric Brock, with a copy to Akerman LLP Three Brickell City Centre,
98 Southeast Seventh Street, Suite 1100, Miami, Florida 33131, Attention: Christina Russo.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>This Agreement shall be
governed by and construed in accordance with the laws of the State of New York without regard to any conflict of law rule or principle
that would give effect to the laws of another jurisdiction.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This Agreement may be signed
in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon
the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature pages follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Please confirm that the foregoing
correctly sets forth the agreement among us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very Truly Yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">ONDAS HOLDINGS INC.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Eric Brock</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>&nbsp;Eric Brock</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chairman and CEO</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">Confirmed:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">OPPENHEIMER &amp; CO. INC.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">By OPPENHEIMER &amp; CO. INC.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><I>/s/ Peter Bennett</I></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;&nbsp;</TD>
    <TD STYLE="width: 5%">Name:&nbsp;</TD>
    <TD STYLE="width: 31%">Peter Bennett</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Managing Director, Head of Equity Capital Markets</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Schedule
I</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Placement Agents</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of Shares to Be Placed</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of<BR>
 Pre-Funded<BR>
 Warrants to<BR>
 be Placed</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of Common Warrants to be Placed</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Oppenheimer &amp; Co. Inc.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">15,200,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">33,432,218</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">97,264,439</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stifel, Nicolaus &amp; Company, Incorporated</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,425,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,134,271</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,118,541</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Needham &amp; Company, LLC</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">665,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,462,660</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,255,319</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Lake Street Capital Markets, LLC</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">475,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,044,757</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,039,514</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Northland Securities, Inc.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">475,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,044,757</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,039,514</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Ladenburg Thalmann &amp; Co. Inc.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">380,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">835,805</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,431,611</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">H.C. Wainwright &amp; Co., LLC</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">190,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">417,903</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,215,805</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Maxim Group LLC</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">190,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">417,903</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,215,805</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">19,000,000</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">41,790,274</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">121,580,548</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Sch I - 1</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Schedule
II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Lock-up Signatories</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eric A. Brock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neil Laird</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Richard M. Cohen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Randall P. Seidl</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jaspreet Sood</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patrick Huston</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Sch II - 1</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Schedule
III</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Issuer Free Writing Prospectuses</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Sch III - 1</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Attached hereto.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See Exhibit 10.1 to the Current Report on Form
8-K filed with the SEC on January 12, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Exhibit A</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF PRE-FUNDED WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Attached hereto]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See Exhibit 4.2 to the Current Report on Form 8-K
filed with the SEC on January 12, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Exhibit B</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF COMMON WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Attached hereto]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See Exhibit 4.1 to the Current Report on Form 8-K
filed with the SEC on January 12, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Exhibit C</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF LOCK-UP AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Attached hereto]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF LOCK-UP AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">January _____, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Oppenheimer &amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">as Placement Agent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o Oppenheimer &amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">85 Broad Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Re: Offering of Ondas Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, an executive
officer or director of Ondas Holdings Inc. (the &#8220;<B>Company</B>&#8221;), understands that you<B>, </B>as placement agent (the &#8220;<B>Placement
Agent</B>&#8221;), propose to enter into a Placement Agent Agreement (the &#8220;<B>Placement Agent Agreement</B>&#8221;) with the Company,
providing for the offering (the &#8220;<B>Offering</B>&#8221;) of shares of common stock, par value $0.0001 (&#8220;<B>Common Stock</B>&#8221;),
of the Company (the &#8220;<B>Shares</B>&#8221;), and/or warrants and/or pre-funded warrants exercisable for shares of Common Stock (the
&#8220;<B>Warrants</B>&#8221; and together with the Shares, the &#8220;<B>Securities</B>&#8221;). Capitalized terms used herein and not
otherwise defined shall have the meanings set forth in the Placement Agent Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the Placement
Agent&#8217;s agreement to enter into the Placement Agent Agreement and to proceed with the Offering of the Securities, and for other
good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees for the benefit of the Company,
you that, without the prior written consent of Oppenheimer &amp; Co. Inc., the undersigned will not, during the period ending 60 days
(the &#8220;<B>Lock-Up Period</B>&#8221;) after the date of the final prospectus supplement relating to the Offering (the &#8220;<B>Prospectus</B>&#8221;),
directly or indirectly (1) offer, pledge, assign, encumber, announce the intention to sell, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or
dispose of, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock owned either
of record or beneficially (as defined in the Securities Exchange Act of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;)) by the
undersigned on the date hereof or hereafter acquired or (2) enter into any swap or other agreement that transfers, in whole or in part,
any of the economic consequences of ownership of the Common Stock or any securities convertible into or exercisable or exchangeable for
Common Stock, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or such other
securities, in cash or otherwise, or publicly announce an intention to do any of the foregoing. In addition, the undersigned agrees that,
without the prior written consent of Oppenheimer &amp; Co. Inc., it will not, during the period ending 60 days after the date of the Prospectus,
make any demand for or exercise any right with respect to, the registration of any shares of Common Stock or any security convertible
into or exercisable or exchangeable for Common Stock. The foregoing shall not apply to (1) Common Stock to be transferred as a gift or
gifts (<I>provided</I>, that (a) any donee shall execute and deliver to Oppenheimer &amp; Co. Inc. not later than one business day prior
to such transfer, a written agreement, in substantially the form of this Lock-Up Agreement and otherwise satisfactory in form and substance
to Oppenheimer &amp; Co. Inc. and (b) if the undersigned is required to file a report under Section 16(a) of the Exchange Act, reporting
a reduction in beneficial ownership of shares of Common Stock or beneficially owned shares or any securities convertible into or exercisable
or exchangeable for Common Stock or beneficially owned shares during the Lock-Up Period, the undersigned shall include a statement in
such report to the effect that such transfer is being made as a gift) and (2) (a) the exercise or vesting of equity awards granted pursuant
to any equity compensation plan of the Company, each such security as described in the Registration Statement, the General Disclosure
Package and the Prospectus and outstanding as of the date of this Lock-Up Agreement, and (b) the sale of Common Stock to cover the payment
of the exercise prices or the payment of taxes associated with the exercise or vesting of such securities described in clause 2(a) (<I>provided</I>,
that for clauses (2)(a) and (b), (i) except as provided for in clause 2(b), any securities received upon such exercise or vesting shall
be subject to the terms of this Lock-Up Agreement and (ii) no public filing, report or announcement shall be voluntarily made and if any
filing under Section 16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership
of shares of Common Stock in connection with such distribution shall be legally required during the Lock-Up Period, such filing, report
or announcement shall clearly indicate in the footnotes thereto that such sale of Common Stock is to cover the payment of the exercise
prices or the payment of taxes).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the avoidance of doubt,
the undersigned hereby waives any and all notice requirements and rights with respect to the registration of any securities pursuant to
any agreement, instrument, understanding or otherwise, including any stockholders agreement, investors rights agreement or registration
rights agreement or similar agreement, to which the undersigned is a party or under which the undersigned is entitled to any right or
benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Exhibit D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In furtherance of the foregoing,
the Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby authorized
to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby represents
and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement. All authority herein conferred or
agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives
of the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned acknowledges
and agrees that the Placement Agent has not provided any recommendation or investment advice nor has the Placement Agent solicited any
action from the undersigned with respect to the Offering of the Securities and the undersigned has consulted their own legal, accounting,
financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although
the Placement Agent may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection
with the Offering, the Placement Agent is not making a recommendation to you to participate in the Offering, enter into this Lock-Up Agreement,
or sell any Securities at the price determined in the Offering, and nothing set forth in such disclosures is intended to suggest that
the Placement Agent is making such a recommendation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that, if the Placement Agent Agreement is not executed by January 16, 2026, or if the Placement Agent Agreement (other than the provisions
thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be sold thereunder,
the undersigned shall be released form all obligations under this Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, whether or
not participating in the Offering, understands that the Placement Agent is entering into the Placement Agent Agreement and proceeding
with the Offering in reliance upon this Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Lock-Up Agreement shall
be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Exhibit D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>[SIGNATORY]</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>ea027241901ex99-1_ondas.htm
<DESCRIPTION>PRESS RELEASE, DATED JANUARY 9, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ondas Holdings Inc. Successfully Prices $1 Billion
Stock and Warrant Sale Above Market Price</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>WEST PALM BEACH, FLORIDA /&nbsp;January
9, 2026 /&nbsp;</B>Ondas Holdings Inc. (NASDAQ:ONDS) (&ldquo;Ondas&rdquo; or the &ldquo;Company&rdquo;), a leading provider of autonomous
aerial and ground robot intelligence through its Ondas Autonomous Systems (OAS) business unit and private wireless solutions through Ondas
Networks, today announced that it has priced its $1 billion registered direct offering of 19,000,000 shares of its common stock and, in
lieu of common stock, pre-funded warrants to purchase up to 41,790,274 shares of its common stock (together &ldquo;Common Stock Equivalents&rdquo;)
to an institutional investor. Each Common Stock Equivalent is being sold with a common stock warrant to purchase two (2) shares of common
stock. The total number of Common Stock Equivalents to be sold in the offering is 60,790,274. The Common Stock Equivalents will be accompanied
by warrants to purchase a total of 121,580,548 shares of common stock, which we refer to as common stock warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Each share of common stock and accompanying
common stock warrant is being sold together at a combined offering price of $16.45, and each pre-funded warrant and accompanying common
stock warrant is being sold together at a combined offering price of $16.4499 (with a nominal exercise price of $0.0001 per share remaining
unpaid as of the issuance date), each priced above-the-market under the rules of the Nasdaq Stock Market and representing a premium of
approximately 17.5% to Ondas&rsquo; closing stock price on January 8, 2026. Each pre-funded warrant will be exercisable immediately after
the original issue date and will expire seven years from the date of issuance. Each common stock warrant will have an exercise price of
$28.00 per share, will be immediately exercisable and will expire seven years from the date of issuance. All of the shares, pre-funded
warrants and common stock warrants in the offering are being sold by the Company. The offering is expected to close on or about January
12, 2026, subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Ondas expects the gross proceeds from this
offering to be approximately $1 billion, before deducting the estimated placement agent&rsquo;s fees and other estimated offering expenses
and excluding any proceeds that may be received from the exercise of the common stock warrants. If the common stock warrants are fully
exercised on a cash basis, Ondas has the potential to raise approximately $3.4 billion in additional gross proceeds. No assurance can
be given that any of the common stock warrants will be exercised. Ondas intends to use the net proceeds from this offering for corporate
development and strategic growth, including acquisitions, joint ventures, and investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Oppenheimer &amp; Co. Inc. is acting as the
lead placement agent for the offering. Stifel, Nicolaus &amp; Company, Incorporated, Needham &amp; Company, LLC, Lake Street Capital Markets,
LLC, Northland Capital Markets, Ladenburg Thalmann &amp; Co. Inc., H.C. Wainwright &amp; Co., LLC, and Maxim Group LLC are acting as co-placement
agents for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">An automatic shelf registration statement
on Form S-3ASR (File No. 333-290121) relating to the securities to be issued in the offering was filed with the Securities and Exchange
Commission (&ldquo;SEC&rdquo;) and was automatically effective upon filing on September 9, 2025. A prospectus supplement and accompanying
prospectus describing the terms of the offering will be filed with the SEC. Copies of the prospectus supplement and the accompanying prospectus
relating to the shares being offered may also be obtained, when available, from Oppenheimer &amp; Co. Inc. Attention: Syndicate Prospectus
Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8055, or by email at EquityProspectus@opco.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>This press release does not constitute
an offer to sell, or the solicitation of an offer to buy, the shares, nor will there be any sale of the shares in any state or other jurisdiction
in which such offer, solicitation or sale is not permitted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Statements made in this release that are not
statements of historical or current facts are &ldquo;forward-looking statements&rdquo; within the meaning of the Private Securities Litigation
Reform Act of 1995, including, but not limited to, statements regarding the expected timing, completion or size of the offering, the expected
gross proceeds therefrom, the intended use of net proceeds therefrom and the exercise of the common stock warrants prior to their expiration.
We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking
statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict.
These risks and uncertainties relate, among other things, to fluctuations in our stock price, changes in market conditions and satisfaction
of customary closing conditions related to the offering. Our actual results, performance, or achievements could differ materially from
those expressed or implied by the forward-looking statements as a result of a number of factors, including the risks discussed under the
heading &ldquo;Risk Factors&rdquo; discussed under the caption &ldquo;Item 1A. Risk Factors&rdquo; in Part I of our most recent Annual
Report on Form 10-K or any updates discussed under the caption &ldquo;Item 1A. Risk Factors&rdquo; in Part II of our Quarterly Reports
on Form 10-Q and in our other filings with the SEC. There can be no assurance that we will be able to complete the offering on the anticipated
terms or at all. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information,
future events or otherwise that occur after that date, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Contacts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">IR Contact for Ondas Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">888.350.9994</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">ir@ondas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Media Contact for Ondas</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Escalate PR<BR>
ondas@escalatepr.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><U></U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Preston Grimes<BR>
Marketing Manager, Ondas Holdings Inc.<BR>
Preston.grimes@ondas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>SOURCE:</B>&nbsp;Ondas Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  D (P# 2(  A$! Q$!_\0
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M  45_91^+GQS^&OP=\?? C0F\&Q>*?A#\.=)\7_!#X R^'/B%#X=\3:]\&?
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M<9HHK^=XU*G]OYLO:5+>T2M[2=K<\%:W/:UFU:VVFVA_T>\)>&WAXO!? 37
MW"7/'@6M.,_]7\J<U-<+8B:FIO!N?,IQ4^;G<N=*=^;WG_<7X9T2V\&^%XM$
MTN\UJ]M?!V@Z.MC=^(M=UCQ/KFJ 0RN/^$A\1:]>ZAKVM'<F2UWJ)8[B"2 @
M3V*BBOZ*DDG9*R6B7DG9+Y))'_.IF#;QDF]6W=Z):RCS/1))7DV[))*]DDDD
AK%%%%2>:%%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>onds-20260109.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWa2FuaPtyJ1xaYkxuG94fbnKrykqi1RLDCMGJk32QXYJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ONDS="http://ondas.com/20260109" elementFormDefault="qualified" targetNamespace="http://ondas.com/20260109">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://ondas.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="onds-20260109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="onds-20260109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>onds-20260109_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>onds-20260109_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="onds-20260109.xsd#Cover" roleURI="http://ondas.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://ondas.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 09, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  09,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Ondas Holdings Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001646188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-2615102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">222 Lakeview Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">West Palm
Beach<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">350-9994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock par value $0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ONDS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea0272419-8k_ondas.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ondas.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0272419-8k_ondas.htm">ea0272419-8k_ondas.htm</File>
    <File>onds-20260109.xsd</File>
    <File>onds-20260109_lab.xml</File>
    <File>onds-20260109_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0272419-8k_ondas.htm": {
   "nsprefix": "ONDS",
   "nsuri": "http://ondas.com/20260109",
   "dts": {
    "inline": {
     "local": [
      "ea0272419-8k_ondas.htm"
     ]
    },
    "schema": {
     "local": [
      "onds-20260109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "onds-20260109_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "onds-20260109_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://ondas.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-01-09",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0272419-8k_ondas.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-01-09",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0272419-8k_ondas.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://ondas.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001213900-26-003169-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-003169-xbrl.zip
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M'Y2?;"(5937L2LZ=;9QC(H*\LTU,2GJD8VF%M:Q\&8[NM&< /P<<]<F- "8
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MHEMLOI@%. &C#:ZOR*NXW(;#1RKL FC"D(A$+?B5:(PS)O7"]&5A.\;@)O#
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MLGG4$'B,MX)9Y5X$GB@W>"0A3M<AT_A4YASGGAHP,TJA!0C!&Y?=&1[T XM
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M<.)222%'V( ,:42+TR1\&'$^3@,*GWQJ8N&ZHBJY:JV4JU9JFU B"6#(C,>
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MK,5)TT6]O!?3A\A@\ !D*0B/BR@*MVE04$GAWZRM099;7#Q)0"<\B9[+B-/
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M8D>5^3(L2]@[L19^#0#G\$8B --P,?T-;KP/WNP\)SBORSNT8KD>BM428V.
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M<]M&MC;ZG57\#SBI=T^)5; C^9:+,ZF293GQNQW;1Y(G9VK7_@"2H(08!!@
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MLA@R3!:6*]1!"GF#$T[B"GK%5+'="9XB-V":X"M@NG0]4R<8OA(9IW1[N2)
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M^SCG?Y28!W'.-P'+A^F)U 7THEX25)]'W4@[CEW:A/4:])87)&NUM?1X7@X
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M)XK:6I@!N7MKD?9CP#?[8=GU9 L+5BP, L&$2HODK4L4MJR%7X2$N0$W"*V
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M7X%EL>U_S,IY6BN>D?X!(YTS[)O^J;7.%O]8>UBD]7H(%R)SS/\<C]ROR23
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MZSYRA6_@,<")TCN0_CMO\48Z/00.-/6_H<>$2?=K:6(8#3$TY93UIT%K_X%
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M)F\;Y6T?;?*VWT2F:;8!W]]PY4I;6]7D]86O0R0P)T6UCI7^WT8H--?L''+
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MZ*J5/<(&W0"Y4_X^N BE?Y"H.E_'[]41 .\@5X1C5^Q#P,*EY45J/Q81I6#
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MBH4\P4.ON8?:2Q4O!.&,"6S(Q]!!$KTLJ"B ACPQ/+Q;1%>W<);Z5,XDV1X
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M7Z*A4&@S6.:&Q-=N=-EUFKN_VCD^(1I^ E91<.*7<R2',XBO:]99^3!F'(9
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MWPN,Z!7]+E=F9TQ2;>S9U2VY#"09+0T-EOY@<J9J^;J05 V<W;B(,&OLRYF
M5*B^P$9OY_&^B>K +W[H78->E<EYNLGD1)F<IW_-3,ZFY/;SE]S^<).2VY.]
MH[?[!UA2^_G+:#]W"=*^)87U/3JE*#7R<M3XCXDLA>N5X9H3,,*@BLS"-8W'
MBP4594_1/QKAQ=DYU8>)U^C,_WXN7'_/Q@-S/\JGD\"?I*2C[P,#35C0%/0M
MM8646!"HE"MQ^F^JK+ !([%GI\.DS7.MT$V=_W.97Q!8<-@SM7@.?22_/P2L
M=I8K-S1M"JX==I]"Y]5KA.;C$;CG>5=2P_W&6QT3E2XY\!P;#E;%PRQK7X,:
M6D0$A:1%R9PS.ZY*<;8TC05?4A_*1Z=64$89#@I#2%V5TZMHE7S9,OXQ+%(V
M-=:39;U@EG3D3\=OR][Y"$?&&$V0!!72&-79+;/8^KR8G2[!=34C%+\%>J27
MT'UM[%SKNC@EC%T@&L VXQ:QNLBA<1R<0:P8YZ!R44+,J4^<@OZ[SLC-8:U]
MGR#,A2-=K!P #1AYIF@<-7U?Q V:N]'^6<IH'HB?/,]Q%:,217^<JYT5M3E"
MG'G2)K*8P)IZ*",C!]'C W+A\(P26\YU5,KZ$7X)9:L;FX!M@J<WL0G>[A_#
M4NT<[!V^/]XT+KH!5\&/[W_Z61HI;V^]R2Z?)_\T>63\UY4[/D4V)=[0':=Z
MT,^5"VG$79@EQ2QIB32Y<",9.\4#V6ZWY2-_@6#P< X5!MUY4',;$.#"A\8Y
M[C@%WGVU42@*ZOXA<5'/#']67'AXKK92$]V&.5*HDQ]<GN>+<].Q88'&BWFD
M1"U)H=AD>S.D6X92K]QO[EPO,EM0((.&!P6/B'MZV!EM;\'[0Q9Z:C]H6LE@
M?YA9L5#"^/SWT72)?=CCBC2\IA?29V"2CR'L3D"#)FD*3$[!587OXZ"N#B--
M7E0U0>(GR=NL=!-?@%S*K9>-?UN.S:QAL..BF2_9BB1=C2%7VX01/D(CT'TB
M@3R]E%HZW'02A!_@#]%0-&J^HULCWPGPGU1'W+&*2*G"+4NXH2!VG*R O-TI
M1LRE8]:E6 !:;21P.&P?FQ-K+@(WIEDQ(\$@2D%XS!R[/F&2(^*;B3>)W@%1
M;M@7[LU *0=X<]+U8F2U/\7=X7$">*@JG9=0P-%S>[2<T2*PQ^ ^67KB^?XG
M8W?VF?OW')IE0($&7^"]*[B])7.5' F\!I_8*(U7(]2+\G=BI( ?<$6"K,**
MH9U")J% \ W7!R]\@H[JL9G+<<$22LW!E)^#;$=NO]1M3!AI,!O!\^*.$*#[
M"H -464IT:-!"AC7GK^,*L6N0LBNTV4&PB=%V67U89Y+ENDR(V-)'15<17T7
M?\O=(2784MAR9L&<'TXK?<2+*^Q'5J,'5&'K7FBW;'J+H>EY"@T\R$POR!C+
M,.VE_-V0]QEQ6C*# *XVJ4 %Q^-M:UNR&:=32B9U O2M;1AZ#V23\G7DQ,6G
MBB3'A<?-.4>$Y@*G.+NHZM!+NILXVP-)O][M')W\FKS>.]I[\6NR?W2T]S^'
M+YW5\6ORR\[^_^P=)SL'OR9'^S^_/DGV3Y*W.^ZK._^SEYP<INZ3W63GYZ,]
M]Z6#PQ,@"3O:^W_O]XY/W$?)/]\?_9J<'.WOO-G>>G5XA 3(.[O_?+^[_Y(X
MQ0Y?X:-W]X_?O3_9PP&\/]C=.TK<E^D_X.-#][LC:ONX@WT>D]W#E^_?0O-'
M][W]@^3EX<'!'GWRR_[):_CKSM'^L3,[D\/W)_"6D]?[QS1.^)E3>.N?"]^P
MG[F7G.R]??=FYV1O5Y:*Y@3_R5;;)GFRFFP#NN@".L2934Z7-=ID,M!27%ND
MN!1(C5Y6V@X*BI'1L,<,ACPJI3X^D[CP#(LUQYB"@9Y2XK C_6UF%:,WUIPK
M9]-Y6&-G7V4A#V[N9-3E_C)I457YRQ^_<#=IQ[WPAD \U;+.N:V+/ $AU*/&
M:<DI!U)F12-F'_J627X'[@Z>.ZL^9/^M:BJWTO:\5&R?#.[.QY-A,BFDNXQ?
M;C,,"(RG?$O(7S%:+I<% LC=>]!&QHF?%EP1U&+EIL5AV*#[QH"@!@1..,W=
M R?QJ]PRR+"&AE,3-X]U7SG6 M4&8D]=@[T$_  V<>(>[')-?0&>\Q=&^/3P
MWB;#%&:8'M[[:V:8OKD[R+1[>9TC<JMYOKWU,\"M:M_I])P_ZHH9,[.ENB+D
M#&!3M%R1'1HDQXI74'H)I!PPZ$_.N[C_-G*0QJ')N\E[ZE?& 0F8DG/&\JS&
M%HIC:8>XX*Y<7++O[.32754KK&VJPR#7?I8U([ 0W:\G.4#,2H" E;E3N+73
M^VX=EM.,P"CSZ1+<:YA4X\W\$XVU,E!3JSQ2QF6&'[A][/Z[_!7KS*$G)GH8
MT^(#U)'"+1;>Z%!.#KT"JVQ,0+MBPFRE/L2"CY'7M&M.[LHK6W.@M9.!;F^9
M/Z-7%4^!%J,U@R2: ,J)L@Z"#>/DR4L7^ Z,T04YIBM3 SP01%=ZDRL6Q>6F
M=]#U>@<=0Q*,\P=N0]]FOR.8\EUVA4N_0XAE4@+[DSBVUE($1:,U*21NT#S3
MMLASQXUR-$HD4)1D(F%<B!TW,,S0<<VD/*:O#B:-I,'$Z8*FLWY4:>\;6SK!
MW7> .$4F'(CU78G)BL<K=Z*84^-9"0+1B]T#O-5GGN^I[7@$&'H+!D%Y'/%%
M_;1P9(#\7%A=Z1\R88CDC!MN=K0#]9O45,FT@F!*TX6&JIPO,:8.KZ!<BW))
MD9/\=^"]:#3P"FA+AG<2K).V0BU)+%\,X.O8.8IX6X6#F4-D1)\@L&M9)2-)
M9+.F:Q9.TWHZ_4&#U9D2SW;&/H?[H-?V B@[,%1G<UB^^33D]T9"\X&U-J,"
MHBV CS4!B&AVU+45QD  5&#<<&/^=V#Q,]5STRNO;NFYH:@VG^87T-4B;\/>
MLB"E&,1P4\70U"1S>P37U5GE9JAQDCJ?.VLSCQ9WQ8$(UI&"L"S:]A/:>('_
M3M37FN%>;V]1(M_M^KQRSAGGQ7'B?KL^;BP8S(+Q*,V"4TP4W6+) M&MH?I2
MHUV(4VZG$'T,JBN%F QL0]EBYN/]&F'U5."&/ N?[&NF4XX08UI>#T8L.:1%
M2E\BQAELZ6#N1G(!#HC[0='N4D0->#FHWD)>QK5'@*H?HNTUSZX$JT RGDL3
M)!.@%S)GB9WVL58/5M>RXD!Y.E[RL?>2TR%P8)Q"^3>QLJ@5!'64S4*,",X=
M> B!NV&&D O)46'3LS7Z:5(-X4^BAM!4/.OTA_?-(?29N8_F?!4B*Q"GEYAG
M"BU>#%1RB;D/D7HNY=ZU<O(P8<8AS*B0*O+W(UX[IT:4^>5$.1W,AB,1*T8?
M#K7#^/61&YPHQ-R7BR5 \PMWR#[D$;HFC86O+7+:/H1V9?5+(:O4:-M<9_Z[
M&Y:UL";VR"Y' V5[BQ\*(LN)-)$4(B@+Z^SP;Z1F":4#]UQHJ9B$GLH(TA'1
MT+H@[4AG$+:@U[)OY#-PFF YXJ)A9^0NN><B:XYJ+EH@7E>9G)]4J*JTU1%J
M6CY$)C^Q+-WP)TNO.V+RIHPTK%OB)4H=_B&,I*\YZG>35^X!9QCF(D V$!9<
MM19$8WA^>^"HGX$=.\'^YPJCT1#]JE&WU51KS*2W5I0UTQ,H<8@.&YPL**3)
MI_(NX3<$D<NSD@NN>G02[@T/W4L0G&-LS1U<[!=%!7#U"PHN=IUBF;T*FY/3
M.S75CU_PEC@%5U14M5A0MS+C M'4-O[/GT0B]/#^)C 8!0;O;P*#W\)!49;<
M']__M(=1F>TM-9Z?)SO@'J-"E2!A2'6P#C^H&2?N94%_R7]G2@O G< GB6CH
M4K6UKY&WA4$:;M3,MOX$ GY+P"ODD,B&=!@EG;"$M:JIXE&@IJ8;V6F^N"1"
M(&\#&\,G)?2S-7OP\P)#FLXGU3[9[Q KT6!&7+F+BIJS.X8#)NTUG .@<&!L
M7J*W9]#504$RXW8LXXQ2["\L>6$+&&"63WYSC1TVV)WTAON;?/SV\N#)]&!9
M17,@)@ 7;PLZ)DVO6L!T,C)E02C-V'Y=)Y*\[ #XXI*94W,-EY/N_4%5=UC,
M0X2KH]D,3]&26_)P;!<]D8WSK!$N&G0]*YRQENC:!0Y_I"86H#U"<W^%GQD4
MA=M:>KO.%% KA?S0N?PY&]CB>[19,LV[$9V.("1(;6- 'D-6-#!02@(ND7T-
MT=^F/>/:">E"(>H&?XE]PB1\8_S!<&OIP*<R$I]0Y\U(<"]P =1DMNLEF@>G
M5$5-O-8X^PAF"MS4_JT.MCE$Z*QY2]]6,[0.^=>P.5+0V]&.0G%5&&5$+,YR
M.J7\-?,#$X%-LD>,"%FC,'*"V&DC)3ZB@O\#A55RB;V=4LGSH;E3N3@)BB7U
M395^. 6WBMAQ%;C(.*=8<7!5/&H.<HZ@TM_3O\^7];QJ^()(CMPL%MF42 <X
M%9;$>:Z#RD>].+;9!0?A,+5%F!+VP:^UI:CSR(S8A:>!L<_UNIJ"]L3(T=A)
M._X&:.J&*9/@8C"'38 .X&W'<,?<S0K">L@FH,"%CH!U4!3QU-DB7A\RE,*M
M"7$:T]5,B$\>-C#EVQO/<AC&G?JD>L3/IJ-VO<.M+19(IH@/!D D(/8H,9F5
M KJ!WY@QA3<Q_+,,Z6)KY%"$Q%C#LFGQ(K6I]F"M[TT ,!I,>QI%RX7=_AB5
M"8#H B469>@,Q)WBEM(_&=D[VH5#4:=!C,62-JX[E@TN85P3"H :,<3PD(HB
M+!AQ7$#XSQ['"RTP@I=@<@/@,AW=%MNR"Y/#H1'5V@KA3%5I\E2J]<FN/RK/
M!@2OV*!;E>?>70F%&;0^2_-]E>;D%H1YP'LOO=;/ #?L_L7CRAI3"0B58$,D
M61D\^(/RG]R*^&.^X+KR+U@Z)OHRFE@KR*2&CI"Q$/HR"JV:3').&TB4"^9&
M1@292VC7$,:B$86KPEISTBZ$Y0?":Z+YW>[8TJ,J$$86SLG=516B[V2H\'XO
M%9K#J/K?0$#$2'Z"JD&R5=I?\DTC,TZB6 XU=]L*D[>UH#!S<UY,R53VC6&A
M]-(+:6C9VD).DT7 W!G:20GW3O$KP_TF,V,$\O!A]/I:.F*4?/0!P7:]9V^V
MH"0^2C>6E#MC3*^HS$+^!=XH-'7)NXQU-=VNJ.+5[1/$;B/L=,? D5J04>4R
M"42;(FZ:(IU8U%*Q 8)P3 #C./U6+)8X-59H^H;&OJ*ES<3&UT'J.8<\I#X$
M_[%FI"#2;H>BH8HWWS-E^?$\N](ZU&#/.]T_O88DA:-GD4N/W"5D_"LB&L;X
M^9@6%+0;UBWP:*]8]W)HV19D._T#'4=KNK(,H554UZJM/Y%NLIIZVE'&N9_8
MDJ,,Q;-7O*2=1N!I:FD.;W&+C07Q0Z2WI)6$N%]K2I_[CD+NG0&U_]E+[$E5
M_&)#*J99&+5V2$.W!Z[S@K!<V2+M?UN+U]/OK2[4R&FW8B&./U#!PJFOZ%O>
M6;25R8M*A"LQ'%E^0972+3K5%F5S-]EI\"PP0(/4@J"<+?D@%DLLT,UN=7V-
MUH4!(-AY1WOB-:W*&6@Y[!9CO(1;TDV+P("2VB%?W]SG10DVF_:C8FM07%=)
MY6"\" B\*M(BQB<-;<4F+/ONN+^U?*:&\ ^SE=&/?!2!FUZ%135HG9SF! D'
MH>!$*PVFNQGEFFXQK5#1-< )/KZ&3X/^RM[.6F&NKH\\(:A<-AGJ?G)#63@_
MK^'.Y108+0"2N8,M! B/L1Q"(#?TE[XDR3JC8\8H"7[U<;L(?N#UMS'Y=+MX
M(XS)74/E&7LPAL83\Y -\LVO8%XD+;R]!2'0Q91,%[D$E$I/^U5C*AJ(!1:H
M+7X#BD'=D+Y&X5'7:)1!X+./^3N4K(1&YB_^CQS'>PBZ3/$FMDQ]ODF2MFAB
MY DL=^>/MK?0KXTB'ZL":>%+AM*7#_06D-:!11'4O(8MM+WANDG&_EG)V >;
M9&R4C'VP2<9^"P=%^T7^^/ZG RIHYB+!'0QLXU]2+;I..39@8#5@C"Y+CA&$
M6,7 U85XB/MI:2! ;,6W0V" QT<0]_:6#>PA++4'ZJ7E>\_0$T5\*WK7\T5*
M)86^P,^7TS\GE[#CVQ@-@3I#0+?5E9L@0).+:3((HV)<T@TI&/S83>0#6/95
M2<5^RA#A'X1)!FM8#^7R<,\9:RS29[*#OP+8F##;/G@ 4<X*6C30LXD2&3U
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M++G;L?L=8HQ; 'F2?'FS3[F8@.%'O3T5V2&T'NY F'UUIS@?U13R7K7MTK%
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M9FS2WU\<[O[Z$_S'ZY.W;W[Z_U!+ P04    "  (12Q<$Z1B5NR@  "HA0,
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M-CRBPP-<=OZ<Q<2]N0YFVR@F&?PQ38944/S^5O>)HEO"_=ML@B?#X<%U 8?
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MO*EG:>0OW3'&J7]6_X;U/,7GCK*C9S__]O:#?=Z]638ORO6/VYY(U[:P1WF
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M-%ZRXEO2^W'\3L$4>/"T>EYTU#]&Q9)L"F^!1__&,P)A)*NJF, V EN@M@/
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M;0N;.> 'F$7 IKK=K;NU.A"\6J(B-7XM7"K-!W%O7V9MN$?<UJ7I=47&! /
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M.4")UJ%=YN8VA1*NLCD3@UBL16.09EV)XTBY-,_UQ(-D&0@#LQ#,$,3.1D)
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M^?!2&MK/K="-&-M:3@&<\L*D^(?B6.XH1[?@@H$Q KU"IDFWJ@@TF(*^ ^=
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MWA%@:[X.T+U<+M+SLRY00G$,X?YEQ=6?..=*%5XX3DWRJ[);;7;HF.KQ./E
MM<":_W3%Q?R>-@9!6.<XYJ?<ZQE%&"A:217P6";-RXV(!@4*&1\F%9<JSFA@
M<$^1XVQD6V0XD]O2=!P>P'P\=2T==8S2.V*M5Y.9AY'&29-SKM1%Z7ENBCGC
MX>EBYS>$'IW2PZZM+MTCNWQ4WZ$I<^N4'S=C* FKCK=6GA$]#$>0FX\YXP^7
MQ;*D8VV68Q8)0\TD?@RR\* -WKR#=^ 8BBO3=5 /2M)SRBUUI!-$M-P?;$=B
M#PRR>\*-5I@[VAY2#XG^:B2> R%R)N":U,P9+!H6K2-F<1"H[LJS>[L!TPT[
MOZ,'8HVOST&LVMR=-1$$DC_6P\G=.DK>]AVPG.QSOZ#D+V]@+JG<X1:(CJ+?
M\;5S+:\05%= &63Q7/2 MI=PY7;6A2::"2R%%]&3;-S>I"<WG_,]TH6+.]2%
MYS"GY,"[9MU=AM+6%_2&B (";%9_47=*#=&N]$[2X)E"LXPH%']*C1$>Z(0,
MD($:8"%,85M#S;)0+:N!-J256U@O[2:P]@ N%7[GU_H2ZM1DJ70G2#6UJV\C
MQ4OQ.&;<.>)8WJQH*&*\@.<PLPX8')=_KC*D4YF5J-Z].9.5V5RBEH[\66/A
M^:*8YI@T( NJDG^OEA2;D4 _N2\P^6">XQ@P]:RC:X2GWA'X%9KO2!D8B$7L
M!+D9(QZH:#')K05O+@*+F*.VS)3FGX<=!&(S!\81<Y:-*1R)S]EL6UM?B0>S
MSEW! D(1S"*T(#TP7_AU>XDYOI@*>)#B^,8@W=29_[&8]<K7Z.PH<4Q=:U76
M)"RUW 7[!(#+7+7J2=T%M)C(F_S#94C60E9,"S9QJ/(9.#<TJ-007PFQ&1<1
M\I ]2Y?\G-Q^.*ZR\"+[I)N][&>L$;TM; ?'Q,5#Q@R#5@-HI^[V2*I+N3R?
MZ<U,/L8;]L@P1D1IZM\BL!<7 Q\&^Z2IK^$&<W"-U\&AZ^XGI \VQ>">*U,
M&X5[;^ F8ZR:9V08/3_BBGAF[1<WQ8#PC/YI%*.]Y:Y"W5RTWAP($5']5HZ@
MQ# OY%VVT8LCQSW#BJG@"26NA[RB#UWUZA37NABOE N.=H>CTJ,GLK2A$\P]
M_E*4HLFE4IAYV& VT:Y.ZJ6)<XJ_\[_J_5'/@P,>OSTR4'9)HGS_+8D2)E&^
M_Y9$^2J%>?3GW291,-)/L33M?I1ZV*D[%'W$*"+&_XL!B\.#SV!W3I@/S;6R
MHXI^.*DNBW'AO(8!4@[Q&MA0=X,G?>MNMH7$N6Z4R>(5AB'X)HZ/('.SE_K6
ML#WS^-=LA1M-ET:?"=PW*RG1,-R+"B'*6%WE@J_D^3-)QDZO)O.RVS3L*C^W
M.B$4V6P#9C:2G7:+\"!$;D/WAW:03RJ1>K/^PC\I,.@KB.BQQE,R5RBW8SN-
MA65RSM630KFW Z;^@$?)#94MGZ\/*S-HAR?J\&!#S:5!^U XFN=GFL\R4VE4
MC[%(C-D]&H7U\I_2 #I'6A-K;<K>]Y178^1F79H0-4?N5,8TU=/'8B7^&\[6
M$'45&<5+=?(0Y,],I/(4?:&4L<CZ=%H;OKN^,=R(1K [:]AFCY+*;?3F%)!S
M6:W#@UM^U^ UV7-=Y<%R$3C9+*; G'#Y4O+0JRQ*S,0LS?W"/BR(6B&:AI5D
M7K?0S,(V7G')&HB-YR6.R&\&^)+U23@O:_EU-%K+36Q(=O&^=MB=J^G(<9<+
M(=D8ZS.836W&J:D[%J']\0E&S5V3?"!$!*/BBI+GY(8K]>KM['3;Z1V2JOCX
MAQ^.V=?DLKB\H3PN1<=:\*0GF@^V&V.<EP7(6BO:ECB8' &[&!3[)#[M78K/
MIN/9*!$,-?,I&B (R-7W?)X,*@4Y+"428'LQH-*]QZR%YB=4_69@^01,RJ<F
M@C31*(H_55$U:C. 0.D*Q9WI^("X>.VM*O1MH37 [7*9ZV/#29UN/+Y2/;_2
M#0>8/(K#,;;F>8*5J9SW!G-BKCW]>GL%)%^R50"620[T"DANTBH@392"86TR
MJXTCVI_U'8Q>^F 8/O3)=QG7U%,G'\-8"$:$#?[H;-(/_#Q-,9:%S\ 7A4FI
MP67KD9J!TSMQAW>QQ(X1O2=S0?$_=X:ZGY@#/CRMY<T+.OC_D(GD$'W/-J/I
M8/!WBF@C6!C$Y:0&Y9=*B)(2$!QD+1 GI!!Q16'0^W(N@>\+%Q2(XDLMZL=-
M"M.RQ.APF-:*"J /#\;U=)TZ=E+4\?4<@283%\ =J91GO%^8LJ\5*D7/$3B&
M)QQ1)-A7%/"A0;M'#HJ)([4=64/$=B9PELC1!M3--^M$CY?EW5HG 0N$(__@
MUBP.E9\*5X44" I1K8^#:"$O0<M,4.2=AJ4''@%JW2/_X\XL&:H05$Q<3NW(
M,LP(UL(G/\Z- RV\,D$6(E)AUL<6YYH<Q4VNLMLP6>M.01BRM 9E=2V,6]H.
ME$TB#T3$*C>LSIQ0RK/%YI\5_KO)[9'(_69PHQ>K.>(ELA4V2JVH[?95OO9.
M%:L Z;VD S$UM^(LX&3(&RMA!]?@U;Y#K&2-7*/3?=IAJSO&H@M?*2Z9<$3(
M1])AGC.5*6>39G6S<8]I(.HU 0:10<#F'9?]^^_PX,R>GK2I8$,UD\)10CGZ
M"K^E(B5 P])633KF[3V9;*-[<K4I1N!#H\+G1.;HEP*V/14DQ]#"!,5M&+G(
M>6'PK6G[Q7-NXZ);%&#,M+-/.^WJ"U5]X"$C>>2$T\A;%L4!P/RV$G.&0-[L
M167$020E@EJ[(4EVKB"D4CL.:,5GSG%RSFU-!G^?FM]RU-<Q9CA6>J('HNT[
MT"A&,M;4\>0>&\*,=9B0G[C4QC<W.*AW.OJ=6+L)E#X*;=]A&TWUQ@CU'FV/
MZSO<'C:0X&PIUW. UR\*LH<48>EVW99VE%LD)4@7HZQ%(=F2X>7:RKGD25'3
MGH(I'J?3U$PQ4<;05HIKA"]TQ$=5R.SH2<6T&T6N1=(EDXYHR%L!6\QXM^8<
MUBHW4860^=.%&3!S1'<)"0,UO8%=6XI6:Q_X-MW8Q8C,A@!7^%GQ?%0><L^C
M("#BD22.I0T11M2P8BAP8@CNFF1SX(0"V#ZTP:20-B 1.N;=D$0G2#]T1&N]
MQ;9(A'.RD01Q2^CAK^4->D)\/2_$R!^W38IF(,' SZ%81ZJ#<3R(J6><9"Z#
M;@0BU;(0%]' 6(:I.*<2/N/51&BJ#>_O8@>YKJR3;%8*( I+QG9)+'(@]M27
MF#P\B)LX:I<C+ZFMS#A'%Z05&AURS/IEFHT.)6SWZ#S:!2SUPS>P5 B6^N$;
M6.JK%.;1IR_H>T1.L\7IAAV4$9Z?D\J"L]AS],!%;/Y(0>T+_I$$B!R)$-Q:
M+GCI_6FR;.0'X _#4_3ZNR%(#_K%D5E1?T3G"_,"KH,@> $$D)THUZ%QO0-[
M453O5)I9\1$G86[B=0MKT^,01>"D1\')PX.S,NYL':^.1\DBRQ/-#R[3AI[5
M6WM4^W (S1<BV[@^20Y8#%8LT+Y8A&4&+5BT9=9H9([ZKXT9$L7@;\IC6.!O
M/]PW>)'P.+4F1=]A[3 K,@9K4N'U+VQJ<08.7=3:W1WB?*MA,XHA#^N_9$VA
MP1/6-I,Y+_&;A'DM\T62764PKVBX*"^ZB81Q7,A)(U?["@O:S K:>(7YPK _
M>B8)HQEZVV(?FF:A[C%J6D2!-W'*.3)(I2R5E2YJ#QL:M5WW[%V3W_MY1?Q<
M&T*-0_?K^WTKN5=9%!2ES[IS^-M.E'&GT*+?2IH/KC1\.7?WDX'TY>BV;K,0
M#K=++S?OT;K&;6A^]G>"C;N_[D##C=YH&S0:D+TH*D"KYUUD->C@JKG) 67@
MYL /,0Y:F0+D6RIFN5D%,D>L!(?<K7=Q\3/_,NRP3[*RI&G13>Y.!?8 I\&-
MD2RE6 IXH<R8T<UGTUV#Q=1/)Y6"]NC4#1K+J5N'"*"$#NA0:IA7"0&"Z E2
M4?0G=W53E24]R+ER@U2&4RR+1N@7.(ZP4$RD'@R\^M@P#WZ;RO#'=;6R_63X
M4U?59*:A349XXS2Q+=[UM5FD?J-G!BPN/,,E=S#*I"-=5C1(HT\P*%<HG?F9
M#>24JM\Y_,)0)0JYR*%SP:LO=;E]H^&:YXM&@[)]UV#[AUQ;4X2G.IL@Y5H:
MZ/K(Y_,:&2SAAB\IG5\W'6_UIAQR1+L6DWN8\(N@9$RU9'@3(2"R^[ETO!B=
M- 4O,1N=?/#:*10IT?EA+FHS+?0WO#<Z;FY18LSOC! /Q"GJ+<&>:.\O9V?O
M'!B71B'+5517F"6=,GY6I&Z,SN&4U)Y(F>.,A/UQC:O"WSI*5OFV79""+NML
MZG]+^EH.@07"T@M$O<7==^@ U[Z-Q/#DI8]W883VMW(0SJ0NAE3L19JKY7OF
MHJ!X>;R/T*-[@P:8-S;B;0T D5C!UBS72H2XI1S UEAK;02=1&.L4L7^9?$\
M<O4\5UT&JH4,:%P[SUOL-$"ZT660W&(\4MQ).E2FC@AED$].;2TL3=H=H<^M
M)2*1HF;# ;='X:31^B[3&S7U^?"X*<M>:?<BN>=J1J4N'FCJ\RE4.$T]"BFX
MF_*-D"#+(Q6[ZR+Y@U4B1,V5SX7$J6NH;7P,00/0HRAJ.G<>GX">6[>F^["H
M)33!0M\@O[$9]SGA *YZDM.03S-) 5R1?0R:M>EC4"=SA>P.OX;V&BG)@?$]
M^_VG\\EECGB8Y/7K9]_]_E,BN_>2K 1-3KIJ'9]M1;5-S<^$VI=CZ#8Y>0U3
MOP0!*&$@]U:+;DD6!R"62V36G79=,)Q>&. K*3=[:8=G>.[>X.U_7QA,1D"2
MMD<*X5]W#+S'6 B'6OIQDL2=EZ,MT,*V8K_BK^5T'/L(65 >2[NKBX"WPRL5
M=2K8YF)F+>",L9#E>O?4"[$*E].MQ2&[4%7L0&ZG5IR=8"*:=$U^R!>*G>$0
MQ"JDQA*+,OV!QE+0LU>'9Y;=^F9Q6^4LZ(7CJAB59"Y"A9I0#9,D]"%!:A\L
MVQ5R("GY&V(.>D+(\D$7 M"-R'0PIZWQIZ2UFKOQABAP&/ 7V&J8 K>P50=Y
MB^O<Q(U"\AS012^Y7*O CA0FZT_*+/W+B-?858V=,CX@#<<2PV!=GA5K3NX<
M"YMX*&R$>25QN5W0JQ2@A"_5:;Q&"I.#R%0!0P/!2<)0N!5H?+$_5A5/'F&W
M9J:.P\V1T.>W!FR/$S++&HHH(_51Y7L6,,:L\L0B+HO>8D2%<&)F]&&(88\4
MYB[)ZR??DM=A\OK)M^3U5RG,H_'X[D[_&S( < $4A^64%3=D4:LP2+W51BQ:
MEU]$VBG^J;?RU#77;W:K>[?I/Z'RT(;<]#3'3DF -#2GX6APHU^NFC%;(G(N
M^R9X'J+(Q6)TK&%<<X4*5IFH35^_W?G?AD?M&D,:XQ<1@>*J(.&6$!^,\^4U
M&B;;0'',X>W>H^.=M\;C<&X&+(]S/M*=Z H30\3,-5Y<+$R%PXGO^NB?ZKO-
M8@,P!R"D^9?S.V ]W*.3;#29W.'FKYT(IT'#+4=>5G?",1(M8\(\^P43K2VI
MT+6:4MP5PTW<@2WG8D$LIFW9)VBTOMB1'4PQH1NWAW31JVORZ!TA.]_6@0W<
MK7U#>\2BJI*:FM+$_K)#"EP;MN]OQ8<_C:;3.Q4]R^P7U'2K/L-C:%X+9FB'
M\(G1;WWY**=OL#16 Y5M:F./I,AGJ!+!DD>#J_,E^;@S! <H&%S_<,>$56Z\
MF20F6C=AG!.&,?PLY2W<1*PE-18!9]7=$6[M=_XBS^]N,WSHZE>.KC"I$IV/
M!7^D]>,:P=._&)P@N\FV&:DUOSLG:,0&[<?-J2V./_6_OF3XBD0AIKO=EGO+
MZ(]8M%KN+?@OI[IAOHJ%@Y9K>EK!# 8]Y' K&S(\7!,B6P"[9PJ&QS2=^55_
M\DJP%0GU<82ASK()^O1T,-%0,X6^:P#):!<?1]JG73";?<'631O;#0@M'^P,
M:=#)-0M8Y% KU8XR'V#_TB8' []2TSPC_$*@6>F&N/!-O;JX]!DU#M:I1Z*W
MH8!V(T!5:<TQG"X'(0IZI6 53HD."9A*K2V#=5U,#@\8^X:=<+)/\,Z<40?Y
M94RF#J/B:Q@<Q^EM]Q1JC.#P"_@LZ>S!PCWG!$G DR]1S@D8@@C#Y2"HSZ3@
M1&:K:;$4%O&@]:)X)CI3UHFP"8S=6+')!Z6D0<Z@5HQOR;6.FS^;,F585O+(
MS"0,L.8-F [[M(4O+N[V(-NEKKH/N5VJ<UZ12_PV:Z?9GP[+_BO!Q?9IG2XO
MOYS!P:F<JNXQ(,@&*(N/DG'D)G,.#T6 2BV.5'A_#&Z(SW#A#NT<PI*8]Y+0
M=_QOD ZVENA]S/LY=<BA+=\!6#H$ZR.XJS..8? !:&S[M"6]KGEU4<SVW9U4
M[Y/@%L4=VPA89()<]X0_E#.0VU9W,E^][.[]H#?AP&4K-2A#+BH^EC$:*56L
ME(#B2UU1JD=:L@'-/96U[3Q?L6UL >;Z[CEP!S#7NUEA&*MC?H0L::G)+YGO
M@G5QO8@I+EJ7":;W#2:TR;$OO$%B1J43F-B:YHGM7=E*$P]QCJG#BETGM!>4
MKX#06'%2$P0N8\BA"PIH#A%]<\WBZ<&4"4L#Y04[3W+P5W387/[<5WUP?TWO
MUNP*AW4)2:HS7Q#W DLW*IDHIPJ/TV5@0=1K)3V9*H$7]53F/EJ.W8P'RN"J
MLC<+_#D3EE(O>]D'.D7!H!B7[\=!)(*-M! 78U7[2/%%V=(* HG655:ZM+)K
MN"G'5Z$G6@Q S:@QPTRHF86E8G1UQ+?,7#>AC+J)_1^RSO&)SS5&^5ZE-GD#
MI]8*\U"[<7=VH+41@O;P (L6M(AMR(^0@(^T;IT.).[-<>:6C='D^/N+58%(
MA"JW: ?%P>[1.;5+COCTY%N2.$P2GYY\RQ)_E>(\^N./?6E%201/&$<$X_HR
MUY:1:HSX=KUJ>G1Z)8\RJ>XDFI4"7VJFV'_LX9"</LCNG3Y*NF[*X0'X*4<2
MXOB145!-WM/7F4T4I\'#6HD03F22O]0]"+/F5?2ET^,N^=R'KE:+TF>HO=&A
MUSC\I(V4NNCI@AB"5V6&9Q5,EKITC#MON86M F3YPV*"Q19X+)IDQ8"#UQ-V
MT[,,WO#)0^ETI\:?EN_I@Y(<R\4"O]*5Y51DWV@IV Y"(*X?]6V:;7_)1-]Q
M^SL0]EWLKL8,<4,Y3:W0,8::$VX,#<V9B[/#YVNNNS*BOT?']>CCQ[N+A_SM
MZLT1L??M^7G=+BF, 69DN ,*<B%"1ZL=]+2"LFRCYT:3(]?5)4J*;$#4D.ZK
M3(OQ:SCBM<D!JD,*M% O%_;K)FO7)(+4)<$AU3UF1O+H3;21(B?O?339--J-
MYTJ)R2F;CY9QRGL>&\P1YQB!DKD$!Z?%S!/9_1(C[KP4.@L$38F&J'VVCY1J
M:47@I:!-G=XLE:0NXZ=:XUT99*@#'5U?.B+DIN8NRCTO3)WR=ES_?=(69?E_
MK37$7FM&;J K2Q[P!&WM<%A(>IZSKWQZ<C:0$(5/SE:$F0Y+Y/(*"=.F#B=G
MN&GU$#/UNC ^JHBB* "<@I0RU9C/* MLKRUCVJORJ/G\E@7X*Y%>MN5]2M%I
M6C!0[X5-;D/V@5!47L/0D@<G#Z+D_OF]_Y"6GZ0Z)8EHT DNDW%X(,K5%^DC
M^HAU\6R%[( NQ[&MOMWT+FJ0A''%54L(@ZBH[3G+,#<"Z_D552MW(\;(UP?;
M=TIQ/*6.HIO"1V3#(NQ4/H<_N6?+/FV2JKH[FS!>[A[&!U"+J:O6<WEVW%V\
M?!,4(O4JR/V@\B60 OU00JA^!_J0'!)H8<9+*4 DA&=J29UNI+Z#MHXT];5)
MBT5=5$S@RZE[X3M9YD0J4Y--E7O#QL2:K1E6M]SY6%D\L?]Q.Z->N?$Q U/T
M1L*W9&0^>GSR"#\T:37.Y4E2375$SP3#5]^)#TACQTHH'3S5<D]K#I []DB&
M%]_:X!B>'<\;X3,&GLU4'_D&[H3^PSD^[]Z[@"TC1ZZ*_%H0M]D4?IAACX\9
M-BYHW0",1[_($/QPG8.AB3V;EY=[I1?J^DYSYTP=I&M#1E&%\+&BQ U?ZPHT
MR\VUOU-/'=,X=*IVTBM(M6<31QZ%<8V4#BX2L;4PR?11J9YG6,J0M_=^^U3F
M:S;GMM FJ^GU\.2^:TT&Z@'[\?";R@4M'+KW.<+QY.2QO=13 >)E^R1MB\67
M06KT)[.),Q'-,09\T3^9C0@=8'##"6!CO,%V46-:B_UDQ4EQ)_>:&(3).R[:
MC\))5 CF+)MSBCWCAW*] /5>% 9KPT%<V:@5!<'8:1!.:X1O<:ST@N@DB,/B
M IP#K-L4Y[[N).*Q%.7+&ZP:U -=OJA+C&1PG)%FVI48SRBIQCP ^*@EM\%J
M^;)B=Q![W?0:FSWU//*=H[K!"*-?@U1RIZD/*:0> L]P!G?,;J \EM??%17
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M!?<WJWWW#VHJQ5TC.^6WBH)7JL-4VMF[<9B'7?!!BV6F;"TX5AYNJNSO(<&
M7\IZ##OZG,I:74@@_#+Z-(P?Z.C>_M?YJ\.#7__C0_+FS0MC5J&%2T3C!)[,
MM:]>]!))U%(X-J?X@ES)'K??OLL@L&7>:4#:Z)&N^$3_1(HJYC733QH:PHPL
M=/JNXUBUV'RO:"_1(I:A$WC2CI\^D!Z#/177XYZ?S-V$C]==OE9T+L?U=-WU
M*YBO'SNJPAAQOO^ :6ZGA?@;Y.=FCJ)QCIE^N![>-'XQ5S<+SU<F67P5+HV1
MQR@+G#?5IT7;K*B'85!J0HXE4C/G#5GFAB/2;I]\N?25)I,RSSC[AORU-/LB
M"+]7M'O([VY37QP5?A&^$O-6<,L+&LUE#9JL%%)5$6P7'IM140O_"]ZL@9=M
MYWI9TZ6]P SB:DEG##D5#0@&F/6:?+$/PWX!=7E% ->>EQE^A"R)0[%GB;*P
M)C!G#:B#R5IZ?ZN4A?.!O=.*R.O"^X/@JC(D.33+V2T]$:V3(+%;/2\FX(?5
M9>&<&.]\F:*VD4ROE/MAC!'WKQN^OY3V4(B5YIW0O_8^C(8#I\HT+;TJEJ[*
MRGE+ ]2>J?'$T/E"O\DZ8WU.EN954#,('YMB&6PSJ2JRC)6J/P.3.(HL?59F
M;H^LY5%SMTPXR4#HC--KPKDAK:*Y070:T&<W6IS6";UE$SISLFF]D%"(U)Z)
M:I^Q>DVE5)"V$5BI,"&A<J\#_>]4?>*;>*>#.!CA0>'0J03XN;:[+S_XU/&7
M%-4?JVH2OJ%0INBPD\ZH,6C8$PWBE[[A:+E0;_-P]VD7M'>Y"[[^R$)#%IDI
M_HZI/C<&+;470T]4PDD9C>.;G"WO&@@VD!+KH&_8]NZGR@_!"8Z,1A:.VL X
MSN_0S2 3$,.VUC[F ]T3UKNBUO!.%-!572?Y\B(@E;4WI4!K+U1LGJT#[*LP
M+J5A4U;X Y,^8BV3?R&]91F20Q9JF8<MJERE'N6(8?YPLGH]!?; A(\_&/<^
M2?OJ;L.U757:(Q"]&X!\]::&A8VP'"[N;A$<1L"/DS.?3#-XM; 7CWEDD"+<
M(? OZ)\E>]::S1.)?/;[3Z\^$7E[<F9P(M+'.^ R=:RTS)IS,^*:@!X-"3%P
M!*S$Q=LP'+;VG<D_SB,>#D7H><\%ID+)N'6';QS@/NV9JSO&3/3(Z&S55!1K
MH?A MFH]@:/[IK\TF)8.+B+U'+!%84;9$:;[KO1@ >-2@]1:]OL7_I='JM<W
MP;!BW9Y/]T-"A#7UD5!E&R8<\/!I#<X&27R<EQN=ET2%O2=TQE^ ^]5NL1ZN
M(C);."#^A4FD_S:MQJM]]T4W.NO4Y@DKY[FA:KO$(ZMNN)\&:;>-6*-B1IZ6
MYS44^MYE,2<3> .UAW1@I]VFS#W"3@2'-*O4B.@W:SV[(OZ[;EML0=5'=;?
M5B7B0!JN"0(",7A8@8OC=7])!HDA<CBRWC8W&>*S'&3:B1L[!+%WWX\%VT@2
M^M'#G/AB[F QU'9B]R14W7#3=T=LE4K0/VO* D>'JY:)4S V[$J*.$.RX7"V
ML[*M=;-BC#);"[C%R OV2.3 9-'ZK+MA_Z3G"N.G?::P7SYZ#+,[.HTXCT?:
MH?.BH"2#\K@YY-55T=8L3T5UI)%/2NM07&?0H?O"I^/?I]]O0%?_PS<$0(0
M^.$; N"K%>G1'32KV^07^$,)\S5Y?Z3%Q%"0P)#H'XG@/2 =WI7%+LHW1P>E
M!FD\:YY6Q_A3+ Z-$UUQ2AQ^$EP7?Z$'(:#]<=U@':'137BUW5UZB;UA*"^<
MRG>1T1ZTPDP"4DK-AW&DS^;FJUUJX6;<[0O#W;[P^&F'J588JL-7, Y5@H)\
M!P>_[?#\$5;UI9L-BLPLECTM7/ _E6VH8,/=KK287Z-U9EF>_+F"?36+^M :
M*V:F>0\Y0L.(I;XB7)OM](9<=&W)XOML.#2;R  +1&W[ FX4>Y$Y=;<Q!JMT
M VQT4 -3TN6;J>)758GB9!< $P\F"-!K5&((C1M,%]0<[:H 142V""V/4*93
M:5MW$GC&FGI!#<?-E,0O[3@[NR,P 0'.BO1,_>'!D$O0G\.;^=$9BLQ,NJYQ
MTHU,^GI,!:)8WE#7E37BZ8XHK=,FN\Y*-MSJV9X98W?;9_7U+$4'C0HNT.3F
M,\CH*^FFZAL\&A4P(N\!:_'RE:X.!W*Y;BMQG7^7F+)ES^CT^P>N&0KR\J+E
M?H25 H-= 3?1E:;&?-<6?KBEI,K#E2-%6YYC9$(02Q@INUT044&U"%*?G.S*
MVHM'14C6:^L%Z))>-MZ >4_\D[]$QMOAXD7E@NV\?&0Z& C-0Z@SQ 7V<X;>
M/_:V,#2=T7J(UJ<E#0/ZSAP*77'G3_<TI'%5@?Z,8I\78YJ:3X.[@*>9+2Z%
M+E(<7&V[\P@D+0V)@$.]J%3#."BEV!:=98]_&1*)27 W^WOQ-NGGW 3D;RA7
M_/NUU5W&WU_/ F7E Q[AN9.\QN.E27YN\CSYIUC85I()::;JHE+U@9R25WE9
M+SBGTZ-&)!^YY?:L.Q"$4!;(ZJZR_1GDF02<BU21:"+#X#V@BOB'M\8>3G^3
M)MZLN':A$4>;(1.[9JD81X>D+N8];.)6G5"(TND4LF[7H6D3-/ .+^_1=70&
M4J_#ZXI*SJI6 V';1*E.Q,IGK%&@1%0$P.;OGAY>K>R;BKCK#-W 5F)GI*2Z
MPDD6.,<N\(BKO,ZSQOF$,:5*,9^#NP(?4B-P$RZ$&S38!**JT&II35]I>:YY
MG*4;WE2R:\4][7E<8IZ6BDL &_8:(P%Y.0M#KE[TABVZO9/$+QL4$I/60";(
M[I! LT_WRKKXQKA1/]>O*MG_%2SB'?I'W46DH\\7N61XCBD>FPIN>6W ]:_+
M::Z=E(=HN8S7ZZ'>6/*[Y,)WDR-Z^"CN]DWG&*N1T_OWYO JEYHS&</6KRIS
MOIIK9P46 6" IUEV>^!,5YR+<6[3*]_]C,!M8C<A>O[)"0^ID YJ\2@F-9@M
MQ31O P,_*%.2P:#295-=2NZ-OAKQ6"I$NM.D8!-SI'K/?=-+5Y>/.>/&=66+
M!I0&!CNC;-8F.:2MJ]5_.#WUKFK7V6'G-3E]]$.0AMK#_7?K&W##_I-HVD:F
MNYBZMEM:H9E"T)T-UJ))1X$0S#;4#-'#<4B!YPPI<YEJ1BM$">QZQ@E'_$'W
M.PYEM,@FP4A.F[.UX1C7#+;;Q1#=EZRD^K-UTI.JW>BL4XJ7(!?N:!IN/^K;
M588M&_H2]V(W>5O;3-,P +4'HT2M,&V>FC%Q"]M;?<B8&GZ/^$^" 'K_/ARZ
M&WD'UM7U.\CG0  @;A8J0]("40>=I//#MLR4R==Y&^[5:^V!5R]_.7N?*DN,
MJT)=TF! [<F],7?NRT+.[WW8-S55?/JBMMZD9@H/$]OJ556H-U1=(< :1IU=
MU8V8YYR$Z>S?&>6D9AQ0IRR,5#)NH#3P4=0RN_9-3W?&A(-V027)4<VI,X8*
MBF/PO8*444M#TJ"8UVQ.+:ERGN*6+<:K_CR3M-O2;B IF%77^162GKK&X-T4
MD=5^6)YL)H8V%\X.=X3TJ%H3P/;S'F#J#0=UPIZ8@)SA&JT_1((52;A(>2B%
M*3'-U?*,].7*M, 3A ']-MS$V2?!^L-94%.C9(7Z]-QCS_;R3OB4)]_P*1$^
MY<DW?,I7*]*C+W0ZI>K?D=/#7AKE_")S;L3\!I^?V4M<8J_3Q7>WS)[!]47L
M$WA%R@86Q[Q*)'!;4#Z:FB/C@$TX11]/B20$Y>]D5SD?\$&:G#[$,9P^<@U&
MS4@&4(MMQ_[6'X&):-[0U^HRDG557O@0/,W/GBGWT:>[#,K]4_P^]OD+0UVH
M)[=S)8(V?HQ,TAT#USP^B:,Q_5T$DQ%^)RW(GCW_B<AN?U\<'KRC6SW[[OE/
MTI'LJ*\&BB@$,04!WB&V;>%B:^2^;7HEV%).PI\_(Z[Y_-X/E&YP-"!HBS#8
M:G[$>"3?/A6L,<(7X7Z?%IC+*)E+KM*_).4.PKW<1)@R4L29OP*F^ HK59A*
M#B'=8$ U$^8S8  04E3(/J&@&GZV[5%'SON9$9?$40>*$FF8.)SJ]9[MH2QC
MRZ.GN<@5B)&KO;S6PB\J4VN9&!=^ARM#KBBLNK9+-N\AM>=V/-D$WK9UM!-(
M;8)>Q$4Q">N'#5B=DGI_<-&]IBW@%E0X1R3)O')U$T]<ZLQJ-J81A,C9;T/'
MU^2^*6VK@HPW;@HB9FRMJ4Z=]484OYAI=I//AH</.?XQ@9G"E%V8G&@P52BD
MD:(WA>N9LI<4M"P))>: B+VIC= )<K:^ZNA=-RUC'AV R8D2[TED*:8@)"Y7
M\H[YJ$<^-R/RJO%?BN#P54=*CHOD'FSK,RZN7EU<=N@:I0,$$4$BE;[EW,1,
M)<5NJ1L3<4]R)8-S$]HU7("3!)+C-(4O(^@6-SG@*DI$3-=I )EC<'5F!<-7
M]6/7P:Z@G(4FI6=P@+4<S3;J3#/9 34L8F%=R-DU3N<M0N%<LWV;8LZ],=6%
M5% D/!(K_$E0E,27UR5S)='7EW@EWV-MO*I6QJY%E>YYTLCZQ1&?B?B\[ (D
MY8(:2*[F8XZA]V]ZMW="G5-@;0>5TI!.X#O[*4)U!K^Y?_SH?SNR@1I?QC_.
M:I_^1]M<Y>%!D#VTK (A>07?R0V6XUU/'4%/H%7;Z.)09)R>S#\)!W@K$U*A
MJX-YT$69L8.;MY.F&-]))U'#Z1J1*80%*72PVJD8F%0V(651!V(N1H=S-J%:
M-NNM+]IAPK[1FQX;&X.5C3$MDGF>501UP6,<]O>*-T;056N1-4MX8'M9++#?
M:K/BFG\#A85?K*K@$U \]:20&_Q1PYF3()8&AIHZ-KFR '^T+*B_DAP[?"73
M:[L//0^ V ZPS9 \2L!Y8QQX:P(U1YYC6K:VG T?X27WSVB^PR1HP+]"T+8\
M*.#3&&.? 4OITHQ=-6+2=FX1.W\^HF]5/(4H4<C!NOF ,-%^XC^;B)'J!+IU
ML+6]DVG=MJ,]E)"[2].]&ZJ<Z\%MD>Y$"Q =+,(7YTP++9LYH QI!YP0$@ZT
ML-R-*,JK./T^2A]G]'+B2,*^:=)/S.W(]Y0"?E<>;F>B\CGBZ/DVD N[;.2-
MO5*I..AGE'-L]7&B@4]%-H*#TI#^%O9:8Q"M5DCM4H0!#]C ^[?!;AW8-ER?
MC6J3PTI5OM0RFM83[&P0MI#LS_>48#TI5L3O;$V_DQN+'>$:,=R:@;9W0G+[
MX$<G)+^#%53VY^^HIH^W>A[2SCARF?!4WRA!'94.=Y;:_8 \P-.F=2D$\'O0
MHV 4D"&IW0$06!2%#WS6^M>ALYR<)HHG%:B_82AE79&2HH- _CU'\X7/&&XB
MA3J]X$0D!AMD"*FO0IP0I:_W3;DKADS;\!M<4MJ0_61NIJ?!&(Z=G1O?$N^W
M1":X)8?2IZL)EXU(GRLLL%*(WWGDD^I;"\*L9]JC6BWTBC=/OMZ2S#:8G-;.
M3)^_/<&:/C+ N)EJ328=N$Z(GF"XJ^%8YEI*YZ/+>=<7I-L_Q?!E0%2T035M
M[W#O#O,N01F"%EPH D;-Z<;V G<N\1ZNU&TOU?!*H1W67/')^3'/%P9OJFL1
MQZD]"1F:;3YB)-1Z_T(#;87%JA+$B ,=&(= QSRCX"_<A9JQ":C!1&3=<Y7C
M+'Z^#C#L%[=GXK(+5@'LK6]8A0"K</_D&U;AJQ5ITH"WK *WE_CU0<7PLG^*
MI_R!8_?4B>&?B)IO29]Y#W7IJ_X:#F9V*P /#[:5 +)6W?FAKL/Q<"'?4$GQ
MX8&M*5[:>VRNZ=NY9(^G9*>*O<,#%\8GU!TV@KR5BKV(IG"W<CTP\(?J]787
MATV5>]_*]93L;_R%4+,!85C*.(=B/J8VCP46>A<.2-.#Y@][+E*^;!O9-B6V
M,;RVFL\SUPLP@&[ '\CQ32*"3 ,$ZVT%921BA_&4"8&\-7JVJ;>=Q#_ BJ)2
M8$ZDL1]4CV$Q).8996?5ZPT'YT+?2\IHFJJ^'QT(@@OM-<$#HUK2SH1/FUHZ
M7J:&8 347P\8=["><E,11-J3B5MOJ:9-H^H(#BGTE@Y(M8&"O))ARA:GX]SD
MNVDPS"K=][:3S0.)%K-;>2=8Y9'V?0G2$"!>NU#JA+!N$_#PV1%*B#T'<S$Y
M_[AV:&Z\YO]K[]I[VDBR_?](?(=6=.<*I [!YI%D-C<2$#)AER0(,CM:K597
M;7<;]Z9Q^W;;$.^GO^=5SZXV)L&$ 7:E#)AV5775J?,^YW>95'DYK;VD;B]7
MSVZ.@%GQL4-*F>T^&&1"M+ ]=!5U9U3Q)'/23M#E%(B-$FMU-@7'=G?%G%*0
M<IUSXJR%?*S;3=DMEUS2P4_TEEUDB# T2A-S8')B4MA!';G,KO"EIXAW/AXK
MDKG@ G:-[-JL :%]L@N*_'H9MQ;(D7%U,SEIP2ND"_T0ENN27+'-7$@-JZFH
M0>K_K=H6*0J:>7#0NF4PD>N4[;]YE0=RBX/0!6TL71"FN*"IYO9%Y87]15D8
MV#6I/D4)\\NU)N*%&1D>PBL#8' %TVY)95D0I(/O 64?R.*WHK7NS-TJZ3HN
MMP*7H=X$7H2HS^['U0[ OBC.NHS.&1$(N 7DI[P]((.2;RB[<]*JXV $C<ZP
MV5$T=* :Q3E<I?<XVDVS!M6_J\:]HM@PFEBP"7A2B[>/: L_(!^?(E=T$O3S
MB2.>C'>IDOQ-BR@IPHB.0.7S<1N'D2*/JD@"BG,]":TH2&;6,H@@#<OIA8P&
M"3V0V-7I:\VI\(KHNPVJ?DD-%+@)&;\IULQ%7T=@5,26]YY3[6RES'WC]YBB
MBF6#RGVFKJ?:NM3L'>F13;LH"=M"[H%@SUPOF?C,_OO[++.SB:4H$L4$J)M]
M2JO9VMC\9?V:DW7\\7./UTL8#!\N,#FQR*1R $:FW6HG+&]2G6!_!0//G@_*
M:16M=;?7HR&"P*N56GDDX9$%;D+5O37>;$]E>_J;:EIFD1$2;N1/_9RY^1^V
M<[XJ88GK3GMFR3KU<XO=O1?,-NE?7%'GT+)E629G4RVMA_149<:%CU$JJV&)
MY3O&Q$RJAR! 00YS85,>5!^Q31?<1XX5!F^<U_!9FVXIAWR9&"Q0)-4'VJ=G
MI>2LKGC;F?L%*1O1IW*"A*"3'DG2EZ!-EJ08)JYNPT*?4H]W.IW-M?/UM<[F
M.OHHYI[OC#/1PV>L*S)P>8IG7<LF$X_4@*$9^TSP-)T[1U,4,]*<M&^>I9?C
MH.>/0(4KRBN[C_C-[W6@17M@!,NP\3D=+&*8%=Q-FXB@HE RJ>%"7,$$EL4F
MUFDNG!HCM-E7.3+ _2D7/BD"(1%G"RA'11!L=*8$IVG;1D" <$G)\>DFYW"I
M(OI49T>XO46E7M-JJ6BR[DMK"3]V-J5!T?2E,BXT+(MX;;"]<C%Q2<9O\HB4
MM(6B-)VG*(T7I>D\16GN)3FOI7?EM>VCNEQDZ7GF@+10@(#4/!]-C')CJ'"(
MDA+I%RH.*(O, ';UDW'25RG=6"<@8Y"]HN"Z/+/!]KN>.45G3=^O),]P>;_.
M_Z1>[=C3ELTB+)'+TRG\J=*&[(%=A#-3J$&<JP,ZI*Z2*6:NGO]]&T5K5!$1
M^L5TDY^W$D$<QC\7V3F"H8)U'UO%.;&2R]+%W )PO<!TI"K<9L!1^W"!Y#\O
M)JJ<-J?TUZN1VDEZH)])0R>&&^?1'>45#Q(&RE56PT5"*-PJP(.D3;CIY.>E
M&IUSXRQ$X9_D=:+S#VS//_E\_../3:>7.5AW5*(FZ^+R!7*SJ%J&(#TXV65^
MHW7E%U?!BJ2B+"C3UP_'< O3I.$UV2;BJ$(#/[1RO[)O;@QD=44N@DZZ5N=B
M]P:D W/&L)'%4]WB1J(9F$K"EUBI85(IIKV?@?XG"K1 NG; KO4R^&#@O4_8
MX!!P5WT[^D627[1?J=A*WIM09O:0K ;4MW%/A&AG!MA=0LRC!"M:^)[0:=)(
MH'4S^U L(ITN1A<!?ZDN-;2V6P,%2/>02 *K*@CRB-2SM>RN?&B5LD^:7)J@
MVR>U74U+X1J@E,IDV'+[;8=I<PD,T1T:Y5[[3;#F[,Q:A4)-K)7P(2A50'P^
M.3O_!^C54= A%K:$*O<*%.!N;VU))8*>P11]F[D07U#F^IY)-G=BOZ5P:[>%
MD#3!KMFL&J",IWBKVW%<!M<>=_5N<UI)&,>0B,3K(BA6. PH"8LG):(0*KB_
MHJP2]<XQREN! ^&H ;D9,7,//G+?V"(U&Z;:POYT"1#,2^%U=N-""Q74I/);
MA^ZTXZ =N"SSE/):]$Y&C#(1;,-..W9:)FET-BSONJ;CY\)$[A),Y!%\>#'2
M <HGN,>E\5[C1\QESZTRKV%279 3*"S925=4O)C4.^ ;Y4Q%ZNA++'ZM$->P
M9/VP*HOPN'9O%RRA-=8%MX;1#6&:O175,]W-8-.8Y#Q!_)](JK.P8J&(BK*N
M<?=(CX'_ILE%HNP%I7E2\C_7SZ(O3 *\C4)(':QT%.:8S0&K2XZ=Q4)Y<:%&
M<K'5W9$]Q>AMIB+YR:10J6NQU$Q,!+R!BR4L#"/1A5A+PY8%Z():CQUPFEEL
M#!JEI7&HE_"L5*.T-FX?-W=:J[COLY3VBGIJH'9=)%>6[4.K!C;<9]^9_-'4
M ^+&U.4@J:AI+^IJ;<=EV0G<08/<=5/2@_'E0%[T$G3%3<?"7T/I9D 0($K2
MQM^XOM!+^5L03H"W!W^=DJUG2[V;YQH(',;,54Z>6S '2E5@'8#V.J ;-,$S
MM[;64K>15.PV%V4=F/?3@RQA(\OX7776AR@"*AF'B<+&9- ?FG2)%A1S6;C,
MP-2DOVU;S!1*T,T$Q1XPJ?(6\882?3BW1[WJFC82K#>)30I4Z;Y-+\/3XN0G
MB3S9B4#D^C"11+U+>V9L.YK(A'LM(9<:@LT0L/Y,):P:B)L?0*.X+J,UY"$*
M$;Y)[7)50/KHN[!W_$38:SI8<H<9%GB3F6T/YR.T.F7MEBT=E%2JW9+8F"+6
M2&T-/;].[:!,;(9<12X_PX!I*T.C!!L50FG)[1%U6U;4$^+U%ZYZA\]+N65.
MT\(0[0>C*\I92J]!:FMRNW:^Z/'!U94 "D@IR'6M\&MSV))UX3BNR+A!ZDZI
M)B-XL:E]C:CHJRO^1AZ9RX^&!C6T$:IBU8H1BU1?8J=Y#Y^_=FXU._&@##;V
M(AJ[C\,46#PZU'V*#GG1H>Y3=.A>DO-2<_H/@^:9V"F%";V0"4/-!!>R^AS?
M]H(6G9MGM1Q#+N:%*)^@[X9G[8(>$>O4S^V')1/X0#U77-GFXH)FA[:J4#*M
MKF!WIUG E(K;/6=N.Y3OM'Y(+Y'P >;@:I5,@R)<IU7>R#J*;FH<-;INA;0
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M2IE8DAK)*)B]3"PK9":2:HA'@]V""_8[DPM84X>5>4\6";NXO5B^+A;^J4A
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MV*KQW?T>CIE6>&-CY#9G)05.;2:K ,JAEWD>FZ%RKB';:]8-Q;S72,HX5:5
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M#^M.W.2"PTTD9Z+(>"U01'<(2,9""33:VO7QG(N<-3V4?"^UUY#)XCD:W6/
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MJ4KA4+UZ-AV;;[*Z5N]^:>SP,2.P^C0-:@3!RG!QI8# &J8K\T7";_45DYM
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MV']U<'B  =)3SJ9XA7F*BPHQ0UO7;2@!'Z.[T9T,KH3]>I:E>/;U\P>FXU!
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M-C'3TB=2%]:V=Y,7C[Z/H_\KJTJ"[,,+")*P*J\?F*K!?<HZ>3)I&"WNV\U
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MX^OH\]_\J-V)GR=O$.+S#ZK>?UYTO=81?OWR:.\WHI[79V_?O/C_4$L#!!0
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M%YD^Q;_3["HIJ[Q@=N+N_N[R)BG\A8+2DQ3(H9B%,%G!-&.8-Q(NLPN\X?@
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MY9C57@MB6']FTV>:]3OQ^M-+^-N"_DO.8@E+3."NCZLDB$JX<O0ROX8+7+!
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M@OV@B-&:H YJY8\XFB/QG7I(IL5ONRXT@VJ&AH7$F>_]/O><>T:IXNNA/Z2
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M"K,OW+O&/;OQ$HX\=)#,V[C",0GC+)[E%_G2E*0Y/[/<7[O+N2TTFAA$\,C
M61&MAV20@P@%%OEXR7K!"N5NYPD&,.NJW4C:T3DZWE.OB5FMUI*?[W;@!W[3
M/2=QD;-@W:O(31L(.0.TK@7%.9<$S^5I-E2BYN:W\SL:U];M-"[.6Y&RP6(Y
MD]M0&/=_Z?G^JR EO;U&/\W,O(QSWO(,)UFT/<G>$"-%5:6<:"T$G;E07-9A
MLNKJLF@0CE&@<,M#6,0-YDI1@.F,D=-@Y4%AJRU>FN=E1?HKS'.891A,/:'P
M@>E$M[/]Z'\&T=^6<,TP(ZWAZ[]9V*C%\GR6CJ-I.E-DVI!R\3 M->Z9\II:
MD[W1GE]HU)0VA7&9.)KG1:)KD G$609&@G1F]('K--1BN F(!#]MOOZ\Q'O<
MFCY4N7&-W&-G(P'DGEN]A9_$;(Z<ASA1ESL$!Y=VZDU1#)"R*9G+=#]U^OEP
M! C!Z_@>@&V')_]1) 8$[D/GK%U"(P!YVJ=4B*#*&7,$"K;=-BR X]P'=]Y4
MM]"@ES9%2%0ML,5[G!W>$"%KXNM$G0[76Y''AJ*!U/H0)Y9:U#4R H16=[;(
M;>8#)S]9CN%%:V M#6CJNH1!Z==:VVU37.=7QU#!)<T@1*,_P8\YK;A>SV^R
ME1UH5D;) (7L!L']#4QK$]%P+F6MG-=!?N/"GH9V@)IG$TZ/I8>%[P#UP/:]
M&E@FKZP".1X&FOV2&#<1)YCSM=_RR8,(D,8A],:9A#TS9DN"9MC0@N23RL3\
M*\+"'U4[TT7&Z:*S 0]HDO@<*ZQ9?6)<-VAB-&%7-67Q:+)P7<W1 W:M64XK
M%<14RZ\HILK!<&N!-#$O;:4I+=JOG=!Z6TF,"[D:UF$[DUUM*#&>I9;@>";;
M:K.!C20+'QXJU08<U=BL Q:>AH<WV,=Z'A\E''H^/^0,C;5Z7S]$>9.WE[EQ
MIQH^U,"9UVZ0/.F8[(U*NI;?-F](K:/UB%P,36PN+/BL.U3,$]*%B71I;J^:
MM[N)NAWC)UKDUUPR>I4S!@(2FL%FY?VUL]N*ADT,UX?%-K%^EYAKK\(YF(8M
M]=5MS+;YQ3[F53O;]E?3[9PUTZS9UJ=;/_SP7ZM4B*J67^,0M]<UKI6MN?4Q
MG^LC"4BKOC1?#7RW0$GE5C*$'1#K-0V^A5%O=@U\$BF#$5\3^7<+;ZBDN:XH
M__8+]&4:[QO.ZP<ZB+"KB)/['Q9E85Z>\4V:.:5M; HK8"R&I\W2M2W:RO1#
M=?-(&A=]%W8NFOA(/9G)FVF%T[<ZC,R2>G+4MX[FA:D^:,G-;AI 2-;[@CAV
MXL@WVV'#=G_G;#])+,X:1*"GH]3-Y?$L!M(1$EE'QLT.9R%GVV_.HX$6(O+0
M5UWAM=XII)!KL@Q'59A2CRAG=8'P*3C'<.>[^!$F.J%*UB"0"(^>\QK3S$!0
MM[3UK&G]")XL(*AN-24IJEYO34T$X_?GZS%5&R%Z+;0SLH3 H2HSEC$X0+=R
M!"N9X/N*ZG=(+YU+=WB%39^#J9TXA3FL2Z#ZRD5HI-SF,)?JIBW-PC6. H/-
M= YA4("BX%B+-],FP!1_\[VRQTFBO(%.E5J2EY7!/2;!AW[G23)I5@\V=A-&
MTC"-:J.T2)K0XA:RB:6S0.(995IH:3Z<SH(<+HA9&X9/[!SX*%?-R=T)W .Y
M:=Q6!A7 "?-CW$?Q'EK5A!D7>55A8)QK[G*?K]@T_6O'&C?)8WGVD,<2YK$\
M>\AC^1T3=6\JY5+[:;E85H)_VNV(M3LVL-T3_EX"!(TQO ;-7K1XU#,NYPFH
M6)&&01JAKFJN+(R@*J[-*BS_)NM#(1P5LFB%^Z2MJIV:;/+")YRS 5_GLRL!
M^M$]617/V?["7/)K)D8]WF):&N[_][O3L[>CP[-NY^A5-/K[Z&3OX'04'9\<
M[(VBX>%^=/CN[>[H)((O?QF>G PQW^?U\&1TRCD;9W5"6MN,RJ@O)I/8M70$
M 3XN!9N^O+T2L#_&-8_EFO^<S\!"BA$%9&@1HW=O].[P 02]7)JC<KF!/G3*
M4?R+2&$SZU;5XA"]O5$-WY9]R_P ^BX5N":@!E& !74()V8, ^YQAW.C =FZ
M *4&E*LB)0\0&Q2[><Q]"O>IWU!>V)P1;59]STCD7$C$TD6W@_X&L03W35<;
MW.]3,& J"Y;MV<G.@5^O ^IY3G;_@B ")8M 6^5XY?_8V_ ]$J%M2B->9?=O
M2N.SEBRB2/B^'C>G0&"B<O,O!Q?.<4\K>%:J;R8Z\9V?9&_87J4Q.L34/S3)
ME^?5P#%Z-95G1<-#D7A!7#+T)/EWIR_E;6 5\@Z6&P7U,E+UI2E?S6,VD*JF
M<3X_Q_"%6W"%GMF8DUNP)P_VB^(#+)$V^AN/7H+B.FL<FXJJKOJ\'25W(1G/
ML*,)0<!JZI"^VV2X.&%Q;X_'\2)%)#K)5O'(U@'1=>!'&U0:(V@$D5$Z?,6F
MC1W1A_59P[*2(JYRI]_G1K&;'N<Z$;]$Q]*RN#$;PPB8_5;?)6O- JG.$0M"
MKIQZ*5@9E>=\_,Q6>TSMF,:?[<82RJ 5X6KWJ)D8\F^V]V4LE?)^?]'5E49:
M=<YI7I@_13;Z9"L:9C=N!P6G]Z$H<LR7'R.3U#E1]UOK>*SO!(E.[H=+(2AE
M#Y[BS*A"M@M6V5@0+^JF98P>%W0#"QO-RGX_$< S.B6K[0L3*2E'B"^_:;X4
MWD&&5$ ?%Q$:YRMS/+YE3QU7#B'_NGH!"W#IXR?9#>G8G"C\VDFD\KL%J<GB
M&1@FYNV\I*XK.@H">S\DF<:]0J 6I7CGXRS)EZ6@I[,>8E<I&E,8X&A+#WA,
M*>!KC1'N['N>.)"Q&]X;]5!/7!?U)+Q. XRXV1Q>*6!P5N6&$)W:50W?L(2T
MS9>,(-3]7:^VDP\Z9AW=&R[<2V301+[=3GL;4V?N/<W&PM<5$]4=K0.-E :S
MDV$:>/\>V6^;>+B^>_!PA1ZN[QX\7+]3@GXB#HF3@Y]>GYV".7-\=!CM'YR>
MG1SLOCL[@#^.7D7#T]/1F7@> E!/G[F7C2@ CR49-K?Y#D_1W*;2@H&*-@NS
MP\B7*Y!+4]^<8@XY0:%;T"@&>:UF* 6V$1M (*H3^ \V&)2** N-#RS4/$&1
M&-5!6I6_@57[-;SO*-:NQ;91BKD[8=*$L+II8-/)PSSV@41),&K) !ZE#T:,
MQW\.$H=2K3QS3_;!3C\V&P@#+C!5"UM0AMK-  MJ"A"6*(K@PN*970CR4SF^
M3!A8P_G8F38L5J 2M-E WVTX[/>)]<Q8)[M=B*K;(>63:<T#7]IW?NEGT)J9
M2%ERS7HR-1F6<G$,C$[B7I-.Y9KS4N%3SQ5QT[1\.XH(WQI37F9+@/X48/#2
M+]W%J7)%:@+'"T5/=-[L@*([[W.0N#SD<L1*IVJ9C0P?OC76;"%(]:1*G!J#
M6G['!MI'80$\0VVD(:E=C<*F*^4$W-WLTGZ#<1B9S+A<X;EBM59@0"S:S&RK
M*_<8!MKX),L5#M7[U<"^.BX#8U@>7<MFG);=3E:9JI5.;Y4\:R:57KU=N-)*
M/4&X(;7,XI'[1&DR5+S1F.BD+77JH2JWYGO  4G"AU<FT) PT0;5K+DO'W.%
MVO(S7'(!]F(,RH8Q&F/D4G?D@ <Y+C1Q9P6]NYON-_,6.1MYIY0/XJ3[9CN=
MX'_]/93!D%9+"WXK:[;6AJUK)!L36#30)1BYV-K(DTGJ]J14IJ22]'^N&\2-
MNG$<'I*/::JB4* RU^%QW!3"MA&-G]5CY;0OV4IWE#'N!I_OE%#B<.ZI=:UU
M.WQ%6_T4&RR.U BL4:ECK&M%M5_0YC,@,A#)^6^4!A<>UK[4O!/!G#=[[S1.
M"VT3=(663IC;2LX^WB?*4\+=O,C2?W/Q_U4B=N=YG+'#>;$HXK2$VT(IWXQV
MWU@'2DZ(JYK?=R F+7T;SS0W[!QSW9R43BH(Y%8#C Y-<HW;C,0W"2?@<K-M
MFWI=^,H1]X=7R4VYT'67K=LU8LUYV^LS\+/]!HT'O]DAB02'74<'YE@.B10Z
MHU)[G=U,,^J::\!/OARJMV*DKR9+-VQ,Z!?!;#H-SS_1[;3/XKA('CFAN15S
MZ?F^ZAJ5.N0%3U[D^02)N[KL1UB+($5I;'F?CA$<M)2FSL1:**:7 _%8<$U3
M622S/?I9<1&FU"*#RR\- ET?C)\$S7GQJ07;[WO700#Y_&RZ+"KN_\$%+ROR
MQ)*L7')2.\OREH-4:$3_ /W][G;\W]PC[\_3+325C]^=[+T>GHXBMIE?=#NO
MWAWN#S&8/WP3G9T,#T^'>V@ZL\5\SV*D&D8_%C]LMW-"-O5G> ^ *SS1EH_
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M3I*)&'R2.NALB&+;2'JI=2P0?_ZXER..0J"<Y!J3J*L!5 2_=A%&[#D#N6/
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MU,QG ?FCS+[:WH?3OFU+:F=3U>XNHEZ;!SYW)/"Y-SHY&QX<PM48O3HX/,#
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MB ZR\7T[L%EP8,8=Q'ZB^H%56O.K+9\XT1M!!A$"**/&"8C99#.4Z''!*)8
ML5@,Z#D%UEDRM&%@^,8!SF)>6&M7@_4F6HX=-[@3B GHAFD'O=A9Z&OJ=NM:
MX(*9D<$NT4QT?8Q%)<_?-_*8ATDJK] '(9:JD^_=()F'_:BY)U5;?IK?9)NS
MK$L7/;+;\=/.3(DJI8XC2CVFTN6%P&HD$S=R2JEI?:?1,3^-79(Y7D)SP<)D
M[4K*>([>_)G<404HKA@AQ&ERC&YY)E]M83'"'$'.X*.TN#+!U7/3AX$QS <L
M<&Z\)5%&NS8:QX2JHMX*V0*$%]B>7E&TL7=J5>M%X>?OJ:\$)D)Z1U9Y6ZU'
MV:-X_U1!)"GM=.?1]F-\S4ER83SLIX_^3I45[AEXFT#@G[P-:9_R,NC/&#,K
M5_Y*ZS6<Q]U5L3-)TM*H8 :;5* BAJOTE#2_6V.N6#9K9HV#<_JFZ7H[B*C[
M1N'J ; A4]L&#[LW8C*"3;"\=-(=*H2>P5HTKIGN?>A'S[;_2\_+S7!HUBF
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M*%5#I'DL-=\@:X&I'PS ?*2J\I:\SB/XA?$.OI51%P-:"Q5A;8118X$M#Y&
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MV"AU&X)*? N& K>YHKLER%X[WY]V)&CE_@[I7!/S1\L*A]*&=.L[16J2DX5
M+_U><&R?]U-@QI!]FW; 2*7Y-??$_&%0_UPX;,%V0PWA  P]<JA!W&=217UN
MU*A_^.#85$M= D ZU-.!/&T(-]_94P1U8\4!4$XD192.MW<,T'D[C6OC;# 2
M+36U8NE(9I>F*LKXEA(+:O@KE<6^C43@6QK!C4;IKCXA9&P4L%INK+_&<V\X
M6:HKZ$Z .OC89*R*TN$:A$84'\2,2P[NT2**E,R^,,AFNO!QV).HY4,X*6]_
M,%L_1E0I*D.QU1O!?(O= UK$]]I2)6-A(."2<*8+J!R:1>@2DXETXVE3A] >
M?LO-)?<O,Z5YI.%B*-2GMRX7U1;J30QSBF!5-,YK'5,7KML"N-&N&"98^K\R
MS1?>A*<![Q_4 SLLA_=6J77WGL:%\9&#5NY>J@5*6'XJ=UKNP&@>8:.F "E&
M="5M+YTN?S!K_.@#(^F=7[@@.[#\@DZP-F\H&)AOOKH2L66F=II7:<('DOG;
M-FF[IN.ITF5><][N=0N"4VY%*X3W>[X^)%:8-FI217/YH6Z 0$A^.EZ$7NO@
M(_VIT:.+3)\ K*DE#A 'O$R/V2D2;>-4ZMF<#[#HR16 =;\'(!+,W+\J1!&Y
M1OS(&!90)7;&#$LBRT)(MMR7+7T#!\^HF*U8@"NDK"*\:D,0QA7$1#/HGKS'
MJ:B5ZYQ*?KC>-XZ)$3?../.@C\[D&G4\OT<XIE>.VE&$[Q&R<&$8X,-K9S7B
M@T)!T+RX]&+UG_[*?0X\,-UDKL)QEG_MYHQJQ%W?2;J;(C<V!@PFR_=SFI=Q
M*)I1G'(-L>;-KE@6;'S^"N^4+>>MLXCP1H9_D6GABT%K_=Y))B::,;;O>S7X
M.<FY</#"R61&JB%E>HSD*=,-SB1W]:EO+Z+X0K"N]\$^R^5"XH4_]U?'/WF?
M %QJZC%V2 ^P&Y]L4)!_O>[K&37_N[6V >/YLC<CE__+C?I^A=Y,D(55.R)\
MJG_4$1A<42T8RS1(7>9%_9...S_X>$ZT']SCQ=&]B[?N7;QW_/[=17O'JV,)
MS'B[\[D]\UR+DLJI:&7_5VIUH$1&L*:*SD9[ZT1[?^[5^,=N_]%;7O(V ^OO
M<6_K=EUT?O:S:)/U;QN^A0,OG^&7W+]N[(KW',#MCCBE7P[]'UW'+NUN]-%G
MM4Z_>70_@J3?2OX74$L#!!0    (  A%+%RY'$>)%!   #E"   :    96$P
M,C<R-#$Y,#%E>#4M,E]O;F1A<RYH=&WM7&M3&T<6_:XJ_8=>:C>%JP8A9.,'
M$*J$P3$;Q5"@F-J/K9F6U/%H9CP/L/+K]]S;W?.01@FX3):4-U4Q8J8?M^\]
M]]WBZ/WXE]%QMW/T_FQXBI^"_CL:GX]'9\='N^8GWN[:UT<G%Z?_$=?C_XS.
M?MR:QE%^(/;Z22[&>J$R\4'=B:MX(2////#$M4KU= L3,?7RH?,.Q4*F,QT=
M"!K:/Q2Y^I+OR%#/\"C5LWF^=7QT<GSV9:XG.A?[O<'1[@FHOGS$_7Z()EER
M^$A[^"K*58I#O;OX,'8K\X \E5$VC=/%@2B21*6^S-36\76DPE#\(!?)8;=S
MH\.%2L6H-^I=]HYV:8G'XL5#Z=Q[U>^+ZUZW<SG\>#XZO_@@WIY]&)]=B=.K
M\X]GV/'7\_&9P*"G1?9H>"T^GOTTO/:ZG0\?Q>LW>\_WGQ:%X[/1V>7[BP]G
M!]W.J_Z@]^KUB][^X*GQ\=WP[?7Y+^>C)I7[@\>E,E33_/XT.KW^MA1M'?];
M1H5,EV)OX(E!?_#R&R[]C4W1UO%%%,A,O(_#0$>S3)Q'?N\;KCX8#,1(?E*W
M&A.&MRHJ%(86.E?B-2'VFVUTH[)<7,IP(4Z4].>>>#<2SY^_Z.\]9=[#CUVI
M W&9QEFB_+S(P)HD"=4"NB;R6%RIF<X W5S'D;C.96[>X)=W@+*XWGD^O+[Z
MIN[O$0XYDH'&<!D%XB=0SZ<[>"3U_ZW(<CU=VH<Z"A0MVN_MZ^B1O?@?[GRC
MQ%S>*B']7 5"T@ZW,I#"CXLH4V&W UFWZ*$G9#4R36(+A.U\KL0/8?"YB _?
MQHM$1LL?4O[MF2=TA+%1!#31T#N=SP4-3U*52#N?)#'5(;:IWE\KOTAU#D%U
M._3^[(L_E]%,"6RPT%G6LJ]][+86\13DMD,YD'1N9Q7?&*-(-.!I24)MIZ1(
MLT)&.3/FJ@B5>#%XL3WA/9K4BJ&?DYH4(9\M$]N6P%9"*EJC56H\<3?7_EQD
MY>#,4648G-%,<.=>.BFVW^%PXD/<@Q%ZOC-XT]\;[#VS6\@B![AR[<LP7(J)
M\N5""36=DLP DB+!6E8^M(5*L,4$09ZA=!^H("%AUP#LFZ;Q0N1 *=D+_KF=
M%=AD YF !YV*/"%]-@0AC%ZC0F<B55.5IM@#*\]5JC!>&J98'M?WZ';*32HP
M%B Q;9,8Y+CWYOES.HIP)ZG#JSF\CFX_+$A!>-$)G#B070J:809"5CF&I>.9
MPHRT0ELK/KSZZ:H1U?ZI(IS1]C$/3>M<)KV)P<"4!DR6 &^%'W-BK]_OT_\B
MF\L49VL<F1_5M:D%?JPD+-#8_^0)J+2XE6&AQ#_[/:R[)Q#:F,77M-6("-.J
MT\ H[$P+9OZ=3!$AY4V2+O'^G7E_8]^7]($!T%(8B8P02[^^V/->O>E[@U<O
MW/%PACJ]&]9&$F,6%TT6>,Q0WRS02I]=W-'FV9FB3=IK)VG(>O5X;'A6S@<-
M]O9?][W]%Z_O<\ F<?9L#R+1S3% :E*ZQBMG,@TR98YX/<VECNJ:=^D.-)RE
MR@*^U31[@"]S?Z+R.Z6B.A1!3FP>Q!&YM2@P@J(G.KI%&!:G8*X;PX>D49OT
M>YVH$F-FV=I9+D/I&SLVG"ER#^6<)K::P]97_IICB]937R"9B.8*=C?M=C@G
MQX2>\]YD0Z%D&;:6;%6M5F?J5J4R%$E)J)RQQXE@# ,RS-?^7 7D^,Z=J=EX
M*+'MQV%HS':X;*)E95(-+VORZ8DQV6D#N5)+2M$V<2?(PM2W;3@+XR7 #T/$
M!=E$O*F$WK-T?%]1X'@.IQHG.B)G@8\318YB6J21SN9D!\G!^HCT AGYJK(,
MJ?I<Z-3&)$#0.;R;>-G?0T"TO<^>H@J $'_\O-GM;@@.7; Q-6)K#QUZ8AB&
MPI>)SG'8WTG2*EUDHLCPT84' $L4YP95=QI*':BICC  !A.S.0@V1V+72BJQ
M4#+BB'>&WR*+=@I.#) K+_SMTM*_!5K.VV15 0AZ?F>S"O5%+IC)<:JQE0PQ
M*,7D1!,99#OU5//KFF T;6:>@^5Q@; ! L^FDO?S" S;^AD+:T,H2<)6I@J;
ML:Q2E<>K(5HEOD.L9Q<<VHB/5KB"PV!;/ 29?FB<*LQG+=]IAD+UF)$_ ^$I
MY95+QHR)8)N>&"8+6'6VCPGY(TI.EJ&\RQZRK8V;:>7;9T:)_M##8: 9M]FJ
MTQ!+) ?KH&8]0N!!*Z.:<<>A2>=H&,8Y/PKUB\/")$STNHB@@XL8L? =:,X5
M0R]S]H9#[5BF%-V* );()Q>_PI\&QT]H](H;!T^25/L$#(KI:)O2'_+X1G"]
M/32G0D)8L#6D13(9EE/6G8HGMD_,)$(<=#!:B\^L+O@0LV<9\_:9]8&\.Q9$
M9@:P9#U*YTSJ7 "*&6^<DOA3@^V:*@JGB0L98'=*OTB/"GAXVB-4,WPR6FJS
M5.#GCHPC1 V[#R5764:!2&6Y?9WZQ0*(Q.$S$VMP[D;14&466.O8-JP: TS!
MN6?V<" 7)M;[$PN!R.Z!)H+/&L2@5'%([=26+#PYLFIUXCEC)BDFH?8I40(8
M0,GZ"'X%$53DK(11+;I)J1>/U!%,E2&'GZ[(14?D2[D>E94\,W(0,D$N"8P2
M^=.F\$'*)NE_?VZ)D%!#<PE_:!2T=6%K.G%!\4:@$L4+B%O:EX1L<6O5 @&%
M]'7."3*%"%BSX- 8 ("FF"P-IK$ J"-HB1N7@50:JNP06>!?P)768FG1H!*9
M$/Z$30Y#N6#IE[I@%H!6D0DE4@CM]F5MB?NL"=W(]$*'RA.*8N,TCK0/4U.J
MF.?V,?XXF<=Y3&X'&N'4T47<]1,YP-?TURJ?F449!T3ZB<.XIGAHI/H"*\FU
MD9JN.O0[H;%M8<S#79*&E"[=V1"YDA'-I:$TB>]46E=^I[<><8;[1H ")08X
M&@1+YP=8P,P8MF!F;2)O9PQ@J;@X:5PC$*I:&,: $;^;XU'*AI4X2,ZHK^#,
M4QLYCK>&(5RVHD>!"F%68'^Q&'/5L6#-Q)4KW$)9 I(,YXL .K'>!A]\$C)D
M46,UXU*L12EMF#4CL';J"QFY*IQF$:U)I\S,[C3%XYB9ZQS"-115#H=*BY:L
M.I=7+:<B-/I*3N!:Y4R2^6P6KMJ3$IV:\+\G+@ W=P9."Z$6OS$78K*HL/6\
M]D1&G](BR?TEA8@(/Q#LT^=I*@M*="/V:[=J2=M0H2U.9PA*C)"A00L2):1>
M+$PH0%HF4\&1FC152XHL$!)HBDYLP<PT\(W4*(/B3@2L"67?H?4;EEX.ZABN
MEB%(BO(E(]A.$/ -D:^3D(KDI%5 7+ZL1[S5 .(SA3DJ)2>'O26L&3&";)@G
M9G$<P%@0,[D:+\'/0$E.P[93B"\-0FOL[N:F4&3I,E5<&)^XP,E,SD@U4%\I
M)@$H 4\(\A26,H7/D+KQT4B<Y+TS"G)@CD&8+2Z4 ES%H*T00[\59W8UBPZ
M4<0,;)GL%5L:&T]6SAD71%44/W!-.R8>8I2+,3.72CCY5#[>(M5% N*>@0"M
M T)HY/>6+I9[_F-G1[S3*@P.Q*6<J4,L_+F KBGL+W9V[&V?H]/SCXXXL^5.
M'B<8,DAR1\3.),[S>'$@7M*S"4R 2LMG)TA</HF]WC[HA#;K "1<-E?D0]1Y
M<K2+75L(F$ ]/NU,%  .*A.FND[4RQ::B-"';EECS2[QQK#C;XV0Q^[?/^)-
M!I; X.EVKA\@U(O(]:,H+YB6Z1I9/_)G5#+W7):N9C''"K40K>:&G$5FOY^P
M)823_N(K]_DSTLHRD#:6,X0S=%833I12_)4@(G5Y,RBQ!4@**)Y"&WX\/!F=
MB;=GH]'E\/3T_,-//V[UM_CWZ\OA6_>[I>Y.!_F<R.O_ZU \E%1C3/HMQH2-
MQM'XRFUS2^&Z+T-W'DRDZXQ'X],50DKC.SX]WOAV6S];'=#"K*WCO*R_LU3+
M0 ^(F)A*B*U4P=X&%*K6/5]KS7>]\F0\9+WJY%ZPNYY0UP/AV+(,LI5M=" ,
M,2"O-0!LV&R+_A3;2T2@E#I;XLI^T(8H$I$FUY#7V_KME&\NEWEUVC@RGMB(
MF ITS#K$F@5%Q4RDJ51'T#*JO" N.S0BVAU?T3^$R6^C&/SOGHY:%>0KE>'F
M_'3\_L<MTH*MKR7O?Z<,#]"&C3W14L0K6!7<F"NQNGD^P=? HI$!NE 5^2$"
M]ZRL-K;TCRW@E^;VQY2#:\K&-/306'570]I,14,KNIVR(7-_K?#^I#?HTM76
M!CA5M,L,S7,\[78>I#?TZ/^Z\U?IS@.4I_4"PCT5IWUNI32BH3/=3JO2K%S/
MN+_"M.^^H3M:UY4_:;O<5UE6[Y5L4)0_\"_&J#04I?=(2O*WR$YOE*V>-TKG
M(H["I35[MB/LPE]7<JF*>%S5L!8QYZK>U%V.A'@RE1-\<JKPB[=SF5#-\=5K
M-\,.O%*WFFH;M$"14T4.A$5*4\&@K+]!;*G0BX3T@RYNE<4SL4HHO^:RA&D8
M&O2ZYF'U]C= ,@NT:=E0*<,0]6ND<TO,:G&0ZTMK/293"ZQ*@>O!XJJ66VWE
MOC].I"O5H9IIK3S'M1APL=0>"N+" AJ5?5KRD;ZS>LI-R>XHKF,@C\G:!;:L
MG-6N:S=N=QCQUQC,J+!W:N64T!E8$#<U(J6Y=Q2)0V(8>D=&UTS@^G=M4I7+
M6;1Q;<^K*H9?=,9545-9H;4E@,A5PN:"IE[M&60MJ&3J2&TK#D(QLM@@)H &
MF5Y/M\-9J.O[6_VMM2[*S)>A;)5.;- Y>RY3"75K4FI;[TFWWTOP; '0]"MD
M@VK3WW>5S1:SLU&COD/TIU;R? V9!),Q^&U_O,[6TO:ZDH-Q?J48,P"$,E9*
M".TM,9DU#6C9=5^])&7<AIEAY4Z0[79LCX4K+1E?!;:Q>W4QHU2 S-I[3Z1%
MR#]J-\9IA=^*@+O1B&D0P=!C=@V!SOQ0ZL6J(R#2 W(EW<XR+LI@QJ@,WX-R
ML$?XD<4(1$RIVE;FLV*2<5$VMTU0/',7!@)UJ\(X<1?0H8^FN\%K.M['M99+
MR7W#$OV]-:1OC/F:+-V=%:?+YE;;FB<%RXF)K=\[H#@O<I>:W#IO#9Y@;A")
M5!?]7^_\;&^1KIA1^[V&9GVFU^W<V';F"IE\<9+J\^Z2Q51C]:J<,U>2+:"]
M6C-BP/QB@.!N$VN7[K;<:>?6\$S?LAX4/F!B"6 [',3<ULDK%OHJL"&&+1R:
M]I8*W"YT3V,6IXQPVZ6'RZ$;,NYDK+9\9S&P![FV]U5>K2>UW0Y_(< <EM73
M=H,J#:WE$^X+(FF\*,*98[_M&S\%Y%=9:#WK7,U*'TQ=H_!I6S%T_U8FF3H0
M[M,6=SK^//\T7_=>S3)?TMJ)# AN=+S!?M5+$8T?G,IL6N9%RS*F6+N3(=4T
MY]V0TG^D)GR>4FX*PYIF7I4T?=7)-IRFG?ZOI+FVY-,F=#?;%;4OCXN5[XXW
MZ'_T#/6O<1GWZXL.#L6%::\<B)',\J?4)OUK>Y9K4MFE/_U@_A8$_<F(_P)0
M2P,$%     @ "$4L7)QEK%]S"P  LB<  !L   !E83 R-S(T,3DP,65X.3DM
M,5]O;F1A<RYH=&WE6FUOVT82_BY _V$1] H'H!7)L1,K\1F5':7QG6.[EHLB
M'U?D2MJ$Y+*[I&7?K[]G9I>D),M!K\C+H0T2.Q+W95Z>F7EFI*-W-^_/C[N=
MHW?CT1O\%O3GZ.;LYGQ\?/3,_\;39^'QT<GEFP]B<O/A?/S/)S.3EZ_$H%^4
MXD9GRHD+M137)I-YY-^(Q$19/7N"C=AZ];_N>RTR:><Z?R5H:?^U*-5=N2M3
M/<=;5L\7Y9/CHY/C\=U"3W4IAL/>X.C9"<2^^AH7QBHOE7UR_&,^=<7KKWP)
MU+K,$^G$.Y,F.I\[<9;'/3&IXE@Y-ZO2]%Y<68T7XH>!.-%IJDW>[4Q*$W\2
M,D_$;]):F9=B(E,E1E-SJ\1[:3^ITF_[BG;Z6+E2S^X?-]26Q:_%G[YZ*N-/
M<VNJ/-F-36KL*[%<Z%*Q"7\;3V[$U>C\O3@9CT[?1>+M^>7UV9N1>.9E^Y?,
M*VGONYUA)/;Z>R_J]\DZV\R_<S&:O!G]\NKRXLWDJ=CY,4U^K\QK7OFCY?\+
M8T6Y4"(\.C59(?/[\/!I)*1(E:0316'-K4Z4%68F9%6:W&2F<MV.A)8R91]Z
MM80U4U,*#6# RW.5QPI7X-%\(73IA!=TU!PA)O>N5)D3.Y<C2#FMG,Z!&5'E
MB!$ZMK#Z5I9*++55*3UQ)JU*X,<UY_*9W<Z%*I?&?H+M2Y/(>^S.(5&L$BR4
M$*D4"UQ=$* 2E@58G'HL"JOF&G)8/$EP45Q"T1ET@^K0>#",^OT^_1-N(2W\
MC3?IA-AD&7:[&L@1%.]V4JTJ6K'Z-,+%:G<&"^&*I8<[-#"BJ&P,N92H"GJY
M/XA>#OO1WLO]SUVU4YJY@N?LBNOHJ8^H\>\5;)8B.&M'/^UV<+;,(1X07++]
MX#:=WRH<:'MB+..%>.00H9V8*C(%3 _A=;D ,M;D"0JMZ0-GB)V]IRMJ^"W=
M#N_IB1L@KS0EY,BK;.JQ]9@>=/)4>0%TSJ!M' 3Q7O1KJ_EC'SUF"7_303*.
M&>Q:)=W.]'Z[1V00CQ"P-X@.#OO1P?[A X5J!R.28<2E I@@&9TDW58SN=X7
M3&:/9I3OG- 846RJ34MQ6-<.N(<'NYVM8%J'78-XA#*C;XI$D;0HX+BFJWX8
MO.CM'T1\BR(A'@;> PG6H?E%)-@?#L5.B!6D.DWQINZ4C360U2[M]Y!5!J+
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M=W_DBU//Z#MW_DMX]%V]_P)02P,$%     @ "$4L7*AZV0<F P  V0L  !$
M  !O;F1S+3(P,C8P,3 Y+GAS9+56VW+:,!!][TS_0?6[L0U)6@@DT\*0(267
M0I-"7SK"EHD&(SF2',S?5[(M<S&X0%N>I-USSNY*NS+-ZW@>@#?$.*:D93@5
MVP"(N-3#9-HRGH;FYV&[US/ ]=7[=T#^FA],$W0Q"KP&Z%#7[!&?7H)[.$<-
M<(,(8E!0=@F>81 I"^WB #'0IO,P0 ))1QJI 2XJ50A,\P#99T0\RIX&O5SV
M18B0-RQKL5A4"'V#"\IFO.+2^6&"0P%%Q',U.[:SWV'T.\S=G&R]AC_YQWB
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M&O:$+B@&W]4"32M5D\O?4$L#!!0    (  A%+%RLK$&R_ H  '^&   5
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MH6@I77,!6#71,&1!T6'W!@)2R?TRLN289HD<P'HA:4N=GVX 9ENG'H8N*$X
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M2P$"% ,4    "  (12Q<$Z1B5NR@  "HA0, &P              @ ']V
M96$P,C<R-#$Y,#%E>#$P+3)?;VYD87,N:'1M4$L! A0#%     @ "$4L7%'$
M)J2$<@  A$X" !H              ( !(GH! &5A,#(W,C0Q.3 Q97@T+3%?
M;VYD87,N:'1M4$L! A0#%     @ "$4L7%<,:^AN;P  2$ " !H
M     ( !WNP! &5A,#(W,C0Q.3 Q97@T+3)?;VYD87,N:'1M4$L! A0#%
M  @ "$4L7"WS,D,0#@  ,CD  !H              ( !A%P" &5A,#(W,C0Q
M.3 Q97@U+3%?;VYD87,N:'1M4$L! A0#%     @ "$4L7+D<1XD4$   .4(
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64$L%!@     +  L ! ,  -*< @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>ea0272419-8k_ondas_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="onds-20260109.xsd" xlink:type="simple"/>
    <context id="AsOf2026-01-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001646188</identifier>
        </entity>
        <period>
            <startDate>2026-01-09</startDate>
            <endDate>2026-01-09</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-01-09" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-01-09" id="Fact000004">0001646188</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-01-09" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-01-09" id="Fact000010">2026-01-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-01-09" id="Fact000011">Ondas Holdings Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-01-09" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-01-09" id="Fact000013">001-39761</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-01-09" id="Fact000014">47-2615102</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-01-09" id="Fact000015">222 Lakeview Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2026-01-09" id="Fact000016">Suite 800</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-01-09" id="Fact000017">West Palm Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-01-09" id="Fact000018">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-01-09" id="Fact000019">33401</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-01-09" id="Fact000020">888</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-01-09" id="Fact000021">350-9994</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-01-09" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-01-09" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-01-09" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-01-09" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2026-01-09" id="Fact000026">Common Stock par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-01-09" id="Fact000027">ONDS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-01-09" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-01-09" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
